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It is now well established that either primary or secondary effects of
the adrenocortical hormones affect the kidney function, sweat and saliva,
cardiovascular system, nervous system, muscle function, carbohydrate
metabolism, protein metabolism, fat metabolism, vitamin metabolism, electrolyte
and water metabolism, lymphoid tissue, reticuloendothelial and mast cells,
blood and bone marrow, malignancy, bone, skin and hair, appetite, resistance to
damage, cellular reaction to inflammation and injury, sensitivity and
antigen-antibody reactions, susceptibility to infection,thyroid gland, gonads
and lactation (Pincus, 1962). Thus, it seems that there are few, if any,
tissues or bodily processes which are not influenced by adrenocortical hormones.
However, we owe our present-day concept of the importance of the adrenal
cortex to the early observation of Addison (1855) who described the clinical
features of the disease bearing his name, and who suggested that these glands
are essential to health and that death occurred in their absence.
Soon after, Brown-Sequard (1856) proved the vital importance of the
adrenal glands by his studies of the effects of bilateral adrenalectomy in
experimental animals. But it was not until the beginning of this century that
serious attempts were made to prolong the life span of adrenalectomised animals
by injection of the adrenocortical extract.
The success of these experiments started an avalanche of investigations
aiming at isolation and chemical identification of the active principle. Thus
in 1930 an extract of the adrenal cortex was prepared simultaneously by two
groups of workers; Hartman and Brownell, and Swingle and Pfiffner, and soon
after, isolation of the Individual active hormones began . It was the work of
Wintersteiner,/
Wintersteiner, Kendall, Reichstein and their associates (Wintersteiner and Ffiffnsr,
1936; Mason et al, 1937; Mason et al, 1938; Reichstein and Schoppee, 1943)
that made possible the chemical identification of a large group of the
adrenocortical hormones and shed more light on their physiological significance.
Since then, more than sixty adrenocortical hormones have been isolated and
identified.
Semiquantitative tests for the assessment of adrenocortical function, by
making use of the laboratory animals, started in 1938 when Anderson and Haymaker
prolonged the life of adrenalectoraised dogs by injecting them with sera from
patients suffering from Cushing's syndrome; adrenalectomised dogs injected
with sera from normal subjects acted as controls. Other biological tests were
also used in these early days, such as assessment of the degree of protection
from exposure to cold after injection of serum, the use of urinary extracts to
measure the survival time of adrenalectomised rats on exposure to cold, the
degree of deposition of liver glycogen in fasting adrenalectomised rats, the
extent of fall of circulating eosinophils in the adrenalectomised mice or the
degree of sodium retention and potassium excretion in the adrenalectomised rats.
Chemical tests for the quantitative estimation of adrenocortical function
started in 1945 when Talbot and co-workers estimated the urinary corticosteroids
by a colorimetric reaction and Hemphill and Reiss (1947) using the same
colorimetric reaction to estimate corticosteroids in blood. These methods
lacked specificity but, since then, marked advances in the field of chemical
analysis and estimation of adrenocortical hormones have occurred with the result
that a great number of simple and reliable tests of adrenocortical function have
been introduced. These tests are nowadays of an immense help to both the
clinician, helping him to combat the various adrenocortical dysfunctions, and
the biochemist, helping him to clarify further the role of the adrenal cortex
in human life.
 
Development of the adrenal cortex
The cells of the adrenal cortex arise from the celomic mesoderm of the
posterior abdominal wall and condense into a small cluster of acidophilic
cells between the root of the mesentry and the genital ridge. Cells of the
genital ridge may, therefore, be included in the cortex, and this explains
the occurrence of androgenic and estrogenic activity in the adrenal cortex
later in life, as well as the frequent occurrence of adrenal rests in the
testes, ovaries, spleen and in other tissues (Graham, 1953). It is estimated
that as many as twenty percent of normal subjects have accessory adrenocortical
tissue which is potentially capable of secreting steroid hormones (Forsham,
1962). Later, bas/Sophilic cells gradually surround and permanently replace the
acidophilic ones. Although the adrenal cortex and medulla form one anatomical
structure in the adult human subjects, yet the medulla has a completely different
origin, namely from ectodermal neurogenic cells migrating down from the neural
crest. Secretions and physiological actions of the adrenal cortex and medulla
are thus completely different} the cortex secretes steroids and the medulla
secretes catecholamines, and no direct functional relationship between them has
been proven in man.
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Morphology. histochemistry and functional zonation of the adrenal cortex
The normal human adrenal glands weigh between 5.0 and 7.0 grams each
(Forsham, 1962). However, Studzinski and co-workers (1963) noted a
difference between glands removed at autopsy, the mean weight of each of
which is 6.0 grams, and those removed at operation, the mean weight of
each of which is significantly less, namely 4..0 grams.
The human adrenal cortex is composed of three zones surrounded by
a capsule. The first zone lining the capsule is the zona glomerulosa,
which varies in thickness in normal glands from a prominent layer to
almost nothing (Symington, 1961) but which usually constitutes a tiny
fraction of the cortex. The cells are arranged in cords which form a
basket-work parallel to the surface of the gland and there is no sharp
division between this zone and the underlying zona fasciculate. The cells
of the zona glomerulosa contain some lipid and are rich in ribonucleic acid,
mitochondria and dehydrogenase enzymes (Symington, 1962). It is well
established now that the zona glomerulosa is concerned mostly with aldosterone
secretion.
The zona fasciculate, the widest zone, is composed of radially oriented
strands of cells separated by capillaries. Under basal conditions, these cells
are filled with large lipid globules which are removed during preparation of
paraffin sections leaving clear spaces, and thus they were called vacuolated
or "clear cells". Since these lipid droplets possess optical and staining
properties characteristic of cholesterol esters and cholesterol, it has been
concluded that such substances are present in abundance as components of the
lipid droplets (Symington, 1962). The cells of this layer are poor in
ribonucleic acid, alkaline and acid phosphatase, dehydrogenase enzymes of the
citric acid cycle and contain only a few mitochondria scattered in their
cytoplasm (Symington, 1961, 1962).
The
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The clear cells of the zona fasciculata change abruptly into the "compact
cells" of the zona reticularis which are arranged in alveoli separated by
sinusoids. These cells are small and have scanty lipid droplets and their
cytoplasm is eosinophilic. They are rich in ribonucleic acid, alkaline and
acid phosphatases, dehydrogenases of the citric acid cycle and packed with
mitochondria. Mitotic division has been demonstrated only in the compact
cells of the cortex.
On section, the outer zone of the cortex is yellow in colour and the
inner zone corresponding to the reticularis is brown.
The extensive study of Symington, Grant and their associates of the
histochemistry of the adrenal cortex has contributed a great deal to the
present-day concept of the relationship between the histochemistry and the
functional zonation of the adrenal cortex. Thus, in 1962, Symington reviewed
previous evidence and concluded that stress caused by conditions such as
severe burning, coronary thrombosis or severe infection, leads, within twelve
to twenty-four hours, to 'focal lipid depletion' of the zona fasciculata.
During this period, the gland elaborates and secretes large amounts of steroid
hormones. If stress continues, complete lipid depletion occurs and the zona
fasciculata and the zona reticularis become a uniform zone of enzyme-rich tut
lipid-depleted compact cells. These changes may be compared to those produced
by administration of ACTH (Symington, 1961) under the effect of which clear cells
change to compact cells. Lipid depletion after A.CTH occurs in a regular manner
and involves the inner aspect of the whole of the zona fasciculata. With large
doses of ACTH, depletion extends outwards to affect a complete change in the
whole cortex and with smaller doses, cellular transformation from clear to
compact/
- 6 -
compact cells involves only half of the fasciculate, but it does so in a
diffuse and not a focal manner* Under the effect of ACTH also, it was
noticed that little or no change in the histochemistry of the zona reticularis
occurs while the fasciculata content of alkaline and acid phosphatases,
dehydrogenases and ribonucleic acid become abundant, mitochondria increase,
the ratio of Cortisol to corticosterone in the adrenal vein effluent increases
and the lip-hydroxylase of the whole gland increased markedly*
From these and previous observations, it was concluded that, firstly,
the zona reticularis in man is the site of production of the C-21 steroids
(with the exception of aldosterone, which is believed to be secreted by the
glomerulosa zone) and probably also the C-19 androgens and the C-18 estrogens;
secondly, the clear cells of the zona fasciculata are a storage zone for
steroid precursors (cholesterol and cholesterol esters); and thirdly, in
conditions of stress and after ACTH stimulation the steroid precursors in the
cells of the of the zona fasciculata, nearest to the zona reticularis, are used
for steroid biosynthesis in the cells of the zona fasciculate; and lastly,
this result-? in time in the morphological, histochemical and enzymic changes
previously described. However, these workers (Griffiths et al, 1963) were
able to prove very recently that lip-hydroxylase activity and free cholesterol
content were equal in both clear and compact cells and thus the increased
lip-hydroxylase activity previously observed in glands of ACTB-treated patients
could not be explained on the basis of increased number of compact cells, but
could be attributed to the compact cells newly formed, under the influence of
ACTH, from clear cells at the fascicular-reticular border. Also, llp-
hydroxylase activity could not obviously be related to the number of mitochondria.
These/
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These workers also isolated ll^-hydroxy-androst-4.-ene-3,17-dione from both the
reticularis and fasciculate zones, a finding which was not in keeping with
these zonation theories which attributed adrenal androgen production to the
reticularis zone alone. Accordingly, these workers modified their earlier
hypothesis to include the view that clear as well as compact cell zones
contribute to a daily basal secretion of Cortisol and adrenal androgens with
principal effect of ACTH on clear cells, and that as far as steroid biosynthesis
is concerned, it is possible that the functioning of the clear cells of the
zona fasciculata in man is a safety mechanism designed to provide additional
cortical hormone in emergencyj if the emergency is prolonged, the functioning
of the clear cells may give time for the cortex to increase enzymes and structures
required to meet the continued demand for cortical hormones. Thus the
previously observed changes in ribonucleic acid and phospholipid, and the well
established increased uptake of amino acids by the adrenal cortex in response to
AGTH would be in keeping with this theory.
Rich arterial blood supply reaches the suprarenal cortex from the aorta,
phrenic artery, renal artery and sometimes also from the ovarian or internal
spermatic artery. Some sixty arterioles may be found, and these break up into
sinusoids which traverse the substance of the adrenal and end in large venous
lacunae in the medulla from which blood is collected in a single large vein, the
adrenal vein, and in a number of smaller ones. Thick longitudinal muscle
bundles are present in the wall of the central adrenal vein, these are evenly
concentric in the centre of the gland, but on either side they become typically
eccentric. Capillaries or venules coming from the cortex enter the lumen of the
central vein only between the longitudinal muscle bundles and never through the
thin/
thin side of the vein wall (Symington, 1962). The importance of the hemodynamics
of this portal circulation lies in the fact that blood-borne diseases, like
tuberculosis, tend to destroy the adrenal gland more extensively, while spontaneous
atrophy affects raostjly its inner layers, which are poorly oxygenated. Moreover,
no secretory nerves have been demonstrated in the adrenal cortex, but only
autonomic ones which either directly pass on to the wall of the central vein or
pass without branching into the medulla. The importance of the musculature
and innervation of the central vein will be discussed later in connection with
regulation of secretion of hormones by the adrenal cortex.
Biochemistry of the adrenocortical hormones
All steroid hormones are ultimately derivatives of the cyclopentanoper-
hydrophenanthrene ring or its methylated derivative sterane (see figure l).
The hormones of the adrenal cortex contain either 21, 19 or 18 carbon atoms.
C-21 hormones comprise the corticosteroids and precursor hormones, often
referred to as 'progesteroids', C-19 derivatives comprise the androgens and
G-18 derivatives, after aromatisation of the A ring, yield estrogens.
Corticosteroids are often subdivided into two sub-groupsj 'glucocorticoids'
which are hormones particularly active in carbohydrate metabolism and
relatively less active in electrolyte metabolism, the most important of which
by far in man is Cortisol (Mason and Sprngue, 1948} Bush and Sandberg, 1953}
Romanoff et al, 1953} Hudson and Lumbardo, 1955), and 'mineralocorticoids'
which are ho:rmones having weak action on carbohydrate metabolism but exert
a pronounced effect on electrolyte and water metabolism, the most potent of
which is aldosterone.
Sterioisomerism occurs among the hcrmones of the adrenal cortex. This is
designated as 'cis' and 'trails' when relating ring A and B} C and D are always
in the 'trans' position in biological compounds. Substituents in ring A and B
are named with reference to the methyl group at C-10 which is assumed to be above
the plane of the ring. Beta groups lie above and alpha groups below the plane;
the former link is represented by a solid line and the latter by a broken line
In the adrenal steroids, all active compounds carry a 21"p"-alpha ketol











origin, is in the beta position. However, a hydroxy1 group, and not a ketone
group, at C-ll is necessary for activity of the hormone (Bush, 1956} Bush and
Mahesh, 1958) all active corticosteroids possess a double bond between C-4. and
A
r C-5 and an oxygen atom at C-3, an arrangement commonly referred to as Za-3«-
ketone group,
'Trivial names' are frequently used instead of the 'chemical names'
of these hormones (see appendix II).
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BiQSYnt^gjrg of a4repocortj.9aJ. hgrqoqeg
This was studied in the past by either perfusion of the isolated
suprarenal gland and isolating the hormones emerging from the main vein
(Hechter et al, 1950), by cannulation of the suprarenal central vein
during operations or by isolation and identification of steroid hormones
from adrenal slices or homogenates (Plager and Samuels, 1952j Wettstein,
1954-)* Since the introduction of isotopes, however, more accurate
observations can be made either in vitro, by incubation of adrenocortical
slices with labelled steroid substrates and isolation of the labelled
transformation products, or in vivo by injection of the labelled precursor
and isolation from the blood of its transformation products.
In the cortex, cholesterol is formed from acetate (acetate aceto-
acetate —^ Heval^onate -) squalene lanosterol zymosterol-^ desmosterol—>
cholesterol).
Cholesterol is believed to be the precursor of all steroid hormones,
and the administration of an inhibitor of cholesterol biosynthesis,
triparanol (MIR - 29), which blocks cholesterol formation by inhibiting
reduction of the 24,25 double bond of desmosterol, results in a significant
diminution of Cortisol and aldosterone secretion (Melby et al, 1961).
Nevertheless, in vitro studies showed that adrenocortical steroids could be
produced directly from acetate without the intermediate formation of cholesterol
(Melby et al, 196lj Forsham, 1962) and accordingly, although corticosteroid
synthesis from cholesterol could be sometimes blocked, secretion rates and
plasma levels of corticosteroids will not be affected, probably by diversion of
corticosteroid synthesis to a non-cholesterol pathway (Melby et al, 196lj
Key et al, 1962).
A/
A number of enzymes affect the biosynthetic transformations to the various
corticosteroids. These include specific hydroxylases, which introduce hydroxyl
groups, dehydrogenases, which affect removal of hydrogen atoms, reductases,
which change ketone groups into hydroxyl groups, and isomerases. These
specific enzyme systems include co-factors such as DPN or TPN, located in
the microsomes, mitochondria or cytoplasm.
The first step in the biosynthesis of corticosteroids is the formation
5
of ( A-pregnenolone) from cholesterol by side-chain scission, possibly through
the intermediate formation of 20-hydroxy-cholesterol followed by cleavage of
the side chain. This step is believed to be enhanced by corticotrophin.
5
Progesterone is then formed from A-pregnenolone. This step is catalyzed by
two enzymes} 3P-hydroxysteroid dehydrogenase found in the microsome and DPN
5 L
or TPN dependent, and/\- , A isomerase in the supernatant. The different
biosynthetic pathways of corticosteroids are shown in figure 1. It is
desirable, however, to sum up the present-day concept of Cortisol biosynthesis.
The main pathway from progesterone involves 17-hydroxylation to 17a-hydroxy~
progesterone followed by 21-hydroxylation to 11-deoxycortisol and finally
11-hydroxylation to Cortisol, A second possible pathway is through 11-
hydroxylation of progesterone to llp-hydroxyprogesterone followed by 17-
hydroxylation to 21-deoxycortisol and finally 21-hydroxylation of the latter
compound to Cortisol. A third hypothetical pathway would be through 21-
hydroxylation of progesterone to 11-deoxycorticosterone followed by 11-
hydroxylatioa to corticosterone and finally 17-hydroxylation to Cortisol.
£
In these major and hypothetic pathways of Cortisol biosynthesis the enzyme
3^-hyoroxysteroid dehydrogenase acts prior to 11£-, 17a- and 21-hydroxylations.
But the recent discovery of 21-hydroxypregnenolone in human urine (Pasqualini
and/
and Jayle, 1962) suggested the existence of an alternate pathway for Cortisol
biosynthesis, in which the enzyme 3p-hydroxysteroid dehydrogenase either
acts after 21-hydroxylation of pregnenolone to give deoxycorticosterone or
acts after both 21- and ll^-hydroxylation to give corticosterone.
Nearly fifty steroids have been isolated so far from the adrenal cortex, but
only nine have been shown to be secreted into the blood, the remainder
being intracellular intermediates. The nine hormones secreted into the blood
include the progesteroid, progesterone; the estrogen, estradiol; the
androgens, DHA., /y-androstenedlone and llp-hydroxyandrostenedione and the
corticosteroids, Cortisol, corticosterone, aldosterone and 11-deoxycortico-
sterone.
The characteristic features essential for corticosteroid hormonal activity
are firstly the steroid nucleus, secondly the oxygen attached to C-3, thirdly
the double bond between C-4 and C-5, and fourthly the side-chain on C-17
(Cope, 1961). In some hormones other additional features are important, e.g.
a hydroxyl group at C-17 in glucocorticoids, a hydroxyl group at C-ll in













Regulation of Cortisol secretion
investigations have helped clarify the mechanisms involved in the
synthesis and release of corticosteroids as well as maintenance of structure and
growth of the adrenal cortex cells. The concentration of total cholesterol is
higher in the adrenals than in any other tissue but the nervous systemj 80-9055
of this cholesterol is esterified. The adrenals synthesise cholesterol and
its esters freely and it also receives a good deal from the plasma. Also, the
adrenals have relatively high concentration of glycogen in the zona fasciculata and
zona reticularis but very little in the zona glomerulosa. Both severe stress
and injection of ACTH cause pronounced decrease in the quantity of cholesterol
and rapid depletion of glycogen from the adrenal cortex. The adrenal lipids
are not decreased significantly until the glycogen is almost gone. These
changes are associated with a maximal release of adrenocortical hormones
particularly Cortisol and corticosterone. Bearing in mind that glucose-6-
phosphate dehydrogenase is also plentiful in the zona fasciculata and zona
reticularis but low in the zona glomerulosa, the following sequence of events
seems significant in synthesis and secretion of Cortisol from the adrenal cortex.
ACTH stimulates formation of 3'"5'-cyclic adenosine monophosphate, which, with
various co-factors, leads to the activation of phosphorylase. The latter
accelerates glycogenolysis, thus increasing glucose-6-phosphate and
consequently acetate and cholesterol synthesis. Since a very active
hexosemonophosphate shunt is present in adrenal tissue, the amount of
glucose-6-phosphate metabolised via this pathway is increased, with the result
that more TPNH is produced which accelerates splitting of the cholesterol
side chain and reduction of certain steroids leading to increased synthesis of
corticosteroids.
ACTH/
FIGURE 3 : Regulation of Cortisol secretion
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ACTH also enhances adrenocortical cell growth. These postulated
actions of ACTH are illustrated in figure 2. In the human being ACTH,
secreted by the basophil "beta prime" cells of the anterior pituitary, is
responsible for these changes. It has long been established that the
adrenal cortex is under the control of the pituitary gland and that the
secretion of ACTH by the pituitary gland is inversely related to the level
of circulating glucocorticoids (Sayers and Sayers, 1948j Sayers, 1950).
No secretory nerves have been demonstrated in the adrenal cortex. It was
also suggested a long time ago that the anterior pituitary is at least
partially under the control of the hypothalamus (de Groot and Harris, 1950$
Hume and Wlttenstein, 1950)#
The principal mechanism responsible for and regulating the secretion of
Cortisol from the adrenal cortex is called the "servo mechanism" or the
"negative feed-back mechanism" (figure 3) whereby Cortisol is secreted from the
adrenal cortex into the circulation, and its level in the blood which reaches
the anterior pituitary specifically controls the synthesis and release of ACTH,
But this blood, derived from the superior hypophyseal artery, reaches the
capillary complexes of Furnagalli in the upper neurohypophysis and passes to the
portal sinusoids which connect the posterior and anterior pituitary. There is
also evidence to suggest selective uptake of Cortisol by the neurohypophysis*
Thus, the negative feed-back mechanism itself is under neurohypophyseal control.
Cytoehemical, radioisotopic and electron microscopic studies have further
suggested that neurohormones are elaborated in submicroscopic form in secretory ,
neurones the terminals of which abut on neurosecretory cores on pituitary pa»eter-
vessels in the neurohypophysis (Sloper, 1962). Transference from a nervous
tissue/
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tissue into such vessels must involve the penetration of the so-called
"blood-brain barrier". These neurohormones have ACTH-releasing activity
and are called corticotrophin - releasing factors (CRF)yamong which are
vasopressin and similar polypeptides, the polypeptide from neurohypophysis,
the pepsin - labile extract of the median eminence and other unidentified
substances. The neurosecretory process involves the synthesis of the
posterior pituitary principle in the neurones of the supraoptic and
paraventricular nuclei of the hypothalamus (SOK and PVN) and their transfer
down the axoplasm of these neurones (the neurosecretory fibres of the median
eminence of the upper neurohypophysis) to be stored in, and released from,
their terminals in the infundibular process in subraicroscopic form
(0,1 p in diameter) which, when aggregated constitutes the microscopic
"neurosecretory granules" (1 - 2 p in diameter). The depletion of the latter
granules is a measure of the activity of the hypothalamo - neurohypophyseal
system, and their accumulation is a measure of the secretory reserve of this
system, Jargmann (1954.) was the first to show that such material is also
occasionally found near the vascular complexes of the pituitary stalk, an
observation which led to the inference that it might be related to the control
of anterior pituitary function. Studies have also shown that the tubero-
infundibular and other nuclei are very active sites for protein synthesis of
these hormones.
So, it seems that the negative feed-back mechanism is a mechanism by which
specifically the excessive production of Cortisol by the adrenal cortex would
tend to inhibit the secretion of ACTH by the anterior pituitary and the
diminished production of Cortisol to increase the secretion of ACTH. Such a
mechanism/
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mechanism ultimately depends upon the Cortisol content of the pituitary portal
blood and the neurosecretory material of hypothalamic origin indicating that
this mechanism is under neurohypophyseal and hypothalamic control. Oppenheimer
and his colleagues (19&1) studied two patients with diencephalic lesions and
found that their control levels of urinary steroids were normal, but^neither
did the excretion of ketogenic steroids rise when SU-4.885 was administered nor
were the urinary steroid levels diminished under therapy with dexamethasone,
although normal response by adrenals was obtained by stimulation with ACTH.
Thus these workers advanced the tentative hypothesis that there existed a
'diencephalic sampling centre' which normally regulated the production of
corticosteroids in the body.
The negative feed-back mechanism maintains the constancy of circulating
plasma Cortisol within relatively narrow limits under normal conditions. Besides
its action on the anterior pituitary, there is evidence that Cortisol acts also
at the hypothalamus and to a very small extent at the adi snocortical level itself
(Forsham, 1962).
A second-mechanism comes to action under stressful conditions, either
physical or emotional, whereby production of an extra amount of Cortisol is ensured
to cope with that stressful condition. Thus stressful stimuli act on receptors
which initiate impulse conduction in peripheral afferent nerves, somatic and
autonomic. Pathways in spinal cord and the cerebral cortex eventually release
QimXtK
the sustained inhibition of the reticular formation or the iyisfeie system upon
hypothalamic centres in and around the tubero-infundibuler nucleus and the
median eminence leading to secretion of GEF by the secretory neurones into the
hypothalamo-hypophyseal portal venous system, a link which is sometimes called
"final/
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"final common path" (Bayers, 1962). This leads to secretion of ACTH from
the anterior pituitary which in turn stimulates the synthesis and secretion of
Cortisol by the adrenal cortex (figure 3)«
Studies of the dynamics of corticotropin activity in man have shown that
the initial rate of activation of steroidogenesis is identical over a wide
range of doses of ACTH. Thus the adrenals respond with an all-or-none
reaction to initial stimulation with corticotropin, or to stress. The
duration of the increased secretory activity, however, varies directly with
the corticotrophin dose, and thus an optimum output of corticosteroids during
the early phases of stress is assured and the duration of increased secretory
activity will vary directly with the magnitude of the stimulus. Only at
very low doses of ACTH, comparable to the levels found during everyday life,
may a graded initial steroidogenic response be demonstrated. Thus a border
line response could be obtained by an infusion of 0.25 units of ACTH over
crv-e. du-%
f? hours and a maximum response by infusion of one unit^/( iayless and Steinbeck,
1954-J DiRaimondo et al, 1955; Beck et al, 1962) denoting that daily output
of ACTH is normally less than one international unit. In conditions of stress
or after ACTH injection, however, maximum stimulation of both adrenal cortices
yields approximately ten times the basal output of Cortisol, Use has been made
of the inter-relationship between the adrenal cortex and anterior pituitary to
establish laboratory tests necessary for diagnostic purposes in various disease
conditions. Thus the degree of response of the adrenal cortex to stimulation
with exogenous ACTH has been used to test the maximum secretory capacity of the
adrenal cortex (Jayle et al, 1959; Beck et al, 1962). This functional reserve
capacity of the adrenal cortex can also be tested after ©tj^aseeus exercise, which
is a form of physical stress producing essentially the same effect as ACTH
(Diczfalusy/
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(Diczfalusy et al,1962). Likewise, administration of synthetic corticoids as
alpha-fluoro-hydrocortisone or dexamethasone has been used to test the degree of
inhibitory effect of circulating Cortisol on the secretion of endogenous ACTH
by the anterior pituitary (LLddle, I960; Liddle and Williams, 1962).
Several other new synthetic drugs such as SU-4.8S5 which blocks llp-
hydroxylation (Liddle et al, 1959j Liddle and Island, 1962) and SU-800G and
SU-9055 which block 17fJ-hydroxylation (Chart and jheppard, 1961) could be
administered to measure what is called "pituitary-adrenocortical reserve" i.e.
the effect of the resulting inhibition of Cortisol biosynthesis and release on
stimulating ACTH secretion, and accordingly on stimulating other adrenocortical
biosynthetic pathways, could be tested, especially as regards congenital
deficiencies of adrenocortical enzymes such as in congenital adrenal hyperplasia,
A third and important mechanism controlling the secretion and release of
Cortisol and other adrenocortical hormones is the musculature and innervation
of the adrenal vein previously mentioned. Thick longitudinal muscle bundles
are present in the wall of the central adrenal vein, in the centre of the gland
the longitudinal muscle is evenly concentric but on either side it becomes
typically eccentric. Capillaries or thin-walled venules coming from the cortex
enter the lumen of the main vein only between the longitudinal bundles, and never
through the thin side of the vein. So, when the eccentric longitudinal muscle
in the central vein contracts, the muscle will shorten and its diameter increase
to impede the flow from the venules draining the zona reticularis and in view
of the innervation previously described Symington (1961) suggested that there is
a neuromuscular control which determines the flow of blood from the cortex to
the main central vein. Thus from an anatomical and mechanical point of view the
function/
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function of the longitudinal muscle fibres seems to be one of control of the
entering venules whereby they exert an effect on the amount of blood coming
from the cortical cells, and accordingly the amount of hormones released into
the circulation by the adrenal cortex, as well as the amount of molecular oxygen
available to the cells. Since molecular oxygen is required for steroid
hydroxylation, Symington (1962) suggested that the adrenal vein musculature,
controlled by a neurogenic mechanism, could be one of the controlling factors
in steroid biosynthesis and secretion. He also suggested that this peculiar
arrangement of the adrenal vein musculature could explain the focal lipid
depletion of the adrenal cortex in response to stress.
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The phvaico-chemica.l state of Cortisol in blood
The association between proteins and a large number of substances,
including hormones is well known. This association may be close or may
be very loose. After being secreted by the adrenal cortex, corticosteroids
circulate in the blood stream in varying degrees of "binding" to plasma
proteins.
Bischoff and Pilhorn (1948) were the first to suggest that 70-85$ of
the solubilities of progesterone and testosterone in plasma could be
explained on the basis of binding by albumin. West et al (1951) used this
hypothesis to explain the limited clearance of testosterone in the kidney, and
later on, Eik-Nes et al (1954 b) actually classified a great number of
corticosteroids according to their solubility in buffered aqueous and 5% albumin
solutions, and concluded that albumin increased the solubility of steroids
and that the increase was in inverse proportion to the number of the polar
groups (hydroxyl or ketone) in the steroid molecule, while the solubility in
aqueous solution is directly proportional to the number of polar groups. These
workers suggested that the binding of steroids with serum albumin offers a
rvevi —
rational means of transport for the non-bongold steroid hormones. Binding of
Cortisol to plasma proteins, however, was studied by Bush (1957), but it was
Oaughaday (1958 a, 1958 b) who, by applying electrophoretic studies to plasma
with added C"^-labelled Cortisol actually discovered that, at physiological
concentrations in the plasma, Cortisol migrated with and was bound firmly to a
protein or proteins associated with Cohn fraction IV-4, or more specifically,
one of the alpha-one globulins which was called corticosteroid-binding-globulin
(CBG), At higher plasma Cortisol concentrations (above 30 pg./lOOml.) the
binding/
binding protein becomes saturated and the additional Cortisol is loosely bound
by albumin. The capacity of albumin to bind Cortisol is relatively large.
Cortisol binding by alpha globulin was soon confirmed (Slaunwhite and Sandberg,
1959} Sandberg and Slaunwhite, 1959) but the protein was given a different
namej "transcortin".
Steroid binding by CBG is made stronger by inclusion of hydroxyl groups
at the lip, 17a and 21-positions of the molecule. Thus Cortisol is firmly
bound to CBG with corticosterone competing for the same binding site while
aldosterone is not bound to CBG but chiefly and minimally to albumin. Definite
selectivity of the steroid interactions with the different plasma proteins was
shown by Westphal (1957), who showed also that plasma proteins bind steroids
through their /A\"~3a ketogroup. The chemical nature of this interaction is
unknown; polar interactions and van der Waals forces have been suggested.
Thyroxine-protein linkage is strong enough to withstand precipitation of the
proteins. Nevertheless butanol will extract the thyroxine from plasma; this is
effected by solubility and not by cleavage of a chemical link. Steroids are
even more loosely bound to protein and any organic solvent which will denature the
protein will extract steroids from plasma.
Cortisol is 90-95% protein-bound in the plasma at physiological levels
(Mills et al, I960) and the degree of binding is inversely related to temperature;
at 37°C, 6-7% of Cortisol is unbound but at 4°C only 2% is unbound. On
the other hand the degree of steroid binding is not highly dependent on pH
(Chen et al, 1961).
In its function as a carrier of eoroisol in the plasma, the CBG mechanism
assures a ready source of available circulating hormone, protecting it from
conjugation in the liver and subsequent excretion in urine, but at the same
time limitation of diffusion into tissues must ensue (Daughaday, 1958 a, 1958 b;
Sandberg/
Sandberg and Slaunwhite, 1959J Slaunwhite and Sandberg, 1959j Peterson,
I960), These authors, and Wallace and Garter (I960), suggested that
protein-bound Cortisol would not be available for direct metabolism by the
usual routes and that only the non-protein-bound fraction is the physio¬
logically active moiety at the tissue or cell level.
When binding is raised by estrogen therapy the half-time for disappear¬
ance was found to be increased from 60 to 120 minutes as estimated using
C^-labelled Cortisol (Mills et al, I960), Mills et al (I960) and
Peterson (1959 a) showed that estrogen treatment does not alter the
biologically active fraction of plasma Cortisol as measured by the non-
protein-bound fraction, and concluded that this binding globulin will,
therefore, provide a buffer action against rapid changes in the biologically
active fraction of plasma Cortisol, Thus it would take up Cortisol if
secretions were suddenly increased or provide a reserve for a short time if
the secretion rate falls. This view seems to be universally accepted
nowadays and it explains the low titres of CBG in cerebrospinal and amniotic
fluids and also explains the presence of great amounts of unmetabolised
Cortisol in urine, in the presence of great amounts of unbound Cortisol in
the blood, as a result of more effective glomerular filtration. Conjugated
steroids are highly water-soluble, do not bind at all and are readily
filtrable through the kidney.
Production of CBG occurs chiefly in the liver but the mode of its
synthesis and metabolism are still unknown. Seal and Doe (1961) claimed
to have isolated the cortisol-binding-globulinj they stated that it is a
glycoprotein}/
glycoprotein; the protein contained 0,3% fucose (methylpentose), 2.7%
sialic acid, 3*6$ hexosamine and 3,8% hexose. Normally the mean CBG
binding capacity of human plasma studied with a double equilibrium dialysis
method using 4-C^-eortisol, is about 20.0 ±5.0 pg. cortlsol/lOQml.
(Daughaday et al, 1962), the steroid-binding capacity of plasma being
defined as the amount of steroid which can be held by protein in the
plasma, and is dependent upon the concentration of protein in the plasma
and upon the number of molecules of steroid bound to each molecule. DeMoor
and Meulepas (1962) showed that the critical level above which disposal of
Cortisol is no longer influenced by transcortln binding is 25-30 pg./lOCtel.
The production of CBG is markedly increased in pregnancy and after
estrogen treatment (Slaunwhite and Sandberg, 1959; Sandberg and Slaunwhite,
1959; Mills et al, I960) without clinical manifestation of hypoadreno¬
corticism since most of the hormone is bound and thus not available to the
tissues. Conversely a lowering of CHI activity is noted in the newborn and
in various clinical abnormalities of serum proteins i.e. dysproteinaemias,
e.g. liver cirrhosis, nephrosis, multiple myeloma, exudative enteropathy, etc.
(Sandberg and Slaunwhite, 1959). No diurnal variation of CBG titre occurs,
nor is it affected by corticotrophin (Mills, 1961 b).
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of Qoyti^oX
The main site of Cortisol metabolism is the liver which is able to convert,
within two hours, about two-thirds of a labelled Cortisol dose into the
conjugated form.
Practically no destruction of the steroid ring occurs in the metabolism
a/te
of Cortisol. The main metabolic pathways of Cortisol -is illustrated in figure
1. The first step in Cortisol metabolism is the reduction of the double bond
between 0-4 and C-5, by the incorporation of two hydrogen atoms in ring A,
catalysed by the TPN7{-dependent enzyme /^-hydrogenase, to form the
biologically inactive compound dihydrocortisol (5£) and its allo-derivative
(5a). Next, the a-3 ketonic group is reduced, by the incorporation of
another two hydrogen atoms, and tetrahydroeortisol (Lieberman and Teich,
1953; Roberts and Szego, 1955J Tomkins, 1956) and allo-tetrahydrocortisol
(Bush and Willoughbey, 1957) are formed. This step is catalysed by the
enzyme 3a-hydroxysteroid dehydrogenase, TPI'H or DFNH dependent. But as
Cortisol and cortisone are interconvertible in vivo (Lieberman et al, 1953;
Gray and Luirnon, 1956; Bush, 1956; Peterson et al, 1957 bj Bush and Mahesh,
1958; Bush and I'khesh, 1959 a, 1959 b) dihydrocortisonejallo-dihydroeortisone,
tetrahydrocortisone and allo-tetrahydrocortisone will be similarly formed
during Cortisol metabolism (Roberts and Szego, 1955; Bush and Mahesh, 1959 b).
The rate limiting step is the first reduction to dihydrocortisol. Biological
activity of Cortisol is lost when the /(v-3a-ketone group is reduced.
Mostly, these tetrahydro derivatives are conjugated through their 3a-hydroxyl
groups, by the action of the enzyme glucuronosyl transferase, with uridine
diphosphate glucuronic acid (glucosiduronic acid) to form the corresponding
tetrahydro/
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tetrahydro-3u, p-d-glucosiduronate, or simply glucuronide3 (Isselbacher,
1956), and to a much lesser extent conjugated with sulphuric or phosphoric
acid to form the corresponding sulphates or phosphates. Glucuronides
circulate in the blood unbound to protein. They are readily water-soluble
and are rapidly excreted in the urine without any significant reabsorption
by the tubules.
A further step in Cortisol metabolism is the reduction of the carbonyl
group at C-20, where two more hydrogen atoms are incorporated, to give
secondary alcohols. The resulting compounds derived from Cortisol and
cortisone are called cortols and cortolones respectively. These can be
a- or ji-cortols and cortolones depending onthe position of the hydroxy1
group at C-20, all of which have £-hydrogen at C-5. Allo-cortols and
allo-cortolones are also found which have an a-hydrogen at C-5 (Fukushima
et al, 1955? Fukushima et al, i960). A last, and quantitatively
unimportant step in Cortisol metabolism involves the loss of the side chain
of Cortisol, cortisone, their dihydro- and tetrahydro-derivatives and of
cortol and cortolone and its replacement by a ketone group; i.e. the
formation of 17-ketosteroids; 5-8% of isotopically-labelled Cortisol appears
in this form in urine (Sandberg et al, 1957 a; Edwards, 1961). These
comprise; 11-keto and 11-£ hydroxy-etiocholanolone and the corresponding
androstane derivatives; 11-keto- and ll§-hydroxy-androsterone.
A further smaller proportion of Cortisol is excreted unchanged in the
urine either unconjugated (Peterson et al, 1955| Neher, 1959) or partly
conjugated, at 0-21 to sulphuric acid or glucosiduronic acid (Pasqualini,
I960; Pasqualini and Jayle, 1961). It was noticed that with increased
plasma concentrations of Cortisol, a disproportionate increase in the urinary
excretion/
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excretion of the primary Cortisol occur3 (Greaves and *'est, 1960j Kornel
and Hill, 1961) probably as a result of the increased level of the unbound
plasma Cortisol being readily filtrable through the glomeruli of the kidney.
2C-#0# of intravenously administered C"^-labelled Cortisol appears in
the urine as the tetrahydro-derivatives} THE, THF, ailo-THE, 20-30# appears
as cortol and cortolone, 7% as the 17-ketosteroids; 11-keto and lip-
hydroxy-etiocholanolone (5#)> lip-hydroxyandrosterone (2#) and 11-keto-
androsterone (less than 1#) (Sandberg et al, 1957 a} Gallagher, 1959}
Fukushima et al, I960) and only very small proportion of the hormone is
excreted unchanged. THE is the main metabolite and it constitutes roughly
about two-thirds of all recognisable urinary metabolites of Cortisol.
The ratio of 11-hydroxy to 11-keto tetrahydro-derivatives is normally
constant. This, in practice is represented by the ratio of THF to THE or
THF plus allo-THF to THE and lies in the range 0.8 - 1.7 (Bassoe et al, 1958}
Romanoff et al, 1958} Hellman et al, 1961} Maeyer et al, 1963). These
workers also found that the 5a-raetabolite allo-THF comprises 9-25# of all
four tetrahydro-derivatives. The ratio of 11-hydroxy to 11-keto
tetrahydro-derivatives tends to increase with increased total excretion due
to increased secretion or to administration of exogenous Cortisol (Gold et al,
1958} Gold et al, 1959} Gray et al, 1962} Cost, 1963). Romanoff and his
associates (1961) using C^-labelled Cortisol found that the ratio of the two
main 11-hydroxyl metabolites of Cortisol THF and allo-THF, to the two main
11-ketone ones, THE and cortolone, is constant in relation to age, and so was
also the proportion of the one 5a-metabolite allo-THF to the three main 5P-
metabolites THF, THE and cortolone.
Cleavage/
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Cleavage or destruction of the steroid nucleus in vivo and excretion of
Cortisol or its metabolites by extrarenal channels are quantitatively unimportant
routes of its disposal by man (Hellman et al, 1954.)*
The half life of free Cortisol in the plasma, as estimated by isotopic
Cortisol is normally between 60 and 120 minutes. As the liver is the main
site of metabolism of Cortisol, the half life is usually prolonged in the
presence of liver dysfunction and is reduced with conditions of increased
metabolism, e.g. in thyrotoxicosis. The rate of metabolism of Cortisol can
be judged fcy the fact that about 60$ of a tracer dose of Cortisol will be
metabolised and excreted in urine in a period of six hours, about 80$ of
that dose will be metabolised and excreted in urine in 2$. hours, 90$ in
4.8 hours, and about 95$ in 72 hours (Hellman et al, 1954$ Romanoff et al,
196lj Flood et al, 1961} Layne et al, 1962). Only about 5$ of radioactivity
has been found in the faeces in the first 4-8 hours and less than 0.5$ was
reported to be present as CO^ in expired air which indicate that excretion
in faeces and degradation of ring A represent only a minor pathway and that
the main excretion occurs in fact in urine. Hellman and his co-workers (1954-)
suggested that these figures indicate that the rate of metabolism of Cortisol
is independent of tissue requirements and of the amount present in the bcdy
and, furthermore, since a small percentage is excreted as unaltered Cortisol,
the rate of metabolism may be inferred to be rapid.
Recently, however, some alternative pathways for Cortisol metabolism were
suggested} Bradlow et al (1962) using isotopic studies proved that some of
the metabolic products formed in vivo from Cortisol could well be derived
through a path that has a reduction of the C-20 ketone as the first stage, and
accordingly,/
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accordingly, that a portion of the other metabolites including the cortols,
cortolones and 11-keto and 11-hydroxy- 17-ketosteroids may be derived from
an intermediate C-20~hydroxy compound. They stressed, however, that this is
not a major route of Cortisol metabolism.
Furthermore, the identification and isolation of 6p-hydroxy-cortisol
by Burstein and his co-workers in 1954 led to extensive research to study this
compound in relation to Cortisol metabolism. Touchstone and his associates
(1959) suggested that 6p-hydroxycortisol is secreted independently from the
adrenal cortex, but Ulstorm and his co-workers (I960) injecting C^-labelled
Cortisol to infants in the first postnatal week showed that 6p-hydroxy-cortisol,
a relatively polar metabolite, is excreted in larger amounts than in adults,
and concluded that very polar metabolites of Cortisol are more important
pathways of Cortisol disposal in newborn infants than they are later in life
and, accordingly, that degradation pathways of minor quantitative importance
in adults are more extensively used during the postnatal period. That 6j3-
hydroxy-cortisol is a metabolite of endogenous Cortisol rather than an
independent secretion from the adrenal gland and in fact that it is the most
abundant unconjugated corticosteroid in normal human urine was confirmed by
other workers using also C"^-labelled Cortisol (Gohn et al, 196lj Lipman et
al, 1961} Lipman et al, 1962, Katz et al, 1962). Frantz and his associates
(1960) noticed the increased excretion of this compound in urine of pregnant
women and stressed the importance of this metabolic pathway of Cortisol in
pregnancy. Furthermore, by studying the excretion of this compound after
estrogen treatment, it was suggested that 6p-hydroxylation is an alternative
route of Cortisol metabolism which may be of quantitative importance in
pregnant or estrogen treated subjects since the excretion of conjugated cortico¬
steroids has been found to be diminished in similarly treated subjects (Lipman
et/
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et al, .1961; Lipman et al, 1962), Increased excretion of this compound
was also noticed in cases of adrenocortical hyperfunction (Touchstone and
Blakemore, 1961; Prantz et al, 1961). 6£-hydroxylation occurs mainly in the
liver and hydroxylation of Cortisol at various carbon atoms is known to render
Cortisol more water soluble and capable of being excreted in the urine in the
unconjugated state (Lipman et al, 1962), Excretion of 60-hydroxycortisol and
probably of other highly oxygenated corticosteroids assumes a more important
role in certain states such as pregnancy, exogenous hyperestrogenism, liver
disease, adrenocortical hyperfunction, and the newborn period (Lipman et al,
1962j Katz et al, 1962). Trying to find the relationship between these
conditions and the excretion of 6p-hydroxycortisol Katz and his co-workers
(1962) suggested that the utilization of this alternate pathway of Cortisol
metabolism may be increased when reduction of ring A is impaired. This was,
however, suggested before by Bush and Mahesh (1959 b) who noticed that hydroxy¬
lation of corticosteroids became much more important with steroids in which the
major reductions in the A ring and at C-20 are partially or totally blocked,
and as it has been shown that estrogen treatment leads to decreased formation
of TFNH which is necessary for reduction of ring A (Peterson et al, i960), so
the resulting reduced formation of THE and THF may favour the formation of
6p-hydroxycortisol, Thus, increased excretion of 6p-hydroxycortisol in
exogenous hyperestrogenism is explained, and its increase in pregnancy could
similarly be due to the increase of circulating level of estrogen. Moreover
the preponderance of unconjugated polar steroids in neonatal urine may reflect
the effect of high maternal estrogen on Cortisol metabolism in the newborn;
large urinary excretion of estrogen metabolites have been reported to occur
during/
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during the first few days of life (Diczfalusy et al, 1957)*
Estrogen also can account for the somewhat higher levels of 6p-hydroxy-
cortisol in normal females than in males. In liver disease the elevated
excretion of 6p~hydroxycortisol may be due to the relative inability of the
diseased liver cells to reduce ring A, But increased excretion of 6£-
hydroxycortisol in adrenocortical hyperfunction could be due to the saturation
of the enzyme systems of the major pathways by the abnormally increased
quantities of Cortisol to be metabolised. Thus it seems that the formation
of 6p-hydroxycortisol and other polar metabolites of Cortisol presents a
metabolic "run off" in situations in which the pathways for the formation
of the more common derivatives of Cortisol are either impaired or saturated.
The other polar metabolites of Cortisol identified and isolated are
2G-hydroxy-6{3-hydroxycortisol (Mpman et al, 1961 j Katz et al, 1962)
6p-hydroxycortisone (Lipman et al, 1961} Katz et al, 1962} Pasqualini et al,
1963), 2a~hydroxycortisone (Lipman et al, 1961), 6a~hydroxycortisol (Frantz
et al, 1961) and other unidentified 20,21-ketols (Katz et al, 1962), Bush
(1962) summarises the metabolic pathways for corticosteroid metabolism asi-
(1) Hydrogenation of the 4,5-double bond to give either 5P- or 5a-hydrogen
atom,
(2) Oxidation-reduction of secondary hydroxyl and carbonyl groups} at
positions 3, 11 and 20 predominantly in the reductive direction, and at
position 17 a considerable amount of the ketone results,
(3) hydroxylation at positions 2,6, 16 and possibly at other positions,
(4) Conjugation of hydroxyl groups either as ester sulphates or as glucurono-
sides, and probably with other radicals.
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Mode of action of Cortisol
The mode of action of Cortisol, and other corticosteroids, is not yet fully
understood, Pincus (1962) justifiably states that the metabolic transformations
which these secreted hormones undergo are probably not indicative of their
modes of action, and that the surprising pyrogenic action of etiocholanolone
and the hypocholestereraic action of androsterone should make us think twice
before we dispose of steroid metabolites as mere excretion products. He goes
on to discuss the various hypotheses put forward to explain the mode of action
of Cortisol, viz:- (1) corticosteroids act as co-factors or catalytic active
centres in a nucleotide or protein complex, (2) corticosteroids act as
intervenors in a transport system operating at the cell surface or at the
surface of intracellular enzyme sites, (3) corticosteroids act to "activate"
specific enzyme systems by any of several means such as competitive action
against a bound inhibitor or the disruption of protein linkages which need to
be 'free' for functional activity. He also suggests other possible roles of
steroids as (l) inducers of specific enzyme synthesis in target sites;
examples are seen in the rapid increase in ^-glucuronidase concentrations under
estrogen stimulation or of uterine carbonic anhydra3C concentrations by progestins,
and (2) causes of enzyme adaptation to their presence, which means that
corticosteroids may induce the intracellular formation of proteins with high
binding affinities for the specific molecular configurations presented by each
of the hormonal steroids.
Talalay (1962) reviewed the first hypothesis, proposed earlier by his
group of workers (Hurlock and Talalay, 1958), which stated that certain specific
hydroxysteroid dehydrogenases which reacted with both DPN and TPN could
promote a reversible transfer of hydrogen between the oxidised and reduced
forms/
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forms of these pyridine nucleotides in the presence of catalytic concentrations
of the appropriate steroid substrates, and that during these transhydrogenation
reactions, the steroids undergo reversible oxidation-reductions and function
catalytically as hydrogen carriers or coenzymes. This could be represented by:
Oxosteroid + TPNH + H+ ^ Hjydroxysteroid + TPN+
Hydroxyurea^ ♦ DPft* OftQgtQroi^ + JPKH ♦ H+
Sum: TPNH + DPN+ ^ DPNH + TPN+
Talalay, thus suggested that some manifestations of steroid hormone action
might involve regulation of intracellular hydrogen balances. This, he stated,
involves interactions of the steroids with enzymes some of which at least exhibit
the affinity and structural specificity which are required of the complementary
cellular receptors for steroids. He concluded that, although there is little
direct experimental evidence for this view, if steroid-mediated hydrogen transport
represents one aspect of the mechanism of steroid hormone action, this would
provide a functional role for some of the known metabolic transformations of steroids
and, moreover, that such a process would reconcile the mechanism of actions of
the steroids with those of other steroid substances which may function in a
catalytic role as coenzymes.
Ingle (1962) stated that the presence of hydroxysteroid dehydrogenases with
steroid specificity and dual pyridine nucleotide specificity, such as the
llji-hydroxysteroid dehydrogenase which intorconverts cortisone and Cortisol with
the participation of either pyridine nucleotide as hydrogen carrier, has been
demonstrated, and that as the balance between pyridine nucleotides plays an
important role in regulating the balance between various synthetic and energy-
yielding reactions, he supports Talalay's hypothesis that corticosteroids act as
coenzymes/
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coenzymes and that the 'action' and 'metabolism' of steroid hormones may be
part of the same processj as the steroids regulate intracellular hydrogen
traffic, they undergo reversible metabolic changes. However, he admitted
that a lot of information is still missing, such as the need for demonstration
of deficient intracellular hydrogen traffic in adrenalectomised and castrate
animals, the answer to the question of whether this reaction is only catalysed
by each 'active' steroid and whether non-steroid electron carriers without
hormonal activity can act in this system.
These questions were partly answered by Bush (1962) in an excellent
article, in which first of all he rejected the idea that corticosteroids act
as coenzymes or catalytic substances in view of the fact that the metabolic
reactions undergone by the steroid hormones are now largely thought of as
steps in their inactivation and elimination from the organism. He also
rejected the theory of the possible action of corticosteroids as activators of
specific enzyme systems in view of the fact that no specific physiological
effect of a steroid hormone has yet been shown to be due to a 'direct' action
upon an enzyme or enzyme system. He also rejected the proposal that the
mechanism of action of corticosteroids is to form chelates with important
metal ions in view of the fact that it is known now that the a-ketol side
chain is not essential for sodium-retaining activity (Fried and Borman, 1958),
He than studied the effect of structural modification of the steroid molecule
on the spatial configuration, molecular volume and distribution of electrons in
the molecule and showed that many o-sided substituents would block oxidation-
reduction at G-ll whereas they enhanced the biological activity of analogues
containing the lip-hydroxyl group and that only the lip-ol can combine with
and/
and directly affect the receptor. Hydrogen of the 11-p-hydroxyl group takes
part in a hydrogen bond with a proton-accepting group in the receptor. In the
natural steroids this bond is too weak to produce much activity unless the
side-chain contains both the 20-ketone and the 21-hydroxyl groups for attachment
to the receptor by semi-polar or hydrogen bonds. About two thirds of Cortisol
metabolites are 11-ketones, which means that the oxidation of the 11-p hydroxyl
group is probably an important 'wastage' reaction. This is because every
molecule of 11-ketone that is produced extrahepatically can only be reduced to
the active llp-ol by passage through the liver and this passage is attended
by the loss of about 50%> of the ketone through the usual metabolic reactions in
ring A and the side-chain. Applying this to studies using 2a-methylcortisol,
Bush (1962) suggested that a-sided substituents will protect the lip-hydroxyl
group from oxidation as well as blocking the usual inactivating reactions in
ring A and/or the side-chain. These effects became particularly apparent with
9a- and 12o-halogeno-steroids j the negative inductive effect of the halogen
increased the acidity and hence the hydrogen-donating tendency of the lip-
hydroxyl group; hydrogen bonding to a proton-accepting group on the receptor
would therefore be strengthened. Bush showed that numerous analogues of
glucocorticoids, often far more active than the natural corticosteroids, exist in
which the a-side of the molecule is grossly deformed by large substituents or by
angulation of the A/B-ring junction and suggested that it is very unlikely that
the steroid is attached to any part of the natural receptor for these substances
by its a-side. On the other hand large substituents axial!y substituted on the
p-side of the molecule reduce glucocorticoid activity to vanishing point. Therefore,
it seems likely that the natural receptors for glucocorticoids combine closely
with the steroid by the p-surface over the regions of the side-chain and at
least the C and D rings, and that the llp-hydroxyl group is probably one of the
main sources of specificity in the attachment of glucocorticoids to their
receptors. Bush then concluded that the steroid hormones produce their direct
effects by some simple consequences of association with specific receptors in
the target tissues and that this association appears not to involve any
metabolic reaction in which covalent bonds are broken. He also concluded
that both the association and the direct effect ensuing from it are very sensitive
to the shape and size of certain regions of the steroid hydrocarbon skeleton,
and to the position and orientation of one special polar group. In the natural
steroid hormones, less specific interaction with one or two other polar groups
may aid their interaction with their receptors but both the steric and electronic
requirements are less strict than for the former type of polar group, and the
groups themselves can be dispensed with entirely in suitably modified analogues.
Bush also concluded that in glucocorticoids the fit with the receptors is likely
to be around the £- and 'top' - sides of the G and D rings and very loose contact,
if any at all, between the 'bottom' edge of the steroid molecule and its receptor;
little or no close fit occurs with the receptors around the a-side of the molecule
especially at the G and D rings; and an interaction of the A- and B-ring structures
could only occur with a part of the receptor that is flexible or else be non¬
existent, He admitted, however, that the nature of the direct effect of these
hormones is still unknown at present, but he stated that whatever the nature of
the receptors for steroid hormones, a large area of contact by rather weak bonds
must be postulated to account for the specificity of the steroid-receptor
combination,/
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combination, and further, that in the absence of reactions breaking covalent bonds,
and the absence of reactive parts of the molecule likely to undergo presently
undiscovered reactions, the only 'event* that can at present be postulated to take
place during the association of the steroid with its receptor is the combination
itself. The steroid as it were, 'sits down* on the receptor in a specific
orientation and the job is done, and that the two most likely consequences of
such a molecular 'event * are that the conformation of the receptor molecule is
altered, or that the access of another type of molecule to that region of the
receptor is prevented by the presence of the steroid, and that the biochemical
manifestations of this type of event might be in the field of enzyme activity
or the 'permeability' of cellular or intracellular membranes and remains to
be discovered*
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Metabolic effects of Cortisol
Although it is a caramon belief that individual corticosteroids have either
an inorganic effect, such as that of mineralocorticoids on sodium retention or
potassium excretion, or an organic effect such as that of glucocorticoids,
androgens, estrogens or progesteroids on protein anabolism or catabolism, yet
there is a considerable functional overlap between the two groupsj Cortisol
for example, a glucorticoid, has a significant effect on electrolyte metabolism,
while aldosterone, the principal mineralocorticoid, has five hundred times
the activity of Cortisol in sodium retention yet only one-third its gluconeogenic
potency.
The different metabolic effects of Cortisol and other corticosteroids were
reviewed by Forsham (1962). The principal metabolic effect of glucocorticoids
in general and of Cortisol in particular is directed towards carbohydrate
metabolism. They cause marked enhancement of gluconeogenesis (Long et al,
194-0)» which leads to very large increases in liver glycogen, catabolism of
tissue proteins with marked nitrogen loss, hyperglycaemia and glycosuria. The
latter two effects of Cortisol are due largely either to direct augmentation of
gluconeogenesis or to a reduction in utilization of glucose by the cells, or
both (Long and Smith, 1962) and to a very small extent to its peripheral anta¬
gonistic action to insulin in conjunction with growth hormone. The rise in
blood sugar is temporarily opposed by increased secretion of insulin, but
eventually diabetes, called 'steroid diabetes', may follow. Steroid diabetes
is seldom associated with ketoacidosis. At the physiological level, Cortisol
effect on fat metabolism induces centripetal redistribution of fat, meantime
increasing the total amount at the expense of protein. Chronic excess of
Cortisol/
Cortisol leads to increased lypelyais, hyperlipaemia, hypercholesterolaemia,
ketogenesis and redistribution of triglycerides in fat depots producing the
so called "spider appearance" characteristic of Cushing*s syndrome.
Cortisol has a definite effect on water metabolism, viz. enhancement of
water diuresis. In absence of Cortisol, a water load is not disposed of
for twelve hours or more, a fact which forms the basis of the so-called water
test of adrenal cortical insufficiency (Moses et al, 1958). Cortisol also
prevents the passage of water into the cell, thus maintaining the extracellular
flptid volume, which, in tuna, preserves adequate glomerular filtration and
safeguards water diuresis. This seems to be a more accepted hypothesis than that
assuming direct antagonistic effect of Cortisol on the pituitary antidiuretic
hormone at the kidney tubules or enhancing its destruction in the liver. There
is no evidence to support the hypothesis that Cortisol suppresses the secretion
of antidiuretic hormone at the hypothalamie-pituitary level.
Cortisol and other glucocorticoids, with or without a 17-hydroxyl group,
lyse fixed lymphoid tissue and reduce the number of circulating lymphocytes.
Glucocorticoids, with a 17-hydroxyl group, depress the number of circulating
eosinophils} this effect is not dependent upon suppression of bone marrow
production but to Increased sequestration of circulating eosinophils in the lungs
and spleen and their destruction in the circulation. Basophils suffer a similar
fate. On the other hand the relative and absolute neutrophil count is raised,
so that the overall picture in Cortisol excess is an increased total leucocytic
count, relative and absolute neutrocytosis, lymphopenia and eosinopenia. The
phagocytic system of the blood is neither suppressed nor stimulated. Erythrocyte




Cortisol also affects striated musclesj in the absence of Cortisol, muscle
weakness occurs which can not be improved by administration of deoxycorticosterone,
saline or glucose. Cortisol excess also leads to muscle weakness due to
depletion of muscle protein, oedema, fibrosis and probably also due to potassium
depletion.
Cortisol also has an effect on the central nervous system. In deficiency
states, slowing of the electrical discharges in the electroencephalogram occurs.
On the other hand, in Cortisol excess, the threshold for electrical excitation
of the brain is lowered, accounting for an increased tendency to epileptic
seizures. Psychiatric disturbances are also common both with lack and excess of
Cortisolj as many as of patients with Cushlng's syndrome show some major
psychiatric disturbance and in fact most of the early cases of that syndrome
described by Cushing were patients of mental hospitals.
On the gastrointestinal tract, Cortisol induces increased gastric acidity
and to a lesser extent pepsin production, thus accounting for the well recognised
tendency to peptic ulceration in patients with excess endogenous Cortisol secretion
(Grey et al, 1953)* These effects can be blocked by anticholinergic drugs.
The effect of Cortisol on bone metabolism is towards enhancement of every
phase of osteoporosis. Thus in excess, Cortisol inhibits the synthesis of the
organic matrix, by impeding the development of cartilage and accordingly thinning
of epiphysial plate and interruption of growth of bonej the formation of new bone
is blocked at the level of the matrix and osteoblasts are scarce. Cortisol also
causes decreased deposition of calcium and increases the renal clearance and urinary
loss of calcium. These effects are aggravated by Cortisol antagonising the action
of vitamin D which leads to decreased absorption of calcium from the gut.
The most important effect of Cortisol on the cardiovascular system is the
sensitisation of the arterioles to the pressor effect of norepinephrine. Cortisol,
however,/
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however, may per se raise the blood pressure to some extent. It enhances
the production of angiotensinogen, resulting eventually in higher levels of
angiotensin which stimulates aldosterone production which in turn further
increases the blood pressure (Forshaa, 1962). By its mineralocorticoid effect,
Cortisol participates in maintaining adequate{sodium/serum^levels and circulating
blood volume. Excess Cortisol, however, leads to a tendency to atherosclerosis
following a rise in circulating blood lipids and cholesterol levels. This
may be due to the effect of Cortisol on cholesterol, decreasing its diffusion
into the vessel wall.
The effects of Cortisol and related 17-hydroxylated derivatives on the
mesenchymal tissues are of greatest importance. Normally, as a result of an
injury or a focus of infection, in the acute phase, perivascular exudation and
marked diapedesis occur and neutrophils surround the site of infection. fix the
subacute stage lymphocytes predominate and in the chronic stage of healing
fibroblasts surround the focus, walling it off. Subsequently the blood vessels
become narrowed by dense fibrosis. In the presence of excess Cortisol, there is
a decrease in hyperaemia, less exudation, diminished diapedesis, cellular
migration and infiltration. The major tissue response is one of mononuclear
cells. The early phase of repair is retarded by inhibition of fibroplasia and
late fibrosis.
Cortisol also interferes with intracellular synthesis of histamine without
antagonising its actionj thus it will not inhibit the local response to histamine
and will only affect an acute allergic response a few hours later when the
histamine present is destroyed and its inhibiting effect upon further production
of histamine becomes manifest.
Antibody/
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Antibody changes may also occur with large doses of Cortisol where initial
liberation of excess antibody occurs subsequently followed by fall due to
suppression of antibody formation, Cortisol inhibits hypersensitivity reactions
to antigen-antibody complexes, probably by interposing a protective layer
between the complex and the target cell surface. The inhibition of production
and the subsequent reduction of the circulating levels of antibodies by very
large doses of Cortisol is due to lysing fixed plasma cells and lymphocytes.
The resistance to infection, already diminished by the mesenchymal effects of
small doses is further aggravated by doses large enough to reduce antibody
formation.
The metabolic effects of mineralocorticoids are mainly directed towards
control of sodium and potassium levels and water volume in intracellular and
extracellular fluids mainly by their action at the distal tubules of the kidney.
The same action occurs to a smaller extent in the salivary glands, sweat glands,
intestinal mucosa and in exchanges between extra- and intracellular fluid
throughout the body.
It must be pointed out that the amounts of Cortisol needed for all the
metabolic effects mentioned to sustain life and homeostasis are greatly
increased by physical or emotional 3tress and, on the other hand, amounts
needed to keep the animal living under extreme stress will cause signs of
hypercorticolism in the resting state (Ingle, 1962),
In addition to these "specific actions" on the various systems of the body,
adrenal cortical hormones especially glucocorticoids are known now to exhibit
a supportive or 'permissive' action (Ingle, 1954.) whereby other hormones exert
their effect only in the presence of small amounts of glucocorticoids. Ingle
defined the conditions implied in this theory:
1./
1. The metabolic response to a stimulus occurs in the presence of the adrenal
gland.
2. The response is not demonstrable when the gland is removed and no
replacement therapy is given.
3» The response is again elicited when a steady intake of Cortisol hormones
is substituted for the adrenal gland.
So, under normal conditions, the eucortical state is necessary to support
biological responsiveness but the cause which incites the response is of extra-
adrenal origin. This view was supported by Crane (1962) who showed that many
of the metabolic and pharmacological responses to stress can develop fully in
£
the absence of the adrenal glands when small constant doses of adrenocortical
hormones are given. Under such circumstances, the adrenocortical hormones
permit or 'normalise1 the responsiveness of extra-adrenal mechanisms. Thus
the metabolic effects of Cortisol assumes that the primary actions of Cortisol
and other corticosteroids are necessary to maintain the normal functions of
cells and entire organs and their responsiveness to extra-adrenal stimuli
especially so under conditions of exposure to severe stress (Ingle, 1962} Crane,
1962). An example of this action is the release of significant amounts of
glucose from liver glycogen by epinephrine and glucagon only in the presence of
Cortisol. This permissive action also serves to explain the occasional
restoration of blood pressure by Cortisol in patients in shock who no longer
respond to norepinephrine alone. Thus the empirical treatment of different
cancers by bilateral adrenalectomy may depend on the carcinogenic process
proceeding at suboptimal speed in the absence of the permissive effect of
corticosteroids./
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corticosteroids. Likewise the relationship of corticosteroids to diseases
such as diabetes and hypertension may be permissive rather than causal
(Ingle, 1962).
Crane (1962) concluded, however, that the term 'permissive1 described
this inter-relationship of the corticosteroids and certain processes of
metabolism and disease but does not define the ultimate mechanisms involved;
the fundamental biophysical and biochemical processes in which the adrenal
cortical hormones participate at a cellular and molecular level are still
largely unknown.
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Fttygiplofflgal variation^ of adrenocortical activity
vaykUoq of atoaasacMsal a&tesZ&L ^ sggacda could not be
demonstrated in the plasma level of Cortisol (Bliss et al, 1953; Lewis, 1957;
DeMoor et al, I960 b) although some data suggest that values in women may be
lower than in man (Bondy and Upton, 1957). Urinary 17-ketosteroids and 17-
hydroxycorticosteroids are, however, usually higher in males than in females
(Korymberski et al, 1953; Heddy, 195-4; Levell et al, 1957; Borth et al,
1957; Loraine, 1958).
This difference has been attributed by some workers to the difference
in weight of total muscle mass between the two sexes, which implies that the
difference will disappear if corticosteroid excretion is correlated to
creatinine excretion or body weight (Romanoff et al, 1961; Mynaryk et al,
1962) and a better way of estimation of urinary corticosteroids seem3 to be in
expressing the results as mg./Kg. body weight/day.
Spontaneous diurnal variation, sometimes called 'circadian rhythm', of a
constant pattern occurs normally in persons not subjected to stress. This was
first described by Pincus (1943 a) in terms of 17-ketosteroid excretion. But
a diurnal variation in the level of 17-hydroxycorticosteroids in plasma (Bliss
et al, 1953; Gemzell, 1953; Sandberg et al, 1954; Tyler et al, 1954; Doe et al,
1956; Migeon et al, 1956 b; Brown et al, 1957; Doe et al, I960 a) and urine
(Doe et al, 1954; Laidlow et al, 1954; Doe et al, I960 a) is more pronounced.
This has been confirmed by a more significant method for Cortisol estimation in
plasma (Lewis, 1957). Plasma 17-hydroxycorticosteroids is highest between
6i00 and 8:00 a.m. falling to a minimum around midnight (Bliss et al, 1953;
Sandberg et al, 1954; Migeon et al, 1956 b; Doe et al, 1956; Brown et al, 1957;
Perkoff/
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Perkoff et al, 1959), but considerable variation exists between subjects, both
with regards to the peak time and the degree of fluctuation observed. No sex
difference of this elrcadian rhythm has been reported. Urinary changes are
essentially the same although there may be a short lag between them and those
of the blood. About 70$ of the 17-hydroxycorticosteroids secretion by the adrenal
cortex occurs between midnight and 6*00 a.m., and the difference between maximal
and minimal secretory activity, reflected as plasma 17-hydroxycorticosteroid
level, is about two-fold in most cases. This cycle is independent of exercise
or food intake. Night workers and blind persons have normal rhythms (Tyler et
al, 1954-J Migeon et al, 1956 b) but significant loss of diurnal rhythm occurs
in clinical conditions associated with alterations in consciousness or sleep
patterns, and total reversal of sleep and activity for five to ten days was
reported to result in a reversal of the normal rhythm (Perkoff et al, 1959). It
was also noticed that adaptation of the ketogenicjexcretory rhythm to a reversed
activity-sleep and light-darkness schedule, in places where day light persists
for twenty-four hours, occurs in two to eight days (Sharp et al, 1961) denoting
that these rhythms probably depend upon habit and environment and synchronization
of pituitary and adrenal responsiveness,
Eik-Nes and Clark (1958), however, noted the lack of diurnal variation in
four patients following severe head injury. This has led other workers to try
to localise specific areas of the brain as centres for this diurnal variation,
Hokfalt and Luft (1959) noted the absence of normal variation in free plasma
Cortisol in patients with suprasellar extension of pituitary tumours, implying
the role of hypothalamic control of ACTH secretion and diurnal rhythm, Krleger
(1961) noticed abnormal patterns of 17-hydroxycorticosteroids in plasma of
patients suffering from pretectal and temporal lobe lesions of the brain and
concluded/
concluded that these areas of the brain are important centres in regulation
of pituitary release of ACTH and of the diurnal pattern of plasma 17-hydroxy-
corticosteroids which is a reflection of such a release, Oppenheimer and his
colleagues (196l), however, showed that the mechanisms leading to the normal
diurnal variation of plasma 17-hydroxycorticosteroids and to the normal
adrenal response to stressful stimuli do not involve those diencephalic
centres postulated to control the reciprocal pituitary-adrenal inter¬
relationship.
Most probably, however, this cycle represents an inborn rhythm implying
either rhythmic changes in pituitary corticotropin release or diurnal
differences in the responsiveness of adrenal cortical cells to it due to
changes in mitotic activity of adrenal cortical cells (Perkoff et al, 1959)*
Adrenal responsiveness to ACTH has been claimed to be less at night than
during the day (Perkoff et al, 1959), Cope (1961) suggested that this cycle
could reflect either relatively increased adrenal activity or relatively
diminished rate of destruction of the adrenocortical hormones in the early
part of the day and it is of interest to know that the normal circadian
variation in plasma conjugated 17-hydroxycorticosteroids is exaggerated in
hyperthyroidism and absent in myxoedema (Martin et al, 1963) and that of
free plasma and urinary 17-hydroxycorticosteroids is exaggerated in myxoedema
and almost absent in hyperthyroidism, indicating that the thyroid, through its
effect on metabolism, and particularly the rate of metabolic transformation of
free to conjugated 17-hydroxycorticosteroids, could be partly responsible for
this diurnal rhythm. Absence of diurnal variation by measuring plasma
17-hydroxycorticosteroids/
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17-hydroxycorticosteroids (Laidlow et al, 1955} Elk-Nag et al, 1955} Lindsay
et al, 1956} Doe et al, I960 aj Ekman et al, 1961), urinary 17-hydroxy¬
corticosteroids (Lindsay et al, 1956) or plasma non-protein-bound Cortisol
(Doe et al, 1963) has been reported in cases of Cushing's syndrome due to
adrenal hyperplasia or adenoma. But cases of simple obesity were reported
to retain the normal rhythm (Simkin and Arce, 1962} Schteingart et al,
1963)* The absence of diurnal variation in Cashing's syndrome is obviously
not due to inability of the adrenal cortices to respond further to increased
stimulation by ACTH, as many cases of Gushing's syndrome are known to exhibit
a hyper-reactive response to ACTH (Christy et al, 1955} Lindsay et al, 1956}
Hinman et al, 1957). According to this hypothesis, non-neoplastic Cushing's
syndrome could be caused by a disturbance in the function of an ACTH -
controlling hypothalamic centre. This is consistent with the known difficulty
of inhibiting endogenous ACTH secretion with glucocorticoids in some patients
with Cushing's syndrome due to bilateral adrenal hyperplasia (Liddle, I960).
Fluctuation from dav to dav in the adrenal activity of normal persons, as
measured by corticosteroid plasma levels (Bliss et al, 1953} Ekman et al, 1961)
or urinary excretion (Zondek et al, 1957) also occurs, and can be considerable.
This type of variation does not follow a definite pattern and is more striking
in cases of Cushing's syndrome (Birke et al, 1956} Bassoe et al, 1958} Doe
et al, I960 a) but was also observed in obese subjects (Balrd, 1963).
Variation <?f afoenpqprtjqal ?9tlYlty as ^ also occurs. In the
newborn infant, relatively high levels of plasma 17-hydroxycorticosteroids were
reported (Uistorm et al, 1961). Similar observations were reported in urine.
The/
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The cause of this rise could either be the increased production of Cortisol by
the infants adrenals, the mobilisation of Cortisol from extravascular sites to
the circulation or its delayed metabolism. The fact that urinary excretion of
17-hydroxycortioosteroids is lower on the first day of life than the subsequent
days is in favour of the redistribution theory. Half life of Cortisol in
newborn infants, however, is markedly prolonged (Bongiovanni et al, 1958}
Reynolds et al, 1962) as compared to that of the adult (Peterson et al, 1955}
Brown et al, 1959} Christy et al, 1959) which indicate decreased rate of
Cortisol metabolism. This could be due to any of the following possibilities.
First, the preponderance of unconjugated polar steroids in neonatal urine,
such as 6p-hydroxycortisol, previously mentioned, may reflect the effect of
high maternal estrogen on Cortisol metabolism, particularly its inhibition
of reduction of the A-ring, or that the hepatic enzyme systems of the newborn
are immature (Reynolds et al, 1962). A second possibility may be due to the
fact that large amounts of progesterone metabolites are excreted in the first
day of life and these, including pregnanetriol, inhibit glucosiduronate
conjugation (Hsia ©t al, I960), ACTH can also produce more secretion of
Cortisol by the adrenal cortex, inhibit conjugation of steroid metabolites,
increase the half life of Cortisol (DeMoor et al, 1961 a) and relatively
increase 6^-hydroxycortisol excretion (Touchstone and Blakemore, 1961), These
observations may indicate that newborn adrenals are under at least moderate
ACTH stimulation. The alternate metabolic pathways of Cortisol in the
newborn have been previously mentioned.
After this early neonatal period, plasma and urine 17-hydroxycorticosteroid
levels drop rapidly, only to increase again gradually with age, reaching a
maximum/
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maximum between 20 and 25 years (Levell et al, 1957; Borth et al, 1957;
Appleby and Norymberski, 1957} Clayton et al, 1963). Very slight and
gradual decrease of level may follow up to the age of 60, after which this
drop may be more pronounced (Baird, 1963), Romanoff and his colleagues
(1961), however, using C"^-labelled Cortisol to estimate Cortisol production
rate from urine studies in eight young (21-35 years) and eight elderly subjects
(65-73 years) showed that the secretion of Cortisol and the total excretion
of its metabolites THF, allo-THF, THE and cortolone were significantly higher
in the younger group. But when they expressed their results in terms of
creatinine excretion per day the differences disappeared. Moreover, they
showed that in both of these two groups there were essentially similar
proportions of the two 11-hydroxyl metabolites (THF and allo-THF) to the
two 11-ketone substituted metabolites, THE and cortolone, and of the three
5p- (THF, THE and cortolone) to the one 5a-(allo-THF) Cortisol metabolites.
They concluded that Cortisol metabolism in the two groups is the same and
that the quantity of Cortisol secreted is related to the muscle mass of the
subject. West and his associates (1961) tested the adrenocortical activity
in a larger group of subjects with wider age range; namely fifteen young
men (25-4-0 years) and fifty old men (60-96 years). They estimated their
plasma levels of free and conjugated 17-hydroxycorticosteroids and urinary
excretion of 17-hydroxycorticosteroids, They also assessed the renal, hepatic
and thyroid functions of these subjects. They found that there was no
significant change in adrenocortical function, as judged by the plasma free
and conjugated 17-hydroxycorticosteroid levels, with advancing age, but there
was/
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was a progressive and significant decrease in the urinary excretion of
17-hydroxycorticosteroids with ageing. Half life of Cortisol was longer
in the old men and there was a significant increase in the level of blood
urea nitrogen, bromeulphalein retention and a significant decrease in endogenous
creatinine clearance and basal metabolic rate. The protein-bound-iodine and
radioactive iodine uptake by the thyroid were unaffected by ageing, These
workers concluded that a combination of decreased Cortisol catabolism by
the liver and other tissues and an impairment in the renal excretion of
Cortisol metabolites could explain their findings and that the thyroid gland
does not appear to be involved.
Vayiatj,on pf adrenocortical aptivi^y in ppegqapcy also occurs. Elevation
of plasma 17-hydroxycorticosteroids (Gemzell, 1953? Bayliss et al, 1955; Birke
et al, 1958) and particularly plasma Cortisol (Gemzell, 1954-5 Cohen et al, 1958;
Martin and Mills, 1958; Jailer et al, 1959) and an increased excretion of
free Cortisol in urine (Migeon et al, 1957; Jailer et al, 1959) were reported
in late pregnancy. These changes are associated with only slight or moderately
increased excretion of urinary Cortisol metabolites (Birke et al, 1958; Cohen
et al, 1958; Martin and Mills, 1958). The discrepancy between the blood and
urinary findings could be explained by retardation of Cortisol metabolism in
pregnancy (Appleby and Norymberski, 1957; Migeon et al, 1957; Martin and Mills,
1958). These changes are also associated with increased binding capacity of
the corticosteroid-binding-globulin to plasma Cortisol (Daughaday, 1959;
Slaunwhite and Sandberg, 1959; Sandberg and Glaunwhite, 1959; Mills et al,
I960). Since the unbound plasma Cortisol is the only active fraction at the
tissue level, and since this fraction remains practically constant in pregnancy,
the/
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the markedly elevated plasma Cortisol levels will not give rise to clinical
manifestations of Cushing's syndrome. Doe and his co-workers (I960 b) showed
that no increase in al-globulin was noticed but that total and protein-bound
plasma Cortisol were markedly elevated in pregnant women in the third
trimester and that the non-protein-bound fraction of plasma Cortisol was
significantly but only mildly elevated than normal. They correlated the
latter finding with the mild symptoms of adrenal hyperfunction commonly
observed in pregnant women, such as the occurrence of purplish striae,
glycosuria, hypertension, increased fragility of cutaneous blood vessels, etc.
They concluded that in pregnancy there is at least an element of increased
adrenocortical activity, thus supporting previous similar reports (Christy
et al, 1959? Cope and Black, 1959 b). The increase in the plasma protein-
binding of Cortisol could explain previously reported delayed Cortisol metabolism
in pregnancy (Christy et al, 1959) and accordingly the discrepancy between
plasma and urinary corticosteroid estimations. This discrepancy may also be
explained by the increase of estrogen titre in pregnancy which in turn can lead
to inhibition of reduction of the A-ring. Delayed metabolism and prolongation
of the biological half life of Cortisol with estrogen treatment was frequently
reported (Robertson et al, 1959; Peterson et al, I960; Wallace and Carter,
i960). Administration of estrogen was shown to increase 6p-hydroxycortisol
excretion (Lipman et al, 1961), Thus, high titres of estrogen in late pregnancy
could explain the previously mentioned increased formation and excretion of
6p-hydroxycortisol and other unconjugated polar metabolites in pregnancy (Frantz
et al, I960),
There are few reports in the literature regarding the adrenocortical activity
during/
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during the various phases of tho menstrual cycle. Staub and his colleagues (1962),
however, showed that pregnanediol, the urinary metabolite of progesterone remains
at relatively lower levels during and after menstruation till ovulation, when the
excretion starts to rise gradually to reach a maximum during the premenstrual
period and to drop again just before menstruation. But as progsterone is a
common precursor to estrogens and corticosteroids, it can not be clear whether
these changes reflect ovarian or adrenocortical activity. Studies of Cortisol
production rate and metabolism during the various phases of the menstrual cycle
are needed to throw more light on this subject.
Inter-relationship of the adrenal cortex and other endocrine glands
The inter-relationship between the adrenal cortex and the pituitary gland
has been fully reviewed (see regulation of Cortisol secretion).
Hyperfunction of the adrenal cortex was sometimes noticed in the condition
called "obese hyperglycaemic syndrome 'Which is due to hyperplasia of the islets
of Longerhare of the pancreas, and adrenocortical dysfunction was also
associated with primary dysfunction of the thyroid, ovary and pancreas with
apparent normal anterior pituitary function; a rare condition called
jyoiMmfoto or pluriglandular failure. Less than twenty cases
have been reported in the literature (Christy et al, 1962) the cause of which
is still obscure.
/□.though the old hypothesis implying that the regulation of secretion,
and probably the action, of the adrenal cortex hormones is under the control of
the adrenal medulla and its hormones, epinephrine and nor-epinephrine, was
recently revived by DeMoor et al (1961 b, 1961 c) it seems to be no longer
accepted by most workers nowadays (Forsham, 1962). CP the contrary, a
permissive role of the adrenal cortex hormones, by which a small amount of
adrenocortical hormones should be present, seems to be essential for normal
function of the medullary hormones (Ingle, 1954). Nevertheless, on rare
occasions, adrenocortical hyperplasia or carcinoma were associated with
phaeochromocytoraa of the adrenal medulla (Williams et al, 1960j Walters et al,
1962).
Pathologic conditions of the parathyroid glands were also sometimes
associated with abnormal adrenocortical function, Hyperfunction of either the
parathyroid/
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parathyroid or the adrenal cortex can cause bone disease (osteitis in
hyperparathyroidism and osteoporosis in hyperadrenocorticism), nephrosclerosis,
renal stones but hypercalcaemia in hyperparathyroidism and bypoealcaemiu in
hyperadrenocorticism. Raker et al (1962) reported the occurrence of primary
hyperparathyroidism in association with Cushing's syndrome. They reviewed
the few cases in literature connecting primary hyperparathyroidism (parathyroid
hyperplasia, adenoma, or even hypercalcaemia or hypercalcaemia and hypophos-
phataemia) with adrenocortical hyperfunction (hyperplasia or adenoma). In
the two patients they examined, they were able to show that hypersecretion of
the adrenal cortex did not influence the associated classic blood findings of
primary hyperparathyroidism, and that the converse was also true, i.e. that
hyperfunction of the parathyroid glands had no influence upon the effect of
excess adrenocortical hormones. They concluded that hypercaleaemia in a
patient with Gushing's syndrome should be evaluated as in an otherwise normal
patient and should not be attributed to the adrenal hyperfunction.
However, the adrenal cortex has been more frequently associated with
the thvroid gland. Gabrilove and Weiner (1962) reviewed the cases reported in
the literature in whom thyrotoxicosis occurred in patients with Addison's
disease and noticed in their patient that as the thyrotoxicosis was controlled,
the patient required less cortical substitution therapy to keep the electrolytes
within the normal range thus supporting the view of Hellman et al (1961) who,
using radioisotopic techniques, noticed an absolute elevation in the endogenous
production of Cortisol with elevated levels of thyroid hormone and diminished
production of Cortisol in hypothyroidism, suggesting that the requirement for
adrenocortical steroids is increased as the metabolic rate rises. They also
noticed/
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noticed that in hyperthyroidism Cortisol metabolism is shifted towards the
11-ketone metabolites and in hypothyroidism towards the 11-hydroxyl metabolites,
suggesting that in thyrotoxicosis the conversion of Cortisol to THE represents
an increased metabolic inactivation of Cortisol, Gold and Crigler (1963)
also found an increase in the relative and absolute amounts of THE excreted
under the influence of tri-iodothyronine. They also noticed increased rate of
steroid-glucuronide formation, increased excretion of total Cortisol metabolites,
suggesting increased general metabolism of Cortisol, but constant 5a- to 5P-
metabolites of Cortisol, The injection in dog of the active analogues of
thyroxin led to accelerated enzymic reduction of the circulating Cortisol and
increased release of corticotropin (Melby et al, I960), Hellman and his
associates (I96l) suggested that patients with thyrotoxicosis might have
increased secretion of AGTH, and Hilton and his colleagues (1962) used plasma
from patients with thyrotoxicosis to perfuse intact adrenal glands of
hypophysectoraised dogs. They noticed increased secretion of Cortisol in the
adrenal venous effluent indicating ACTB-like activity of such plasma. This
increase was not noticed when the adrenals were perfused with normal plasma,
L-thyroxine, tri-iodothyronine or thyrotropic hormone indicating that the
stimulatory substance present in the hyperthyroid plasma could probably be
ACTH itself, in which case the action of the thyroid hormone would be to
accelerate enzymic reduction and metabolism of the circulating Cortisol, thus
providing the stimulus to the release of corticotrophin through the negative
feed-back mechanism. These workers also found that plasma Cortisol levels
were slightly less in hyperthyroid than in euthyroid subjects. They concluded
that this is not surprising since the stimulus for increased ACTH production
comes from the rapid degradation of Cortisol, due to the hypermetabolic state,
with/
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with the result that the increased ACTH produced merely serves to maintain
Cortisol concentration in the plasma at normal levels. It has been
mentioned before that hyperthyroidism accelerates the disappearance of plasma
free 17-hydrcxycorticosteroids leading to exaggeration of the circadian rhythm
of the conjugated 17-hydroxycorticosteroids and that the opposite is true for
cases of myxoederaa, suggesting that the thyroid gland, through its metabolic
effects on free 17-hydroxycorticosteroids may be partly responsible for the
circadian rhythm previously discussed.




The earliest attempts to assess adrenocortical function depended upon
extraction of adrenocortical hormones and assessing their activity by
administering the extract to, and observing its effects on various laboratory
animals.
The activity of the extract was assessed by observing the survival time
of adrenalectomised rats on exposure to cold, the degree of deposition of
liver glycogen in fasting adrenalectomised rats, the extent of fall of
circulating eosinophils in the adrenalectomised mice but the more popular
of these early methods measured the degree of sodium retention and potassium
excretion in the adrenalectomised rat (Dorfman, 1950).
These methods only confirmed the presence or absence of adrenocortical
activity in urine extracts, and could not possibly assess the adrenocortical
activity quantitatively. Today they are only of historical interest and they
have given way to the more rapid, simpler and more precise chemical methods.
B. Chemical methods
I. Groun steroid estimations (see table 1 and 2)
a. Neutral 17-ketosterolds (17-KS)
The earliest chemical methods used to asr.ess adrenocortical function in
urine estimated the neutral 17-ketosteroids, sometimes called 17-oxosteroid
(or 17-OS), the basic chemical structure of which is either 5 a-androstane
or 5p-androstane (etiocholanolone). The main 17-KS compounds in urine are
DHA, etiocholanolone and androsterone. Smaller amounts of their 11 oxo- and
lip-hydroxy derivatives are also present, and trace amounts of /(*-androstenedione,
HP-/
Table (1)
Methods of estimation of group steroids in urine





















17 0...0h g...0h c...0h c...0h g c g







4" — — 4~ —


























Formaldehydogenic steroids 4- -h — — 4- +
4 Porter-lilber reaction — + — — — —





















g...0H C.a.oh g...0h G...0h c G C c





















































Zinmermann reaction -1- 4- ~b + — — —
8 107
4 ps















g c...0h g c c c
Zimmermann reaction
— + + — —
Table (1) oontd.






























+ ~b -b — —
10 1. NaBiO^ 0 OH OH( OH OHi OH1 COH1 GOH
2. c G C C c C c C
3. NaBiO^
+Zimmermann reaction
























C...0H c C 0 c C c C


































Z inanermann reaction + -b — —— ■■ ——
14 1. BH~
2. NaBiO^ (ferric hydroxamatea)
3. HNO^ — — 4- 4-
4. Fe
lli3-hydroxy-androstenedione and adrenosterone are included (see figure l).
Urinary 17-KS are excreted in urine mostly conjugated to sulphuric or gluco-
siduronic acid (Zumoff and Bradlow, 1963)f DHA is almost entirely excreted
conjugated with sulphates while etiocholanolone and androsterone as gluco-
siduronates (Bush and Gale, I960) and there is reason to believe that
3^-hydroxysteroids in general are conjugated with sulphates and 3 a-hydroxy-
steroids with glucosiduronates (Staib et al, i960). 17-KS are either of
adrenal or gonadal origin, but 11-oxygenated 17-KS are definitely of adrenal
origin. The latter sub-group is either derived from C-19 androgens or
indirectly by the oxidative scission of the side chain of the C-21 cortico¬
steroids and their metabolites. In males about two-thirds of the neutral
17-KS is of adrenal origin and one-third of testicular origin. In females
almost all the neutral 17-KS are of adrenal origin with the possible
contribution of a trace amount from the ovary (Lieberman et al, 1962). The
difference in the total neutral 17-KS excretion values between males and females
is probably due to the testicular contribution in males (Dorfman, i960).
The first method for estimation of urinary neutral 17-K3 was described
by Callow and co-workers (1938). Estimation of total neutral 17-KS involves
either preliminary extraction of conjugates or their hydrolysis followed by
extraction into an organic solvent, removal of acidic (phenolic) estrogens by
alkaline wash and application of a colour reaction.
Hydrolysis of conlugates can be achieved by one of many methods. The
first to be used was boiling the urine in acid, hydrochloric or sulphuric, for
thirty minutes. Hot acid hydrolysis partly or totally destroys the steroid
molecule (Edwards, 1961j Noryraberski, 1961) especially in case of glucuronate
conjugates, and is not quantitative (Lieberman and Teich, 1953) and in the case
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of sulphate will also result in marked changes of the steroid molecule which
will affect the colour reaction on which the final assay depends (Teich et al,
1953).
Milder methods for hydrolysis of sulphate conjugates were introduced. The
first is the continuous ether extraction method of Lieberman and Dobriner (194S)
in which urine acidity is adjusted to pH 1 and extraction carried on for three
days, steroids freed from sulphates together with unhydrolysed glucuronides can
be recovered from the ether layer. The second method is that of Cohen and
Oieson (1953) in which 17-KS are extracted in ether-ethanol or butanol, extract
evaporated, dehydrated over then dissolved in trichloracetic acid in
anhydrous dioxan and left to stand overnight. Sulphates are hydrolysed and
excess acid is removed by alkali wash. The third method is often referred to as
the "solvolysis" method of Burstein and Lieberman (1958) in which urine is
brought to 2 N with sulphuric acid and steroids extracted three times by ethyl
acetatej steroid sulphates hydrolyse if allowed to stand overnight at 37°C.
Few (1961) described another method of hydrolysis using 2.5N sodium hydroxide}
hydrolysis was allowed to take place at 37°C for 15 minutes. No destruction of
the steroid molecule occurred with this method and hydrolysis was more complete.
The enzyme ^-glucuronidase is ideal for hydrolysis of the glucuronate conjugates}
acidity of the urine is usually adjusted to the optimal pH of the enzyme used and
the enzyme added, usually 500 Fishman units to each ml. of urine, and allowed to
act from few to 4.8 hours, usually 24 hours, according to the preparation used.
Maximal hydrolysis of 17-KS conjugates is achieved by -glucuronidase hydrolysis
of the glucuronates followed by a hydrolysis of the sulphates by one of the mild
procedures described. Some commercial ^-glucuronidase preparations were found to
yield only 65% or less of the glucuronates of 17-KS (Cohen, 1951} Glenn and
Nelson,/
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Nelson, 1953J Wotiz et al, 1957). Preparations of ^-glucuronidase obtained
from the molluscan viscera are highly active (Dodgson and Spencer, 1953)*
Some preparations of this enzyme, however, namely those obtained from the
visceral hump of the common limpet, Patella vulgata. provide ^-glucuronidase
5
as well as a sulphatase specific for 3^-sulphates of 5ct and steroids
(Roy, 1956; Stitch and Halkerston, 1956} Stitch et al, 1956). Moreover,
^-glucuronidase obtained from the Roman snail, Helix nomatia. contains
p-glucuronidase activity as well as sulphatases for both 3 j3-sulphates of
5a- and /^-steroids and 3o-sulphates of 5P-steroids (Leon et al, I960),
No sulphatase activity specific for 3a-sulphates of 5a-steroids (androsterone)
was discovered.
Hydrolysis is followed by extraction of the 17-KS into an organic solvent.
Ethyl acetate and benzene are popular solvents but it has been noticed that the
latter does not extract all 11-oxygenated 17-KS (Edwards, 1961) and that the
former extracts contain more contaminating substances.
The crude extract is then washed with alkali to remove phenolic steroids.
Qrekter and coworkers(1952) were the first to use sodium hydroxide for purification
of the extract.
Colour reaction is then applied to the alcoholic solution of the residue and
compared to a standard 17-KS, usually DHA. Although several colour reactions
have been used, the most commonly used is the Zimraermann reaction (Ziramermann,
1935) in which methylene groups adjacent to ketone groups react with m-dinitro-
benzene in strong alkali. Sodium hydroxide was first used, but it was noticed
that colour reaction with alcoholic potassium hydroxide is more stable than
alcoholic sodium hydroxide (Wilson and Carter, 194-7). Tetraraethylammonium
hydroxide renders this colour reaction even more stable and much less
sensitive to light (James and deJong, 1961). In 17-KS the active methylene
group/
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group is at C-16 and reacts with meta-dinitrobenzene producing a violet colour
with maximum extinction at 520 mp, (reaction 1, table l). This reaction could
be applied to steroids on paper chromatograms} non-polar steroids give a blue
colour, relatively polar ones a dirty grey colour, and 5'>-steroids a violet
colour. Although urinary 17-KS constitute the great majority of all urinary
substances giving this reaction (Bush, 1961), a few other chromogenic substances
with ketone groups remain in the extract after the alkali wash thus contributing
to the end result. Further modification of the shade and intensity of the
colour produced can also occur in the presence of ketone groups other than at
w
C-17 in the 17-KS molecules themselves, i.e. at C-3 and C-ll, as well as in the
presence of llp-hydroxy group. Multiple carbonyl groups have a summation
effect and hydroxyl groups inhibiting effect on the colour reaction (Edwards,
1961} Bush, 1961), For this reason elimination of the effect of the remaining
interferring material is often achieved by measuring the colour intensity at
the appropriate wavelength and at tiro other wavelengths equidistant from it and
applying an appropriate correction formula (Talbot ot al, 194-2} Engstrom
and Mason, 194*3} Allen, 1950)*
Other types of colour reactions have been used, e.g. the antimony
trichloride reaction (Fincus, 1943 b) in which all four saturated 3-hydroxy-17-KS
give a blue colour with a maximum extinction at 610 mp. Only faint colour is
given by DHA, while pregnanediol and other non-ketonic steroids as well as some
17-hydroxy C-19 steroids contribute to the colour produced (Edwards, 1961).
A third colour reaction is the Pettenkofer reaction originally described by
Pettenkofer (1844)• A blue colour, with maximum extinction at 660 mp., is
produced with 3 p-hydroxy- /^-steroids in the presence of furfural, acetic acid
and/
- 63 -
and sulphuric acid at 67°C. Munson and co-workers (194-8) applied this method
to estimate DM, the principal substance in urine estimated by this method.
Normal values of urinary neutral 17-KS differ in the hands of various
workers but a range of 6-25 mg./24 hours for adult males, 20-4.0 years old,and
3-20 mg./24- hours for females (Loraine, 1958) is accepted by most authors.
In patients with adrenocortical hyperfunction 17-KS level is generally increased
if androgen production is affected, since only 5-8$ of Cortisol is metabolised
as 17-KS (Sandberg et al, 1957 a; Edwards, 1961). In Addison'3 disease and in
pituitary disorders which affect ACTH release, 17-KS production is diminished.
The use of chromatography could separate 11-deoxy- from ll-oxygenated-17-KS
and this may be a more sensitive index of adrenocortical function which could
be helpful in differentiating normal values from those of Cushing's syndrome
(James, 1961), Goldzieher and Axelrod (1962) using paper chromatographic
analysis claimed that up to 90$ of the clinical total 17-KS may consist of
noh-specific chromogens. The specificity of 17-KS estimation is diminished
by the inevitable presence of artifacts in the final residue} moreover it
measures androgenic more than corticosteroid activity because only a small
percentage of Cortisol is metabolised as 17-KS. This means that 17-KS
excretion should be considered as a measure of the weakly androgenic secretion
of the adrenal cortex and not as a measure of overall adrenocortical activity.
Even as a measure of androgenicity the 17-KS are only a rough estimate, since
the individual compounds differ widely in their androgenic potencies. Thus
the usefulness of this estimation as an index of adrenocortical activity is only
limited to the finding of a gross departure from the normal.
In this study, however, a 17-KS method based on that described by James and
i




b. Group corticosteroids (see table 2)
The C-21 corticosteroid estimations should give a better idea of the
adrenocortical function. The chemical reactions of corticosteroids depend
upon the type of side chain attached to C-17. It must be noticed that,
unlike 17-KS, corticosteroids side chain is very labile in strong acid or
alkali solutions (Edwards, I960) and for this reason ^-glucuronidase hydrolysis
is often resorted to. These chemical reactions may be discussed under the
following headings.
1. IMuplng corticpgtprrtcte
Substances with o-ketol groups which include steroids with this functional
group at C-20jC-21 [-CQ.CHgOH] are reducing in nature. Talbot and co-workers
(1945) applied this fact to estimate total reducing corticosteroids in urine
containing this group using alkaline copper sulphate reagent. Heard and Sobel
(1946) used phosphomolybdic acid reagent and claimed an enhancement of the reaction
in the presence of /^-3-ketone group, and Chen and Tewell (1951) used a
tetrazolium salt (2:3:5 - triphenyl tstrazoliura chloride) in alkaline medium.
Corticosteroids estimated by this method are; Cortisol, cortisone, compound S
and their dihydro and tetrahydro-derivatives, DOC, compound B, compound A and
their dihydro- and tetrahydro-derivatives and aldosterone, (see reaction 2, table
l).
The alkaline copper sulphate and phosphomolybdic acid methods mainly
estimate unconjugated reducing corticosteroids and moreover these reduction
reactions in general can include estimations of other non-steroidal reducing
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alkaline hydrolysis 7.6 - 19.5 4.9 - 15.1
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purification. Thus due to the lack of specificity of these procedures
serious errors in calculations may result. Moreover, important metabolites
of Cortisol, e.g. cortols and cortolones, are not included in this estimation.
Because of all these disadvantages, these techniques are no longer popular,
The tetrazolium salts, however, especially 3,3 - dianisole bis-4.,A (3,5-
diphenyl) tetrazolium chloride (= blue tetrazolium), are very widely and
successfully used now, only after isolation of individual steroids by
chromatography, for detection and estimation of corticosteroids. They give
bright red or blue coloured formazans with a-ketol groups.
2. Foy^l4e^pgenj.c gtproidg
These are corticosteroids with a hydroxy —methyl group at C-Zl- adjacent
to either a ketone or another alcoholic group [-CO.CH^OH or -CHOH.GH^OH]
with or without a hydroxyl group at C-17. They can react with periodic acid
to yield one molecule of formaldehyde per molecule of corticosteroid.
Corticosteroids estimated by this method arej Cortisol, cortisone, compound S
and their dihydro- and tetrahydro-derivatives, a- and p-eortol, a- and p-
cortolone, DOC, compound B, compound A and their dihydro- and tetrahydro-
and 20-dihydro-derivatives and aldosterone (see reaction 3, table l). The
original technique based on the reaction of chroraotropic acid with formaldehyde
(KacFadyen et al, 194-5) was described by Lowenstein and co-workers (194&) and
was later improved and modified by Daughaday et al (194-8), Corcoran and Page
(194-8) and Hollander et al (1951). Formaldehyde is liberated from the
reaction mixture by steam distillation, trapped in sulphite solution and
allowed to react with chromotropic acid, giving a violet colour. Disadvantages
of this technique are many. First, the reaction is not specific} any
contaminating/
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contaminating compound with hydroxymethyl group adjacent to a ketone or
another alcohol group which could not be removed by preliminary washing can
give this reaction (Patterson, 1961). Secondly, some urinary contaminants
can bind formaldehyde inhibiting either its liberation or its reaction with
chromotropic acid. Thirdly, the technique is difficult to standardise
(Patterson, 1961) and adjustment of the acidity at the beginning of the test
to pH 1 leads to marked losses of the total metabolites of corticosteroids.
An advantage of this method, however, is that it estimates practically all
metabolites of Cortisol and corticosterone and none of their precursors.
Figures given by this method, 3-26 mg./24. hours for normal subjects, are often
higher than those given by other methods, and on the whole, on account of the
great disadvantages of this method it is abandoned nowadays.
3. gt(?ro^g
Similar to the previous method, periodate oxidation of C-21 steroids
with 21-raethyl~17,20 dihydroxy side-chain [-COH.CHOH.CH2] results in liberation
of acetaldehyde which can also be quantitatively estimated by a colour reaction,
This method first introduced by Cox (1952) measures only pregnanetriol (and its
11-keto derivative) and /\-pregneietriol and may be of value in diagnosis of
adrenogenital syndrome where deficiency of 21- or 11-hydroxylase enzymes in the
adrenal cortex results in blocking of Cortisol synthesis and increased excretion
of the metabolites of its precursors.
A. Porter-Sllber chromoaens (P-S chromogens)
These are corticosteroids with dihydroxy-acetone side chain [-COH.CO.CH^OH]
often called 17-hydrojycorticosteroids especially in the U.S.A. To avoid confusion
between this method and that described by Norymberski (see later) a better
terminology/
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terminology is 'Porter-Silber chromogens' or 'dihydroxyacetonyl steroids'.
This group of corticosteroids in alcoholic solution react with phenyl-
hydrazine in the presence of sulphuric acid to give yellow coloured osazones
with maximum extinction at 410 mp. The corticosteroids estimated by this
method, therefore, arej Cortisol, cortisone, compound S, their dihydro- and
tetrahydro-derivatives (see reaction 4., table l). This reaction was first
described by Porter and Silber (1950) but was applied in two different ways.
Reddy and co-workers (1952) extracted the free and conjugated corticosteroids
directly into butanol, the extract was subjected to a short step purification
and the Porter-Silber reaction carried out directly on the corticosteroids
contained therein. This method is rapid and simple but butanol contains
impurities which give positive Porter-Silber reaction and even when redistilled
butanol is used this method is still thought of as a crude method not to be used
for estimating normal levels or in research work but only suitable where
exceptionally high results of corticosteroids are expected (Patterson, 1961).
Glenn and Nelson (1953) however, performed this method by applying hydrolysis
of conjugates using ^-glucuronidase as the first step followed by extraction
of the corticosteroids into chloroform, purification by alkali wash and
florisil columns. The organic solvent for extraction could be ethyl acetate,
methylene chloride or ethylene dichloride and more purification could be
achieved by chromatographic separation of the corticosteroids. Patterson (19&1)
summarised the disadvantages of this method in two main points. First, only
the main group of Cortisol metabolites are estimated, while cortols and cortolones
for example are not included. Secondly, mar\y drugs interfere with the test e.g.
iodine,/
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iodine, potassitim iodide, quinine, sugars, ascorbic acid, paraldehyde, chloral
hydrate, sulphamerazine and senna. Nevertheless Patterson stated that with
careful attention to the details, this method, as far as adrenocortical function
is concerned, can provide the basis of a sound and accurate method for group
analysis better than any routine 17-KS method in accuracy and reproducibility.
Normal figures given by this method arej for the Reddy technique, 2.9-12.0
mg,/24 hours for males and 1,1-8.6 mg./24- hours for femalesj and for Glenn and
Nelson technique, 3.3-9.3 mg,/24. hours for males and 2.1-5.0 mg./2Z. hours for
females. As it is known that about one third of the Cortisol secreted by the
adrenal cortex is estimated as urinary Porter-Silber chrorogens (Forsham, 1962),
multiplying the figure obtained from urinary measurement by three yields the
approximate twenty-four hours adrenal secretory rate.
5. 17-^gtogpp;c fitqrpjdg (17-KGS)
*
It has been shown that three groups of corticosteroids can be oxidised by
sodium bismuthate to yield 17-KB (Norymberski, 1952$ Norymberski et al, 1953).
These groups were termed 17-ketogenic steroids, and are sometimes referred to as
17-oxogenic steroids (see reaction 6, table l). These three groups are; the
dibydroxyacetone group [-COH.CO.CH^OH] which includes Cortisol, cortisone, compound
S and their dihydro- and tetrahydro-derivativesj the 17,20,21-trihydroxy- group
[-GOH.CHOH.CH^OH] which includes the cortols, cortolones and pregnanetetrolj and the
17,20-dihydroxy~21-methyl group [-COH.CHGH.CH^] which includes pregnanetriol (and its
20p-hydroxy~isomer, 5a-isoraer, 5 a-2Op-hydroxy-isoraer, 5a-3P-hydroxy-isomer, and
5a-2Op-hydroxy-3P-hydroxy-isomer), 11-keto-pregnanetriol and /^-pregnenetriol.
The original method described implies oxidation of the urinary corticosteroids by
bismuthate carried out in 50& acetic acid, to 17-KSj hydrolysis of conjugates by
hot acid hydrolysis, extraction and application of Zimmermann reaction. If 17-KS
were/
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were estimated on another aliquot of the same urine, the difference between
the two estimations will give the value for the 17-KS formed by bismuthate
oxidation, i.e. the 17-KGS.
In 1955, the Norymberski group (Appleby et al) extended their research
a step further. They showed that sodium borohydride has marked reducing
properties on the earbonyl groups at C-ll, C-17, and C-20. Thus it can
transform the dihydroxyacetone group [-COH.CQ.CH^OHj to the 17,20,21-
trihydroxy group [-C0H.CH0H.CH20Hj and the 17-hydroxy, 20-keto, 21-aethyl
group [-COH.CO.CH^J to the 17,20-dihydroxy-21-methyl group [COH.GHOH.CH^]
as well as the 17-KS [-CO] to 17-hydroxysteroids [-C0H] (see reaction 5,
table l). They applied this finding to their previous technique. Thus
by applying sodium borohydride reduction followed by sodium bismuthate
(see reaction 7, table l), the naturally occurring 17-KS in urine will not
be included in the final result, while the 17-KS formed will be derived
from all 4- groups of corticosteroids containing a hydroxyl group at C-17
and accordingly this method estimates total 17-hydroxycorticoids, better
called total 17-ketogenic steroids (total 17-KGS), Thus this method will
estimate the groups and compounds mentioned in the previous technique plus
an extra group, the 17-hydroxy, 20-keto, 21-methyl group [-C0H.C0.GH ] which
includes 17a-hydroxypregnanolone (and its 5a-isomer and its 5u-3|i-hydroxy-
isomer), 17a-hydroxyprogesterone and the di- and tetrahydro-derivatives of
both 21-deoxycortisol and 21-deoxycortisone (see figure l), A great
advantage of this modification is that the initial reduction eliminates the
pre-existing 17-KS and thus one final colorimetrie determination is needed.
This increases markedly the precision of the technique. Another advantage is
that/
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that borohydride reduction also eliminates other non-specific ketonic chromogens
which could give a positive colour reaction. Potassium borohydride is cheaper,
less hygroscopic and as efficacious as the sodium salt.
Appleby and Noryraberski (1955) used borohydride and bismuthate in the
sequences oxidation-reduction-oxidation (see reaction 10, table l). The
resulting 17-KS formed are derived only from the 21-deoxvketola. i.e. 17-hydroxy,
20-keto, 21-methyl group [-CQH.C0.GH^J.
The same group of workers (iixley et al, 1961) devised a similar technique
to estimate ppyt^pogtepoqe aqd j,tg ^afolj^qg in urine. Thus they subjected
the urine to the sequencet reduction-oxidation (see reaction 14., table l) which
results in transforming the groups; -C.CO.CH^OH and -C.CHOH.CH^OH into C-2Q
aldehydes, which could be converted into the corresponding hydroxamic acids,
which in turn could be transformed into their purple ferric hydroxamates. This
technique estimates the compounds; DOC, compound B, compound A, their dihydro-
and tetrahydro- and 20-dihydro-derivatives and aldosterone.
Norymberski and Stubbs (1956) showed that the dihydroxyacetone group can
be specifically attacked by zinc. Subsequent oxidation by bismuthate (see
reaction 11, table l) leads to estimation of the 17,20-dihydroxy-21-methyl and
the 17,20,21-trihydroxy groups together with the pre-existing 17-KS. The
difference between this estimation and that of the original bismuthate method
gives en estimate of the important dihvdroxvacetone otquo.
Norymberski (1961) also showed that oxidation with chromic anhydride alone
converts all 17-hydroxyeorticosteroids and 17-hydroxyandrostanes to 17-KS (see
reaction 12, table l) thus the tot^ 17-KG3ti ^-KS an<* lYHwdTPmnflregteBSB
could be estimated at the same time by the Zimmermann reaction.
Although the original 17-KGS method is superior to the Porter-Silber
technique/
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technique at least as far as its being able to estimate more Cortisol metabolites
besides its being more simple, yet many drawbacks have been noticed. The
method as a whole suffers from two inevitable disadvantages; the first is that
it measures pregnanetriol and so this technique will be of limited value in
diseases such as the androgenital syndrome (Kent et al, 1963). Secondly, a
considerable lack of precision appears with subnormal corticosteroid levels in
urine. The use of bismuthate further adds to the disadvantages of the method.
Few (1961) summarised these disadvantages. They include the deleterious effect
on DHA and interference with 17-KS estimation, both of which, however, could be
avoided by the use of borohydride. Serious underestimations occur in the
presence of excess sugars in the urine. This could also be avoided by using
larger amounts of bisrauthate. Duration of use of bismuthate is also important
since some batches could transform llp-hydroxy-17-KS to ll-keto-derivatives.
It is known that llji-hydroxy-etiocholanolone and its 5a-isomer, llp-hydroxy-
androsterone, are the two 17-KS which should be formed in this reaction. But
it was observed that in the sequence borohydride reduction-bisnruthate oxidation-
9—11
acid hydrolysis 11-oxoetiocholanolone and /\ ' -etiocholanolone were formed
by oxidation and then dehydration, by hot acid hydrolysis, of the llp-hydroxy-
etiocholanolone initially formed. This could be avoided by using ^-glucuronidase
or periodic acid for hydrolysis. It was also shown that ll^-hydroxy-otiocholanolone
can be formed from corticosteroids not possessing oxygen atom at C-ll, and that
this can be included in the final result thus severely limiting the accuracy of
the quantitative evaluation. Another disadvantage of bismuthate oxidation is
that only about 80$ could be recovered from the starting material. A last
disadvantage in the use of bismuthate is the variation of reactivity with the
type/
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type of bismuthate used.
Tompsett and Smith (1955) were the first to use periodste oxidation for
elimination of all the disadvantages of bismuthate, but they included a hot-
acid hydrolysis step between the reduction and oxidation steps and they
conducted the periodate oxidation in a strongly acid medium. Few (1961)
believes that these acid conditions are likely to cause the partial dehydration
of lip-hydroxysteroids. He, therefore, used sodium meta-periodate and
alkaline hydrolysis. Periodate alone transforms only the 17,20,21-trihydroxy
and 17,20-dihydroxy, 21-methyl groups to 17-KS (see reaction 8, table l) but
if the sequence: sodium borohydride - sodium meta-periodate is applied all
four 17-hydroxycorticosteroids are transformed to 17-KS (see reaction 9» table
l). Thus Few estimated the total 17-KGS by applying sodium borohydride then
sodium meta-periodate followed by mild alkaline hydrolysis and extraction
into ether. The extract was purified by chromatography, partition column
using Celite, to separate 11-deoxy- from 11^-hydroxy 17-KS, Using this method
all the disadvantages of using bismuthate were eliminated and if any formates
of Hj5-hydroxy-etiocholanolone were formed they did not survive the alkaline
hydrolysis and were transformed back to llp-hydroxy-etiocholanolone. But still
pregn-5-ene-triol could be detected which might have formed some artifacts, and
the llp-etiocholanolone could be formed from 11-oxopregnanetriol thus emphasising
the fact that this method also will be of limited use in diseases like the
adrenogenital syndrome.
Rutherford and Nelson (1963), applying the sequence sodium borohydride
reduction - sodium raeta-periodate oxidation proposed by Few (1961) with chloroform
as the extracting solvent, noticed marked improver""«t in reproducibility over the
bismuthate/
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bismuthate method. James and Caie (1964) reported that the method of Few
compared to estimations of Cortisol production rate by labelied Cortisol
studies is satisfactory as regards precision and accuracy, but the correlation
became poor as the secretion rate increased.
Michelakls (1962) resorted to a preliminary step of separating urinary
17-KS from urinary C-21 corticosteroids by using benzene-water partition; 17-KS
and contaminating material were extracted in the benzene layer and C-21 steroids
were separated into the water layer. This was followed by the sequence sodium
borohydride reduction - periodate oxidation and the two llp-hydroxy-17-KS formed
were extracted into either benzene, diethyl ether or ethylene dichloride and the
estimations performed using the Zimmermann reaction. High recoveries and
better reproducibility and specificity were also reported by this method; only
less than 5$ of the Cortisol metabolites, excreted as 11-oxygenated 17-KS,
will not be measured.
In most instances 17-KGS and total 17-KGS methods will give identical
results since the contribution of the 21-deoxyketols in the normal subject is
negligible (Norymberski, 1961). But either of them should give higher results
than the Porter-Silber method; the difference should mainly represent the
contribution of cortols and cortolones. There are many advantages of those
indirect methods of corticosteroid estimation, as a whole, over the direct
Porter-Silber one. First, the reaction sequence to which the steroids are
subjected ensures a considerable degree of specificity especially when it involves
both reduction and oxidation steps. Secondly, the labile acid and alkali
sensitive side-chain is degraded into a stable 17-carbonyl group which simplifies
subsequent manipulations. Thirdly all the known major metabolites of Cortisol
are/
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are estimated by these methods. Lastly all these metabolites are converted
into a mixture of llp-hydroxy-etiocholanolone and llp-hydroxy-androsterone
of which the latter is only a minor component, or may even be lacking altogether
in some cases. These two compounds have the same chromogenicity in the
Zlssermann reaction, which enables accurate estimates of the excretion of
Cortisol metabolites to be made.
Normal levels of 17-KGS, which could also represent total 17-KGS
(Norymberski, 1961), are 9.6-19.2 mg./2£ hours for males and £.6-13.4, mg./2£
hours for females (Norymberski et al, 1953)• Figures given by the method of
Few (1961) are nearly similar; namely 7.6-19.5 rag,/2£ hours and £.9-15.1
mg,/2£ hours for males and females respectively. Multiplying the estimated
figures by two gives an approximate value for twenty-four hour secretory
rate of Cortisol (Cope, 1961; Forsham, 1962).
In this study total 17-KGS were estimated by a method based on that
described by Few (1961) and compared to other indices of adrenocortical function.
6, <?9a,iw»teti gwtisgstwgtaa
Very recently Zurnoff and Bradlow (1963) isolated urinary conjugates of
corticosteroids as a group by a method based on the ability of albumin to bind
steroid conjugates. Thus albumin was added to urine and co-precipitated with
ammonium sulphate. Precipitated albumin was separated by centrifugation and
conjugates of injected C"^-labelled Cortisol were eluted from the protein by
denaturation with organic solvents. The authors of this method claimed better
recovery of oortisel conjugates than the usual acid or enzyme hydrolysis
procedures. The method is simple, not expensive, time saving and may well be
suited for routine use.
u/
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II. Individual steroid eatimatlons
a. Cortisol excretion
The estimation of the unmetabolised primary hormone, Cortisol, as excreted
unchanged in urine is of a great biological significance. This is usually
achieved by extraction of the acidified urine, with chloroform, ethylene
dichloride or methylene dichloride, and the application of chromatography. The
use of C"^-labelled Cortisol, to allow estimation of losses during the procedure,
renders the quantitative estimation (usually carried out by the Porter-Silber
reaction or fluorometrically) very accurate.
Only a very small proportion of the endogenous Cortisol is excreted
unchanged in urine; and the values given by various workers range between
G-250 pg./24 hours (Burton et al, 1951 b; Cope and Hurlock, 1954; Bongiovanni,
1958; Ross, I960; Kernel and Hill, I96I; Dohan et al, 1962; Rosner et al,
1963). This estimation is the urinary reflection of the biologically active
unbound plasma Cortisol. Mills and co-workers (1959) found that circulating
Cortisol was 95% bound when the plasma concentration was 10 pg./lOO ml.,
80% at plasma concentration of 4.0 pg-,/100 ml. and only 72% at a plasma concentration
of 80 pg./lOQ ml. Assuming a glomerular filtration rate of for example 100 ml.
/minute, at plasma concentration of 10 pg./lOO ml. and 95% protein binding only
0.5 pg. of Cortisol is filtered per minute, while at plasma concentration of
80 pg./lOO ml. and 72% protein-binding 22.4 pg» of Cortisol is filtered per
minute. Thus there is a forty-five fold increase in the filtered load for
an eight-fold increase in plasma concentration.
Even though 80-90% is reabsorbed from the renal tubules in normal subjects
(Schedl/
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(Schedl et al, 1959) there is sufficient urinary loss to afford a sensitive
indicator of free physiologically active plasma Cortisol, Cope and Black
(1959 a) also suggested that detection of increased excretion of unmetabolised
Cortisol in the urine may be a more sensitive index of raised blood levels
than the measurement of the total urinary corticosteroids. Similarly in cases
of Cashing^ syndrome, there is an increase in total plasma Cortisol level,
disproportionate increase in the unbound fraction, increased excretion of
metabolites and a disproportionate and very significant increase of the excretion
of unmetabolised Cortisol (Greaves and West, 1960} Kornel and Hill, 1961).
This is presumably because of the weaker binding of large quantities of the
circulating Cortisol to albumin and the subsequent rise in glomerular filtration
rate. Contrary to the belief that unmetabolised Cortisol is excreted
unconjugated (Peterson et al, 1955} Neher, 1959) recent studies proved that
it could be conjugated as glucosiduronate or sulphate at C-21 (Pasqualini,
1960} Pasqualini and Jayle, 1961).
Very recently, Rosner and co-workers (1963) estimated unraetabolised Cortisol
excretion using glass fibre chromatography and corrected for losses by C^-
labelled Cortisol. Besides confirming the clear separation between normal
values and those found in adrenocortical hyperactivity states, they also
observed that no difference existed between figures of males and females, no
diurnal variation existed in the pattern of unmetabolised Cortisol excretion and
marked daily variations existed in cases of Cushing's syndrome. They enumerated
the advantages of this test. As a diagnostic tool, it clearly separates normal
values from those found in adrenocortical hyperfunction and also differentiates
cases/
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cases of Cushing's syndrome from obesity, the latter with normal excretion of
unmetabolised Cortisol, Secondly, it is more sensitive than other methods of
measurement of adrenocortical function including estimations of the biologically
active fraction of plasma Cortisol, Thirdly, conditions like thyrotoxicosis
may lead to increased hepatic enzyme activity leading, in turn, to accelerated
degradation of Cortisol with compensatory increase in Cortisol production to
values well within the range found in Gushing's syndrome. The normal excretion
of unmetabolised Cortisol in such conditions excludes the diagnosis of Cushing's
syndrome. Lastly it is superior to plasma Cortisol estimations where emotional
upset may cause transient high values which would not be reflected in 24 hour
urinary collection,
b. Gggrefaon Of i,nd.y/idua,! metqbolj.toq of coyt^pl
This line of study is of extreme importance in the knowledge of the various
metabolic pathways of Cortisol, It is also important in determinations of specific
activity of the various metabolites necessary for estimating Cortisol production
rate by the radioisotope studies (see later). Hydrolysis and extraction of
corticosteroids are carried out as previously described. It should be noted here
that polarity of steroids increases by increase in number of ketone groups and
increases more with increased numbers of hydroxyl groups, and that solvents also
show a gradation in polarity from the unsubstituted saturated hydrocarbons such
as light petroleum through the aromatic hydrocarbons, benzene, ethylene dichloride,
ethers, ketones, ethyl acetate, chloroform and alcohols to water (Brooks, 1961),
Steroids are iaost soluble in solvents of similar degree of polarity. Apart
from using this information to extract steroids, it can be used also to separate
them/
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them by applying two immiscible solvents to the steroid mixture one of which
should be most suitable for extracting a particular steroid, i.e. with a high
partition coefficient for that steroid, a method used in "counter-current
separation".
Separation, however, is best achieved by partition chromatography, either
on column or better still and easier on paper together with a standard steroid
on a separate lane. Two systems of paper chromatography are often usedj the
Bush system (Bush, 1952) is based on a volatile solvent as the stationary phase,
namely methanol, and impregnation of the filter-paper occurs entirely via the
vapour phase. This is in contrast to the methods developed by Zaffaroni
and his co-workers (Burton et al, 1951 a) where paper is first impregnated
with a non-volatile solvent to provide the stationary phase of the chromatogram.
The disadvantage of the first system is its great sensitivity to temperature
changes and that of the second system is the difficulty in removing the
stationary phase at the end of the run. Detection of the steroid with the
/^-3-ketone grouping, characteristic of Cortisol and other active adrenal
steroid hormones, on the chromatograms can be achieved by visualising them as
dark spots on exposure to ultraviolet light of wavelength 25Z mp. Other
steroids can be detected on paper by the Zimmermann reaction or better still by
blue tetrazolium. -^xantitative estimation of the steroid can be done by elution
of the part of the chromatogram containing it in a suitable solvent, the eluted
steroid then being estimated photometrically in solution using the absorption or
fluorescence of the compound itself or that of a reaction product. Alternatively
the steroid can be measured by treating the chromatogram with reagents which form
coloured/
coloured or fluorescent spots with the compounds on paperj the intensity of the




These, as in the case of urine studies, were the oldest methods for
estimating adrenocortical activity. They included prolongation of the life
of adrenalectomised dogs by injection of serum (Anderson and Haymaker, 1938)
and the cold protection test in rats (Vogt, 194-3)* etc. Today these tests
also have given way to the more accurate and simpler chemical tests.
B, Chsmipfrl tggta
I. MqthoflB fo:T tHe de^epmin^tj,op of ccrti,po?t^ol4g pp cort^o], i,p
In bloodyunlike in urine, Cortisol is the main corticosteroid, constituting
over 80$ of the circulating corticosteroids (Mason and Sprague, 194-8; Bush
and Sandberg, 1953i Romanoff et al, 1953; Hudson and Lumbardo, 1955). Bush
and Sandberg (1953) applied chromatographic methods to separate Cortisol in
peripheral blood and identified this compound by several criteria including
light absorption, reaction with tetrazolium salt, fluoresence in sodium
hydroxide and degradation to the expected 17-KS.
Methods for estimation of adrenocortical activity in blood are very limited;
they could be either crude methods of estimating corticosteroid levels or more
refined for the estimation of Cortisol levels after chromatographic separation.
As the concentrations of steroid in peripheral blood are very low, it is particularly
important from the analytical point of view, especially in Cortisol estimations,
that any degree of contamination or interference should be minimised,
a. of
Standardised times are important since a diurnal rhythm of Cortisol level
in blood is well established (Lewis, 1957). Blood from fasting patients is
preferred/
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preferred to avoid interference by lipid material in the plasma, especially
with some of the refined techniques (Braunsberg and James, I960). An
anticoagulant is usually used, most often heparin. Oxalates may be used,
but citrates interfere with coloriraetry in the method of Kelson r^ad Samuel
(1952).
Plasma,not serum, should be used since redistribution of steroids occurs
between the red cells and plasma during the clotting process and low levels
have been reported in serum (Bongiovanni, 1954-). Eik-Nes and co-workers (1953)
stated that migration of steroids into red cells takes place if blood is allowed
to stand, an observation confirmed by Peterson and his associates (1955)
using C"^-labelled Cortisol. DeMoor and Meulepas (1962) also showed that
increased removal rate of corticosteroids from plasma was under certain
circumstances due to an increased storage of plasma corticosteroids within or on
the red blood cells. Whole blood also is unsuitable for estimation of
corticosteroids, since it is very difficult to extract Cortisol from lysed cells
(Bush, 1957). Once separated from the blood cells, the plasma can be stored
at 4°C for a short time (Kelson et al, 1951) or deep frozen for longer periods
(Harwood and Mason, 1956), but it must be noticed that some denaturation of
protein occurs on deep freezing (Brown et al, 1957).
b. E^traq^lon of yoyt^ost^rpi^s
There is no evidence to indicate that precipitation of proteins offers any
advantage over direct extraction. Pre-wash of plasma to remove lipid with carbon
tetrachloride (Silber and Busch, 1956), iso-octane (Sllber et al, 1958) or
petroleum ether (Moncloa et al, 1959) prior to extraction, produces considerably
cleaner/
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cleaner extracts. The solvent of choice for extraction is methylene chloride,
because of its greater stability (Bongiovanni and Eberlein, 1955j Silbar and
Busch, 1956). One extraction with 5 volumes of methylene chloride yields about
98$ of the Cortisol in plasma (Peterson et al, 1957 a). Ethyl acetate and
chloroform (Kelson and Samuels, 1952) may be usadj two extractions with 1.5
volumes of chloroform appear to be adequate (Harwood and Mason, 1956).
Metabolic products of Cortisol, like the tetrahydro-derivativea, occur
mostly in the conjugated form in blood. They are thus water soluble and are
not extracted by these lipid solvents.
Dialysis procedures, which are supposed to provide an extract which is
relatively free from lipid and pigment, do not offer any great advantage
over straight-forward extraction methods? further purification is still desirable.
The use of solvent partition, especially benzene/water partition, achieves
considerable purification of Cortisol (Eik-Nes, 1957). To remove some steroidal
estrogens and other phenolic and acidic compounds, an alkali wash of the organic
solvent extract is incorporated in some methods. One-fifth to one-tenth volume
of 0.1N sodium hydroxide is commonly used (Silber and Porter, 1954-J Silber and
Busch, 1956). Potassium carbonate and sodium carbonate were used (Bush and
Sandberg, 1953) but none of these methods effectively removes the less polar
estrogens such as estrone and estradiol.
Crude chromatographic purifications on "Florisil", a commercial magnesium
silicate preparation (Nelson and Samuels, 1952), magnesium silieate/Celite
(Nelson and Samuel3, 1952), reverse phase partition (Morris and Williams, 1953 b)
and silica gel columns (Bush and Sandberg, 1953) have been used in some methods.
It/
- 83 «
It is not known whether or not these offer advantages over simple solvent
partitions. On the other hand they need careful preparation and variable
losses may occur. However, among these crude chromatographic purification
methods, that using silica gel offers advantages of simplicity and reproducibility,
d. Separation of Cortisol
The more refined methods resort to separation of Cortisol by chromatography.
Generally speaking, fractionation of the steroids is brought about by adsorption
and/or partition chromatography. In column adsorption chromatography, a mixture
of steroids in solution is passed through a finely divided adsorbentj the various
steroids are adsorbed at different distances along the length of the column, and
may be separated, either by cutting the column and dissolving each steroid in a
suitable solvent, or by passing a solvent through so that the various steroids
pass out of the bottom of the column in an order which is dependent upon their
physical properties and the adsorption of the column. In column partition
chromatography, the column is impregnated with one solvent (the stationary phase)
and the mixture of steroids, dissolved in a second solvent (the mobile phase), is
passed through it. The steroids are separated in an order depending not upon
the adsorption but upon their relative solubilities in the two solvents. This
principle is also applied in paper partition chromatography, where filter paper
is used as the support for the stationary phase.
Column adsorption chromatography, e.g. silica gel adsorption columns (Sweat
1954. b) has been used for determination of steroids in blood (Sweat, 1955), but
it did not give reproducible results; "tailing" occurred and the steroid fractions
from plasma extracts were contaminated with other compounds which interfered
with subsequent determination (Takeda, 1956).
Column/
— 8,4 ••
Column partition chromatography was first used by Morris and Williams
(1953 b) to separate adrenocortical steroids. They used columns containing
a stationary phase of 25$ aqueous ethanol with toluene as eluent. Excellent
recovery of Cortisol was achieved by these methods, but exceptionally high
values of corticosterone plasma levels were obtained. Many useful systems
have, however, been derived from this method, and their application to blood
extracts has met with some success (Ayres et al, 1957; Braunsberg and James,
I960).
Paper partition chromatography, on the other hand, has been used
extensively for separation of Cortisol and other steroids in blood. Crude
plasma extracts have been fractionated on either the Bush (Bush, 1952) or the
Zaffaroni (Burton et al, 1951 a) systems. The latter are capable of handling
larger quantities and thus are more suitable for relatively impure extracts, and
offer advantages for larger blood volumes.
The use of paper chromatography presents two difficulties. First, the
value of the "blank" is often high and has to be reduced by adequate washing
of the paper before use, to ensure that the blank is sufficiently low and
uniform over the length of the paperj secondly, the problems of determination
of steroids in situ after chromatography or quantitative elution from paper
prior to assay, which in most cases still leads to a lower degree of precision
than does, for example, the use of partition columns. However, trace amounts
of isotopically labelled steroids, added to blood before extraction, help to
obviate this difficulty (Avivi et al, 1954; Peterson, 1957; Bondy and Upton,
1957). Paper chromatography on the other hand offers an advantage when large
numbers of samples are to be analysed.
Counter/
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Counter-current distribution which has been applied to urinary extracts and
extracts from adrenal vein blood was not applied to peripheral blood. Counter-
current separation of a large number of samples, however, is inconvenient and time
consuming.
e. Determination of corticosteroids (see table 3 and 4-)
1.
As in the case of urine, periodic acid can affect oxidative release of one
formaldehyde molecule per molecule of steroid containing a hydroxymethyl group at
C-21 [-CHgCH], Corcoran and Page in 194-8 published a method based on this
principle for determining corticosteroid levels in plasma and urine. They
extracted heparinised plasma with acetone after precipitation of plasma proteins
by an alcohol-ether mixture, periodic acid was added and the formaldehyde liberated
estimated after reaction with chromotropic acid. This method, although very
simple, is nonspecificj phospholipids, traces of which could not be eliminated
produced formaldehyde, and other steroids containing the C-21 hydroxymethyl group
also produced formaldehyde. Thus, values given by this method were very highj
110-4.20 pg./lOO ml. and this method is no longer used.
2. Ultraviolet absorption methods
Light absorption at 24.0 mp. is typical of /^"-3-ketosterolds. However,
reagent background, other steroidal and non-steroidal compounds may give absorption
in this region, necessitating a considerable degree of purification. Also, the
molecular extinctions are lower than those produced in some colour reactions,
necessitating the use of larger blood volumes (tfeichselbaum and Margraf, 1955).
3. Colour reactions
i, Porter-Sllber reaction. The alcoholic solutions of steroids containing
the dihydroxy-acetone group, with some degree of specificity, react with phenyl-
hydrazine/
Table (3)
Methods for estimation of oortiooateroida in plasma
Author Sample Extraction Purification Determination No. of Age
(years)
Sex Time Value (pg./lOO ml.)
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hydrazine in sulphuric acid yielding yellow coloured osazone derivatives with
peak absorption at 410 rap (Porter and Silber, 1950; Silber and Porter, 1954)*
In normal persons, Cortisol accounts for approximately 90$ of the unconjugated
plasma corticosteroids that give this reaction (Peterson et al, 1955) and the
unconjugated dihydro-derivative'accountsfor most of the rest of them. Steroids
other than Cortisol with 20-keto-17,21-dihydroxy grouping may contribute to
this colour reaction and so do a-p-unsaturated ketones like compound S and
even non-steroidal compounds such as sugars, ascorbic acid, aldehydes, ketones,
quinine, colchicine, potassium iodide, chloral, paraldehyde, chlorprornazine,
sulphamerazine, bilirubin, etc. (Braunsberg and James 1961). Thus Cortisol
can sometimes account for as little as two-thirds or even one third of the
Porter-Silber colour produced by plasma extracts (Bayliss and Steinbeck, 1953)•
Accordingly Allen's correction formula was frequently used to eliminate or
minimise this source of error (Allen, 1950). A related reaction with
2,4-dinitrophenylhydrazine is more sensitive but less specific (Gornall and
MacDonald, 1953)? most steroids produce considerable colour, and absorption
peaks are not sufficiently different to allow determination of individual compounds.
The use of these methods applied to crude preparations from blood is,
therefore, not likely to yield meaningful results, but they may be useful after
separation and careful purification. Methods using the Porter-Silber reaction
include Nelson-Samuels method (Nelson and Samuels, 1952), which needs considerable
training and care but has low specificity for Cortisol and is not very sensitive?
the lowest measurable blood concentration is 5 pg./lOO ml. It can reflect
grossly increased or decreased adrenocortical activity but is not suitable for
precise/
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precise and accurate determination of Cortisol,
Silber and Porter (1954-) suggested a method not involving chromatographic
purification, and using direct extraction of corticosteroids into the Porter-
Silber reagent. Its sensitivity and specificity are not better than the
Nelson-Samuels method, and its precision remains low at low levels; this
is why the originators of this method added 5 pg. Cortisol to the extract,
to increase the sensitivity of the method, and subtracted this amount later
from the final result,
ii . Reduction of "blue tetrazollum" (3:3'-dianisole-4.:4 '-3:5-diphenyltetrazolium
chloride) in alkaline solution, by a-ketols (leader and Buck, 1952), to purplish
or mauve-coloured water-insoluble pigments called formazans was applied to the
determination of Cortisol and other corticosteroids in peripheral blood
(Chen et al, 1955). Sodium hydroxide, choline or tetramethyl-ammonium hydroxide
were used to provide an alkaline medium. Although many steroids not containing
the a-ketolic grouping react more slowly, these do not usually interfere with
determination of adequately purified Cortisol. Thus, the sensitivity of this
method slightly exceeds that of the Porter-Silber reaction, but its use for
crude blood extracts (Weichselbaum and Margraf, 1955) must be condemned since
it has low specificity, Elution of the chromatograms either precedes (Vogt,
1954-) or follows (Cope et al, 1955) reaction of the steroid with the tetrazolium
salt, or the paper may be added to the reagent (Chen et al, 1955). Sensitivity
of these methods is reduced by the paper blank, and the method is thus difficult
to apply to the small amounts of steroid available from peripheral blood,
iii. R?a<?Vi.op yi^h j-pofli<?qtfc4<? hyflragjfle of Zf-3-ketosteroids produces
hydrazones with absorption maxima at 380 mjx. (Umberger, 1955), and was suggested
as /
as a basis for determining physiologically active corticosteroids in plasma
(Vfeiehselbaum and Margraf, 1957)# The sensitivity of this method is considerably
lower than that based on direct ultraviolet absorption, but the difference in
the rates at which the various ketones condense with this reagent, and in the
absorption maxima, lend some specificity to the method# Compounds other than
a-p-ketones may, however, contribute to the reading at 380 mp.
4# F^orprretpip
Cortisol and corticosterone undergo reactions in alkaline media (Bush, 1952j
Abelson and Bondy, 1955) and sulphuric or phosphoric acid (Wintersteiner and
Pfiffner, 1936; Sweat, 1954 a; Goldzieher et al, 1954; Goldzteher and Besch,
1958; Kalant, 1958) with the formation of unknown products, which can be measured
fluorometrically. Fluorescence in alkali is specific to A^-l-ketones
(Bush, 1952) and high specificity of fluorescence in acid requires a /^-3-ketone
group and a hydroxyl group at C-ll (Sweat, 1954 a)# Interference by impurities
also occurs but careful preparation and purification of the samples and the
attention to details of fluorescence development, activation and measurement
may reduce any interference. The availability of highly sensitive phot©multipliers
makes it possible to use these methods for very dilute solutions, and the
fluorescence is directly proportional to concentration when the extinction is
0,05 or less (Braunsberg and Osborn, 1952). This is the range of concentrations
in which absorptiometry methods become inaccurate. The use of fluorometric
techniques, therefore, seems attractive for work with small quantities of steroids
such as those present in blood.
Fluorescence reactions in alkaline or acid media can be applied to steroids
on paper after chromatography (Bush, 1952; Zaffaroni and Burton, 1951) or in
solution (Abelson and Bondy, 1955; Sweat, 1954 a; Goldzieher et al, 1954)*
Fluorometric methods can thus be applied with success to purified fractions from
human/
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human peripheral blood, but their use for crude plasma extracts raises problems
of specificity. The introduction of a simple and rapid technique using
fluorometric methods for the estimation of Cortisol and corticosterone levels
in crude extracts of peripheral blood, by making use of special curves to
exclude interfering substances (Osman, 1961), was a great achievement towards
increasing the specificity and simplicity of these methods.
Methods involving fluorometric determinations include that of Silber
et al (1958). In this method a minimum of purification is adopted and the
method depends almost entirely on the specificity of the fluo.vescence reaction.
Although high precision, accuracy and sensitivity were described for this method,
'residual fluorescence' appears to be fairly constant, reviving the problems
of specificity, and so these methods may be useful for following changes in
plasma levels of Cortisol, or only employed after separation of Cortisol in
silica gel adsorption columns, paper partition chromatograms or Gelite partition
columns.
For separation of Cortisol, adsorption on silica gel has been used (Sweat,
1955)• Florisil columns were used prior to silica gel chromatography (Ely
et al, 1958), but unknown contaminants lead to lowering of the specificity of
this method. This, together with poor reproducibility, render the use of
this method very limited. Celite partition chromatography (Braunsberg and
James, I960) of Cortisol is lengthy and exacting and liable to interference by
impurities. Taper chromatographic methods were used by some workers to separate
Cortisol. Lewis (1957) employed a preliminary reverse phase chromatogram to
remove less polar contaminants from plasma fractions, followed by a benzene/5
methanol chromatographic system. The steroids were determined by sulphuric
acid fluorescence after elution. In other similar methods (Bondy et al, 1957;
Bondy/
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Bondy and Upton, 1957) steroids were deterrained by estimating their fluorescence
in potassium t-butoxido and radioactive steroids were added to the plasma to
allow for losses in the isolation procedures. Specificity of these paper
chromatographic methods depends upon the resolving power of the paper system and
the fluorescence technique. High precision was described for these methods, and
they are reasonably specific for Cortisol, but high sensitivity is achieved
only when paper blanks are sufficiently low or constant.
5. j qtof9g«?hta M&bgflft
These were first introduced by Morris and Williams (1953 a). Although this
technique gave recoveries of 8C$, it has not found further application because
it requires critical purification of each compound.
6. Fwttofla
There are three methods utilising radioactivity measurements for determination
of corticosteroid levels in blood. The first involves the addition of a known
amount of isotopically labelled steroid to the sample, and radioactivity measurement
of the final fraction submitted to quantitative chemical analysis. This
constitutes an internal standard to correct for all losses occurring during
chemical manipulations. Thus, in those methods, manipulations need not be
quantitative resulting in saving of time, and the assessment of accuracy is more
valid than that based on conventional recovery experiments. Greater precision
can be achieved if the quantity of tracer compound added is sufficiently small
to be ignored in the final determination. This requires tracers of very high
specific activity. This method has been applied to the determination of Cortisol
in plasma (Bondy et al, 1957).
The second application of tracer isotopes is in quantitative reaction of the
steroid with a suitable reactive reagent to yield a chemically stable derivative,
the/
the radioactivity of which is a measure of the amount of steroid present. The
reaction in this method must be highly specific, or a rigorous purification
procedure must be adopted to isolate the required compound, Acetylation with
C^-acetie anhydride (Berliner, 1957j Hollander and Yinecour, 1958), or the
35
reaction with 8 -labelled-'pipsan1 (p-iodophenyl-sulphonylic acid anhydride)
(Bojesen, 1956) followed by paper chromatography were applied to the determination
of Cortisol in plasma,
A combination of the previous two methods utilising two different and
distinguishable radioactive isotopes, one for chemical reaction with steroids
and the other for correction of losses during the procedure, is called the
•double tracer technique• and can offer high precision, accuracy and sensitivity
(Avivi et al, 1954.), A third application of the radioisotopes was demonstrated
by Murphy and co-workers (1963), These workers made use of the steroid
binding capacity of the plasma, by adding increasing amounts of unlabelled
Cortisol to an equilibrium dialysis system containing a standard plasma and a
constant amount of C^-labelled Cortisol, This led to decrease in the proportion
II
of the percentage of protein-bound C-labelled Cortisol from which a standard
curve could be drawn. The plasma to be tested was similarly treated, and its
Cortisol content could be determined from the standard curve. The authors of
this method reported high degrees of reproducibility and specificity for
Cortisolj the method was not affected by drugs or haemolysis. Recoveries were
91$, and only 1 ml, plasma was required. Its precision was high at low levels
(0-10 pg,/l00 ml.), and many samples of blood could be estimated at a time which




Examination of table 3 and table 4. reveals that the methods employing
the Porter-Silber reaction give similar means and ranges, and that techniques
employing careful chromatographic separation of Cortisol produce mean values
which are slightly lower than those obtained by the cruder methods. It must
be noted, however, that no appreciable difference between sexes could be
demonstrated (Bliss et al, 1953; Lewis, 1957; DeMoor at al, I960 b), although
some data suggest that Cortisol values in women may be lower than in men
(Bondy and Upton, 1957).
In summary, the inclusion of an adequate chromatographic stage appears
to be necessary at present, if reliable estimation of Cortisol in blood is to
be made. Since small volumes of blood are used, the question of sensitivity
is important. Isotopic techniques are capable of the highest possible
im¬
precision and sensitivity. Also, the sensitivity of the fluremetric methods
is relatively high. The development of methods for the determination of
Cortisol in plasma has been prompted to a large extent by the desire to obtain
a chemical measure of the hormonal activity to which tissues are subjected.
However, other factors, e.g. the diurnal rhythm, variation in response to
stress and emotional upsets, day-to-day fluctuation of plasma levels, function
of the thyroid gland and liver, and the extent of protein-binding of plasma
corticosteroids, must modify our concept of the relationship between these
chemical methods and the biological activity of corticosteroids. Therefore,
the interpretation of plasma steroid levels must be made with caution, since




n* Methods for the determination of plasma-protein binding of Cortisol
Soon after the discovery that Cortisol and other corticosteroids circulate
in the plasma bound to proteins, and with the knowledge that the organic solvents
used in the classical methods of estimation of Cortisol level in blood extract
both the bound and unbound Cortisol, several methods were proposed to estimate
the degree of binding of Cortisol and to correlate it, and apply it as a
diagnostic measure, to the various clinical dysfunctions of the adrenal
cortex. The oldest of these methods (Eik-iies et al, 1954. b) was based on the
difference in 'solubility1 of steroids in saline and albumin solutions. Other
methods were based on dialysis of plasma (Bush, 1957; Qaughaday, 1958 a;
Slaunwhite and Sandberg, 1959; Sandberg and Slaunwhite, 1959); ultraviolet
spectrophotometry of steroids containing the Z^-3-keto group (,/estphal,
1957); electrophoresis of the plasma and separation of the various protein
fractions and identification of the steroids attached to them (Westphal et al,
1955; flaughaday, 1958 b; Slaunwhite and Sandberg, 1959; Sandberg and
Slaunwhite, 1959) or ultrafiltration of the unbound fraction and estimation
of its proportion to the total Cortisol in plasm (Sandberg et al, 1957 b;
Chen et al, 1958; mis et al, 1959),
The method based on solubility did not give a true picture of the binding
in plasma, since Cortisol in particular is mainly bound to globulin, and that
based on ultraviolet absorption showed a marked overlap of the steroid peaks
in the ultraviolet spectrum. All the previously mentioned methods, however,
were only either qualitative for the detection of the unbound fraction of
Cortisol, or at the best semi-quantitative.
More recently, Mills and his associates (Mills et al, I960; Chen et al,
1961;/
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1961 j Mills, 1961 aj Mills, 1962) improved the ultrafiltration technique
to measure the degree of Cortisol binding in a truly quantitative manner.
These workers added C"^-labelled Cortisol in a small quantity, so chosen
that the ratio of bound to unbound Cortisol was not disturbed even at the
lowest concentration of steroid, i.e. they added a small amount of Cortisol
fie
of high specific activity. Plasma was then transferred to 9 vlsking tubing
and ultrafiltration was carried out by centrifugation at 37°C overnight.
The proportion of radioactivity of a certain volume of the ultrafiltrate,
representing the unbound Cortisol, to the same volume of total plasma,
representing both the bound and the unbound Cortisol, was a measure of the
proportion of the unbound to the total Cortisol in plasma.
In 1962, Oaughaday and his co-workers improved their method of measuring
the binding capacity of the corticosteroid-binding globulin (CBG). They
devised a double equilibrium dialysis procedure based on differential heat
inactivation of the CBG at J^°C and 60°C, thus rendering it more quantitative.
The CBG-binding capacity as estimated by this method was 20.1 ± 5,2 pg./lOO ml.,
with no significant difference between males and females. Murphy and Pattee
(1963) found it easier and more accurate to measure the CBG-binding capacity
in terms of the amount of Cortisol required to saturate it. They thus modified
the dialysis method and carried out their estimations at 37.5°C. They obtained
higher values, but also without significant sex difference (30,9 - and
31.8 i 5.5 pg./lOQ ml, for females and males respectively)* These workers
noticed no diurnal variation of CBG-binding capacity and no effect of AGTI! on
it.
The ultrafiltration technique, however, has many advantages over the dialysis
methods./
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methods. It is rapid, simple and is carried out at 37°C which renders the
technique more accurate from the physiological point of view. The use of
radioisotopic Cortisol gave high precision to the method, even at low
concentrations of plasma unbound Cortisol, but most important is the fact
that only this technique measures directly the unbound fraction of Cortisol
in plasma, while the dialysis methods measure the CBG-binding 'capacity',
and, as Daughaday pointed out (Daughaday et al, 1962), no correlation was
observed when CBG-binding capacity was plotted as a function of the plasma
17-hydroxycorticostero.ids,
Quantitative estimation of the degree of binding by plasma proteins to
Cortisol, has been used to assess if it could be of any diagnostic help in
adrenocortical or other dysfunctions. Under normal conditions, i.e. at
physiological level, 90-95$ of the Cortisol in plasma is bound and 5-10$
is unbound (Kills et al, I960), Doe et al (i960 b) reported a significant
rise of the unbound fraction after ACTH stimulation, and in cases of
adrenocortical hyperfunction due to bilateral hyperplasia. More recently
Doe and his associates (I963), using a dialysis technique and G"^-labelled
Cortisol, showed that overlap occurs between the percentage of non-bound Cortisol
in normal subjects and in patients suffering from Cushing's syndrome, but
pointed out that if the absolute level^ of the unbound fraction is taken into
consideration no overlap will be noticed. These workers showed for the
first time a eircadian rhythm of the non-proteia-bound Cortisol in normal
subjects (with values of 1,2-2,7 pg,/l00 ml, at 9*00 a,m. and, 0,12-0,7$
pg./lOO ml. at 9*00 p.m.) which was absent in cases of Gushing's syndrome.
So, it seems that study of the binding of plasma proteins to Cortisol is more
promising/
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promising as far as it is throwing more light on the problems of understanding
and diagnosis of adrenocortical dysfunction*. In this thesis, a method based
on the ultrafiltration technique was studied as an index of the adrenocortical
function.
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Bgtimqtlop of Cortisol procfecti.oB rfrtft (see table 5)
It has been mentioned before that plasma Cortisol levels should be
interpreted with care because of the many factors which influence them.
This means that these estimations are not sensitive indicators of the
actual adrenocortical activity.
Attempts to estimate the actual production rate of Cortisol by the
adrenal cortex started in 1952 when Knowlton successfully maintained
Addisonian patients on 12.5-25 mg, of cortisone per day and suggested that
the actual daily output of the normal gland must be of the same order,
later, Bondy and Altrock (1953) estimated 17-hydroxycorticosteroids
simultaneously in the plasma of the renal artery and renal vein and
calculated the production rate by multiplying the difference of the two
values by the value of the renal plasma flow. They obtained values in
normals of 15.0-25.0 mg./24 hrs. Hardy and Turner (1957) estimated Cortisol
production rate by simultaneous determination of Cortisol secreted in the
adrenal vein and the adrenal vein blood flow. They reported values of 34.0
mg./24 hrs.
Although the last two approaches were more direct ones, yet these
methods were performed under abnormal conditions and therefore are only of
very limited use. Dorfman (1954) applied a different approach. Observing
the proportion of an ingested dose of Cortisol excreted as 11-deoxy- and
11-oxy-metabolites of 17-KS in urine, calculated a production rate of
21.0 and 18,0 mg»/24 hrs. for males and females respectively. Silber (1955)
administered graded doses of Cortisol and calculated the production rate by
subtracting the amount of metabolites estimated by the Porter-Silber reaction,
excreted/
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Cortisol in adrenal vein
and adrenal vein blood flow. 34.0
Dorfman (1954.) Excretion of ll-oxy- and
11-deoxy- neutral 17-KS
after test dose. 21.0 18.0
Silber (1955) Excretion of 17-hydroxy-
corticosterolds after test
dose. 21.9 ± 8.3
Moxham and
Kafcarro (1956)
Excretion of P-S chromogens
and 17-KGS after test dose.
(F-S 14.0-45.0 9.5 - 36.0
(17-KGS 8.5-49.0 5.5 - 40.0
Samuels et al
(1957)
Rate of disappearance of
administered Cortisol. 36.0
Peterson and
Wyngoarden (1956) Isotopic dilutions blood




method. 4.9 - 25.3
excreted at basal (or control) period from that excreted after the test dose
and expressing it in terms of Cortisol. His value for males were 21.9 ±
8.3 mg,/24 hrs. Moxham and Nabarro (1956) used the same approach to
correlate an oral Cortisol dose with excretion of either 17-KGS car Forter-
Silber chromogens, and their values calculated from 17-KGS were 8,5 - 49.0
and 5.5 - 40.0 and from Porter-Silber chromogens 14.0 - 45.0 and 9,5 - 36.0
mg./24 hrs, for males and females respectively.
Samuels and co-workers (1957) were the first to measure the rate of
disappearance of infused Cortisol, as estimated by the plasma Cortisol level,
and to apply it to calculate the production rate, which was about 36.0
mg«/24 hrs. All the methods described so far, however, are based ultimately
on estimation of Cortisol in blood, and so, beside the difficulties in
performing some of them, they suffer from lack of precision due to incomplete
enzymatic hydrolysis, incomplete extraction, losses during the procedure
and other analytical difficulties. Measurement of production rate by
estimating the disappearance rate of infused Cortisol is the nearest approach
to a sound technique, but the administration of Cortisol in measureable amounts
most probably disturbs the normal distribution and metabolism of Cortisol, and
thus renders the physiological significance of the test dubious.
It was only by the use of isotopically labelled Cortisol that accurate
estimation of Cortisol production rate was made possible. In the blood method
(Peterson and .iyngaarden, 1956) the principle of the technique is to
administer intravenously a trace amount of C"^-labelled Cortisol, in a quantity




Cortisol. Plasma samples are withdrawn at half hourly intervals. Plasma
Cortisol is extracted and purified by chromatography. Both the radioactivity
and quantity of the purified Cortisol extract are determined from which
the specific activity is calculated (radioactivity divided by quantity).
Because the radioactive Cortisol is continuously removed from the body, the
specific activity of the first sample is highest and that of the fourth
sample is lowest. The rate of turnover of Cortisol at a unit time is
proportional to the amount of Cortisol in the body, because turnover of
Cortisol follows an exponential or logarithmic manner. Therefore, if the
specific activities of the four purified Cortisol extracts were plotted on
a semilogarithmic graph against the time of withdrawal of the corresponding
blood samples, they fall more or less on a straight line (see figure U)•
If this straight line is extrapolated back to zero time, it will provide the
zero time specific activity (Io, expressed as counts per minute/pg., or
cpm/pg). Io, therefore, represents the degree of dilution of the radioactivity
of the administered C"^-Cortisol into the endogenously produced Cortisol at
zero time had the mixing of the radioactive and non-radioactive Cortisol been
instantaneous,
If Ii is the specific activity of the C^-cortisol dose solutions, also
in cpm/pg., then the ratio Ii represents the degree of dilution of the administered
Io





or Ao = a[^]
But the amount of Cortisol present in the body at zero time, Ao, equals
the/
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the endogenously produced Cortisol present in the body (A, in pg.) plus the
trace amount of injected labelled Cortisol. Therefore, the endogenously
produced Cortisol, also called the body miscible pool of Cortisol, can be
calculated from the isotope dilution expression:
A = ~ a
or A = a["|~ - 1] pg.
or A = a[^ - 1] x 10"3 (l)
To estimate the biological half clearance time, the value Jo is calculated and
2
a line drawn horizontally from that point on the ordinate of the graph to
meet the line of fit at a point, from which another line is drawn vertically
to meet the abscissa at a point representing the biological half clearance
time (t£).
To estimate the Cortisol production rate two values are needed to be known:
a. the raisclble pool of Cortisol in the body
b. its rate of turnover
Calculation of the miscible pool has already been discussed.
To estimate the rate of turnover we assume that
Fo is the amount of Cortisol present in the body initially,
F the amount of the original Cortisol present in the body at a given time,
£F the amount of Cortisol replaced by endogenously produced Cortisol in a short
period ( St minutes)
Thereforei-
S y
The rate of turnover = jj-
It has been mentioned that the rate of turnover at a unit time is
proportional/
- Id-
proportional to the amount of Cortisol in the body because turnover follows
an exponential or logarithmic manner. Therefore:-
— ~ = kf where k = turnover constant
The negative sign means that a given amount of Cortisol secreted in
the body diminishes by time.
Upon rearrangement of the last equation we get,
( p
-j; = — kit Therefore,
dF -J" kdt + M Where M is the integration constant.
Carrying out the process of integration we get
logeF = - kt + M Where e is the base of natural logarithms.
But, when t = 0, F = Fc Therefore, the last equation could be
rearranged to geti
log Fo = M and log F = -kt + log Foe e e
log F - log Fo = - kt
e 6
log F_ = - kte
Fo
H -kt or F = Fo e"kt
Fo - e
Conversion of this equation for the first order reaction to ordinary
(Briggsian) logarithms is made by introducing the conversion factor
0.4-34-3 so that last equation could be written:
l0§ fc = ~ °^3 kt
When/
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When we want to estimate the half clearance time,
F
|£ = •§■ and t = t^- so last equation could be written:
log £ = - O.4.34.3 kti or log 2 = 0,4.34.3 kti
or 0,3010 = 0,434.3 kti or o'|^43 ~
Therefore, k pool/minute
This last equation expresses the rate at which the body miscible pool of
Cortisol is replaced by newly synthesised endogenous Cortisol, It can be
written:
The product of the miscible pool, A, and the rate of turnover, k, i.e.
(1) x (2), gives the production rate in mg./24 hours.
In proposing this method Peterson and Wyngaarden proved the validity of
the various assumptions that had to be made before accepting this technique.
These assumptions were:-
1. That the injeoted Cortisol is pure,
2. That the injected Cortisol does not significantly alter the size of the
miscible pool and does not disturb the normal metabolism of endogenously
produced Cortisol,
3. That the size of the miscible pool remains constant during the period of
the study and that the rate of synthesis of Cortisol equals the rate of
transformation.
4» That the administered radioactive Cortisol is handled like the endogenous
steroid/
(2)
steroid and that there is a random disappearance of both the endogenous and
labelled Cortisol.
5. That the mixing of the injected steroid is homogeneous within the pool
and is rapid compared with its metabolism,
6. That the rate of metabolism of Cortisol is proportional to its concentration.
7. That the radioactive steroid does not re-enter the pool,
8. That the isolated plasma Cortisol is pure.
Nowadays, practically the only assumption that has to be checked by
workers using this method is that the miscible pool remains constant during
the period of the test by comparing Cortisol plasma levels of the first and
last samples withdrawn. This of course assumes that a reliable batch of
Cortisol of great purity is used, and that a reliable method of purification
of the extracted plasma Cortisol is used. The main advantage which this
technique offered, besides giving the correct information about the actual
state of activity of the adrenal cortex, is its high degree of precision} the
volume of plasma samples, completeness of extraction and recovery of Cortisol
did not matter because only the specific activity i.e. the proportion of
radioactive to non-radioactive Cortisol is measured, and as this proportion
is constant throughout the test only the very last step of the technique
i.e. the estimation of the specific activity, needs to be strictly quantitative.
Cortisol production rate of normal subjects by this method was estimated to be
12.0-29.0 mg./2% hrs.
Cope and Black (1958 a) applied the same principle to estimate Cortisol
production rate from urine studies. The radioactive Cortisol dose could
a
either be given intravenously or orally andjtwenty-four hour urine sample
collected./
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collected. The total radioactivity of urine was measured and metabolites of
Cortisol in urine were hydrolysed and the specific activity of the major
metabolite THE estimated. If C is the total radioactivity in urine and S.A»„
u C *
the specific activity of the administered dose then the ratio — equals
the amount of radioactive Cortisol present in the urine in the form of all
metabolites. If S.A. is the specific activity of the urine metabolites, then
3.A.f u
— equals the degree of dilution of the administered Cortisol with the
* #u
endogenously produced Cortisol, and the production rate will be
C S.A,™ C
JI x I = _LL
b»A,™ i>»A. S.A.
r U U
The specific activity of THE, the main metabolite of Cortisol, is
representative of the specific activity of all Cortisol metabolites and so
C
Cortisol production rate = ■? ■111 • mg,/2A hrs.
b,A*THE
The validity of the same assumptions of the blood method are also applied
to the urine method. Other factors, however, may contribute to a low
excretion of the radioactive Cortisol in the urine method and thus affect the
measurement of the true production rate. These factors may be: incomplete
administration of the oral dose; incomplete absorption from the alimentary
tract, both of which could be avoided by giving the dose intravenously}
retention in the tissues or body fluids} impaired renal function or incomplete
collection of urine. However, if the excretion in twenty-four hours is
found to be above 80%, it indicates that these interfering factors play a
minor role and that the calculated production rate represents more than 80%
of the true value,




H -labelled Cortisol and proved that an important factor influencing the
accuracy of this method was the rate of secretion,on the day before the
test; 70% of the metabolites measured are excreted on the day of the test
afaUn.
and 30$ on the day before. Under basal conditions this factor will not
significantly affect the r .cults, but in non-steady states such as in
Gushing's syndrome, after ACTH stimulation, and in stress the calculations
may not be equal to the amount of Cortisol secreted on the day of the test.
The figures given by this method by Cope and Black for normal subjects are
4.9-25.3 mg./24 hrs.
In the blood method, the curve of decline of specific activities consist
of two parts; an initial rapid decline after injection of the dose lasting
about 30 minutes followed by a less sharp decline. Peterson (1959 a)
interpreted this curve as indicating a fairly rapid distribution of Cortisol
into about 6 litres volume, and assumed that this volume was a single
compartment in which the hormone has a metabolic half clearance time of
about 80 minutes. Tait et al (1961), however, interpreted this curve as
representing a two compartment model indicating an extremely rapid
distribution into a space of about 6 litres (inner pool), followed by a
relatively slow movement into a total volume of about 13 litres (inner and
outer pools). The smaller volume can be regarded as a single compartment
which has a metabolic half clearance time of about 30 minutes, and they
worked out an equation for calculating the production rate from a double
equilibrium models-
R





where R = total radioactivity of the dose (cpm)
B = intercept of second part of the curve on ordinate (cpm/pg)
p = turnover rate as calculated from the second part of curve (pool/day)
= intercept of corrected first part of the curve on ordinate (cpra/pg)
I
a = turnover rate as calculated from the corrected first part of
curve (pool/day)
If a plot is made of the total radioactivity in a known volume of plasma
as a function of time, a similar graph results from which the volume of
distribution can be worked out. Dividing the total radioactivity injected
by the figure of the intercept of the second part of the curve on the ordinate
provides the volume of the inner pool. Dividing the same figure by the
figure of the intercept of the corrected first part of the curve on the
ordinate provides the volume of the outer pool.
Nugent et al (1961), using infusions of large amounts of non-radioactive
Cortisol to normal subjects receiving suppressive doses of dexaraethasone,
examined the levels of plasma corticoids during and after cessation of the
infusion. Their observed data, compared with the predictions of the single-
compartment-exponential disposal theory showed a poor correlation; corticosteroids
did not disappear from the plasma as though they were in a single compartment
and disposed of at a rate proportional to their concentration. They concluded
that methods for quantitative measurement of adrenocortical function that
utilise the assumption of single - compartment distribution and exponential
disposal of plasma corticosteroids are based on a theory which does not
describe the data accurately.
Tait (1963) using radioactive techniques showed, {10waver, that unlike
estimations/
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estimations of aldosterone production rate, which necessitated using the
double compartment model (because of the initial distribution in a volume
of 20-30 litres), using a single compartment model for Cortisol production
rate (in spite of the presence of two exponentials), the resulting error
is likely to be only about 10% when Cortisol concentrations are low and
when the volumes of distribution are small. The difference between the
behaviour of Cortisol and aldosterone may be due to a slower metabolism
caused by the marked protein-binding of the former. Suggestions
favouring a single mathematical approximation are} firstly, the possibility
that there is a single rate-limiting step in the degradation of Cortisol
(Tomkins, 1959) and, secondly, the seemingly satisfactory agreement of
plasma corticosteroids disposal data with first order kinetics when the
logarithm of concentration is plotted as a function of time (Samuels et al,
1957} Peterson, 1959 b)» However, an accurate mathematical description of
plasma Cortisol distribution and disposal is complicated bys
1, The number of corticosteroids with the dihydroxyacetone group (DeMoor
et al, I960 a)} this can be avoided by complete separation of Cortisol,
2, The limitation of diffusion into tissues by plasma-protein binding of
Cortisol,
3, The differences in the apparent volume of distribution and rate of
disposal of Cortisol when determined after tracer and load doses of Cortisol.
4., The time necessary to ensure equilibration of Cortisol within the body
fluids (Samuels et al, 1957} Peterson et al, I960).
The radioactivity counting technique used by Peterson and Wyngaarden
(1956) utilised the gas-flow type of counter, while Cope and Black (1958 a)
used/
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used an end-window Geiger-Muller counter. in this study, Cortisol
production rate was estimated by both the blood and the urine methods but
using a liquid scintillation counter. Glasstone (1958) pointed out that
organic scintillators, either in the solid state or in solution, produce
scintillations when exposed to nuclear radiation and that they are
transparent to the light they emit. As a result, relatively large quantities
of scintillator can be usedj this ensures a high probability of interaction
with the radiation and a high detection efficiency, especially when used
with the sensitive photomultiplier tube. Glasstone enumerated the
advantages of the scintillation counters which made them superior to other
type of counters. These include their simplicity, great flexibility and
versatility, high sensitivity to all forms of nuclear radiation, rapid
response, very short resolving time, great efficiency and accuracy.
- 1C9 -
/ufrgiupcorUqft], gtiiffiiflatlop qnd guppyq^op tggtg
Making use of the discovery of the negative feed-back mechanism,
several workers demonstrated the effect of administering exogenous ACTH
as a means of assessing the maximum capacity of the adrenal cortex to
secrete corticosteroids. Likewise, in the presence of an efficient
negative feed-back mechanism, the endogenous pituitary ACTH should be
suppressed by administration of synthetic glucocorticoids and this, in
turn, should lead to suppression of endogenous corticosteroid secretion
by the adrenal cortex. These are the bases of the adrenocortical
stimulation and suppression tests widely used nowadays as complementary
to the study of the adrenocortical function,
i. ^dssBgsfidAgaX fi&BBto&ga tests
The response to ACTH affords a direct method for the assessment of
adrenocortical capacity. It seems that the first of these tests was
described by Thorn and co-workers in 194-8 and was used in investigating
adrenocortical insufficiency. It was called 'the four-hour intra¬
muscular ACTH test', or "Thorn test". A preliminary eosinophil count was
performed, then 25 I.U. of ACTH were injected intramuscularly, and four hours
later a second eosinophil count was made. Normally, a moderate fall in
eosinophil count occurs spontaneously due to the diurnal rhythm, but a
fall of 50$ or more excludes significant adrenocortical insufficiency.
This test, however, was not quantitative, and the absence of the fall did
not prove the diagnosis since some conditions, like acute allergy, may lead
to increased production of eosinophils in the bone marrow exceeding the
eosinopenic action of Cortisol.
The second type of stimulation tests introduced was called 'the eight-hour
intravenous/
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intravenous ACTH test1 (Renold et al, 1952) later called "the standard
intravenous ACTH test". In this test 25 I»U» of ACTH in 500 ml, saline
were infused within a period of exactly eight hours. Eosinophil counts and
levels of 17-KGS or P-S chromogens in 2% hour collections of urine were made
before and on the day of the test. Again, in this test, eosinophil count
normally drop in eight hours by 94.%; a drop of less than 50% is diagnostic
of adrenocortical insufficiency. Also, a rise of 300-500% of urinary
corticosteroids in 2%. hours occurs in normal subjects; a rise of less than
100% is diagnostic of adrenocortical insufficiency. This test is sensitive,
specific, and estimates the 'actual functional Cortisol reserve' of the
adrenal cortices and, when repeated over a period of two or three days in
succession, measures the 'potential functional reserve', i.e. the maximal
cortical production under exceptional conditions.
The eight-hour test produces a threefold to fivefold increase of
corticosteroid output above the control levels, while a twenty-four hour
infusion yields as much as tenfold increase which is a true absolute maximum.
If the eight-hour test is repeated for several days, it could differentiate
primary adrenocortical insufficiency, where no rise or a slight fall of the
urinary corticosteroid output occurs after the first day, from hypopituitarism
where gradual and sustained increase occurs after the first day. The
intravenous ACTH test was modified and estimations of plasma corticosteroids
were made before and after the test to avoid the need of accurate urine
collection and to save time. Thus, 10 I.U. over a period of two hours,
25 I»U, over a period of A hours, 25 I.U, over a period of 6 hours (lik-Iies
et al, 1954- a) were proposed. Elevation of plasma corticosteroids excludes
adrenocortical insufficiency and a hyper-response suggests Gushing's syndrome
(Jailer/
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(Jailer et al, 1954.J DiKaimondo et al, 1958). Marked responsiveness
suggests bilateral adrenocortical hyperplasia, a lesser degree of
responsiveness suggests adrenal adenoma while cases of adrenal carcinoma
are less responsive or even unresponsive (Lindsay et al, 1956; Nabarro
et al, 1958; Birke et al, I960).
Intravenous ACTH administration, however, is sometimes risky.
Sudden elevation of blood pressure may occur and is sometimes fatal. To
render this test simpler and safer, ACTH-gel was used (DeFilippis and
Young, 1957) but it was, however, applied differently by various authors J
1. Bayliss and Steinbeck (1954.) administered 80 I.U. once and estimated
plasma 17-hydroxycortlcosteroids after 4., 8 and 24- hours.
2. Dyrenfurth et al (i960) administered 20 I.U. every 6 hours for 48 hours
and they estimated urinary and plasma steroids during and after the
stimulation,
3. Jenkins (l96l) administered 40 I.U, and estimated plasma corticoids
after two hours; 'two-hour test'.
4. Futterweit et al (1962) administered 4-0 I.U. and estimated plasma
corticoids after 4- and 6 hours.
5. Brooks et al (1963) administered 20 I.U, twice daily for 4. days.
The standard intravenous test, however, is still widely used (Birke et al,
I960; Hoet et al, 1961; Silverman et al, 1963; Sehteingart et al, 1963).
In this thesis stimulation tests were studied using ACTH-gel,
2. Endogenous - ACTH suppression tests
Suppression of urinary 17-KS output by cortisone has been known for a
long time. It was Laidlow et al (1955) who applied 9 a-fluorocortisol (9a-FF)
(3 mg./12 hours/
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(3 mg./l2 hours for 4 days and 25 mg./day for 3 days) to patients with
Cushing's syndrome, and failed to demonstrate a significant decrease in
either 17-KS or 17-KGS, Cope and Harrison (1955) and Cope (1956) on
the other hand showed that 9a-FF in divided doses totalling 5-10 rag.
per day partially suppresses urinary corticosteroid excretion of cases
of Cushing's syndrome due to adrenal hyperplasia, but did not suppress
patients with carcinoma. Gennes et al (1956) using 9o-FF in doses of
2-4. mg./day found that urinary steroid excretion was abnormally resistive
to suppression in cases of Cushing's syndrome due to adrenal hyperplasia
but definite suppression occurred when the dose was increased to 6 mg./day.
Jenkins and Jpence (1957) also noticed this partial suppression of urinary
corticosteroids in Cushing's syndrome using 9a-FF in doses of 1 or 2,5
mg./6 hours for 2-3 days. Nabarro and his associates (1958), on the other
hand, noticed that this partial suppression was demonstrated only in 4.
oui of 9 cases of adrenocortical hyperplasia, but failed to demonstrate
suppression in two patients with adrenal tumour. They used 9u-FF in
doses of 10-20 mg./day.
Liddle (i960) suggested that, when performed under carefully controlled
conditions, the ACTH-suppression tests can be reliable diagnostic procedures.
He proposed his tests which have been extensively used in the study of the
pituitary-adrenocortical inter-relationship. 9a-FF and, better still, its
extremely potent C-l6-methyl derivative dexamethasone were the two synthetic
glucocorticoids used. Administration of 0.5 mg. every 6 hours for two days
followed by 2.0 mg. every six hours for another two days were said not
only/
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only to differentiate normal subjects (who will suppress markedly by the smaller
dose) from cases of Cushing's syndrome, but also to differentiate cases of
adrenocortical hyperplasia, in whom relatively more suppression occurs
especially with the large dose, from cases of adrenocortical adenoma or
carcinoma, who are more resistant to suppression even to the large dose
(especially cases of carcinoma which on the whole do not suppress at all).
Suppression tests as described by Liddle were widely used, mostly with
encouraging results (Liddle and /illiams 1962; Slater et al, 1962;
Futterweit et al, 1962; Gogate and Prunty, 1963? Schteingart et al, 1963)
but sometimes with disappointing results (Dyrenfurth et al, I960; Meador et
al, 1962; Silverman et al, 1963; Baird, 1963). In this thesis suppression
tests using dexamethasone were also studied.
3* W-b^m of epfrymeg
It is known that hydroxylase enzymes are necessary for the biosynthesis
of Cortisol by the adrenal cortex. Blocking of the action of these enzymes
can occur in certain disease conditions, such as in congenital adrenal
hyperplasia, with the result that Cortisol secretion is diminished and its
precursors and their metabolites like THS and pregnanetriol are excreted in
urine in large quantities.
Recently, synthetic compounds have been introduced whose action is to
block certain hydroxylase enzymes specifically. This leads to reduction
of Cortisol synthesis and accordingly, through the negative feed-back mechanism,
in an increase in AGTH production and secretion, which in turn will enhance
the biosynthetic pathways reflected as increased excretion of precursors of
Cortisol and their metabolites in urine, SU-4,885 (Metopirone), an llp-
hydroxylase/
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hydroxylase inhibitor, is the most important of these compounds and its
use is a measure of the so called "Pituitary-ACTH reserve" or the
"Pituitary-Adrenal reserve". Liddle et al (1958} 1959) applied this
test to study the intermediate metabolism of corticosteroids and as a
diagnostic tool in adrenocortical dysfunctions. The use of this test,
however, appears to be more limited te the diagnosis of cases of congenital
adrenocortical hyperplasia (Cleveland et al, 1962} Liddle and Island,
1962} Grant, 1962).
- 115 -
Complementary tests of adrenocortical function
These are indirect tests which are carried out whenever adrenocortical
dysfunction is suspected. They are suggestive or confirmatory rather than
diagnostic.
E-gtfeqaUon of SQfllW?* potagslum, ghlgrlflg blcfflrl?o^ta qerqffi elevated
sodium levels and lowered potassium and chloride and sometimes hypokalemic
alkalosis occur with excess adrenocortical activity. These changes are
reflected, and can also be detected in the saliva.
Fagtyig fylood sqgar, glucose ,, tolerance guyvp ^nd fflnftose \t\ elevated
fasting level and diabetic curve with glycosuria are common with excess Cortisol
secretion.
Blood lipids and cholesterol are also raised with excess Cortisol secretion.
Blood picture. Relatively low counts of lymphocytes, eosinophils and
basophils with relative and absolute neutrophilia, leucocytosis, polycythaemia,
increased packed cell volume and platelet count are frequent with Cortisol
excess.
X-ray of bones may reveal ostoporosis, compression fractures of vertbrae,
fractured ribs or dorsal curvature of spine often observed with hypercortisol
states.
X-ray of the skull may reveal enlarged sella turcica denoting a pituitary
tumour as a cause of the hyperfunction of the adrenal cortex.
X-ray of the chest may reveal cardiac enlargement as a result of raised
blood pressure often observed in cases of hyj ereortisol secretion.
Electrocardiographic tracings often reveal low voltage and prolonged P-R and
Q-T intervals with Cortisol defficiency states#
Mas/
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Urine examination may reveal polyuria and increased calcium excretion in
hypersecretion states of the adrenal cortex.
ACTH assays in plasma or urine can be elevated in adrenocortical
insufficiency and in hyperfunction duo to ACTH-dcpendont hypoadrenocorticism.




In pathological conditions of the adrenal cortex, namely hyperplasia,
adenoma or carcinoma, a variety of syndromes may appear depending upon the
excess production of one or the other of glucocorticoids, mineralocorticoids,
androgens or estrogens, Cushing's syndrome is the syndrome of preponderant
glucocorticoid excess, properly called "the syndrome of excess Cortisol".
Pure forms of the disease are not common and usually there are varying
degrees of excess secretion of one or more of the other hormones as well.
This syndrome was first described by Harvey Cushing (1932) who suggested
that basophilic pituitary adenoma was the cause behind the bilateral
adrenocortical hyperplasia leading to the clinical manifestations of the
syndrome. As much as 15% of normal subjects, however, show small basophilic
adenomata of the pituitary at autopsy without previous history suggesting
adrenocortical hyperfunction. The aetiology of the syndrome is still obscure.
The most accepted theory is that it is due to excess corticotropin production
by the anterior pituitary, but in the absence of the anterior hypophysis, the
secretion of Cortisol is greatly reduced but interestingly enough not to
zero. The possibilities that exist as to the mechanism by which Cushing's
syndrome may be brought about include (l) stimulation from the hypothalamus
via the pituitary to the adrenal cortex with adrenal hyperplasia; (2)
hypothalamic stimulation plus pituitary tumour j (3) autonomous pituitary
tumour; (/J adrenal hyper-reactivity due to inherent adrenal abnormality as
well as the known and (5) autonomous adrenal cortical tumours. Recently





Cushlng's syndrome is a rare condition occurring nearly once in every
thousand persons and A-5 times commoner in females. It occurs in any age
but mostly in the third and fourth decades. 60# of the cases show
bilateral adrenocortical hyperplasia, 30# show adrenocortical tumours,
adenoma or carcinoma, and 10# have normal adrenal glands. In bilateral
adrenocortical hypoplasia the microscopic picture is not unlike that
observed after stimulation with ACTH, with widening of the cortex. Pituitary
tumours are rare and enlargement of the sella turcica is even rarer.
A fascinating feature of Gushing1s syndrome is its occasional appearance
in primary malignant disease in various organs. This includesj bronchogenic
carcinoma, ovarian neoplasms, thymic, pancreatic, prostatic and thyroid
carcinomata (McCullagh, 1962). It has also been recently reported in
association with phaeochromocytome (Williams et al, i960),
a. Signs and symptoms due to excess Cortisol
1. Obesity is present in 97# of cases. There is not necessarily any
marked gain in weight; obesity is mainly due to redistribution of fat, with
a particular tendency for a great proportion of fat to be deposited along
the trunk, and especially on the anterior abdominal wall, around the shoulder
girdle, in the supraclavicular region, in the upper dorsal region (buffalo
hump) in the neck and in the cheeks (moon face and fish mouth appearance)
but characteristically sparing the extremities, which appear unduly thin.
The moon face, trunk obesity with thin extremities give the "spider appearance"
characteristic of Gushing's syndrome. The mechanism by which these changes
are/
are produced is not yet known.
2. In 75$ of cases thinning of the skin due to wasting of skin muscles and
the disappearance of elastic fibres occurs leading to subcutaneous dehiscence
and purple striae over the abdomen, thighs and upper arras forming deep
gullies in the skin which can be felt by the fingers. Red striae, however,
are not restricted to Cushing's syndrome; they may be present also in
pregnancy and in rapidly growing and developing girls, in whom they may
radiate from the areola like spokes on a wheel. There is no excess
corticosteroid in these cases to account for them; it is merely excessive
stretching of skin with consequent dehiscence of the subcutaneous tissue.
Gogate and Prunty (1963)* however, reported that the striae in subjects with
Cushing's syndrome are characteristically broad, of purplish colour, have
an atrophic dermatitis and occur mostly on the flanks and lower abdominal
wall. This is in contrast to striae sometimes found in obese subjects
which are neither purple nor associated with thinning of the skin; their
colour is of a typical light pink nature. These workers found that striae
in obese subjects occur on the flanks, abdomen and about the axillae, upper
arms and breast and occasionally on the buttocks. They also observed that,
in a given area, striae in obese subjects are more numerous than in Cushing's
syndrome. The skin in Cushing's syndrome is of fine texture, almost paper
like. The face is plethoric because of transparency of subcutaneous tissue
and polyeythaemia. There is easy bruisability with ecchymoses (in the
presence of normal or elevated platelet count) and poorly healing wounds,
frequently infected,
3. General and progressive muscle wasting associated with extreme weakness
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and negative nitrogen balance* This may be mainly due to potassium
depletion and to the anti-anabolic effect of Cortisol.
U* Thinning of the bones (demineralisation) and marked osteoporosis, due to
the anti-anabolic effect of Cortisol, resulting in compression fractures of
the vertebrae, kyphosis, fractures of ribs and commonly associated with
backache occur in Cushing's syndrome. Increased excretion of calcium in
urine may occur and nephrosclerosis or urinary calcinosis are not uncommon.
5. Marked and irreversible progressive atherosclerosis in the large blood
vessels with systolic and, occasionally later with diastolic hypertension
occur in about 90$ of cases.
6. Hyperglycaemia, glycosuria and diabetic glucose tolerance curve, latent
diabetes occurs in 80$ of subjects and overt diabetes in 20$,
7. Sodium retention, low serum potassium and chloride. Hypokalaemic
hypo-chloraemic alkalosis is seen in about 15$ of cases.
8. Depression, psychosis and mania are frequent.
b* ai/m ^ BCTPtpfU? to ffy-epq flWW1?1? nq r>r usees'"'
of Cortisol or both
These include acnej bushy eyebrows; wiry, thin and lateral receding scalp
hair; hirsutism; marked increase in musculature in females with changes to
the male figure; metrorrhagia or amenorrhoea in females; impotence in males;
deepening of voice and clitoral enlargement in females. Only the latter
symptom can be attributed to androgens since all the others occur also with
excessive administration of Cortisol.




These include hypertension} hypokalaemia; hypernatraemiaj polyuria
not responding to antidiuretic hormone (nephrogenic diabetes incipidus) which
may be due to potassium depletion nephropathy} oedema due to diminished
glomerular filtration rate and increased plasma volume.
Clinical Tqan^feptations dug to ^trop^ are rarely encountered.
Course and diagnosis
The onset of the syndrome is insidious and the course is progressive
with transitory remissions and exacerbations often associated with increased
psychic stress. Patients become bed-ridden due to muscle weakness, multiple
fractures or intercurrent infection. If untreated, patients die within five
years of general debility, vascular accidents, infection or diabetic coma.
The more the clinical manifestations of the syndrome are present together,
the more it should be suspected. Sudden onset may denote adenoma or
carcinoma, Sven when all the signs and symptoms associated with Cushing's
syndrome are present, diagnosis, however, still needs to be confirmed and the
extent and nature of the adrenal hyperactivity evaluated by laboratory tests.
From the discussions in Chapter II measurement of urinary 17-KS excretion
is of little help in the diagnosis of this condition. On the other hand,
elevated plasma corticosteroid or Cortisol level with loss of the normal
diurnal variation, elevated urinary Porter-Silber chromogens and 17-KGS
especially in the mixed type of the syndrome, are diagnostic. However, sometimes
the results of these tests overlap with results in normals and in obese subjects
and the blood estimations are liable to variation with emotional upset.
Moreover, day-to-day fluctuation of Cortisol secretion is characteristic of
this syndrome which further adds to the liability of obtaining normal results
with/
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with these tests. About 90$ of cases, however, could be diagnosed b4)
these tests, especially if repeated.
More sensitive tests are:estimations of free Cortisol in urine,
Cortisol production rate by radioactive dilution techniques, plasma non-
protein-bound Cortisol, tests of adrenocortical capacity by stimulation
with erogenous ACTH, and tests of pituitary-adrenocortical suppressibility
by dexamethasone, These tests are less simple and need special training;
moreover they are time consuming and are only suitable for research work.
Reliable routine tests are unfortunately still unavailable. The last
mentioned two tests may also be valuable in differentiating bilateral
hyperplasia from tumours. The laboratory diagnosis could be supported
by the X-ray findings of osteoporosis (thin skull, cod fish vertebrae due
to compression of bodies of vertebrae by the nucleus pulposus), elevated
ACTH assays in blood or urine, the haematologic findings of lymphopenia
(less than 15%) eosinopenia with relative and absolute neutrophil leucucytosis,
total white cell count of 10,000 - 20,000 in the absence of demonstrable
infection, polycythaemia and packed cell volume of 50% of more, increased
platelet count, as well as by elevated fasting blood sugar level, glycosuria,
diabetic glucose tolerance curve and by the finding of hypokalaeraie
hypochloremic alkalosis. Diagnosis of tumours can be confirmed by plain
X-ray, tomography, intravenous pyelography, aortography, arteriography,
retroperitoneal pneumography and X-ray of the sella turcica.
Treatment
a. Bilateral adrenocortical hyperptaglq
Because Cortisol is supposed to be the responsible direct agent causing
this/
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this clinical condition, the rational step is to reduce or eliminate this
factor by one of the following methodsj
1, Unilateral adrenalectomy. With this line of treatment there is a 3<$
chance of a complete return of the pre-operative steroidogenic capacity.
2, Subtotal adrenalectomy. With this approach, there is a possibility
of leaving too much adrenal tissue and accordingly of recurrence of the
syndrome or of leaving too little with the inevitable development of Addison's
disease unless replacement treatment is given.
3, Bilateral adrenalectomy. Again, with this line of treatment there
is subsequent need for continued substitution therapy.
U* .Electrocoagulation of the pituitary, separation of the pituitary stalk,
partial or total hypophysectomy when Cushlng's syndrome is due to pituitary
adenoma. With these approaches sterility develops and the substitution therapy
is more complex, viz. Cortisol, desiccated thyroid and stilbosterol in females
or testosterone in males.
5. X-ray therapy to the pituitary (5000 r), the use of proton beam or the
implantation of radon, gold or yttrium-90 seeds. Again, with these lines of
treatment there is a 30$ chance of remission.
6. Combined unilateral adrenalectomy and pituitary irradiation. A 70$ chance of
remission exists with this approach.
7. Adrenocortical inhibitory,therapy is still in its experimental stage
and seems to be only applied in carcinomatous conditions or in cases where
remissions might be anticipated as in patients with psychosis or hysterical
anxiety states. This is achieved by administering either5 amphenone; the
insecticide/
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insecticide DDD or its less toxic and more active derivative o,p'-DDD
or the inhibitor of cholesterol biosynthesis triparanol (MER - 29). In
all of these drugs toxic effects can be pronounced and tolerance eventually
develops and it seems that their use is only limited to hopiees cases.
Bilateral adrenalectomy seems to be the therapy of choice in the rapid
progression of Gushing^ syndrome, especially when the syndrome is accompanied
by psychosis, multiple bone fractures or severe uncontrollable diabetes,
b. Tuqoupg
Treatment is by extirpation of the tumour or most often by the removal
of the entire gland. Due to the fact that the contralateral gland will be
atrophic, substitution therapy is most important. This must be gradually
reduced to encourage the contralateral adrenal cortex to regain its
function, A very few cases, however, require the substitution therapy
permanently because of irreversible atrophy of the contralateral gland and/or





Obesity is the increase in weight of 15$ or more above the 'desired
weight', calculated according to the height and body build. Normally
about 12$ of the body weight in males and 19$ in females occurs as fat depots.
Thus, a man is obese when the total fat content of his body exceeds 25-30$
of the total body weight, and a woman is obese when hers exceeds 30-35$.
The subject of obesity was excellently reviewed recently by Williams and
Glomset (1962).
Numerous factors contribute to development of obesity, in the same or
different subjects, some of these initiate obesity and some of them are
induced by obesity which they then intensify thus setting in motion a
vicious circle. But once obesity has become marked, they all become
operative, contributing to the number of disturbances. The work of
Mayer (1959 a, 1959 b, I960 a, I960 b) has contributed much to the understanding
of these various factors. These include:
1. Neurologic factors (see figure 5). Normally the ventromedial area of
the hypothalamus, called 'the regulatory centre', acts as a glucostat. When
hyperglycaemia occurs or there is an increase in arterial-venous glucose
difference, impulses travel to the lateral hypothalamic area, called 'the
feeding centre' inhibiting it. On the other hand when glucose utilization
increases, hypoglycaemia leads to the removal of this inhibitory effect on the
feeding centre. Impulses created by this mechanism as well as those coming
from the cerebral cortex as a result of visual, olfactory, or other stimuli
are transmitted through Schultz bundle, to the vagal nuclei, to the stomach
stimulating/
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stimulating contractions. Afferent impulses travel through the splanchnic
nerves, medulla, midbrain, thalamus to the cerebral cortex. A sensation
of hunger is produced in the subcortical area and a conscious desire for
food is created in the cerebral cortex. Dysfunction of the regulatory
centre, therefore, leads to removal of the inhibitory impulses and marked
ingestion of food and obesity. Convincing evidence to the validity of this
theory is available in cases of craniopharyngioma, meningitis and trauma
to the hypothalamus in connection with surgical operations. But although
many patients are obese, there are very few in whom the obesity is clearly
the result of hypothalamic damage.
2. Psychological factors, 'Reactive obesity' is a well known condition
where 'compulsive eaters', usually suffering from grief or severe depression,
sometimes overeat in response to a compensation for tension and frustration.
The more or less automatic food-regulatory mechanisms, which seem to work
nicely at essentially a subconscious level in normal individuals, become
blunted and are succeeded by the conscious effort to control food intake.
Since the guide lines do not seem to be clearly demarcated, the subject
ends up by ingesting far more food than he or she needs. It is also known
that frontal lobe lesions can increase the appetite by influencing the
hypothalamic food-intake centre, as well as the amount of exercise and the
emotional reactions. But frontal lobe lesions are very rare in obese patients,
and emotional disturbance and obesity may co-exist without necessarily being
related to each other. Sometimes marked obesity can occur without significant
psychologic disturbance, and sometimes marked psychologic problems similar
to/
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to those found in the obese occur without obesity or even with weight loss.
However, there are definite psychologic consequences of obesity; an already
lazy, lethargic and weak-willed obese person may feel discriminated against
in social life and may develop hostile attitudes, due to repeated reproaches
by physicians, parents or well wishers. Obesity may be intensified leading
to more withdrawal and avoiding physical or social activities, further
intensifying the obesity and so on.
3. Endocrine and metabolic factors. Obesity is frequently associated
with hypopituitarism, hyperpituitarism, hypothyroidism, hypogonadism and
some pancreatic disorders (Spence, 1961). Grafting of ACTH-secreting
pituitary tumours in animals leads to obesity. Also injection of
glucocorticoids, and in Cushlng's syndrome definite increase and
redistribution in the fat depots are observed associated in some cases with
increased plasma level or urinary excretion of corticosteroids. Castration
in males after puberty leads to obesity and eunuchoid males are usually
obese. Administration of testosterone tends to reduce and estrogens to
increase obesity in males. The following conditions associated with
endocrine and/or metabolic disturbances occur with increased frequency in
obesity s diabetes, increased resistance to insulin, hypertension, nephro¬
sclerosis, atherosclerosis, biliary calcinosis, hirsutism, amenorrhea and
sterility,
A. Genetic factors. It is usually difficult to differentiate between
genetic and environmental factors because of the eating habits of the family,
the social and economic status, the emotional status, etc., all influence the
familial /
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familial incidence of obesity. It is interesting to know, however, that
fclayer (1959 a, I960 a) found that less than 10$ of children were overweight
when both parents were normal, 4,0-50$ were overweight when one parent was
obese and 80$ overweight when both parents were obese, and that studies of
identical and fraternal twins have revealed that family food habits are not
the only or even main factor concerned in the development of obesity. When
there is a distinct excess of food, there is an instinct to accumulate
greater body stores than are needed, presumably a carry-over from earlier
days when cycles of plenty and famine prompted the body to store extra
energy while it was available. Perhaps this genetic factor can explain
the two types of obesity, the easier to treat 'juvenile or constitutional*
type of early development and the fluctuating and more difficult to treat
•adult or developmental' type starting later in life. Furthermore, the
obese hyperglycaemic syndrome is suggested to be a genetic disorder of a
Mendelian recessive type.
5. Sxtrin^sic factors. In view of the high incidence of mild obesity,
these are the most important factors leading to obesity. Social, economic
and family factors, customs and habits of eating, type of processing of
food, quality and quantity of food provided, type of occupation and readily
available transportation, are all of great importance.
Incicieqqq qpi p^thoge^gig
Obesity is a very frequent condition, and if the actual weight is compared
to the ideal weight, as much as 40$ of the total population of most developed
countries can be considered obese.
When/
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When lipid stores exceed their limits, new fat cells are formed to
accommodate new fat deposition. Presumably macrophages and other elements
of the reticuloendothelial system take over this role. Obesity is
associated with enlargement of the gastrointestinal tract, liver, kidney
and other organs, increased rate of intestinal absorption and decreased
spontaneous physical activity, A suggested sequence of changes (Williams
and Glomset, 1962) accounting for most, or all of the clinical manifestations
of obesity is: ingestion of great quantities of food leads to stimulation
of the p-cells of the pancreas producing more insulin. Excess insulin
promotes lipogenesis. Insulin also increases the output of glucocorticoids,
which in turn play an important role in stimulating increased production of
insulin antagonists. At least some of these antagonists have been shown
to antagonise the action of insulin in muscle but not in adipose tissue.
The body is thus left in a state where there must be too much insulin action
on adipose tissue for insulin action on other tissues to be sufficient. This
possibly, then could account for a number of the so-called complications of
obesity which simulate those of diabetes mellitus. With marked reduction
in food intake these biochemical and clinical alterations are reversed in
due course of time.
Clinioal manifestations
In the majority of cases obesity constitutes only a relatively mild
deviation from normal without significant signs and symptoms. But as the
process becomes severe and of long duration we may find; (l) psychological
disturbances; anxiety, depression, feeling of inferiority, etc., (2) heart
affection;/
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affectionj dyspnea, orthopnea, cyanosis or frank heart failure and oedema,
(3) decreased vital capacity; decrease in the gaseous exchange in the lungs
with drowsiness and other features of the 'pickwickian syndrome', GO skin
thickness, coloured striae, fungus and yeast infection, intertrigo, (5)
hirsutism, (6) gastrointestinal disorders such as dyspepsia, liver cirrhosis,
cholecystitis, cholelithiasis, (7) varicose veins of the legs, (8) hypertrophic
arthritis, (9) menstrual abnormalities; amenorrhoea, oligomenorrhea and
sterility, (10) hyperglycaemia, glycosuria and decreased glucose tolerance,
(ll) atherosclerosis, coronary occlusion, hypertension, (12) nephrosclerosis
and (13) increased incidence of malignancies (Williams and Glomset, 1962).
There is a distinct increase in morbidity and mortality with increasing degrees
of obesity. Obesity is not quite as harmful in women,
Gpupqe find ^iqgpogj.g
With significant weight reduction, associated conditions likewise improve.
This applies only to mild obesity. Obesity is much easier to deal with in
its early phases when there are fewer psychological, metabolic and endocrine
alterations. With severe obesity, the sensitivity of the satiation centre
seems to be greatly blurted, so that the normal food - regulating mechanisms
do not prevail. Obesity, however, tends to produce hyperinsulinism and
JcAjCut tv
hyperadrenocorticism whicn can in turn signify further the obesity. Thus
U.
moderate and severe obesity are usually progressive, irreversible and very
difficult to treat.
Assessment of the degree of obesity can be made by one of several methods;
inspection (correlating muscular development with height and skeletal build);
weight as correlated to height, best and easily found out from tables constructed
to/
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to indicate the 'desirable' weights for men and women according to their
heights and frames (see appendix III)} measurement of the thickness of
subcutaneous tissue either by the pinch technique, by calipers or by
roentgenograms of the soft tissue; densimetric determinations by weight in
air and under water; or by estimating the total body fat which is the
difference between the lean body mass (estimated by heavy water dilution
technique) and the total body weight.
Treafrnert
As it is easier to maintain normal weight than to reduce excess weight,
preventive measures are most important in the form of educational programmes
for the general public and for those who supply and deal with food. Individual
psychological problems cf obese patients should be evaluated and treated
and patients warned that during weight loss, some psychological problems may
be intensified and fresh ones acquired.
Attention should be given to the caloric equivalents of different food
elements of diet. Carbohydrates and proteins tend to promote retention of
approximately 3 parts of water per each part of these food materials that is
stored. Fat is deposited without a store of any significant amount of water.
Thus, with the loss of a pound of protein there is a loss of four pounds of
body water. When the protein intake is increased, the lost weight is rapidly
regained. Thus, although the weight loss may appear greater with a low-protein
diet, true weight loss is best accomplished with a diet high in proteins and
low in fat and carbohydrates (of SOD - 1200 calories) and rich in vitamins and




Anorexigenic drugsj amphetamines, may be of help especially in the
early phases of weight reduction, propping up the patients will power
until progress begins after which the patient carries on under his own will.
These drugs, however, are not free from side-reaction3 and eventually
become of limited value because tolerance develops. Various pituitary and
thyroid hormone products as well as nauseating and diuretic drugs are
useless.
Exercise and massage are adjunct to weight reduction.
- 133 -
Atai Subjgqtp aqfl outline of tfris? gt^y
The previous review of Cushing's syndrome and obesity, shows very clearly
that many clinical manifestations and laboratory findings can occur in either
of the two conditions, such as; hypertension, psychological changes,
hyperglycaemia, impaired glucose tolerance, hirsutism, cutaneous striae,
infective conditions, oedema, raised plasma level and urinary excretion of
corticosteroids, etc. But it is also clear that prognosis and the
therapeutic approach are so different; in Gushing's syndrome the patient
if not treated dies within five years (Forsham, 1962) and the treatment of
choice is adrenalectomy while obesity is a less grave condition which is
treated mainly by dietary regimen. This, together with the fact that a
previous study in this department (deWitt, 1961) failed to separate clearly
normal subjects from patients suffering from Gushing's syndrome on the
basis of urinary excretion of 17-KS, 17-KGS or even Cortisol production rate
by either the urinary or blood method, provided the initiative for this
study. The aim of this study was to try, by careful grouping of the subjects
and by selective application of certain tests of adrenocortical function, to
separate clearly patients suffering from Cushing's syndrome from simple obese
and from normal subjects.
Accordingly, the subjects oi this study were divided into four groupst
1. Normal subjects; who were either normal healthy volunteers, who showed
no symptoms or signs of disease; or 'hospital normals' who were either patients
suffering from minor clinical conditions such as bronchitis, dermatitis,
dyspepsia, etc., patients waiting to be operated upon for minor surgery, e.g.
piles/
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of ACTH to allow pituitary-adrenoccrtical axis to get back to its normal
state. In addition, from the technical point of view, not more than tiro
cases could be studied at the same time. This, together with the fact that
it was very difficult to find volunteers to provide for the control group and
that cases of Cushing's syndrome were vary rare, accounted for the relatively
small number of cases studied especially among the normal and Cushing's groups.
Each case in this study was investigated first clinically by recording
the presenting symptoms and their duration, family history of diabetes, obesity
or endocrine disease, assessment of the degree and distribution of obesity if
present followed by a thorough clinical examination. Then a series of
chemical tests were carried outj to assess the adrenocortical function
under basal conditions and in response to stimulation with exogenous
ACTH and to endogenous-corticotropin suppression by doxamothaoono administration*
Other chemical tests were performed to exclude renal insufficiency; to exclude
liver insufficiency; to detect diabetes; to detect any electrolyte disturbance
or alkalosis and to find out the relationship between adrenocortical function
and both the total body muscle mass and the total body fat. Other laboratory
investigations were performed; these included X-ray of the chest to detect
any cardiac enlargement; X-ray of the skeleton to detect osteoporosis;
haematologic investigation; electrocardiography; medical photography; and
histological examination of the removed glands in cases of Cushing's syndrome
treated by adrenalectomy.
A special proforna was designed for this research. All the information
available from the clinical and laboratory investigations of each case could
be/
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be recorded in a copy of this proforma, thus facilitating study and
interpretation of the data in each case.
It was planned that treatment of cases of Cushing's syndrome should
be either by bilateral adrenalectomy followed by substitution therapy or by
bilateral adrenalectomy with transplantation of a part of one adrenal
into the rectus sheath of the anterior abdominal wall, Obese subjects and
'Cushingoid1 subjects in whom the suspicion of Cushing's syndrome was not
so strong as to warrant surgery were treated by a low caloric dietary
regimen. It was also planned to repeat the tests of adrenocortical
function in obese subjects and 'Cushingoid1 subjects treated by dieting if
they responded sufficiently to the dietary regimen, (see appendix IV) by
a significant reduction in weight, to see if there was any correlation between
the intensity of obesity and the state of adrenocortical function. It was
planned also to repeat these tests In cases of Cushing's syndrome treated
by transplantation to assess the success of such operation, and in 'Cushingoid'
patients in whom mild clinical manifestations became florid to see if there was







1. Estimation of Cortisol production rate
Cortisol production rates were estimated by both blood and urine
methods on three occasions in each patient (l) a first basal estimation,
(2) a second estimation a week later following ACTH stimulation, and
(3) a third estimation, two weeks after the second one, following
dexamethasone suppression.
1L
In each estimation 1 pc. 4.-C -Cortisol was given intravenously
at 9i30 a.m. Later on, however, with the aim of investigating the
problem of plasma protein binding to Cortisol it proved more convenient
to increase the dose to 2 pc,
i. Eptimatfrop of Coptic production r^e by blood qethofl
The method was based largely on that described by Peterson and
Wyngaarden (1956).
Principle (see introduction, Chapter II)
Reagents
1. Cortisol standard
(a) Stock standard: 0.25 mg, Cortisol (B.D.H.)/ml. absolute ethanol.
(b) Dilute stock standard: 2 pg. cortisol/ml. absolute ethanol.
(c) Working standard: 0.2 pg. cortisol/ml. absolute ethanol.
2. Cortisol marker (for chromatography): 2 mg. cortisol/ml. absolute ethanol.
All Cortisol standards and marker, were kept at 4°C,
3. Dichloro-raethane (^ethylene chloride) (B.D.H,) Analar grade,
4-. Benzene (B.D.H.) Analar grade,
5. Sodium hydroxide (B.D.H,) 0,1 N approximately.
6./
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6. Acetic Acid (M & B) 0,1 N approximately.
7. Sulphuric acid (Hopkins & Williams) Analar grade. 80% (v/v) in distilled
water.
8. Purified ethanols 4.0 pellets of potassium hydroxide (B.D.H.) were
added to about 500 ml. absolute ethanol, refluxed for two hours, and on
gentle distillation the first and last portions were discarded and the
middle one was collected,
9. Radioactive compounds: Two types of radioactive Cortisol were used
in this study:-
17
(a) 4-C -Cortisol of specific activity 25 raillicuries per millimole
was obtained from New England Nuclear Corp. Boston, Massachusetts, U.S.A.
This substance was contained in vials each containing either 10 or 50 pc, in
1 ml. 10$ methanol/benzene.
The contents of the vial were carefully transferred by a clean sterile
2 ml. syringe to a Quickfit (C2A, 50 ml.) test tube. The vial was rinsed
several times with 1 ml. absolute ethanol and the rinsings added to the test
tube containing the radioactive material. This solution of radioactive
Cortisol in ethanol was then evaporated to dryness under reduced pressure
using a water pump and a water bath at 4-0°C.
The molecular weight of Cortisol is 362, Its specific activity was
25 raillieurles/millimole (= 25,000 pc./m.mol.) so that the specific activity
was 25.000 = 69.1 pc./mg. The Cortisol content of the vial was 725 pg.,
362
but since it was convenient to use Cortisol whose specific activity was
about 20 pc./mg. 1.81 mg, non-radioactive Cortisol was added.
To the dry residue, 7,25 ml. of Cortisol standard (0.25 mg./ml.) were
added,/
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added, together with 5.25 ml. absolute alcohol. The tube was stoppered and
left overnight in the deep freeze. Next day 37.5 ml. sterile distilled
water were added. The total volume was 50 ml. containing 50 pc. in 25%
absolute alcohol. 1 ml. of this solution containing 1 pc. served as one
dose.
To evaluate the specific activity of the dose solution, 0.1 ml. of this
solution was diluted with absolute alcohol to 17.5 ml. 1 ml. of this
dilute dose solution was used for the estimation of radioactivity and 1 ml.
for the estimation of Cortisol content. The specific activity of the dose
solution was calculated from the formulai
S A dose - In I ml, dilute dOj?q (cpm) CT3n/ue"
Cortisol in 1 ml. dilute dose (pg)
(b) A-C"^-Cortisol of specific activity 22.3 millieuries/raillimole
xm.e obtained from the Radiochemical Centre, Araersham, Buckinghamshire,
England in sealed ampoules containing 50 pc, in 1 ml. of a benzenelethanol
(9si) mixture.
The ampoule was carefully cut with a file and the contents transferred
to a test tube and evaporated as described before. It was thought better
at this stage, however, not to add any Cortisol standard to the test tube
in order to minimise the amount of Cortisol injected lest this should introduce
an error into measurement of Cortisol production in patients with markedly
suppressed plasma Cortisol levels due to the administration of dexamethasone.
The specific activity in this case was 3L0 = 61.7 pe./mg.
362
To the dry residue 5 ml. of absolute alcohol were added and the volume
made up to 25 ml. with distilled water. 1 ml. of this solution served as
one/
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one dose and contained 2 pc.
Dilute dose solutioni 0.1 ml. of the dose solution was diluted with
absolute alcohol to 35 ml. 1 ml. of this dilute dose solution was used for
the estimation of radioactivity and 1 ml. for the estimation of Cortisol
content from which the specific activity of the dose solution could be
calculated as previously mentioned. Both the dose solutions and the dilute
dose were kept at 4°C.
10. Scintillation counting solutions*
(a) Organic scintillator: Toluene Phosphor (Panax) Type TTP/A. The
solvent is toluene and the solute is:
p-Terphenyl A gnu)
) in 1 litre
1:4. Di-2-(5 phenyloxazolyl) benzene (P.O.P.O.P.) 0.1 gm.}
Toluene phosphor was always kept at 4°C in brown bottles.
(b) Silicone fluid: (Hopkins and Williams) Type MS 200/20 CS. This
fluid provided optical contact between jars and photoraultiplier of the counter.
As dirt affects light transmission of the silicone oil, the photomultiplier was
stripped, removed and cleaned with xylene every 6 months and fresh silicone oil
pipetted.
Other requirements
Physiological saline. (0,15 M NaCl) sterile for intravenous injection.
Heparin (Waddel Pharmaceuticals) 5,000 units/ml.
EBBflfiflaca
(a) aMatofcaftlaa sL j&s isast
All patients were fasting and resting in bed during the test (9:30-11*30
a.m.). The dose was administered at 9«30 a.m. A sterile 1 ml, pipette
was/
— l /- l Mi
was used to transfer 1 ml. of the dose solution to a sterile beaker. The
solution was withdrawn into a syringe and the beaker rinsed twice with 2 to
3 ml. of physiological saline and the rinsings withdrawn into the syringe.
The ^dose/'test]was then administered intravenously over a period of three
minutes. hen injection was completed, blood was withdrawn into the
syringe and reinjected. This was repeated twice to make sure that all
the dose was administered.
At half hourly intervals 20 ml. of blood were withdrawn from the
patient into a heparinised syringe. The time of withdrawal of the blood
samples was always recorded exactly. Four blood samples were taken
instead of six 60 ml. samples in the original method (Peterson and
Wyngaardan, 1956). Blood was centrifuged immediately at 54.0 g. for 10
minutes at 20°C. Plasma was separated into 250 ml. glass stoppered
flasks.
ft) pf gprUssfl
100 ml. methylene chloride were added to each plasma sample (about
10 ml.) and extraction carried out by gentle swirling rotation of the flasks
for 10 minutes. The contents of the flasks were then transferred to 250 ml.
centrifuge bottles, centrifuged at 710 g, for 10 minutes. The contents of
the bottles separated into two distinct layersj the plasma constituted the
upper thin one, and methylene chloride containing the Cortisol formed the
lower layer. The upper layer was removed by a fine pipette attached to a
water suction pump. The methylene chloride extract was then transferred
back to the same flask and washed first with 15 ml, 0.1 N NaOH to remove
acidic and phenolic steroids, then with 15 ml. 0.1 N acetic acid and lastly
with/
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with 15 nil. distilled water. Each washing was always performed in the
flasks followed by centrifugation at 710 g, for 5 minutes and the removal
of the upper layer by suction. The washed extracts were then transferred
from the centrifuge bottles to clean 150 ml. glass stoppered flasks and the
extracts evaporated to dryness under reduced pressure by a water pump and
in a water bath at 40°C. The dry residues were then redissolved in 3 ml.
of methylene chloride, and transferred to 50 ml, glass stoppered test
tubes. The flask was rinsed with 2 ml, methylene chloride and the rinsing
again transferred to the test tube. The extract was then evaporated to
dryness again using the water pump and water bath at 40°C«
10 ml. distilled water were treated in the same way and acted as
a blank extract.
(c) lgqta14on Pf 9°rUs°), J.Y
Paper chromatography was used for fractionation of plasma steroids
and isolation of Cortisol. The chromatography system used was the Bush
B5 system (Bush, 1952} of benzenejmethanoltwater (4.00*200*100)j the
benzene layer was used as the mobile phase. The chromatography tank used
was a rectangular Shandon all glass tank 57 x 30 x 20 cm., containing a
longitudinal rounded bottom glass trough about 3 era. deep, and lined with
filter paper dipped into about 1 cm. of benzene. At the bottom of the tank
there was a 500 ml. beaker also lined with filter paper and containing 450 ml.
of the stationary phase (300 ml. methanol and 150 ml. distilled water) both
benzene at the bottom of the tank and stationary phase in the beaker were
changed every fortnight. The glass cover of the tank was lined on its lower
side by a frame of rubber foam and a plastic sheet and was kept tight by the
application of heavy weights on its upper surface to make sure that the
atmosphere/
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atmosphere inside the tank was kept saturated with the vapours of the solvents#
In the middle of the cover there was a stoppered hole, just opposite the middle
of the trough, for the introduction of the mobile phase. The chromatography
paper used was Whatman No.l previously treated by exhaustive capillary
washing continuously for 3 days with 95/ methanol to reduce the blank.
The sheet was then cut into smaller sheets each 15.2 cm. wide and 4-5 cm,
long. The starting line was 12 cm. from the upper edge of the paper.
The middle section of paper was subdivided into 7 limbs each 2 cm. wide
with a 2 hbs, strip between each limb (see figure 6). The limbs were cut
so that their upper end lay 11 cm, from the upper edge of the paper and
their lower end lay 5 cm, from the lower edge of the paper, thus making sure
no tangling or cross contamination of the limbs could occur in handling the
sheet because their upper and lower ends are joined together.
Support of the chromatography paper during application of the spots
was conveniently provided by means of 2 rectangular plywood plate3 50 x 30 cm.
joined at one end by adhesive plaster so that they could be opened or closed
as a book and lined with a sheet of Whatman No.l chromatography paper, Both
the plates and the paper had a window 20 x 3 cm. through which only that part
of the paper to be spotted on could show. The edge of the plates containing
the window was slightly raised and a metal tube perforated at its upper
edge in a slit-like manner was fixed just under the window to direct upwards
a draught of the drying current of air coming from a hair dryer placed on its
side with its nozale pointing across the longitudinal axis of the window
in the plates. This arrangement kept the chromatography paper clean and
allowed/
Figure 6 as Chromatographic separation of plasma Cortisol
Identification by U.V.L. absorption.
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allowed drying the spots at the time of their application thus limiting
their diameter and keeping their spread to a minimum.
The dry residues were redlssolved in 2 x 50 pi. of methylene chloride
and transferred to the starting line of a Whatman No.l chromatography sheet
divided into 7 strips} 4 for plasma extracts, one for the paper blank and
one at each side for the standard Cortisol of which 10 pg. in 10 pi, were
used on either limb.
The sheet was then placed in the chromatography tank in such a way that
the starting line was at least 6 cm. from the trough edge and the first 4- cm,
of the sheet horizontal. Paper was allowed to equilibrate overnight then
descending chromatography was started by pouring the solvent (mobile phase)
into the trough and chromatography was allowed to proceed in the dark at
room temperature for 4 hours. The paper was then taken out of the tank
and dried for half an hour In the dark. After drying, the paper was taken
to the dark room, pinned over an 8 x 18" sheet of Ilford reflex paper No.50
lying horizontally and photoprinted by exposing it for 25 seconds to ultra¬
violet light using a lamp emitting nearly all its energy in the 254- mp region
and situated 50 cm. above the paper. The reflex paper was then developed
in 200 ml. Copyphen developer (Ilford), diluted 1:5, for 1 minute and fixed
a3 visual. Cortisol standard spots applied to the outer limbs showed as
white spots against a dark background (sea figure 6a), The zones
containing plasma Cortisol and blank on the other limbs lay between the two
marker spots. Occasionally when plasma Cortisol levels were high, the
zones containing plasma Cortisol showed also on U.V.L. exposure as faint
spots/
Figure 6 b: Chromatographic separation of plasma Cortisol after
stimulation with ACTH.
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spots especially so with chromatograms of plasma after ACTH stimulation
(see figure 6b), The zone containing plasma Cortisol and the paper
blank were then cut out, fluted and eluted by immersion in 5 ml* of ethanol
overnight,
(<*) <?f cprtisffjl fry sraqtagphptofluprOTgta'Y
The theory of fluorescence states that when a molecule or atom is
exposed to radiation, an electron transition may occur putting the molecule
or atom in a higher energy level (excited state). If the energy which
the molecule absorbs is not released by collision with another molecule (or
atom) or by other means, then in a fraction of a microsecond, the molecule
(or atom) may return to a lower energy state. During the return,
radiation of frequency corresponding to the difference in energy of the
initial and final energy states is emitted. It is this radiation which
constitutes fluorescence (Aminco-Bowman Spectrophotofluorometer, 1956)*
The machine used was the Aminco-Bowman Spectrophotofluorometer,
consisting of an optical unit, a ballast and control for a Xenon lamp, a
photoaultiplier microphotometer, a cathode-ray oscillograph and a recording
drum. In the optical unit, light from the Xenon lamp is dispersed by the
activating monoehroaator (grating type) into monochromatic radiation incident
on the sample. Fluorescent light from the sample is dispersed by a
similar raonochromator into monochromatic radiation incident on the photo-
multiplier. The light is transformed there to a weak electrical signal
and fed to the photometer where it is amplified. Photometer output is
coupled to the cathode ray oscillograph, or is indicated by a self-contained
meter/
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meter on the photometer in terms of optical densities or percent transmission
or recorded by a recording drum.
The efficiency of the fluorometer for estimating accurately small
quantities of Cortisol was tested by preparing a set of tubes containing
0,d, 0.02, 0,05, 0.1, 0.2, 0,3, 0.4. and 0,5 pg, of standard Cortisol
and treating them with ethanol and sulphuric acid, as will be described
later, and measuring their fluorescence. The result (see figure 7) shows
first that very small amounts of Cortisol could be detected and secondly
that there is a linear relationship between fluorescence and the
concentration of Cortisol.
The time needed for the development of maximum fluorescence in the
dark was estimated by preparing sets of alcoholic solutions of Cortisol
standard and keeping them in the dark for varying periods after pipetting
sulphuric acid, A curve was drawn which showed that maximum fluorescence
occurred after AO minutes in the dark and was stable for over two hours.
Figure 8 shows the relationship between the development of fluorescence
and time,
0.2 jig. standard Cortisol was used to obtain the activation and
fluorescence spectra of 0,2 ml, ethanolic Cortisol solution treated with
1,8 ml, sulphuric acid &0%» Figures 9 and 10 show that maximum activation
was obtained at a wavelength of ASG mp, and maximum fluorescence at 54-0 mp.
using the green filter (0G l).
Concentration of sulphuric acid needed to produce maximum fluorescence
was estimated by preparing several test tubes containing 0,2 pg« standard
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of gradually increasing concentration. Figure 11 shows that maximum
fluorescence was obtained with 3 concentrations of sulphuric acid 75, 80
and 85%. Therefore sulphuric acid of a concentration of 80$ was used
throughout this study.
For fluorosaetry, eight 50 ml. glass stoppered test tubes were used,
four for the plasma samples, one each for paper blank, standard (= 0.2 pg.),
blank (ethanol) and dilute dose solution;into each 1 ml. of the corresponding
eluate or solution was pipetted. 0.5 ml, of eluate of plasma and of paper
blank were used in estimations after AGTH stimulation. The contents of
these test tubes were evaporated to dryness under reduced pressure on a
water bath at 40°C» 0.2 ml, ethanol was added to each and tubes rotated
thoroughly to dissolve the residues. Then 1.8 ml, 80$ ii,S0. were pipetted
rapidly and contents mixed well. Tubes were then left in the dark for
45 minutes at room temperature to allow fluorescence to develop. At the
end of this time contents of the tubes were transferred to the quartz cells
of the fluorometer (cells previously washed with tap water, distilled water,
twice with ethanol and dried). The fluorescence of each was measured at
an activation wave-length of 480 mp. and fluorescence wave-length of 540 nip.
using the green filter (0G l). The value of the blank was subtracted from
that of the standard and dilute dose solution, and that of the paper blank
subtracted from each of the plasma samples.
Gortisol content of the plasma samples in pg./l ml. eluate equals
v.3 « rtHate - Auprsstfew? gf gaas-r. Mantel
(fluorescence of standard - fluorescence of blank)






The machine used, was the assembly Type SC/LP, Panax Equipment Ltd,,
consisting of:
1, An automatic counter, type AG 300/6, which comprises an automatic timer,
type T 300, and a decatron scaler type D 657.
2. A lead castle and an amplifier, type £250* with a gain of x 1GQQ.
For nuclides such as C"^ (0,155 MeV) the basic requirements are a head
amplifier, a scaler and a high stability power unit.
Tap water was allowed to pass continuously, for 1 hour before and during
counting, through the cooling coils of tho head unit of the castle. Activity
was counted in glass stoppered 15 ml. Panax jars. Optical contact at the
window between the jar and the photomultiplier tube was provided by the
silicone oil.
Optimum working conditions for counting of by the machine had
to be determined and checked once every 6 months. This was carried out by
counting a background and a source of at varying E.H.T. volts (extra-high
tension volts) and varying Discriminator Bias volts and recording
1 j 2 2^(com of the C *• source - com of the background) (i.e. ^ ) for each E.H.T.
cpra of the background
against the Discriminator Bias volts. An example is given in figure 12 which
shows the different curves obtained. From this it is seen that conditions
needed for optimum working are provided by an E.H.T. = 1300 volts and Disc.Bias
S= 19 volts.
Counting C1^ was performed by the liquid scintillation method. This
method is based on the small flashes of light (or scintillations) which
accompany/
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accompany the exposure of certain materials to nuclear radiation. The
mechanism of formation of these scintillations is complex, but essentially it
involves the absorption of most of the energy from the nuclear radiation by
the solvent of the phosphor. This energy is then transferred to the solute
leading to the formation of a high-energy (or excited) electronic state of
its molecules (or atass). The excess energy is then emitted, within a
very short time, as a flash of light. It is due to the use of the
electron multiplier tube with a photoelectric cathode (photoraultiplier tube)
that light produced in a single scintillation, which is too feeble to be
measured directly, causes the emission of electrons from the cathode of the
tube due to the photoelectric effect* The number is greatly increased in
successive steps, so that ultimately a measureable current pulse is produced
which can be recorded by means of a suitable counter (Glasstone, 1958).
Toluene phosphor was used as the organic scintillator] 5 ml. of which
were used, blended with either A ml. of ethanol for the background counting
or with smaller volumes of active samples (dissolved in ethanol) and completed
to /+. ml. with ethanol.
3 ml, of the eluates were used for counting. 6 counting jars were used
A for the plasma samples, one for the diluted dose solution and one for
the background. They were prepared as follows j-















Contents of the jars were mixed by gentle swirling till the toluene
phosphor and ethanol were completely blended. Jars were then placed in
the dark for 10 minutes (in order to reduce fluorescence in the phosphor)
in a petri dish containing tap water to bring them to the same temperature
as that in the castle. Jars were then housed in the castle and further
10 rainutes were allowed to pass for dark adaptation before counting started.
Radioactivity was measured initially in terms of the time required to
register a certain number of counts as follows* the background - 4-000
counts, plasma samples - 10,000 counts and dilute dose solution - 40,000
counts. The value of background (cpm) was always subtracted from the
values of the other active substances. The activity of the plasma was
expressed as cpm/3 ml, eluate.
Counting of the background was almost always 100 cpm (ranged between
96 and 104),those of the plasma eluates ranged from 240 - 52 cpm for the
first sample, to 67 - 11 cpm for the last one using 1 pc. as a dose and
321 - 63 cpm for the first sample, to 52-18 cpm for the last one using
2 pc. Dilute dose solution was around 7000 cpm. The validity of the
count rate of the plasma samples, especially the last one, looked questionable
in relation to the count rate of background. Thus, an experiment was
performed in which 4 ml, of a standard solution containing fairly high
amount of radioactivity was counted, together of course with a background.
Steadily decreasing volumes of the same standard i.e. 3 ml,, 2 ml,, 1 ml.,
0.5 ml,, 0.2 ml., and 0.1 ml. were also counted and the value of background
subtracted from each. The observed count rates were compared with the
theoretical/
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theoretical ones based on the count rate of 4. ml. standard. The results,
shown on table 6 indicate a fairly high efficiency for counting small
count rates down to 6 cpta.
Tabfr (6)









k 24.0 240 100
3 180 186 103.3
2 120 118 98.2
1 60 62 103.3
0.5 30 30 100
0.2 12 13 108.1
0.1 6 6 100
98.2 - 108.1
(f) Estimation of the specific activity of Cortisol
The specific activity of each plasma sample was calculated by
dividing the total count of the sample by the corresponding fluorometric
estimation. Thus:
specific activity (S.A.) eluate = vSl! )elmte Cpra/{Xg
and for the dose solution:
S A do=?e - ^cUvjrty jW/l r4,) dj-^tp foge gojMloR . ern/uffb* , dose - Cortisol (^g./l ml.) dilute dose solution Cpm/^g*
(g) Oalculation of the body miscible pool, rate of turnover, biological
half clearance time and production rate of Cortisol
These were calculated using the isotope dilution expressions:
(1)/
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(1) A = a - 1] x 10"3 rag.
for estimation of the miscible pool, and
(2) k = pool/24- hrs.
for estimation of the rate of turnover.




The amount of Cortisol in the dose (a) is 30 H-g.
The specific activity of the dose (li) is 20,200 cpra/pg.
The specific activity at zero time (Io) is 200 cpm/jig.
Biological half clearance time (1*) is 100 minutes
then the aiscible pool of Cortisol will be:
A = 30 [20»^° - 1] x 10*"3
~ 3 rag.. (1)
and the rate of turnover will be:
k » = 10 pool/24 hrs (2)
and the production rate will be (l) x (2), i.e.
3 x 10 = 30 mg,/24 hrs.
waste and
Besides the fact that C is a very weak p-eraitter (0.155 MeV), the
amounts handled were very small. Accordingly, and after consultation with
the Medical Physics Department of the Royal Infirmary of Edinburgh, it was
agreed/
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agreed that it is quite safe from the public health point of view, both to
store the various solutions containing radioactive Cortisol in the
refrigerator used for storing various chemicals and to wash the radioactive
waste down the sink using plenty of water. So, glassware which contained
radioactive C"^ were thoroughly cleaned by brushing using teepol, and
plenty of tap-water then rinsed with distilled water. Pipettes were
treated in the same way, then rinsed at the end with acetone.
Film badges, supplied by the Physics Department of the Western General
Hospital of Edinburgh, were used by all people handling and were
changed every fortnight and checked for the degree of exposure to radio¬
activity,
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ii. Estimation of Cortisol production rate by the urine method
The method applied here is based largely on that described by Cope and
Black (1958 a),
frtaqjflle
The principle of the urine method is the same as that of the blood
method except that the degree of dilution of the administered dose refers
to Cortisol metabolites (particularly tetrahydrocortisone which is the main
metabolite of Cortisol) instead of to Cortisol as in the blood method
(see Introduction, Chapter II).
After administration of the dose, a 24 hour urine sample was collected.
The total radioactivity was measured and conjugates of Cortisol metabolites
in urine were hydrolysed using ^-glucuronidase, oortieol metabolites
extracted and separated by chromatography. The S.A, of tetrahydrocortisone
(THE) was then determined by estimation of both its radioactivity and its
content spectrophotometrically. Cortisol production rate was calculated
as the total radioactivity in the 24 hour sample divided by the S.A. of
THE, i.e.
Cortisol production rate = W yipe (off.) x 10-3 ^
1. Tetrahydrocortisone standard
(a) Stock standards 0.4 mg./THE (Steraloid)/ml. absolute ethanol.
(b) Working standards 20 y.g. THS/ml. absolute ethanol.
2. Tetrahydrocortisone markers 1 mg. THE/ral, absolute ethanol.
o
THE standards and THE marker were kept always at 4 C,
3. ^-glucuronidases (Limpet), 2,000,000 units/g. (Baylove Chemicals)
u
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4. Chloroform, R (K & B)
5. Sodium hydroxide (B.D.H.) 0.1 N approximately.
6. Ethane-diol (Ethylene glycol) (B.D.H.).
7. Toluene (B.D.H,) Analar grade.
8. Methanol (B.D.H.) Analar grade.
9* Glacial acetic acid (M & B)
10. Purified alcohol.
11. Tetraraethyl-ammonium hydroxide (B.D.H.) 25%
12. Blue tetrazolium [3s3,-Dianisole~Bis-£:£,~ (3:5 Diphenyl) - Tetrazolium
Chloride] (B.D.H.)
13. 10^ Sodium hydroxide in 60$ methyl alcohol (1:1 v/v)
14. Methanol/ethylene glycol (1:1 v/v)
15. Acetate buffer : pH 4.6} 0.5 M
16. Hydrochloric acid: 0.1 N approximately,
17. Radioactive compounds
a. Dose solution )
) Prepared as described before
b. Dilute dose solution)
c. Internal Standard: with doses of 1 pc,, the dose solution was
diluted with absolute ethanol to give about 650 cpm/ml. With
doses of 2 pc. it was diluted to give about 1800 cpm/ml.
18. Scintillation counting fluids: as in the blood method,
fo-opedurt?
(a) ,\jffljj,nxgt^tion pf the dosq collection of yjp?,
Patients were made to empty their bladders and dose administered as in




ft) Estimation of total radioactivity
10 ml. of the urine were filtered and the total radioactivity determined
on 0.5 ml. of filtrate. Urine does not mix with toluene, but by blending
5 ml. of the phosphor with 4 ml. ethanol, up to 0.5 ml. urine may be
incorporated by gentle swirling to ensure good mixing. The incorporation
of 0,5 ml, urine into ethanol and liquid phosphor, however, produced some
turbidity, presumably because of the presence of dissolved salt and other
substances in urine and this sometimes exerts a considerable quenching effect.
Correction for this quenching was made by adding an internal standard.
Counting the urine was carried out before and after the addition of the
standard, the observed count of the standard in urine was compared with its
true value and so a correction factor for quenching was obtained. Accordingly




2. Urine 4 0.5 5
(U)
3. Internal standard 3
(S)
1 5






The value of the background (cpm) was subtracted from the radioactivity
(cpm) of the other samples,
ranched/
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quenched standard = cpra (U + 3) - cpm (U)
Urina count corrected for quenching was ^ If^quencS (S)
As only 0.5 ml, of urine was used for counting, the total radioactivity of
sample (expressed as cpm/24 hrs.) was:
Total count of 0,5 ml, urine x 2 x total volume of 2U hour sample.
The background was counted till A,000 counts were recorded, urine samples and
standard till 10,000 and dilute dose solution till 4.0,000. Jars were kept
in the dark in a petri dish containing tap water for 10 minutes, then housed
in the castle for another 10 minutes before counting started. Counting of
the background was almost always 100 cpm (ranged between 96 and 104), that
of the urine sample varied according to the volume of urine and percent
of dose excreted in 24 hours, but generally more than 300 cpm were recorded
with 1 pc, dose and more than 700 cpra were recorded using 2 pc. dose. The
internal standard was prepared such that the counting of urine + internal
standard should always be more than double the counting of urine. By this,
the maximum correction for quenching could be made. Thus an internal standard
of 900 cpm/ml, and 1800 cpm/ml. were found to be suitable to use with the
different activities of the urine samples estimated after administration of
doses of 1 pc, and 2 pc. respectively.
The validity of this method for correction of the quenching was tested by
preparing 8 sets of jars each is composed of:
1. Background.
2. 0.5 ml. different urine sample plus a quantity of radioactivity
equivalent to 900 cpm,
3» 0,5 ml, urine, plus a quantity of radioactivity equivalent to 900 cpm
plus 1 ml, internal standard (1800 epm/ral.)
•&./
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4. 1 ml* internal standard.
Ethanol was added to A nil,, and then 5 ml, toluene phosphor were added and
jars counted as usual, Countings of the added radioactivity were recorded
before and after correction for quenching using the internal standard and
the results compared to the original activity added (900 cpm). Results are
shown in table 7,
Trtfo (7)















1 900 846 917 101.8
2 900 839 905 100.5
3 900 869 883 98.1
A 900 851 894 99.2
5 900 815 926 102.8
6 900 842 919 102.4
7 900 836 928 103.3
8 900 853 897 99.6
98.1 - 103.2
These results clearly indicate that the employment of an internal
standard to correct the quenching is essential and also that this method of
correction is reliable,
(c) Enzymatic hydrolysis
For estimations at basal conditions, one tenth of the 2A hour urine
sample was used. Its pH was adjusted to 4.6 with 0,1 N KC1 (using narrow-
range pH papersj B.D.H,, A - 5,5) and the pH stabilised by the addition of an
equal volume of acetate buffer (pH 4.,6, 0,5 M). ^-glucuronidase (500 units to
each ml. of urine, dissolved in few mis. acetate buffer) was then added and
thoroughly/
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thoroughly mixed with the urine, which was then incubated at 37°C for 2U hours.
After ACTH stimulation, urine contained increased amounts of Cortisol
metabolites, so that one twentieth of the total 24. hour urine sample was
quite adequate for this estimation. On the other hand markedly diminished
quantities of Cortisol metabolites in urine after dexarethasone suppression
justified the use of one fifth of the total 24. hour urine sample for this
test.
(d) Extraction of Cortisol metabolites
This was carried out in one-litre separating funnels using 2 x 50 ml.
chloroform. The lower chloroform layer was transferred to centrifuge
bottles and the emulsion formed during extraction broken by centrifugaticn at
710 g. for 15 minutes. The upper layer was removed by suction and the lower
chloroform layer washed in a 250 ml. glass stoppered flask twice with 15 ml.
of 0.1 N NaOH, to remove acidic and phenolic steroids, and twice with 15 ml.
distilled water. Centrifugation was carried out after each washing and the
upper layer was removed by suction. After the last washing, the extract was
transferred to a clean 150 ml. glass stoppered flask and brought to dryness
under reduced pressure in a water bath at 50°C,
An equal volume of distilled water was treated as urine and served
as the blank,
(e) Isolation of tetrahvdrocortisoi.e b.v chromatography
Paper chromatography was used for the fractionation of the urinary
metabolites of Cortisol. Isolation of tetrahydrocortisone, the main
metabolite of Cortisol, was the main factor which determined the solvent
system to be used, namely that of Zaffaroni (Burton et al, 1951 a) subsequently
modified/
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modified by Nowaczynski and Koiw (1957) in which ethylene glycol/toluene
as the partition system replaced Zaffaroni1s original propylene glycol/
toluene* This modification shortened the running time from 96 hours to
13 hours without loss of sharpness of separation*
Paper used was Whatman No. 54-J A5 x 15 cm. previously washed for 3
days with 95% methanol while hanging in a chromatography tank. The paper
was divided into U limbs with spaces of 1 cm. between each. The outer two
limbs were 2 cm. wide and were used for spotting tetrahydrocortisone marker
and the inner two were 4. cm. wide, one of thorn for spotting the sample and the
other for the paper blank. The starting line was 12 cm, from the upper
edge of the paper and the limbs started 11 cm, from the upper edge of the
paper and ended 5 cm. from its lower edge (see figure 13). Paper had
first to be impregnated with the stationary phase (methanol/ethylene glycol
1*1 v/v) and the wet paper pressed between two sheets of previously washed
Whatman paper to remove excess solution.
Orled chloroform extracts were then redissolved in 2 x 0.2 ml.
chloroform in acetone(99*1 v/v)and transferred to the starting line of the
chromatography paper, 10 pi. tetrahydrocortisone marker was applied to
the starting line of each outer limb and paper was then transferred to the
chromatography tank, which is similar to that used with the Bush B5 system.
No beaker was used at the bottom of the tank and filter paper lining the
tank dipped into about 1 cm, of mobile phase, toluene saturated with
ethylene glycol. As equilibration is not needed with this solvent system,
descending chromatography was started by pouring the mobile phase, toluene
saturated with ethylene glycol, through the stoppered hole in the middle of
the/
Figure 13: Chromatographic separation of urinary THE.
Identification by the 131'2 reaction. ~
the cover directly to the trough and chromatography was allowed to proceed
in the dark at room temperature for 13 hours. Paper was then taken out
of the tank and dried in the dark. But owing to the presence of ethylene
glycol drying took at least 6 hours using a hair dryer.
To locate the tetrahydrocortisone zone, a 1 cm.-vide strip of the urine
sample limb was cut off and dipped, together with the outer 2 standard
tetrahydrocortisone marker limbs in a solution consisting of 15 mg.
blue tetrazolium dissolved in 3 distilled water to which 9 ml. of 10$
sodium hydroxide in 60$ aqueous methanol were added. In few seconds, in
the strip of the urine sample limb, 3 purplish-mauve bands appeared; the
one nearest to the origin was a dense narrow one due to the water insoluble
formazan formed by the interaction of tetrahydrocortisol with the blue
tetrazoliura. The middle one was broader and much denser and was due to
the formazan formed by the interaction of blue tetrazolium with tetrahydro¬
cortisone. A third faint band further away from the origin was occasionally
seen and was due to allo-tetrahydrocortisol. Similarly, THE standard
marker applied to the outer two limbs appeared as purplish-mauve spots
at the same horizontal level as the THE of the urine ehromatogram (see figure
13). The bands of the urine chromatograms were, on the whole, much denser
for urines after ACTH stimulation and very faint after dexamethasone
suppression. The section of the urine sample limb and of the paper blank,
opposite the developed tetrahydrocortisone band and standard marker spots,
were cut out, fluted and eluted by Immersion in 5 ml. ethanol overnight.
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(f) Estimation of the radioactivity of the eluate
For this purpose 3 ml, of the eluate were taken for counting; 2 jars
were set as follows:
alcohol eluate toluene phosphor
ml• ml• ml«
Background A - 5
Eluate 13 5
and counting carried out as previously described.
(g) estimation of THE
0.5 ml. of the eluate was taken for spectrophotometry estimation of
tetrahydrocortisoae relative to THE standard. The procedure used in this
study for the quantitative estimation of THE was a modification of that used
by Nowaczynski et al (1955). In principle it is based on the fact that
alcoholic solutions of certain steroids reduce tetrazolium salts in the presence










Blank 2.5 - mm 0.25 0.25
Papor blank 2 0.5 - 0.25 0.25
Standard 1.5 - 1.0 0.25 0.25
Eluate 2 0.5 mm 0.25 0.25
* Standard THE solution used was 20 pg./ml.
** Blue tetrazolium solution was prepared immediately before use by dissolving
50 rag. blue tetrazolium in 10 ml. ethanol.
***Tetramethyl-aramoniura hydroxide solution was prepared immediately before use
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This arrangement was convenient to use for estimation at basal conditions
and after ACTH stimulation. tfith urines containing small amounts of THE as a
result of dexamethasone administration, 1 ml. of eluate was used instead of
0,5 and ethanol added was 1.5 ml. Solutions were thoroughly mixed and kept
in the dark for 25 minutes, at the end of which the reaction was stopped by
pipetting 1 ml. glacial acetic acid into each tube. Optical densities were
read against an ethanol blank in an S.P. 600.
Amount of THE in 0 5 ml eluate — i^r g&nple — C'tfft ,|ffif Italia,?, u~x iil . l. l t - fa.D. of standard - O.D. of blank) ^g*
which if multiplied by 6 gives the amount per 3 ml. eluate.
(h) Estimation of specific activity of THE
Specific activity of THE could be calculated as follows!
S.A. TBS = in 3 ri,, jtet, (m) ( ^ ,THE in 3 ml. eluate (pg.} v ^ ^
The spectrophotometer used was the Unlearn S.P. 600, designed for
absorptiometry measurements within the visible and near-infra-red regions of
the spectrum. A wave-length of 520 mp. and the blue photocell were used.
Figure 1/,. shows a plot of optical densities against wave-lengths using
the S.P. 600. An absorption maximum at 520 mp. for eluted and standard
tetrahydrocortisone was obtained.
(i) GalculfttlQp of Cortisol profocUon rat?
CPR _ Tqtel count in 2A hour urine (cpm) < .~
S.A. THE (cpm/pg.) xlOOO tirs'




If volume of the 2/, hour sample of urine is 1000 ml, and radioactivity of
0,5 ml. after correction for quenching is 800 cpra then total count of 24
hour urine is 800 x 2 x 1000 = 1,600,000,
If activity of 3 ml, eluate is 4.800 cpm and THE content of the same
amount of eluate is 30 ^g» then the specific activity of THE is
a 160 cpra/pg. and
CER - A|61Q^00° x 10"3 = 10 mg./24 hrs.
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2. Estimation of 17-ketostsroids In urine (17-KS)
The method applied in this research is a modification of that
described by James and deJong (1961).
yri-wlpta
After acid hydrolysis, urinary 17-ketosteroids were extracted by
ethylene chloride and other acidic and phenolic steroids washed away by
sodium hydroxide. The extract was dried and colour produced by a modified
Zimmermann reaction} thi3 was compared to the colour produced by a
staidard dehydroepiandrosterone (DHA) solution treated in the same way.
Colour reagent
a.m-e/initrobenzene: 1% solution in absolute ethanol.
b. Tetramethyl-ammonium hydroxide 25% aqueous solution (B.D.H.),
The colour reagent for the Zimmermann reaction was prepared by thoroughly
w-
mixing equal volumes of /dinitrobenzene solution and tetramethyl-ammonium
h
hydroxide solution immediately before use.
D^A gtqqdarflt
a. Stock standard; 1 rag,/ml. in absolute ethanol,
b. Working standards t
(1) 25 pg./0.2 ml. absolute ethanol.
(2) 50 pg./0,2 ml. absolute ethanol,
(3) 75 pg./0.2 ml. absolute ethanol.
CO 100 pg./0.2 ml. absolute ethanol.
Procedure
24. hour urine samples were used, the volume measured and aliquots
containing 4-5 drops of chloroform as preservative were kept in the deep
freeze until required. Urine was well shaken and 10 ml. pipetted into
clean/
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clean 3/4 x 6" ^luickfit test tube. 10 ml. distilled water were treated
in the same way and served as a blank. 1 ml. concentrated hydrochloric
acid was added and the contents of the tubes mixed and. tubes placed in a
boiling water bath in a fume cupboard for exactly 10 minutes. Tubes
were then cooled and 10 ml, of ethylene chloride were added from a
burette with ungreased tap. The tubes were then stoppered, sealed
firmly with sellotape and contents mixed by gentle inversion (tumbling
on a turntable) for 15 minutes at 4.5 r.p.m.
The aioparc were removed and the tubes were centrifuged at 540 g.
for 10 minutes. This should break any emulsion formed during the mixing.
The top urine layer was carefully removed by suction with fine Pasteur
pipette joined to a suction pump and 1 ml, N sodium hydroxide added. Tubes
were restoppered, sealed and their contents mixed by tumbling on turntable
for 7 minutes. Stoppers were removed and tubes recentrifuged at 540 g.
for 10 minutes. The top alkaline layer was removed by suction and 1 ml.
distilled water added. Tubes were stoppered and their contents mixed by
tumbling for 7 minutes. Stoppers were removed and tubes centrifuged at
540 g. for 10 minutes. 2 gm. anhydrous sodium sulphate were added and
tube shaken. An aliquot, 5 ml., of ethylene chloride extract was removed
through cotton-wool into a clean dry 1/2 x 5" ^uiekfit test tube and
evaporated to dryness under reduced pressure in a water bath at 80-90 C.
0.2 ml, absolute ethanol was added to each of the dry residues. Hasidues
were dissolved by gentle but thorough mixing (stoppered tubes were
warmed in hot water if necessary) 0,4. ml, of colour reagent was added
and mixed. Tubes were allowed to stand in the dark at 25°C for 60
minutes./
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minutes. 5 ml. of 70% aqueous ethanol was added and mixed.
"Specimen blank" was prepared for every batch of specimens substituting
water for urine. 0.2 ml. of each working standard was pipetted into a
standard specimen tube and test continued from the step of adding the colour
reagent. "Standard blank" was prepared by processing 0,2 ml. absolute
ethanol and test also continued from the step of adding the colour reagent.
Optical densities of the specimen blank, standard blank, sample and
standard tubes were determined using the S.P. 600 at wavelength 520 np.
and at two other wavelengths equidistant on each side, viz. IJ+0 mp. and
600 mp. (Allen, 1950), and the corrected final reading, i.e.
O.D. at 520 mp. - at mp, + GtDt at 600 iqp.
was calculated.
Blank standard values were subtracted from standard values and
specimen blank values subtracted from unknown values.
C^pulptlop
A standard graph was constructed by plotting the amount of standard
per tube against corrected optical density and the corrected unknown values
were read off from this graph, the result obtained was expressed as
pg./0.2 ml. final extract. As only 10 ml. of urine were used in this
estimation, the 17-KS in the 2A hour sample is:
Pfft/0«2 x total urine volume pg./2£ hrs.
or K,/0,Z -1, * total urine volume x 10"3 mg./24. hrs.
But/
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But since only 5 ml* of the 10 ml. ethylene chloride extract were used,
the final formula isi
tiflt/°»? "lit. •untolo*fn x total urine volume x 10~*^ x mg»/24 hrs.
±U 5
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3. Estimation of total 17-ketogenic steroids In urine (total 17-KGS)
The test used in this research is a modification of that described by
Few (1961).
In urine samples, reduction by potassium borohydride of the C-17
ketone group of the pre-existing 17-KS and of the C-ll and C-20 ketone
groups of the C-21 corticosteroids was followed by oxidation of all
ketogenic steroids with sodium meta-periodate to the 17-KS, llp-hydroxy-
etiocholanolone and its 5a-isomer llp-hydroxy-androsterone (see
Introduction, Chapter II, and table l). After alkaline hydrolysis the
mixture was extracted with ethylene chloride, the extract washed and dried
and the colour produced by Ziramermann reaction compared to the colour
produced by a standard DHA treated in the same way.
The reagents and procedure were similar to those described by
Few (1961) except that no chromatographic separation of 11-oxy and 11-deoxy
total 17-KGS, by chromatography was attempted in this study and that
tetramethyl-ammonium hydroxide was used in the colour reagent, as in
estimation of 17-KS. Standard DHA solutions were prepared as in 17-KS
method.
24- hour urine samples were used. The total volume was noted and
an aliquot of about 100 ml. containing 4-5 drops of chloroform as
preservative was stored in the deep freeze till required. The urine was
well shaken, 5 ml. pipetted into a clean -§• x 5" Quickfit test tube. Few
drops of ether were added to prevent frothing caused by the potassitrn
borohydride,/
borohydride, of which 0.5 ml. was added (solution freshly made by
dissolving 1 g. in 10 ml. 0,1 N sodium hydroxide). 5 ml. water ware
substituted for a blank. Tubes ware stoppered and contents mixed then
left either for 2 - 3 hours or overnight at room temperature to allow the
reduction to take place. 0.25 ml# of 25$ acetic acid was then added
dropwise and tubes were shaken to mix their contents and allowed to stand
for 15 minutes. For oxidation, 2 ml. of sodium meta-periodate solution
(freshly made by dissolving 2 g, in 20 ml. distilled water) were added
followed by 0.5 ml. of IN sodium hydroxide. After thorough mixing, the
pH was adjusted, if necessary,to 6.1 - 6.4, using narrow range pH papers
(B.D.H., 5.5 - 8.5) externally and adding drop by drop IN NaOH or IN HC1
where appropriate. The tubes were stoppered and placed in an incubator
at 37 C for 1 hour. Hydrolysis was then carried out by adding 0.5 ml, of
2.5 N NaOH and mixing the contents of the tubes. Tubes were replaced
in the incubator for 15 minutes.
Extraction with ethylene chloride was carried out as in the 17-KS
method and 2.5 ml, of alkaline sodium dithionite solution (freshly
prepared by dissolving 2.5 g. in 100 ml, 1.25 N sodium hydroxide) were
added for purification. Extract was washed with 1 ml, of distilled water
and anhydrous sodium sulphate was used for drying as in the 17-KS method.
An aliquot, 5 ml, of solution,was removed, dried and the colour reaction
proceeded as in the 17-KS method.
"Specimen blank", working standards and "standard blank" were prepared
as in the 17-KS method and 0,D. read in the S.F. 600, as previously
described,/
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described, at wavelengths 44 °» 520 and 600 my. Standard blank values
were subtracted from standard values, and specimen blank values from
unknown values.
Calculation
A graph was constructed by plotting the amount of standard per tube
against corrected optical density. The corrected unknown was read off
from this graph. The result obtained was expressed as pg./Q,2 ml. final
extract. Total 17-KGS in the 24 hour sample, therefore, equals
upknovfn x total urine volume pg./24 hrs.
or 'is./0.2 ml. unknown x total urine volume x 10~^ mg./24 hrs.
But since only 5 ml. of the 10 ml, ethylene chloride extract were used, the
final formula isi
.fflL .unknown x urine volume x 10"*^ x ^7 x 1.33 rag./24 hrs.
5 5
where 1.33 is a factor compensating for small extinction coefficient of
llp-hydroxy-etiocholanolone and llp-hydroxy-androsterone as compared to
DHA, This is because lip-hydroxy- derivatives have only 74% of the
chromogenicity of the corresponding 11-deoxy- compounds in the Zimmermann
reaction (Few, 1961).
The presence of glucose in urine interferes with this estimation. In
every specimen of urine, glucose was tested by Clinitest (Ames. Go.). If
the glucose concentration exceeded 0.5 g./lOO ml.,the following procedure,
recently recommended by the Medical Research Council Committee on
Endocrinology/
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Endocrinology (19&3), was carried out in some of the specimens*
U inl. of the urine were pipetted into a glass-stoppered test tube.
2 g, of ammonium sulphate were dissolved la the urine, which was then
extracted four times with U ml. of an ether/ethanol (3A) mixture.
Extractions were made by shaking the two phases in the stoppered test
tube. After allowing them to separate, the upper phase was transferred
to an extraction tube. The combined ether/ethanol extract was evaporated
on a water bath at 4.0°C in a current of nitrogen. U ml. of water were
added to the residue in the extraction tube, and the normal procedure
for determining total 17-KGS was then carried out as if the U ml, were
urine.
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4. Adrenocortical stimulation by ACTH
Initially ACTH gel (Crooks cortico-gel U0 I,U./ml.) was given by
deep intramuscular injection, 60 I.U. every 12 hours for two days and
once at 9i00 a.m. on the third day (i.e. 5 injections altogether) and Cortisol
production rate estimated by both blood and urine method on the third day, as
usual. Urinary 17-KS and total 17-KGS were also estimated on the third day of
ACTH stimulation. With this procedure, however, Cortisol production rate
obtained by the urine method was sometimes lower than that obtained by the blood
method (see tables 11 and 12). It was thought at this stage that this
discrepancy was due to the fact that the blood method involved specimens
obtained only half an hour after the last injection of ACTH, i.e. during
maximum stimulation of the adrenal cortex, while the urine method measured
Cortisol produced during the whole day. The interpretation of this observation,
at this stage, was that stimulation of the adrenal cortex by this dosage of
ACTH failed to produce a plateau of Cortisol production lasting till the end of
the third day. This observation was supported by the occasional finding of
a lower urinary steroid output on the third day of adrenocortical stimulation
than on the second day.
Accordingly, in the later part of the study, the dosage of ACTH was
changed so that the patients received 60 I.U./12 hours for three days.
Changing the dosage of ACTH, however, did not make any difference. The
interpretation of these findings will be discussed later.
- m -
5* Pjtultar.y-fiflrenogort3^3, suppreg^pp by ^^neth^gon^
This was carried out by oral administration of dexamethasone (Roussel)
which was given in a dose of 0,5 mg, six hourly for two days and once at
9*00 a.m. on the third day, Cortisol production rate was estimated by
both blood and urine methods on the third day,as usual. Again, urinary
17-KS and total 17-KGS were also estimated on the third day of dexamethasone
suppression.
With this dosage, it was found that the Cortisol production rate was
so low that blood Cortisol values, were below the sensitivity of the
fluorometer. It was also found that most of the values of Cortisol
production rate after dexamethasone suppression obtained by the urine
method were higher than those obtained by the blood method. The inter¬
pretation of this observation, at that stage, was that estimation of Cortisol
production rate by the blood method was carried out on the morning of the
third day of adrenocortical suppression, only 30 minutes after administration
of the last dose of dexamethasone, i.e. during the maximum suppression of the
adrenal cortex, while the urine method measured the Cortisol produced during
the whole of the third day. This meant that suppression of the adrenal
cortex by this dosage of dexamethasone was not being maintained till the end
of the third day. This conclusion was supported, by the occasional finding
of higher urinary steroid outputs on the third day of adrenocortical suppression
than on the second day (see tables 17 and 18),
For these reasons it was decided, later on, to change the dosage of
dexamethasone to 0,5 rag. six hourly for two days only, i.e. 8 doses altogether,
and/
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and to carry out the estimation of Cortisol production rate, urinary
17-KS and total 17-KGS excretion on the second day of administration of
the drug instead of the third day. Changing the dosage of dexamethasone
did not make any difference. The interpretation of these findings will
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6. Simultaneous estimation of Cortisol production rate, plasma Cortisol
flnfl pV^mq-protein binding of cgrtlgpl,,,
A desire to estimate the degree of plasma-protein binding of Cortisol
as another index of adrenocortical function initiated the work which led to
developing a method by means of which Cortisol production rate, plasma
Cortisol and plasma-protein binding of Cortisol could be simultaneously
estimated, using ,4-C -cortisol.
An in vitro method was tried firstj radioactive Cortisol was added to
plasma collected before the C^-cortisol was administered. Later on, an
in vivo method was developed in which use was made of the plasma labelled
by the injected dose to serve the three purposes,
a. in vitro method
Principle
A sample of blood was withdrawn and plasma separated. A trace amount
of radioactive Cortisol was added. A portion of this plasma was taken for
total radioactivity counting. A second portion was subjected to ultrafiltration
and the ulirafiltrate counted. A third portion, together with the plasma of
the blood samples withdrawn after injection of a radioactive Cortisol dose, was
processed in the usual way, i.e. extraction, purification, chromatography,
elution, radioactivity counting and fluorometric estimation of Cortisol in
the eluate.
Figure 15 (a and b) shows the main steps of this technique and the mode
of calculating the results. Cortisol production rate was estimated, as
previously described, from the specific activities of the blood samples
withdrawn after injection of the dose. Cortisol was estimated fluorometrically
in/
Bloodsample1 (40ml.) I Plasma 0.5ml.forBGcounting
RadioactiveC rtisol standardad e
-0.5ml.forcounting©1 5ml.forultrafilt ation 1 0.5ml.ultrafiltrate forcount!tm3© ui.npb CORTISOL
10ml. Extraction Washing Chromatography Elution
Fluorometry^^ Counting(B t Correctionforl sses^.
II.PLASMACORTISOL
FIGURE15b:SimultaneousestimationofCP ,plasmaCortisolndlNPBl(ivi r ) 2.CalculationofplasmaCortisolndp sman bCortisol
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in the purified extract of the pre-lnjection plasma, to which labelled
Cortisol was added, and the plasma Cortisol obtained from this value by
applying a correction, for the amount of Cortisol lost during the extraction
and purification. The correction factor was derived from estimation of the
total radioactivity of the plasma and that of the purified extract.
The percentage of Cortisol not bound to plasma proteins was calculated
by comparing the total count of the ultrafiltrate to that of the original
plasma,
1, Ultrafiltration apparatus (see figure 16a). The apparatus used for
ultrafiltration in this study was essentially similar to Toribara's
ultrafiltration apparatus (Torlbara, 1953) later used by Mills et al (i960)
to study plasma-protein binding of Cortisol, but much simpler.
The ultrafiltration apparatus used in this study consisted ofs
(a) !4ercury levelling bulbs. These were glass tubes 7.5 cm. long and
2.5 cm. wide, with a narrow lower part, 3.5 cm. long and 0,75 cm. wide.
Each was fitted with a rubber stopper at the upper end and a rubber tubing
around and projecting for 0.5 cm. down the narrow end. The stopper was
pierced by a thick syringe needle whose lower end was cut flush with the
lower end of the stopper,
(b) 3 x 17 cm, centrifuge tubes (MSB - HR).
(c) Visking seamless regenerated cellulose tubing, size 18/32" with an
average pore radius of 24 angstrom unit (H.M.C.)
u&
The mercury bisb held inside the visking tubing, containing the plasma,
and was placed inside the centrifuge tube where the ultrafiltrate collected.




ultrafiltrate by air from the centrifuge tube. The rubber tubing around
the lower end of the bulb minimised friction between the glass surfaces
of the latter and the bottom of the centrifuge tube and prevented either
of them from getting broken during centrifugation. Parafilm and adhesive
plaster were used to seal the centrifuge tube to prevent the ultrafiltrate
from evaporating during centrifugation.
2. Carbon dioxide cylinder (5% in oxygen).
The reagents were as for the estimation of Cortisol production rate by
the blood method, plus:
1. Kyamine solution; 1.5M: prepared by adding 33 ml. methanol to 75 g.
to
Hyamine 10-X (Hopkins and Williams Ltd) i** a flask and shaking vigorously
till completely dissolved. This solution was kept in a dark place.
2. Internal standard: 5 ml. dilute dose solution (1:350) were further
diluted with ethanol (1:1) so that 0.1 ml. of the final solution gave 4,00 cpm.
3. Dilute radioactive Cortisol standard: prepared by diluting 0,1 ml. of
the dose solution with 7 ml. saline; 0.05 nil. of this solution added to
plasma (15 - 20 ml.) gave a total radioactivity of about 180 cpm/0,5 ml.
plasma. This solution and the internal standard were kept at 4°C.
Procedure
The main steps of this procedure were the same as in the estimation of
Cortisol production rate by the blood method. Just before administration of
the C"^-Cortisol, 4,0 ml. of blood were withdrawn from the patient in a
heparinised syringe and the plasma separated by centrifugation at 54.0 g. and
37°0. The C^-cortisol was then administered. Four blood samples were
withdrawn/
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withdrawn at half hourly intervals and plasma separated from each as
previously described.
0,5 ml. of the pre-injection plasma was pipetted in a counting jar for
background counting. 0.05 ml. of the diluted dose solution was then added
to the rest of the pre-injection plasma which was then mixed, by gentle
inversion of the tube for few times, and incubated at 37°C for 10 minutes.
Three portions of that plasma were used!
fa) A portion, 5 ml,, was taken for ultrafiltration. This portion
fiiS.
was pipetted in a. visking tubing knotted at one end, and 5% carbon dioxide
in oxygen^bubbled gently into the plasma for two minutes to maintain a
relatively constant pH, utilising the buffer system of the plasma. The
visking tubing was then held upright and gas driven out by pressing the
walls of the tube between the thumb and index fingers. All the equipment
necessary for •ultrafiltration was warmed beforehand to 37°C in an incubator.
The visking tube was then knotted at its upper end and introduced into the
ultrafiltration tube so that it rested on the lower end (see figure 16b).
The tube was stoppered and introduced into the centrifuge tube. The
whole apparatus was again gassed with 5% carbon dioxide in oxygen and the
centrifuge tube sealed with parafilm which was fixed with adhesive plaster
iviAa
(see figure 16c). The whole was introduced i» a centrifuge bucket and
spun at 54-° g. for 5 hours at 37°C.
The centrifuge tube was taken out of the centrifuge bucket and left
to cool to room temperature. The adhesive plaster and parafilm were then
removed and the ultrafiltration tube taken out, leaving the crystal clear
ultrafiltrate/
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ultrafiltrate at the bottom of the centrifuge tube. 0.5 ml. of the
ultrafiltrate was removed by a pipette into a jar for radioactivity counting,
(b) A second portion, 0.5 ml., of this plasma was pipetted into a
counting jar and used for the estimation of total radioactivity of the plasma.
(c) A third portion, 10 ml,, and all the plasma of the four post-injection
samples were subjected to the same procedure, i.e. extraction, purification,
chromatography, elution, radioactivity counting and fluorometric estimation
of Cortisol in the eluate.
Plasma and ultrafiltrate were counted in a way which was different from
that described for counting urine or eluates. This was because plasma did
not blend with the phosphor and the incorporation of alcohol as in
counting urine or plasma eluates rendered the solution very turbid. But
plasma can be blended with the phosphor if it is first dissolved in hyamine
solution, 1.5M. Accordingly three counting jars were prepared as follows:
Kfl(UqqgUY9 Ultrafiltrate Hy^nine Toluene
active Plasma solution phosphor
Bl&gfflft
ml. ml, ml. ml, ral»
Background 0,5 - - 2 9.5
Plasma - 0.5 - 2 9.5
Ultrafiltrate - - 0.5 2 9*5
Plasma, or ultrafiltrate, to be counted was dissolved thoroughly in
hyamine solution before adding the phosphor. The counting jar was then kept
in the dark in a petri dish containing tap water for 10 minutes to bring it to
the temperature of the castle and then housed in the latter for another 10
minutes/
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minutes before counting started. Background was counted till 4»000 counts
were recorded and all active samples counted till 10,000 counted were
recorded.
A
Because plasma is invariably not clear, quenching occurs as with urine.
The amount of quenching varies with the different plasmas. Allowance for
quenching was made as followst after counting the plasma, 0.1 ml. of the
internal standard was added and the (plasma + standard) jar counted again.
The plasma activity was corrected for quenching by multiplying the observed
value by the ratio of actual/observed activity of the standard.
The validity of correction for quenching was tested by an experiment
in which a known amount of activity was added to 8 different plasma samples
and the observed counts were compared to those corrected after using a
radioactive standard.
(9)
Validity of the correction method for quenching of plasma
Plasma Added Observed Corrected Efficiency
Sample radioactivity radioactivity radioactivity
(%)(No.) (cpm) (cpm) (cpm)
1 250 238 259 103.6
2 250 227 247 98.8
3 250 236 255 102.0
4 250 218 242 96.8
5 250 221 246 98.3
6 250 214 252 100.7
7 250 232 250 100.0
8 250 2H 257 102.9
96.8 - 103.6
The results (table 8) show clearly that not only is this correction
necessary but also that it is very reliable. Such correction, however, was
not/
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not found necessary with the ultrafiltrate, which was always clear, i.e.
could not produce any quenching; the observed activity of ultraftitrates
in cpm were directly used in the calculations.
Counts of the background were almost always 100 cpm (ranged from
96 - 104 cpm), those of the active samples, after subtraction of the
background count,were about 180 cpm for the plasma, 12 - 28 for the
ultraf.titrate and 4-00 for the internal standard.
The internal standard was prepared such that the activity of the
combined standard and plasma ma always more than double the activity of
the plasma in order to determine the amount of quenching correctly,
lifter dexamethasone administration counts of the ultrafiltrate in the
great majority of cases approached the background count, thus rendering their
value questionable. This problem could not be overcome without adding much
higher amounts of radioactive Cortisol to the plasma. The amount of
radioactive Cortisol which was used in this technique raised the plasma
Cortisol by less than 0.1 pg./l00 ml. To obtain comparable counts after
dexamethasone would mean adding measureable amounts of Cortisol, which would
significantly affect the results of Cortisol estimation and most probably
also affect the proportion of bound to unbound Cortisol, thus invalidating
the whole test,
&qpulatioK
1. -436 ^9 qigqlftte. pool* frfo3 <4e«yqnqs -t^e, the
of turnover and production rate of Cortisol. These were calculated, as
previously described, from the specific activities of the purified extracts




(a) Correction for quenching:
Suppose the actual activity of the internal standard added to the
pre-injection plasma was 4.00 cpra, the observed activity of 0,5 ml# plasma,
with added C^-cortisol, was 200 cpm and that of the plasma plus internal
standard was 520 cpra.
The observed activity of the internal standard, therefore, is
520 - 200 s 320 cpm.
The activity of plasma corrected for quenching equals
observed activitv of nlasria x ^ctivity oi plasma x quenched activity of standard
which in this example equals
^^320^° = cPm/®*5 ml. plasma
= 5000 cpm/10 ml. plasma
(b) Correction for losses during extraction and purificationi
Suppose the final extract, which corresponds to 10 ml, plasma has a
total activity of 2500 cpm and contains 0.6 yg, of Cortisol, The original
plasma has an activity, corrected for quenching of 5000 cpm/10 ml. The
recovery is therefore
|g£j X 100 % = 5<s
The plasma Cortisol, uncorrected for losses is 0,6 pg,/l0 ml.
{= 6 pg./l00 ml.). The corrected plasma Cortisol
= 6 x pg./lOQ ml,
= 12 pg./lOO ml.
Correction/
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Correction for losses in this way is based on the assumption that the added
radioactive Cortisol mixes homogeneously with the non-radioactive endogenous
one, so that losses of the radioactive Cortisol should also represent losses
of the endogenous one.
3. . on-nrotein-bounrl Cortisol (NPB Cortisol)
The number of Cortisol molecules per unit volume of ultrafiltrate
equals the number of NPB Cortisol per unit volume of plasma water. In theory,
the orcentage of NPB Cortisol equals the activity in 0.5 ml. ultrafiltrate
expressed as a percentage of the activity of the same volume of the
original plasma, with a correction for the protein content of plasma.
Suppose the activity of the ultrafiltrate was 25 cpra/0.5 ml. The
activity of the original plasma, corrected for quenching, was 250 cpm/0,5 ml.
plasmaj this corresponds to an activity of 250 x cpm/0.5 ml. plasma,
assuming the plasma water content to be 93%. The percentage of NPB
Cortisol is then
25 x 250^x 100 x ^ ^
The amount of non-protein-bound Cortisol equals
% NPB Cortisol x plasma Cortisol
i.e. x 12 pg./lOO ml,
— 1.12 ^g./lOO ml.
In this study, data for plasma protein values were not available. Percent
NPB Cortisol was calculated directly from activities of original plasma and
ultrafiltrate. Thus, using the figures of the previous example:
% NPB Cortisol = x 100 = 10 %
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Because the majority of Cortisol in plasma is bound to proteins, the error
resulting from not including a correction for the volume of plasma proteins
is likely to be slight. Mills (1961 a), using the ultrafiltration technique
for estimation of NPB Cortisol, did not find it necessary to apply such a
correction.
The theory behind estimation of NPB Cortisol in this way is based on the
assumption that radioactive Cortisol added to plasma gets in equilibrium with
the endogenously produced Cortisol, protein-bound and non-protein-bound, and
that the amount added is too small to affect the Cortisol level, or equilibrium,
to any significant extent. Radioactive Cortisol used in this study was of
very high specific activity (60 pc./mg,). Accordingly, the amount added
only raised the plasma level by less than 0,1 cj./lQQ ml. Such a very
small amount was assumed not to be able to affect the equilibrium between
protein- and non-protein-bound Cortisol,
6. in vivo method
principle
This is the same as in the in vitro method, A trace amount of C^-cortisol
was injected intravenously and 5 blood samples withdrawn. The first of these
samples was used to obtain the plasma Cortisol and the plasma NPB Cortisol
values (see figure 17 a and b)
idqqipment qnfl mgqfita
The same as in the in vitro method,
.Procedure
Again, the main steps of this procedure were essentially the same as in
the/
Bloodsample1 (40ml.) I Plasma -0.5ml'orcounting .5ml.torultrafilt ation
i
0.5ml.ultrafiltrate forcounting ELNPB CORTISOL
10ml. Extraction Washing Chromatography Elution
/̂
FluorometryCounting T Correctionf rlosses
HPLASMACORTISOL
FIGURE17b:Simultaneousestimati nofCPR,pl smaCortis la dplasmaNPBCort l(vivo) 2.CalculationofplasmaCortisolndasmaNPBrtisol ™-
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the in vitro method, 1 pc, A-C^-cortisol was used at first as one dose, but
a3 has been discussed, the activity of the ultrafiltrate was a relatively
small percentage of the total activity of the plasma. This meant that the
counting of the ultrafiltrate was so near that of the background, that the
accuracy of counting the ultrafiltrate and accordingly of calculating the
NPB Cortisol was too low. Accordingly, the dose was Increased to 2 jac.
and ouch better results, well within the reliability margin, were obtained.
Just before administration of the dose, 2 ml, blood were withdrawn from
the patient in a heparinised syringe and plasma separated, 0,5 ml. of this
plasma was used as background in counting the active plasma.
The dose was administered at 9*30 as described before. At
half hourly intervals, starting 3 minutes after administration of the dose,
5 blood samples were withdrawn into heparinised syringes, as previously
described, with the exception that 4.0 ml. of blood were collected for the
first sample instead of the usual 20 ml. Plasmas were immediately separated.
10 ml. plasma of the first sample, and all plasma of the other samples
were extracted, washed, chromatographed and the specific activities of their
Cortisol content estimated as previously described.
Prom the remaining plasma of the first sample a 0,5 ml. portion was
pipetted into a counting jar and used for the estimation of the total activity
of the plasma.
A third portion of 5 ml. was used for ultrafiltration as described in the
In vitro method. Again, all the equipment necessary for ultrafiltration was
warmed beforehand to 37°C in an incubator.
Counts/
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Counts of the background were almost always 100 cpm. (ranged from
96 to 104.), those of the radioactive samples, after subtraction of the
background count were: 178 - 268 cpm for the plasma, 400 cpm for the
internal standard and 16 to 40 cpm for the ultrafiltrate.
After dexamethasone suppression, counts of the ultrafiltrate, again,
approached that of the background. This problem could not be overcome
without administering a large dose of radioactive Cortisol which would
result in significant increase of plasma Cortisol and probably also in
disturbance of the equilibrium between protein-bound and NPB Cortisol.
1. gi?e of body mlpciblq pool, biologic^ half clearance; time, rate
of turnover and production rate of Cortisol. These were calculated from
the specific activities of the second, third, fourth and fifth blood samples
and the application of the isotope dilution expressions, as previously
described.
2. Plasma Cortisol and NPB Cortisol were estimated as in the in vitro
method, with the only difference that figures obtained from the first plasma
sample withdrawn after Injection of the C^'-Cortisol in the in vivo method
were used instead of those of the pre-injection plasma to which radioactive
Cortisol was added in the in vitro method.
The theory behind this technique is based on the following assumptions:
(a) that the amount of radioactive Cortisol administered to the patient
should be so small that it will not significantly affect either the plasma
Cortisol or the proportion of protein-bound to NPB Cortisol. This was




(b) that the administered Cortisol will get in equilibrium with
endogenous Cortisol (protein-bound and HPB). Binding of the injected
radioactive Cortisol occurred rapidly after injection, in fact more
efficiently than in the in vitro method. This will be evident later, from
comparison of the results of the in vitro and in vivo methods.
(c) that the radioactivity contained in the plasma withdrawn after
injection of the C^-cortisol should be due to Cortisol and not to its
radioactive metabolites. This was verified by collecting the first
sample 3 minutes after injection of the radioactive dosej the amount of
radioactive metabolites formed in this very short period should not be
significant.
(d) that the three-minutes1 interval between starting the injection
and collecting the first blood sample is sufficient to let the radioactivity
circulate in the body and get back to the site of venepuncture. This is




Besides the previously mentioned tests for the direct assessment of
adrenocortical function, other chemical tests were performed for every case
whenever possible. These tests include:
(1) Estimation of creatinine excretion (AutoAnalyzer) for correlation
of the total body musculature to the adrenocortical activity,
(2) Tests to exclude renal Insufficiency, viz, creatinine clearance
(AutoAnalyzer), blood urea (AutoAnalyzer) and urinary proteins (Albustix,
Ames Co,).
(3) Tests to detect diabetes, viz, glucose tolerance tests (AutoAnalyzer),
urinary glucose (Clinitest, Ames Co.) and urinary ketones (Acetest, Ames Co.)
(4) Tests to detect any electrolyte disturbance or alkalosis, viz.
serum or plasma sodium (Flame photometer, SSL), potassium (Flame photometer,
EEL), bicarbonate (AutoAnalyzer),calcium and phosphate.
(5) Tests to exclude liver dysfunction, viz, serum bilirubin, serum
glutamic-pyruvic transaminase, alkaline phosphatase and thymol turbidity.
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£• C^er l^bor^tory investigations
These included tests of additional diagnostic help such as:
(1) Histological examination of adrenal glands removed from patients
with Gushing's syndrome treated by adrenalectomy.
(2) Haematological examination (haemoglobin, packed cell volume,
mean corpuscular haemoglobin concentration, total and differential white
cell count and platelet count).
(3) X-ray of the chest to detect any enlargement of the heart.
(X) X-ray of the skeleton to detect osteoporosis.
(5) X-ray of the skull for any widening of the sella turcica.
(6) Electrocardiography.
(7) Medical photography (anterior and lateral views).
(8) Estimation of total body water from which the lean cell mass and
total body fat could be calculated and correlated to the adrenocortical
function.
Estimation of total body water was carried out in the Department of
Medical Physics of the Hoyal Infirmary of Edinburgh and was performed by
the isotope dilution methods described by Langham et al (1956) and Cooper
et al (1958).
Estimation of total body water required the administration of tritiated
water with an activity of 500 |j.c. As the counter used for C^-counting was
not adjusted to exclude counts due to tritium, it was felt more convenient to




Prom estimation of the total body water, the body lean cell mass (LCM)
and body fat cen be worked out from the following equations (Csserman et al,
1950):
(1) % LCM = Ak
where % LCM is the total body lean cell mass as a percentage of
total body weight.
A is the total body water as a percentage of the total
body weight.
1 000
k is a constant or 1.393) •
(2) % Fat = 100 - % LCM
where % Fat is the total body fat as a percentage of total body weight.
Accordingly:
Total body LCM (Kg.) - % LCM x Total body weight (Kg.) and
Total body fat (Kg,) = % Fat x Total body weight (Kg.)
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Clinical investigations
Each patient was thoroughly assessed as follows i
(1) Injthe family history patients were questioned particularly
about obesity, diabetes or any other endocrine disease.
(2) The history of the presenting condition and its duration,
including any menstrual disturbance in females.
(3) Clinical examination
(a) Face, hair, skin (with particular reference to acne, bruising
and oedema),
(b) Muscle development and power.
(c) Genitals and their development.
(d) Assessment of the degree of obesity and, if present, the
patient was asked about its duration and a note made of its
distribution,
(e) Assessment of the extent of cutaneous striae, if present,
their colour, distribution and duration.
(f) Examination of the blood pressure.
The surface area of each patient was calculated from the height and
weight as suggested by DuBois and DuBois (1916) from the formula:
S.A. s x H0.725 x 0#00718A
where S.A. is surface area in square meters.
W is weight in kilograms,




it Cortisol, profoqtjon r^je qnfl g^o^d m^t^on
1. CprtjpbX prpdpqtion r^tp (blood mel^od), pontppX ssjiraatjcpg.
Table 9 shows the results of estimation of Cortisol production rate
by the blood method in the four groups under basal conditions (see also
figure 18). The results reveal the following:
(а) The mlscible pool
There is overlap between the ranges found in the four groups. Statistical
analyses of these results (see table 28) show that the increase of the mean
in the patients with Cushing's syndrome above the mean of either the normal
or obese group is highly significant.* No significant difference exists
between the means of the normal and obese groups nor between the 'Cushingoid1
and other groups. The range in the 'Cushingoid1 group is wide.
These results are in agreement with those reported by Hoet et al (1961) who
reported mean values of 1.54. rag. for normal subjects, 1.27 mg. for obese subjects
and a range of 2.3 - 7.3 rag. for patients with Cushing's syndrome, Peterson
and Wyngaarden (1956) reported a lower range for normal subjects, namely 2.4 rag,
(б) Tfa ftlbXoflXcflX teOf c^aryiCQ 1^9 (frf) ^nd tfag rate tupnpy^
There is an overlap between the ranges found in the four groups and no
significant differences exist between the means of the normal, Cushing's and
obese group. Only the difference between the means of the Cushing's and
'Cushingoid' group is significant.
Figures reported by other workers for the biological half clearance time
of normal subjects arej 60 - 90 minutes (Peterson et al, 1955), 50 - 130
minutes/
* Throughout part III of this thesis:
not significant = statistically not significant (P> 0.05)
significant = statistically significant (0,05> P> 0,01)
highly significant = statistically highly significant (P cO.Gl)
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la&a (9)
Cortisol production rate (blood method)
Control estimations
Case Age Sex Miscible t£ Rate of Production
pool turnover rate
(yrs.) (rag.) (min.) (pool/hr) (mg./24 hr.)
1. Normal group
1. B.A.* 29 M 1.2 63 0.66 20.4
2. R.B.** 65 M 3.1 108 0.38 30.0
3. W.J.** 35 M 1.3 75 0.55 17.5
4. W.H.** 55 M 2.6 72 0.50 31.2
5. M.L.** 42 F 1.6 72 0.57 21.8
6. M.H.** 35 F 1.2 60 0.65 28.8
7. M.R.** 23 F 1.4 54 0.77 26.9
Range 23-65 1.2-3.1 54-108 0.38-0.77 17.5-31.2
Mean 40.5 1.8 72 0.58 25.2
S.D. 0.74 0.11 5.3
S.E. 0.28 0.04 2.0
2. Gushing*s group
a. Operated upon
10. J.A.* 55 M 7.4 42 0.99 177.6
11. J.T.* 17 F 2.5 45 0.93 54.7
12. M.C.* 36 F 2.9 75 0.54 37.9
b. Not operated
upon
17. C.M.* 18 F 2.6 78 0.54 34.1
Range 17-55 2.5-7.4 42-78 0.53-0.99 34.1-177.6
Mean 31.5 3.9 60 0.75 76.1
S.D. 2.38 0.25 68.3
...
S.E. 1.19 0.12 34.1
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Table (9) contd
Case Age Sex Miscible t* Kate of Production
pool turnover rate
(yrs) (sag.) (min.) (pool/hr) (mg./24 hr.)
3, 'Cushingoid' group
18. A.D.* 19 F 2.1 56 0.74 37.0
19. W.C.* 27 M 2.1 92 0.45 23.0
20. D.M.** 21 M 4.7 105 0.40 45.6
21. T.M.* 18 M 2.6 88 0.50 31.2
22. C.A.* 26 F 1.2 144 0.29 8.6
23. D.S.** 34 F 2.0 105 0.39 18.7
24. M.K.** 15 F 2.1 63 0.60 30.2
25. D.Y.** 32 F 2.2 81 0.51 26,4
Range 15-34 1.2-4.7 56-144 0,29-0.74 8.6-45.6
Mean 24.0 2.3 91.8 0.49 27.6
S.D. 1.00 0.14 11.2
S«£. 0.35 0.05 3.9
4. Obese group
26. A.M.* 34 M 0.8 50 0,84 18.0
27. R.A.* 12 M 0.9 34 1.20 25.9
28. T.A,** 17 M 1.3 60 0.70 22.1
29. C.S.* 14 F 3.3 110 0.37 28.8
30. H.L.* 31 F 1.9 100 0.41 18.7
31. A.I.** 24 F 2.3 108 0.38 21.4
32. C.R.* 20 F 1.0 78 0.53 13.2
33. M.S.* 14 F 2.3 75 0.55 30.5
Range 12-34 0.8-3.3 34-110 0.37-1.20 13.2-30.5
Mean 20.8 1.7 76.9 0.62 22.3
S.D. 0.85 0,28 5.8
S.E. 0.30 0.10 2.0
* Dose 1 p.c.
** Dose 2 p.c.
minutes (Peterson and ./yngaarden, 1956), 81 minutes (Slaunwhite and Sandberg,
1961) and 78 minutes (Tait et al, 196l), Hoet et al (1961) comparing
normal subjects, obese subjects and patients with Cushing's syndrome reported
a mean of 58 minutes in the normal group (0.88 ± 0.34- pool/hr.), 61 minutes
in the obese group (0.72 ± 0.19 pool/hr.) and 45-66 minutes in the patients
with Cushing's syndrome (0.62 - 0.93 pool/hr.).
(c) Cortisol production rate
The normal and obese subjects are narrowly separated from the patients
with Oushlng's syndromej all normal and obese subjects had values below
31.2 rag./24 hrs. and all those with Cushing's syndrome had values above
34.1 mg./24 hrs. The increase in the mean of the patients with Cushing's
syndrome above the mean of either the normal or the obese group is significant.
The range of the 'Cushingoid' group is very wide. Difference between the means
of the normal and obese groups is not significant.
The range and mean of the normal group is slightly higher than those
reported by Peterson and Wyngaarden (1956), namely 12.0 - 29.0 and a mean of
21.0 mg./24 hrs. Hoet et al (1961), however, reported comparable figuresj
namely 1,09 ± 0.26 mg./hr* (= 26.2 ± 6.2 mg./24 hrs.) in a normal group, which
was not significantly different from the mean of an obese group, 0.97 ± 0.31
mg./hr. (= 23.3 ± 7.5 mg./24 hrs.), while a third group of patients with
Cushing's syndrome due to adrenal hyperplasia were in the range of 2.1 - 4.5
mg./hr, (= 50,4 - 1GB.0 rag./24 hrs.) which was significantly higher than
both the normal or obese group. Similarly, Prunty (1961) reported a range
of 39 - 420 rag,/24 hrs. in 12 cases of Cushing's syndrome.
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2. Cortisol production rate (urine method) and urinary steroid excretion.
control estimations
Table 10 shows the results of estimation of Cortisol production rate
by the urine method and the urinary excretion of 17-ketosteroids and total
17-ketogenic steroids under basal conditions (see also figures 19-21).
In those cases in which the blood method was also performed, all tests were
carried out on the same day to allow comparison between the results of the
four tests that were made.
(a) jpflrgent Of rfldlrertjve qortjffQl ifl qrihO In tfre ffrret 24
Of all the 30 subjects studied, 27 excreted more than 70$ of the
radioactive dose, 23 more than 75$ and 18 more than 80$, No significant
differences exist between the means of all four groups (see table 28).
The ranges and means for the excretion of radioactivity after 24 hrs.
were of the same order as those reported by other workers after administration
of labelled Cortisol for normal subjects viz, 70 - 82$ (Peterson et al,
1955), 75 - 85$ (Cope and Black, 1958 a), 68 - 95$ (Cope and Black, 1958 b),
79 - 94$ (Romanoff et al, 1961), 83 - 96$ (Flood et al, 196l) and 90$ (Layne
et al, 1962). In a more detailed study, Hellraan et al (1954-) observed that
15$ of the radioactive dose was excreted after 1-2 hours, 56$ after 6 hours
and 72 - 84-$ at the end of 24- hours. Similarly, Migeon et al (1956 a)
observed excretion of 2 - 14$ in 2 hours, 25 - 33$ in 4 hours, 40 - 60$ in
8 hours, 60 - 70% in 14 hours and 70 - 83$ in 24 hours and 80 - 90$ in 48
hours.
Gray et al (1962) observed excretion of 86$ in a case of Gushing's




Cortisol Production rate (urine method) and urinary steroid excretion
Control estimation
Case Age Sex Dose excretion S.A. Production 17-KS Total
first 24 hr THE rate 17-KGS
(yrs) {%) (cpm/pg) (rag./24hr.) (mg./24hr) (mg./24hr)
1. Normal group
8. T.T.* 72 M 73.0 20.0 26.6 11.0 7.4
9. S.F.* 42 M 79.6 16.4 29.0 11.2 7.3
2. R.B.** 65 M 84.1 95.3 23.7 7,0 19.0
3. W.J.** 35 M 76.5 151.8 13.5 5.0 22.0
4. w.a.** 55 M — 10.0 18.0
5. M.L.** 42 F 82.7 187.8 11.6 13.0 14.0
6. M.H.** 35 F 72.6 142.3 12.9 4.0 10.0
7. M.R.** 23 F 84.0 101.1 22.4 10.0 18.0
Range 23-72 72.6-84.1 11.6-29.0 4.0-13.0 7.3-22.0
Mean 46.1 78.9 20.0 8.9 14.5
S.D. 4.9 7.1 3.2 5.6




10. J.A.* 55 M 80.0 5.6 107.0 18.7 54.9
13. J.M.* 31 M 99.0 16.1 36.5 22.5 35.3
14. G.F. 27 M - - mm 32.7 45*4
11. J.T.* 17 F 85.9 10.9 62.2 14.2 15.8
12. M.C.* 36 F 78.0 37.7 24.6 10.2 21.8
15. H.T.* 21 F 87.9 16.7 25.2 14.5 14.2
16. E.S.* 22 F 49.0 11.6 33.8 11.0 12.7
b. Not operated
upon
17. C.M.* 18 F 92.0 23.6 44*7 10.8 29.0
Range 17-55 49.0-99.0 24.6-107.0 / 0.8-32.7 12.7-54.9
Mean 28.4 81.6 47.7 16.8 28.6
S.D. 16.0 29.1 7.6 15.5
S.E. 6.0 12.0 2.7 5*4
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w? go)
Case Age Sex Dose excretion S.A. Production 17-KS Total
first 24 hr. THE rate 17-KGS
(yrs) 00 (cpm/pg) (mg,/24hrs) (mg/24hr) (rag/24hr)
3. 'Cushingoid' group
18. A.D.* 19 F 80.8 23.3 33.2 2.3 30.6
19. W.C.* 27 M 69.2 29.2 22.1 10.3 20.7
20. D.M.** 21 M 88.9 39.3 41.2 30.0 30.0
21. T.M.* 18 M 87.9 40.4 26.8 7.4 28.9
22. C.A.* 26 F 78.0 28.0 13.4 16.7 17.5
23. D.S.** 34 F 73.2 132.7 15.0 8.0 13.0
24. M.K,** 15 F 76.7 72.6 27.4 12.4 16.9
25. D.Y.** 32 F 82.8 120.9 18.7 5.0 13.0
Range 15-34 69.2-88.9 13.4-41.2 2.3-30.0 13.0-30.6
Mean 24.0 79.6 24.0 11.5 21.3
S. D. 6.8 9.4 8.6 7.4
S.E. 2.4 3.3 3.0 2.6
4. Obese group
26. A.M.* 34 M 39.6 22.1 19.2
27. R.A.* 12 M 81.3 49.3 15.5 8.6 9.5
28. T.A.** 17 M 89.8 152.2 15.8 6.0 22.0
29. C.S.* 14 F 88.4 34.5 27.7 6.7 13.0
30. H.L.* 31 F 85.8 47.1 17.0 8.6 16.3
31.' A. I.** 24 F 80.8 59.6 22.5 5.0 16.0
32. C.R.* 20 F 87.1 52.7 17.8 9.2 11.7
33* M.S.* H F 83.5 40.2 19.6 8.2 12.9
Range 12-34 39.6—89.8 15.5-27.7 5.0-9.2 9.5-22.0
Mean 20.8 79.5 20.8 7.5 14.5
S.D. 16.4 4.0 1.5 4.0
S.E. 5.8 1.4 0.6 1.5
* Dose 1 pc.
** Dose 2 nc.
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(1963) comparing normal subjects, obese subjects and patients with Cushing's
syndrome found that the means of excretion were 84.1, 83.1 and 85.0$ for
these three groups respectively, also with no significant difference between
them. It is clear, therefore, that Cortisol metabolism is, firstly, very
rapid and, secondly independent of the state of adrenocortical function,
(b) proflpgtfop rate (0Ht)
The levels reached by two of the normal and one of the obese subjects
overlap with those reached by two patients with Cushing's syndrome. The
range of the 'Cushingoid' group is again wide. The mean of the group of
patients with Cushing's syndrome is significantly higher than that of the
normal or the obese group. The difference between the means of the normal
and obese groups is not significant.
The results obtained by the urine method are mostly lower than those of
the blood method especially in the normal group (see table 12 a). The reason
could be that the urine method measured the production rate during 24 hours,
while the blood method measured it between 9:30 and 11:30 a«su in the morning,
a period known to be associated with increased adrenal activity relative to
the rest of the day.
Similar figures of CHI by the urine method have been reported by other
workers for normal subjects; namely, 4,9 - 25.3 mg./24 hrs. (Cope and
Black, 1958 b), 4.2 - 24.0 mg./24 hrs. (Cope and Black, 1958 a), 15.9 - 31.1
mg./24 hrs. (Romanoff et al 1961), 16.1 ± 0,8 mg./24 hrs., mean and S.E.,
(Layne et al, 1962) and 9.5 - 31.3 mg./24 hrs. (James and Caie, 1964).
Prunty (1961) reported a range of 41 - 111 mg./24 hrs. in a group of
patients with Cushing's syndrome, and Brooks et al (1963) reported a range of
32.0/
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32.0 - 96.0 mg./24 hrs, for cases of Cushing's syndrome due to adrenal
hyperplasia and 39#0 - 82.0 rag./24 hrs. due to adrenal adenoma, against
7.0 - 29«0 mg./24 hrs, in a normal group,
Klynaryk et al (1962) obtained significantly higher means in obese
subjects than in normals (23*9 ± 6.0 mg./24 hrs. against 16.1 ± 6.5 mg,/24 hrs.)
and Schteingart et al (1963) also obtained higher means in an obese group
(24.4.6 ± 2,92 mg./24 hrs. against 15.07 t 1.3 mg./24 hrs, mean and S.E.).
The difference between these two means was significant. In a third group
of patients with Cushing's syndrome, these workers obtained a mean of
52.74 - 5.0 (3.E,) mg./24 hrs. which was significantly higher than the mean
of either the normal or obese group. None of their cases with Cushing's
syndrome overlapped with the control group but two cases overlapped with the
obese group and 15 of the 24 obese subjects showed higher-than-normal values.
Gogate and Frunty (I963), however, obtained a range of 10,4 - 37.5 mg./24 hrs.
for an obese group against 7.0 - 29.0 mg,/24 hrs. for normal subjects with
only 2 obese cases higher than normal.
(c) %pp?tion o£ 3,7-KS
Marked overlapping occurred among the range of values in the four groups;
the levels reached by 6 normals and 6 obese subjects overlap with those
reached by 4 patients with Gushing's syndrome. Again the mean in the group
with Gushing*s syndrome is significantly higher than either that of the normal
group or the obese group. The difference between the means of the normal and
obese groups is not significant.
The range obtained in normal subjects in this study compares well with
that reported by James et al (1962), namely 4«4 - 14»2 mg./24 hrs. (8.7 ±
0.83 J mean and S.E.), The sensitivity of estimations of 17-KB as a measure
of/
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of adrenocortical activity especially in diagnosis of Gushing 's syndrome, has
been doubted by many workers. Levell et al (1957) observed an excretion
of 4.0 - £0,0 mg,/day in 7 cases of Cushing's syndrome; raised value was
noticed only in one case. Cope and Black (1959 a) reported insignificant
rise in Gushing's syndrome (1.4. times the normal) and very poor relationship
between this method and Cortisol production rate estimation; values of 25 mg.
for the former and 10 mg. for the latter or 30 mg. for the former and 225 mg.
for the latter were associated. These workers stated that the relationship
between GPR and urinary 17-KGS excretion was more encouraging. Prunty (1961)
also reported that the upper limit of normal for this method was exceed in
6 of 12 patients with Cushing's syndrome and adrenal hyperplasia.
Hoet et al (I96I) reported a mean for normal subjects of 13.0 ± 3«9 mg./24 hrs.
and 1G.0 ± 3,6 mg./24 hrs. for males and females respectively and 10.4 ± 3.7
mg./24 hrs. for obese subjects and a range of 2.3 - 3Q«7 mg./24 hrs. for cases
of Cushing's syndrome. Brooks et al (I963) reported a range of 1.0 - 38.0
mg./24 hrs. in adrenal hyperplasia, 9.0 - 20,0 rag./24 hrs. in adrenal adenoma
against 4.0 - 17.0 mg./24 hrs. and 6.0 - 26,0 mg./24 hrs. in normal females
and males respectively. Values were raised only in 9 of their 25 cases of
Cushing's syndrome. Gogate and Prunty (1963) obtained similar values for
obese and normals, namely 8.0 - 23»0 mg./24 hrs. for obese subjects, against
4.0 - 17.0 mg,/24 hrs, and 6.0 - 26.0 mg./24 hrs. for normal females and males
respectively. Only in one obese case wa3 the upper limit of normal exceeded,
Baird (1963) reported a mean of 14*5 t 1.9 (S.B.) mg./24 hrs. in an obese
group in some of whom Cushing's syndrome was suspected against 13.7 ± 0.76 mg./24 hrs.
in normal subjects. Many of the former group were above normal, but the
difference/
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difference was not significant.
Dyrenfurth et al (i960), however, reported a high mean in Cushing's
syndrome, namely 28.6 rag./24- hrs. and 20.6 mg./24. hrs. for males and females
against 16.4. mg./24- hrs. and 10.9 mg./24. hrs. in normal subjects, and
Borrell (1961) reported a range of 7.3 - 21.5 ®g./24. hrs. in Cushing's
syndrome against a normal mean of 6.14. mg./24 hrs. Similarly Rosner
et al (1963) reported elevated values in 3 out of 5 obese subjects, but found
that values in all cases with Cushing's syndrome were higher than normal,
(d) excretion of total 17-KGo
Overlapping, more marked here than in the urine method of Cortisol
production rate is also present among the range of values of the four groups;
the levels reached by 5 normal and 5 obese subjects overlap with those reached
by 5 cases with Cushing's syndrome, but once more the mean in the group of
Cushing's syndrome is significantly higher than either that of the normal or
the obese group. The difference between the means of the normal and obese
groups is not significant.
Other workers, also using the method of Few (1961), reported similar
ranges and means for the normal subjects. Thus Kichelakis (1962) reported a
range of 10.1 - 20.5 and 6.3 - 17,4. mg./24, hrs., Rutherford and Nelson (I963)
9.0 - 17.0 mg./24- hrs. and 7.0 - 12.0 mg»/24. hrs. and James and Caie (1964.)
7.6 - 19.5 mg./24. hrs. and 4_,9 - 15.1 mg,/24. hrs. for males and females
respectively.
Investigators using the 17-KGS method to compare normal, obese and subjects with
Gushing's syndrome reported the following ranges and means. Levell et al
(1957)/
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(1957)» 6-34 mg./24 hrs. in 7 cases of Cushing's syndrome, 4 of these
showed elevated values, Szenas and Pattee (1959)» 5.36 ± 0.38 (S.E.) mg./24 hrs.
in 16 obese subjects and 3.49 ± 0.4. mg./24 hrs. in normals, with considerable
overlap in the individual results, Dyrenfurth et al (1960)i 5.45 rag./24 hrs.
and 3,83 mg./24 hrs, in normal against 14.4 ®g./24 hrs. and 11.2 mg./24 hrs.
for males and females in a group of patients with Cushing's syndrome, Ross
(i960): 10 - 46 mg,/24 hrs. in Cushing's syndrome against 5.0 - 20.0
mg./24 hrs. in normals. Few (1961) estimating the 11-oxy- 17-KGS obtained
the range of 7.1 - 13,5 mg./24 hrs. in normals, a mean of 32.4 mg./24 hrs. in
Cushing's syndrome and 16,4 mg./24 hrs. in 'Cushing-type of obesity', Hoet
et al (1961) reported a mean of 11.1 ± 3.1 (S.S.) mg,/24 hrs. and 9.8 ±
2.3 mg./24 hrs. for normal males and females against 12.0 ± 1.3 mg./24 hrs.
for obese subjects and 13.5 - 49.5 mg./24 hrs. in Cushing's syndrome, Simkin
and Arce (1962) obtained the range of 5.0 - 18.0 mg./24 hrs. (mean 11.0) in
females and 8.0 - 25.0 rag./24 hrs. (mean 16.l) in males of a normal group against
a mean of 15.8 t 0.67 mg,/24 hrs. in an obese group of whom those with coloured
striae had a mean of 20.4 t 1.62 mg,/24 hrs. These last named workers noticed
that 78$ of the obese females with coloured striae had their 17-KGS exceed
the upper limit of normal. Brooks et al (1963) found a range of 8.0 - 28.0
mg,/24 hrs. in cases of adrenal hyperplasia and 10,0 - 21.0 mg./24 hrs. in
adrenal adenoma against 5.0 - 18.0 mg./24 hrs. and 6,0 - 22.0 mg./24 hrs. for
normal males and females respectivelyj the level was increased above normal
in 13 of the 25 cases of Cushing's syndrome. Baird (I963) obtained a mean of
19.6 ± 1.89 (S.E,) mg./24 hrs. in an obese group, in some of whom Cushing's
syndrome/
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syndrome was strongly suspected, against a mean of 15.6 ± 0.71 rag./24 hrs.
in normal subjects. The majority of levels in this obese group were beyond
the normal range. Schteingart et al (1963) also obtained a mean of 8,97 ±
1,67 mg,/24 hrs. (S.D.) in an obese group against 5.37 t 0.55 mg,/24 hrs.
in normals (the difference was significant) and 13.97 t 2.3 mg./24 hrs. in
a group of Gushing's syndrome. The mean in the last group was significantly
higher than in normal or obese groups, but considerable overlapping occurred
among the ranges of the three groups.
Gogate and Jaunty (1963), however, reported a range of 8.0 - 16.0 mg./24 hrs.
in an obese group against 5*0 - 18,0 mg./24 hrs. and 6.0 - 22.0 mg./24 hrs. in
normal females and males respectively} all the obese subjects were within
the normal range.
Commenting on the sensitivity of the 17-KGS estimations, Cope and Black
(1959 a) reported poor correlation between this estimation and estimations of
Cortisol production rate} in low, normal or moderately raised adrenal activity,
the relationship was poor. Prunty (1961) stated that Cortisol production rate
estimations are more sensitive than 17-KGS estimations} recovery of Cortisol
as 17-KGS was between 12 - 46% and that levels in Gushing's syndrome were
slightly elevated or within the upper limit of normal in 6 out of 18 cases.
Grant (1963) also believes that the correlation between these two measurements
is not always very good.
700-











NORMAL CUSHING'S CUSHINGOID OBESE
FIGURE 18: CORTISOL PRODUCTION RATE (BLOOD METHOD)
CONTROL ESTIMATIONS AND ESTIMATIONS AFTER AC T H
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3. Coyt^gol pro^ugtlon r^e (feM ^tftod), egtiaatjon;; AQTII gtW^gfl
Table 11 shows the results of estimation of Cortisol production rate by
the blood method in the four groups after ACTH stimulation (see also figure
18),
(a) The aiscible pool
The range of the normal subjects is clearly separated from that of the
patients with Oushing's syndrome at the range of 12,1 - 13,8 trig, as all normal
subjects have values below 12.1 mg. whereas all patients with Cushing's
(tw-owJi4"
syndrome have values above 13,8 mg. There are overlaps aae**t the other
ranges. The increase of the mean i» the group of patients with Cushing's
syndrome above the means ef* either the normal or obese group is significant,
(r
Jlo significant difference exists between the mean ef the normal and obese
groups nor between the 'Cushingoid' and the other groups. In each group,
however, the rise of the mean above the corresponding control mean i3 highly
significant (see tables 9, 28 and 29),
(b) Tfa tl-^g ^4 the ratg of turqovep
There are marked overlaps among the ranges of the four groups. In
estimations of the rate of turnover, only the mean of the 'Cushingoid1 group
is significantly lower than that of either the normal group cr the group of
Gushing's syndrome. However, the difference between the mean of each group
and its corresponding control mean is significant in the group of Cushing'3
syndrome and the obese group and highly significant in the normal and 'Gushingoid'
group denoting increased rate of turnover after ACTH stimulation,
(c) Coptifiojl, production ratq









































































































































































































































































































































































from the patients with Cushing's syndrome. The increase in the mean of the
group with Cushing's syndrome above the mean of either the normal or of the
obese group is highly significant. It is also significantly greater than
that of the •Cushingoid* group. Differences between the means of the normal
and obese groups are not significant. However, the rise in the mean in each
group, after ACTH, over its corresponding control mean (see table 9) is
highly significant.
Expressing the results of Cortisol production rate estimation as "increase
above the control value" in mg.t results again in overlap, but still the
difference between the mean of the group with Cushing's syndrome and that of
either the normal or obese groups is highly significant. Differences between
other means are not significant. On the other hand, expressing the results
of Cortisol production rate estimation as "percent increase above the control
value", results in marked overlapping, and the differences between the means of
any of the four groups is not significant. Thus, it seems best to record results
of CFR after ACTH stimulation simply as the absolute value reached after
stimulation and not as the increase over the control value.
Comparison of these results with those obtained by other workers cannot
be made, because this dosage of ACTH has been used for the first time in the
present study, DeMoor et al (19&1 a), however, stated that the biological
half clearance time was prolonged after ACTH (294- minutes against 163 in the
control estimations) which is not in agreement of the present finding of
significant shortening of this period, Peterson and Wyngaarden (1956) and
Hoet et al (1961), on the other hand, found that the rate of turnover did
not/
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not significantly change from the control value. The latter workers found
no difference between the raiscible pools of normal an obese subjects
(14.7 ~ 5.6 mg. against 13.4 i 4.7 mg.) on the first day of ACTH stimulation
(intravenous infusion of 25 I.U. over 8 hrs.) but a much larger pool was
noticed in 3 cases of Cusking's syndrome (41.2 - 59»5 mg,). On repeating
the test on the second day the values for the three groups were 19.7 t
5+3 mg., 24.1 ± 4*9 mg. and 49.2 - 59.0 mg. respectively. Accordingly
the production rates as calculated for the three groups were 7.56 ± 2.54
mg./hr. (= 181.44 i 60.96 mg./24 hrs.), 8.4 ± 3.0 mg./hr. (= 2CEL.6 ± 72.0
mg./24 hrs,) and 26.7 - 51.5 mg./hr, (= 640 - 1238 mg./24 hrs.) for the
first day and 12.2 ± 2.5 mg./hr. (= 292.8 1 60.0 mg./24 hrs.), 14.1 - 3+5
rag./hr. (= 338.4 - 84.0 mg,/24 hrs.) and 41.9 - 50.1 mg./hr. {= 1005 - 12(22 mg.
/24 hrs.) for the second day. Although values of the second day of aCTH
stimulation are higher than those obtained in the present study the normal
and obese subjects show similar means while cases of Cushing's syndrome show
more hyper-responsiveness. Nugent et al (1963) had stated that 110 pg,/Kg,/hr.
is the rate at which normal subjects produce Cortisol in response to maximal
stimulation with ACTH for 6 hours. This corresponds to about 160 mg./day
for a 60-Kg. subject. Values obtained in this study were higher, which
indicates that the dosage of AGTH used by Nugent and his co-workers were
inadequate to produce maximal stimulation of the adrenal cortices.
C P R








NORMAL CUSHING'S CUSHINGOID OBESE
FIGURE 19: CORTISOL PRODUCTION RATE (URINE METHOD)
CONTROL ESTIMATIONS AND ESTIMATIONS AFTER ACTH
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A. Cortisol production rate (urine .method), estimations after ACTH stimulation
Table 12 shows the results of estimation of Cortisol production rate by
the urine method after AGTH stimulation (see also figure 19). i/henever the
blood method was performed, the urine method was carried out on the same day
for the sake of comparison.
(a) of radioactive porti^pl flpgs sypretefl fa urlflg jfa tfrp ffc-gt 24 Hare,
Again, of all the 27 subjects studied, 21 excreted more than 70% of the
radioactive dose, 20 more than 75% and 17 more than 80%. Mo significant
differences existed between any two means of all four groups nor between the
mean of any group, after ACTH stimulation, and its corresponding control mean.
Cope and Black (1958 b) reported excretion of 58 - 89.5% (mean 76,4.) of
a radioactive Cortisol dose in the first 24- hrs. in normal subjects which is
in agreement with the present findings.
(b) CorUspl product^ rqte
The normal and obese subjects were again clearly but narrowly separated
from the patients with Cushing's syndrome} the upper limit of the normal
group did not overlap with the lower limit of the group of Cushing's syndrome.
The mean in the group of Cushing's syndrome is significantly higher than that
of either the normal and 'Cushingoid' group and the difference between the means
of the group with Cushing's syndrome and the obese group is highly significant.
The difference between the means of the normal and obese groups was not
significant. Again, the increase in the mean of each group, after ACTH
stimulation, over its corresponding control mean is highly significant,
Expressing the results of Cortisol production rate as "increase above the
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(3.? q?
Comparison of CPU estimations by blood and urine method
GPR control CFR ACTH
Case m£./24 hrs. mg./24 hrs.
Blood method Urine method Blood method Urine method
1 • Normal group
2, R.B. 30.0 23.7 -
3. W.J. 17.5 13.5 250 134
4. W.H, 216 179
5. M.L. 21.8 11.6 226 199
6. M.H. 28.8 12.9 218 246
7. M.R. 26.9 22.4 269 263
2 . Cushing's group
10» J*A* 177.6 107.0 350 264
11, J.T. 54.7 62.2 631 355
12. M.C. 37.9 24.6 500L 450
17. C.M. 34.1 44.7 —
3. 'Cushingoid1 group
18. A.D, 37,0 33.2 359 155
repeated 31.0 36.1 614 268
19. W.C. 23.0 22.1 451 155
20. D.M. 45.6 41.2 195 106
21. T.M. 31.2 26,8 187 137
22. C.A, 8.6 13.4 ~ mm
23. D.S. 18.7 15.0 233 133
24. M.K. 30.2 27.4 241 226
25. D.Y. 26.4 18.7 - -
A.. Obese group
26. A.M. 18.0 19.2 118 148
27. R.A. 25.9 15.5 195 90
28. T.A. 22.1 15.8 199 84
29. C.S. 28.8 27.7 269 243
30. H.L. 18.7 17.0 233 A2
31. A.I. 21.4 22.5 199 87
32. C.R. 13.2 17.8 168 118
33. M.S. 30.5 19.6 169 58
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difference between the mean of the group of Cushing's syndrome and the obese
group is highly significant, whereas the difference between any other two
means is not significant. Again expressing the results of Cortisol
production rate estimation as "percent increase above the control value",
results in marked overlapping and the mean of the normal group is significantly
Increased over that of both the 'Cushingoid' and the obese group. Thus it
seems best to describe the results of ACTH stimulation in terms of absolute
value reached after AGTH stimulation.
Comparison between these figures and those of other workers is impossible
because of the unique dosage of ACTH used in the present study.
Comparison of the Cortisol production rates obtained by blood and urine
methods in individuals reveals a discrepancy} the values given by the
blood method were on the whole higher than those given by the urine method
(see table 12, a). Administration of ACTH in 6 doses instead of 5 did
not remove the difference; the results of the urine method remained well
below those of the blood method. This suggests that a plateau of increased
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5. Estimations of urinary 17-KS and total 17-KGS after ACTH stimulation
Table 13 shows the results of estimation of urinary 17-ketosteroids
and total 17-ketogenic steroids after ACTH stimulation (see also figures 20
and 21). Whenever Cortisol production rate was estimated, these tests were
carried out on the same day for the sake of comparison.
(a) ibfflyet4,op of j,7-KS
Overlapping exists except between the normal and obese groupj values
in 5 normal subjects and in 4 obese patients overlap with those of 3
patients with Cushing's syndrome. The increase in the mean of the normal
group over that in the obese group is highly significant and the increase in
the group of Cushing's syndrome over the obese group is significant. No
significant difference exists between the means of the normal group and the
group of Cushing's syndrome nor between that of the 'Cushingoid' and those
of the other groups. Considering the rise in the mean of each group, after
C-
ACTH stimulation, above the corresponding control mean,) highly significant
^ to
difference exists i&i the normal group,^significant difference exists in the
obese group but no significant difference exists in either the group of
Cushing's syndrome or the 'Cushingoid' group. It was observed in one
patient with Cushing's syndrome and in one obese subject that the value of
17-KS excretion after ACTH was lower than the control value which is
evidence that this method does not reflect the actual state of adrenocortical
function.
Expressing the results of 17-KS excretion as "increase above the control
value" in mg., results in marked overlap and only the differences between the
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is significant. Again, expressing the results of 17-KS excretion as
"percent increase above the control value", results in a more marked
overlap and the difference between any two means of the four groups is not
significant.
(t>) ,17-^3 excpetjpp
Overlapping is present except between the ranges of normal and obese
groups. Values in 5 normal and 2 obese subjects overlapped with those
of 3 patients with Gushing's syndrome. The increase in the mean of the
normal group over that of the obese one is highly significant, the increase in
the mean of the normal over that of the 'Cushingoid' group and in the mean
of the patients with Cushing's syndrome over that of the obese group is
significant. No significant difference exists between the means of the
normal subjects and the patients with Cushing's syndrome. The increase in the
mean of each group, after ACTH,over its corresponding control mean is highly
significant.
impressing the results of total 17-KGS excretion as "increase above the
control value" in rag, shows overlapping among all means, but the difference
between the mean of the normal group and those of both the 'Cushingoid' and obese
group is highly significant. Expressing these results as "percent increase
above the control value", produces marked overlapping among the mean of all
four groups and only the difference between the mean of the normal group and
those of both the 'Cushingoid' and obese groups is significant. Expressing
the results as their absolute values, therefore, provides the most useful
Information. This agrees with the finding of Beck et al (1962) who found
significant increase of 17-KGS excretion, after ACTH stimulation, of the
mean/
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mean between a normal group and a group of Gushing's syndrome, but when the
results were expressed as increase in mg. over control the means overlapped
and when expressed as percent Increase over control value the normal mean was
nearly double that of the Cushing's.
It has been known for a long time that the relationship between CPR and
urinary steroid excretion gets even poorer at higher secretion states. Cope
and Black (1959 a) reported that at high rates of adrenocortical activity,
the excretion of 17-KGS is approximately half the CHI. James and Caie (196$.),
employing the same method used in this study (Few, 1961), reported that 17-KGS
values were 78 - 92$ of CHI up to 35 mg./day but only 26-55$ of it above
that* They suggested that the decreased conversion of Cortisol to 17-KGS
at high secretion rates might be due to increased formation of metabolites which
were not determined as 17-KGS, i.e. probably polar metabolites.
Ho detailed comparison can be made with figures obtained by other workers,
comparing normal subjects, obese subjects and patients with Cushing's syndrome,
because of the different dosage of AGTH, Poisnick and DiRairaondo (1956),
however, noticed a 30$ increase in the mean of an obese group above that of a
normal group, but the ratio of the stimulated to the basal levels were the
same in both groups.
Birke et al (i960) reported that in cases of Cushing's syndrome due to
hyperplasia of the adrenal cortex, the upper limit of normal was exceeded, but
they observed only a weak response In adenoma and no response in adrenal
carcinoma. They suggested that the increase in patients with hyperplasia was
due/
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due to the presence of an increased functioning mass of the adrenal cortex.
These workers found that 17-KS estimations were less sensitive than 17-KGS}
two patients with adrenal hyperplasia and the patients with adrenal adenoma
showed normal resting excretion and normal response to ACTH stimulation. They
concluded that the usefulness of 17-KS or their variation from day-to-day
in patients with Cushing's syndrome due to adrenocortical hyperplasia was
limited.
Etyrenfurth et al (I960) obtained significantly higher results for 17-KGS
excretion in Cushing's syndrome than in normals. 17-KS determinations were
again less sensitive. Hoet et al (1961) obtained identical means in aormal
and obese subjects after ACTH stimulation but much higher levels in Cushing's
syndrome. Rosner et al (I963) also reported a normal response to stimulation
in obese subjects and Baird (1963) noticed that the level of 17-KGS after
ACTH, in an obese group, rose but that the rise was slight. Gogate and
rrunty (1963) also observed normal adrenal response in an obese group after
ACTH stimulation, as measured by both 17-KGS and 17-KS estimationsj the latter
test was as usual less sensitive than the former.
The most brisk response of 17-KGS to ACTH stimulation in the present
study was obtained in case 12 (M.G.) who later on at operation proved to
have nodular hyperplasia with adenomata. Nabar.ro et al (1958) also observed
unexpected responses of supposedly autonomous tumours, and Prunty (1961)
stated that one of his patients with adenoma responded well to ACTH.
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suppression with dexamethasone
Table 1A demonstrates the results obtained after dexamethasone
suppression. None of the subjects of the normal group was studied by this
parameter. In each case included in table 1A, an attempt was made to
estimate the Cortisol production rate by the blood method, but suppression was
so marked that the fluorometric readings of the eluates of the plasma
chromatograms were (except in one case, J.A.) the same as that of the paper
blank. Accordingly, it was not possible to estimate the specific activities
of the blood samples from which the production rate could be calculated. Only
in one patient in the group of Gushing's syndrome (case 10. J.A., after
unilateral adrenalectomy) suppression was not so marked and estimation of a
production rate of 33.6 mg./24 hrs. was made possible from a miscible pool of
l.A mg. and a rate of turnover of 0,99 pool/hr. (biological half clearance time
42 minutes). This represents a drop of about 65$ and 32$ of the pre-operative
value for the miscible pool and CPR respectively.
(a) forcfflit of tfrg retUpaotfoe ctflrtigoj, flogq pKQaretgfl t^ fjrpt fra
Again, of all 16 subjects studied, 15 excreted more than 70$ of the
radioactive dose, 13 more than 75$ and 11 more than 80$. No significant
difference exists between any two of those means and no significant difference
exists between the mean of any of these groups, after dexamethasone, and its
corresponding control mean.
(b) Cortisol production rajp egt^tlyn by tfy> urine method
Marked suppression occurred in all cases except case 10, (J,A., see also




Gortiaol production (urine method) and urinary steroid excretion
Estimations after- suppression vith dexo ---thasone
Case Age Sex Dose excretion S.A. CFR 17-KS Total
first 24 hr THE 17-KGS
(yrs) (%) (cpm/pg) (mg./24hr) (rag./24hr) (mg./24hr)
2. Gushing fs group
a. operated
upon
10. J.A.** 55 M 72.5 16.7 39.5 3.0 15.7
11. J.T. 17 F 284.5 3.1 4.0 5.2
12. M,C. 36 F 83,3 157.7 3.7 - -
Range 17-55 72.5-83.8 3.1-39.5 3.0-4.0 5.2-15.7
Mean 36 79.4 15.4 3.5 10.5
S.D. 6.0 20.8 0.7 7.4
S.E. 3.4 12.0 0.4 5.2
3. 'Cushingoid1 group
18. A.D. 19 'F 91.4 53.6 3.4 1.0 2.4
19. W.C. 27 M 91.5 430.0 2.0 4.7 6.7
20. D.M. 21 M 86,8 846.4 1.7 6.0 5.0
21. T.M. 18 M 81-.3 232.6 3.7 - -
23. D.S.* 34 F 81.6 2009.6 1.1 2,0 1.0
Range 18-34 81.3-91.5 1.1-3.7 1.0—6.0 1.0-6.7
Mean 24 86,5 2.4 3.4 3.8
S.D. 5.0 1.0 2.3 2.5
S.E. 2.2 0.4 1.1 1.1
4. Obese group
26. A.M. 34 M 78.5 206.0 4.0 — -
27. R.A. 12 M 79.7 626.5 1.2 2.8 1.1
28, T.A. 17 M 88.7 928,9 2.5 3.0 5.0
29. C.S, 14 F 72.0 306.9 2,5 7.2 4.3
30. H.L. 31 F 85.3 238.4 2.1 3.8 4.2
31. A.I.* 24 F 83.2 433.7 5.0 3.0 5.0
32. O.K. 20 F 48.6 66,0 7.8 3.7 2,5
33. M.S. 14 F 87.4 405.5 2.0 2.5 3.8
Range 12-34 48.6-88.7 1.2-7.8 2.5-7.2 1.1-5,0
Mean. 20.8 77.9 3.4 3.7 3.7
S.D. 13.0 2.0 1.6 1.6
S.E. 4.6 0.7 0.6 0.6
* Dexamethasone was administered to these patients 4 times daily for 2 days and
estimations carried out on the second day. To all the other patients
dexamethasone was administered 4 times dally for 2 days and once on the
morning of the third day and estimations carried out on the third day.
** Estimations carried out after unilateral adrenalectomy.
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the drop in the mean from its corresponding control value was highly
significant in the 'Cushingoid' and obese groups but not in the group with
Cushing's syndrome (see table 29).
No attempts were made by other workers to estimate CFR after dexamethasone
suppression.
(c) 3,7—KS e^cr^on
Marked suppression occurred in all cases and there was no difference
between any two means after suppression. There is, however, a significant
drop of the mean in the group of Gushing's syndrome from its corresponding
control value, and a highly significant drop in the obese group but there was
no significant drop in the 'Cushingoid' group,
(d) Total 17-KGS excretion
Marked suppression occurred in all cases except case 10, (J.A.). All
the cases in the obese group, however, had values below 5.0 mg«/24 hrs. whereas
the two cases of Cushing's syndrome were above 5.2 mg./2U hrs. The difference
between the means of the group with Cushing's syndrome and the obese group is
significant, and the fall in the means of both the 'Cushingoid' and obese
groups from their corresponding control means are highly significant, but the
change is not significant in the patients with Cushing's syndrome.
It can be observed from examination of the individual cases in table 14 that,
inspite of changing the dosage of dexamethasone to 8 doses instead of 9, and
performing the test on the second day instead of the third, marked suppression
still occurred, denoting that a plateau of diminished Cortisol secretion must
have been attained, starting from the second day of suppression with dexamethasone.
The markedly low excretory values either on the second day (8 doses) or on the
third/
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third day (9 doses) denotes that this plateau of diminished Cortisol secretion,
and accordingly the effect of dexamethasone administration, could last to the
end of the third day, even though the last dose was administered on the morning
of that day.
Marked suppression of urinary 17-KG3 in obese subjects with the smaller
dosage (0,5 mg. every 6 hours for two days) have been reported by Simkin and
Arce (1962), Slater et al (1962), Gogate and Prunty (1963), Rosner et al
(1963) and Baird (I963) to values below 4- mg./day. Slater et al (1962)
reported that cases of Cushing's syndrome always excreted values above 5 mg./day,
Schteingart et al (1963) noticed that obese subjects were suppressed to 2,5
mg, or less, while patients with Cushing's syndrome excreted not less than
3.3 mg,/2A hrs. Other results which support the usefulness of the dexamethasone
test in diagnosing cases of Cushing's syndrome were obtained by Brooks et al
(I963) who noticed that their cases of Cushing's syndrome, except one, failed
to suppress in response to dexamethasone. Their 17-KS values were less
sensitive; the changes in 17-K3 excretion following dexamethasone suppression
were much more variable, and the test was of less diagnostic value then
17-KG5 determination,
Liddle (I960), who was the first to suggest the use of dexainethasone
(0.5 ntg,/6 hrs. for 2 days then 2 iag,/6 hrs* for another 2 days) as a useful
tool in diagnosis of Cushing's syndrome, reported that normal subjects excreted
2.5 mg. or less/day, and patients with Cushing's syndrome due to hyperplasia
4.0 - 35,0 mg./day after dexamethasone. In another group of cases suspected
of suffering from Cushing's syndrome, Liddle (i960) observed basal steroid
levels which were higher than normal, and in this group excretion after
dexamethasone/
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dexamethasone was as low as 1.0 - 4.0 rag./day. He concluded that there were
different resistances to suppression by dexamethasone in patients with
bilateral adrenocortical hyperplasia, and that extreme cases might be
encountered in which normal suppression with small doses or complete resistance
to the large dose might be found. He also concluded that this test did not
distinguish adrenal hyperplasia frcm tumour, but rather ACIll-dependent
hypoadrenocorticism from autonomous adrenocortical hypersecretion, and
accordingly that this test was not in itself sufficient evidence to justify a
diagnosis of Cushing's syndrome; definite clinical features and elevated levels
of Cortisol metabolites should be present to justify the diagnosis. Laddie
further stated that spontaneous diminution in adrenal secretory activity might
coincide with administration of the suppressing agent, leading to a mistaken
impression, and he recommended repetition of the test to males sure of its
results. He noticed that 17-KS excretion did not fall as readily as the 17-AGS.
Syrenfurth et al (I960), using 9o»FF, noticed some degree of suppression
but there was no difference between patients with Cushing's syndrome and normal
individuals, and Rrunty (1961) observed that the suppression was very variable in
a group of patients with Cushing's syndrome due to adrenal hyperplasia. He
noticed also that a patient with adenoma responded well. This last observation
supports the finding in the present study of marked suppression in a case of
Gushing's syndrome with nodular hyperplasia and adenoma (Case 12, M.C.).
From the findings of the present study, the author believes that suppression
of total 17-KGS with dexamethasone, at the best, separates normal and obese
subjects on one hand from cases of Cushing's syndrome on the other, but that the
separation may not be marked. In table 14> the lowest value for 17-KGS in
a/
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a patient with Cushing's syndrome, following administration of dexatnethasone,
was 5.2 mg./24. hrs., and the highest value in an obese subject was 5.0 mg./24- hrsj
the difference between these two being within the limits of experimental error.
By contrast, the separation after AGTH as measured by CPR (blood method), is
"magnified" to the wide range of 268 - 350 rag,, thus rendering the latter
technique much superior as a means of differential diagnosis.
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7. Calculation of Cortisol production rate from double compartment model
Comparison of the results of Cortisol production rate estimations in
individual cases shows a discrepancy between the blood method and the urine
method in the control estimations and, more markedly, in the estimations after
AGTH (see table 12 a). It was mentioned in the description of table 12 that
the dosage of ACTH was not responsible for this discrepancy. It was considered
desirable to investigate whether calculation of Cortisol production rate by the
blood method from a double compartment model could explain this discrepancy.
For estimations from the double compartment model, two extra blood
samples were withdrawn in the interval 0-30 minutes, after injection of the
radioactive cortisolj their time of withdrawal was recorded nd their specific
activities estimated as usual. The slope of the first part of the graph
(S,A, against time) could be drawn by joining these two specific activities and
that of the blood sample withdrawn at 30 minutes after injection of the dose
into a straight line, and extrapolating it back to zero time specific activity
on semilogarithmic graph, Cortisol production rate could then be calculated
from the appropriate formula (see Introduction, Chapter II). Calculation of
the volume of distribution (inner and outer pools) was made from plotting the
proportion of the injected radioactive Cortisol, recovered in these blood samples,
on a similar graph (see also Introduction, Chapter II).
T^blp (jg)
Cortisol production ratex control estimations




























Table 15 shows the results of estimation of Cortisol production rate from
single and double compartment models, together with that calculated from
the urine method, in one subject from the normal group and in another from
the 'Gushingoid' group. Estimations from the double compartment model were
only 1.1 mg,/2£ hrs. (U%) and 0.7 mg./24. hrs. (2.9%) lower than estimations from
the single compartment model in the first and second cases respectively.
Estimations from the double compartment model were still well above those of
the urine method. This means, at least in these two cases, that estimations
from a single compartment are quite accurate for estimations of control Cortisol
production rates, and that the presence of more than one compartment does not
explain the whole of the discrepancy between the blood ar: ' urine method, at
least in the control estimations,
Hoet et al (1961) stated that, if more than one compartment exists, the
changes of the miscible pool are too slow, in relation to the duration of the
experiment (2 hours), to influence the results to any significant extent.
Kb attempt was made in this study to investigate the significance of this factor
after ACTH stimulation. Hoet et al (1962) also suggested that in secretion of
elevated amounts of Cortisol, such as after ACTH stimulation, transcortln is
saturated and the free Cortisol constitutes an important fraction of the total
pool, which is associated with a great increase of volume of distribution.
These workers suggested that free Cortisol, in these conditions, enters the
intracellular space (a second compartment). They concluded that equilibration
between the two compartments, if a second one exists, must occur? if this is
slow, other calculations must be used, but, if it is rapid, calculation from a
single compartment vrill be quite accurate.
The/
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The volume of the inner pool was almost identical in the two cases
studied tut the volume of the outer pool was larger in the second case, which
suggests that a larger volume of distribution of Cortisol exists in obese
subjects, Peterson (1959 a) reported an inner pool of 6 and an outer pool
of 16 litres in normal subjects, and Tait et al (1961) 6 and 13 litres
respectively, Hoet et al (1962) reported an outer pool of 14.77 in normal
subjects but a 13.4-5 litre in obese ones, and Gray et al (1962) reported a
volume of distribution 67 litres in a case of Gushing's syndrome due to
hyperplasia.
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8. Repeated assessment of adrenocortical function for the diagnosis of
Qwahla^'B aao&aaa
Case 18 (A.D.) was classified in the 'Cushingoid' group on account of
the uncertainty of the clinical features, in spite of a higher than normal
control Cortisol production rate and a hyper-response to ACTH stimulation.
It was decided to observe the patient for a while to see if there was any
deterioration, or improvement, in her clinical condition. Five months
later, an exacerbation of the clinical condition necessitated re-admission,
and tests of Cortisol production rate and steroid excretion were repeated
to see if there had been any change that would parallel the worsening of the
clinical condition.
Examination of table 16 shows that in the second control estimation,
the miscible pool and rate of turnover were almost the same as in the first
control estimation and the production rate of Cortisol by the blood method,
which was first slightly higher than normal, dropped to the upper limit of
normal. Production rate by the urine method, which was slightly higher than
normal on the first occasion, was more abnormal on the second occasion. The
urinary 17-KS excretion was almost the same but a marked drop of the total
17-KGS excretion had occurred.
After ACTH, a marked increase of the Cortisol production rate by the
blood method occurred in the second estimation and the new level was high up
in the range observed for other patients with Cushing's syndrome. The
miscible pool, which in the first estimation had been high up in the Cushing's
range, rose slightly more but the rate of turnover increased markedly in
the second estimation, Cortisol production rate by the urine method followed
these changes, though to a lesser extent, by increasing from a level well in
the/
Table(16)
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the normal range to just above it. Although 17-KS excretion increased
nearly three-fold, the new level was still well within the normal control
range, and the total 17-KG3 excretion even dropped in the second estimation
but the level after ACTH stimulation in both cases was much higher than the
corresponding control level.
Marked suppression after dexamethasone occurred in all tests, being
more marked on the second occasion despite the fact that dexamethasone was
given for 8 doses instead of 9 and that estimations were carried out on the
second day instead of the third.
The striking difference, therefore, between the first and second
estimations was the marked hyper-response in the Cortisol production rate to
ACTH in the second estimation especially as estimated by the blood method.
Because of the worsening of the clinical condition of this patient, supported
by the new laboratory findings, a final diagnosis of Cushing's syndrome was
agreed upon and it was decided to treat this patient by adrenalectomy.
Unfortunately further deterioration of the psychological symptoms occurred,
which necessitated transfering the patient to a mental hospital, and surgery
was postponed for the time being.
Similar observations were reported by Schteingart et al (1963), who
found that Cortisol production rate in a patient suspected of having Cushing's
syndrome was below the range for this clinical condition. When the test
was repeated three months later, the results fell clearly within the
range for Cashing's syndrome.
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9. irWsffn pf wlW7 17-KS
Table 17 and figure 22 provide information about the daily excretion
of 17-KS for the four groups, both under control conditions (repeated
estimations) and during ACTH and dexamethasone administration.
(a) Coptpoj, ^gt^t3,ops
The mean in the group of patients with Cushing's syndrome is higher than
that of either the normal or obese group and the mean in the obese group is
similar or even slightly lower than that of the normal group. Marked
overlapping of the ranges is noticed. In individual cases, however,
wide variation and marked day-to-day fluctuation occurred mostly in the
group with Cushing's syndrome, and to a lesser extent in the 'Cushingoid'
group. Less variation and fluctuation occurred in the normal and in the
obese groups.
(b) ffmrtag acth aflffinigiraUoft
Maximum stimulation occurred, in the normal group, on the second and
third day. In the group of Cushing's syndrome maximum stimulation occurred
on the third day and in one case on the first day. In the 'Cushingoid' group,
maximum stimulation occurred mostly on the third day but sometimes also on the
second or first day of ACTH administration. In the obese group maximum
excretion was noticed on the second day, -gain, examination of individual
cases showed marked variation and day-to-day fluctuation in the group of
Cushing's syndrome and the 'Cushingoid' group, and relatively more uniform
patterns in the normal and obese groups. The highest excretory values were
recorded for patients with Cushing's syndrome and for the 'Cushingoid* group.
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Tablo (17J
Puttorn of 17-KS excretion under control, stimulation and suppression states
Case Age Sex Control estimations ACTH stimulation Dexam. suppression
(yrs) (day: ( iavs)
-1 1 2 3 + 1 -1 1 3 4- 1
1. Normal group
2. R.B. 65 M 7.0 4.0 V
3. W.J.* 35 M 5.0 6.0 3.0 4.0 11.0 13.0 4.0
4. W.H.* 55 M 10.0 16.0 24.0 14.0 17.0
5. M.L.* 42 F 13.0 13.0 11.0 12.0 22.0 14.0 30.0 14.0
6. M.H.* 35 F 4.0 4.0 6.0 6.0 13.0 31.0 15.0
7. M.R.* 23 F 10.0 9.0 9.0 18.0 31.0 18.0 16.0
range 23-65 4.C - 13.0 6.0-12.0 4.0-22.0 11.0-31.0 13.0-31.0 4.0-17.0
mean 42.5 7.85 7.5 14.6 20.0 21.2 13.2
2. Gushingi* s group
a. Operated upon
10. J.A. 55 M 18.7 13.8 9.7 27.9
repeated** 4.8 2.9 2.9 3.0 5.5
13. J.M. 31 M 22.5 22.4 22.9 24.0
14. G.F. 27 M 32.7 12.9 2.8 11.5 13.1 3.6
11. J.T. 17 F 14.2 42.0 22.1 33.4 15.7 4.0
12. M.G. 36 F 5.6 10.2 27.5 16.1 18.6 6.4
15. H.J. 21 F 14.5 15.6 14.5 6.0
16. E.S. 22 F 11.0 9.5 9.8 22.3
d. Not operated upon
17.617. C.M. 18 F 11.1 2.2 10.6 9.8f 16.9 17.6 16.9 22.7
range 17-55 2.2 - 32.7 16.9-22.1 9.7-33.4 15.7-27.9 2.9-16.1 3.4-4.0
mean 28.3 13.23 19.5 23.3 20.4 9.5 3.5
3. •Cushingoid group
18. A.D. 19 F 2.4 5.1 5.4 2.3 4.2 3.6 2.7 5.0 5.5 3.2 1.0 3.9
repeated* 1.0 3.0 2.0 8.0 9.0 14.0 12.0 3.0 4.0 1.0 — 1.0
19. w.c. 27 M 10.3 6.1 9.1 8.2 18.4 I8.it-
28.0
4.7
20. D.M.* 21 M 30.0 22.0 19.0 24.0 36.0 30.0 40.0 18.0 6.0 — 9.0
21. T.M. 18 M 7.3 2.3 7.4 12.6 10.9 23.3 7.2
6.023. D.S.* 34 F 7.0 5.0 13.0 7.0 8.0 8.0 9.0 8.0 8.0 9.0 9.0 2.0 2.0 — 3.0
24. M. K. * 15 F 13.1 16.3 12.4 14.4 14.6 18.6 32.9 26.4 15.1
25. D.Y.* 32 F
"
5.0 5.0 3.0 8.0 8.0 12.0 7.0
range 15-34 1.0 - 30.0 3.0-24.0 3.6-36.0 2.7-32.9 5.0-40.0 7.0-18.4 3.0-28.0 2.0—4. 3 1.0-
6_o
1.0-4.7 1.0—9.0
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doses of ACTH arxl 8 doses of dexamethasone (see text), tests were performed on the third and second day respectively. All other patients received
9 doses of dexamthxtone; tents were oerfonned on the tidrd day on each occasion. ** After unilateral adrenalectomy.
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10. W^--y,7 totfil X7-KQ3 e^etj,9n
Table 18 and figure 23 provide results of estimations of the daily
excretion of total 17-KGS for the four groups under control conditions
(repeated estimations) and during ACTH and dexamethasone administration.
(a) Qop.tpp,], qgj^mty^ong
The ranges and means of the normal and obese groups were almost
identical whereas those of the patients with Gushing's syndrome were much
elevated. Harked overlapping occurred. Wide variations and day-to-day
fluctuations occurred in the group of Gushing's syndrome and to a lesser
extent in the 'Cushingoid' group. Only slight variation and fluctuation
occurred in the normal and obese groups.
Day-to-day fluctuations in the level of 17-KGS excretion of patients
suffering from Cushing's syndrome were reported by Birke et al (1956)*
Bassoe et al (1958), Dyrenfurth et al (I960), Ekraan et al (1961), Prunty
(1961), Slater et al (1962) and Brooks et al (1963). The last-named
authors observed levels of 11.0 and 4.0.0 mg./day in one patient for 17-KGS
and 14.,0 and 20.0 for 17-KS, and Prunty (1961) reported similar fluctuations
in plasma Cortisol and Cortisol production rate. These observations could
explain the occasional finding of normal results in Gushing's syndrome,
especially among less sensitive tests such as ths urinary steroid excretion
tests.
Eosner et al (1963) observed normal daily variations of steroid excretion
in obese subjects, and this observation is supported by the findings of the
present study.
(b) Duj-tag AGTH ptizqul^tlop
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Table (18)
Case Age Control estimations AC^H stimulation (days) Dexam, suppression (davs)
(vrs) -1 1 1 2 3 I + 1 -1 1 r 2 1 3 I + 1
1. •formal group
2. R.B. 65 M 19.0 6.0 ,
84.03. W.J.* 35 M 22.0 16.0 4.0 35.0 53.0 27.O
4. W.H.* 55 U 18.0 63.0 102.0 117.0 46.0
5. M.L.* 42 F 15.0 14.0 12.0 15.0 (gl.) 95.0 124.0 50.0
6. M.H.* 35 F 10.0 7.0 13.0 15*0 64.0 125.0 (gl.)
7. M.R.* 23 F 18.0 17.0 16.0 75.0 114.0 125.0 34.0
range 23-65 6.0 - 22. 0 4.0—16.0 35.0-75.0 53.0-114.0 84.0-125.0 27.0-50.0




60.6 109.0 85.110. J.A. * . 55 U 54.9 ,
(repeated) 20.3 26.4 26.4 15.7 29.6
13. J.M. 51 M 40.5 8.3 35.3 45.8
14. G.F. 27 M 45.4 13.6 24.0 10.8 27.3 18.4
(gl.) (gl.) (gl.) (gl«; vgi.; (gl.)
64.0 56.711. J.T. 17 F 15.8 73.° 31.1 5.2
12. M.C. 36 F 8.7 21.8 176.0 12.5 22.1
15. H.T. 21 F 14.2 18.2 15.8
16 . E. S . 22 F 12.7 11.6 13.4 52.1 17.7
b. not operated
upon
56.0 39.817. C.M. 18 F 5.7 36.2 25.7 12.2 54.4 15.5 54.4
range 17-55 8..5 - 6o. 6 54.4-56.7 56.0-176.0 31.1-85.1 12.5-26.4 5.2-15.7
mean 28.3 25.3 55.5 103.0 19.5 19.5 10.5
3. •Cushingoid' group
-
18. A.D. 19 F 18.1 22.6 44.9 30.6 32.8 93.1 67.8 118.Q 18.2 4.5 2.4 6.8
repeat* 8.0 16.0 14.0 60.0 44.0 100.0 22.0 15.0 2.0 2.0 — 1.0
19. W.C. 27 M 20.7 21.1 18.0 12.3 99.0 35.6 6.7
20. D.lk* 21 M 30.0 29.0 24.0 26.0 48.0 6o.O 77.0 13.0 • 30.0 * 5.0 2.5
21. T.li. 18 U 16.7 30.5 28.9 16.5 14.6 59.0 10.8
5.023. D.S.* 34 F 13.0 15.0 15.0 10.0 13.0 11.C 10.0 93.0 49.0 83.0 17.0 9.0 5.0 1.0 —
24. M.K.* 15 F 20.4 19.7 16.9 15.8 17.2 42.5 ' 67.8 58.0 13.4
25. D.Y.* 32 F 13.0 13.0 3.0 (gl.) (gl-) 50.0 13.0
range 15-34 CO . 0 1 p • 9 3.0-32.8 16.5-93.1 14.6-67.8 50.0-118.0 10.8-35.6 9.0-30.0 2.0-5.0 1.0-5.0 2.4-6.7 1.0-6.8
mean 23.7 19.4 17.8 58.9 50.5 80.7 17.8 18.1 3.5 3.1 3.5 3.8
4. Obese group
27. R.A. 12 M 8.6 9.5 11.8 45.5 84.6 48.0 14.4 1.0 1.1 7.4
28. T.A.* 17 M 22.0 22.0 23.0 27.0 51X 57.0 16.0 23.0 10.0 5.0 — 6.0
29. C.S. 14 F 20.4 13.0 84.0 26.6 20.4 4.3
11.430. H.L. 31 F 14.5 9.7 7.3 16.3 14.3 21.5 98.3 42.0 10.8 1.1 1.0 4.2
31. A.I.* 24 F 17.0 14.0 16.0 11.0 15.0 35.0 73.0 48.0 '4.0 9.0 5.0 — 6.0
32. C.R. 20 F 11.7 2.5
33. M.S. 14 F 12.9 11.0 45.5 33.0 6.9 11.9 17.0' 3.8
range 12-31 7.:5 - 22.0 14.3-23.0 21.5-45.5 45.5-98.3 33.0-*84.0 4.0—26.6 9.0-23.0 1.1-20.4 1.0—17.0 1.1-4-3 6.0-11.4
mean 18.9 13.8 17.4 32.3 70.5 52.0 13.1 16.0 10.9 5.8 3.2 7.7
* Patients received 6 doses of ACTH and 8 doses of dexamethasone (see text) tests were performed on the third and second day respectively.
5 doses of AOTH and 9 doses of dexamethasone; tests were performed on the third day on each occasion.
** After unilateral adrenalectomy.
All other patients received
gl. refers to glycosuria.
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and in the group of Cushing 's syndrome. In the'Cushingoid' group maximum
excretion mostly occurred on the third day, but sometimes on the second
day, and on three occasions a first peak was noticed on the first day
followed by a drop on the second day and a higher peak on the third day. In
the obese group, maximum excretion occurred mostly on the second day but
sometimes on the third day. Although the highest excretion value was
reached by a patient with Cushing's syndrome, the mean of the normal group
on the third day was higher than the corresponding mean of any of the other
groups, Overlapping of the ranges is noticed, but wide variations and
fluctuations are not observed, except to some extent in the 'Cushingoid1
group.
The occurrence of maximum excretion on the second day in many cases
is further evidence that estimations carried out on the third day of ACTH
stimulation, using this particular dosage, represent a measure of the
maximum capacity of the adrenal cortex.
An interesting observation in the study of the total 17-KGS pattern in
response to ACTH stimulation, was the detection of glycosuria in two
subjects of the normal group (Case 5, M.L, and case 6, M,H,) and one subject
of the 'Cushingoid' group (case 25, D,Y.) during the first, second, or
third day of ACTH administration or even on the following day. Glycosuria
was detected also in the urine of one patient with Cushing's syndrome (patient
14., G.F.) both when showing high levels of total 17-KGS excretion, and when
levels were well within the normal range. The interpretation of these
observations could be that excess ACTH, rather than Cortisol, is sometimes
directly responsible for the occurrence of glycosuria and that glycosuria, and
indeed/
indeed Cushing's syndrome, are sometimes due to faults in the ACTH -
secreting mechanism, i.e. of pituitary cr hypothalamic origin, rather than
of adrenal origin.
Other indirect evidence that the cause of this clinical condition
lies in the pituitary rather than in the adrenals was offered by Jailer
(1962) who, commenting on the hyper-sensitivity to ACTH characteristic of
this syndrome, stated that this hyper-sensitivity existed in patients with
pituitary tumours just as it did in those with bilateral adrenal hyperplasia
as the only pathology. He stated that hypersenistivity to ACTH
disappeared after successful treatment of the pituitary, by irradiation, and
furthermore, when the disease recurred a few years later, the characteristic
hyper-sensitivity to ACTH once again developed. Jailer concluded that these
data are compatible with the hypothesis that Gushing1 s syndrome with adrenal
hyperplasia is primarily a pituitary disease due to secretion perhaps of an
abnormal ACTH, or another abnormal hormone, which potentiates the action of
ACTH.
Further evidence pointing to the same conclusion was offered by Hugent
et al (i960). These workers stated that the pathogenesis of Cushing's
syndrome associated with administration of glucocorticoids or ACTH or with
tumours of the adrenal cortex was readily apparent. They postulated that
the syndrome, when associated with adrenal hyperplasia, was the result of
increased secretion of ACTH, which satisfactorily explains the bilateral
adrenal hyperplasia, the increased responsiveness of the adrenal glands to
ACTH stimulation and the increased amounts of adrenal steroids secreted by
the glands, found in the blood or excreted in urine. This postulate, they
stated,/
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stated, is also compatible with the fact that therapeutic success has been
achieved in some cases following hypophysectomy or irradiation of the
pituitary gland, but would not be compatible with reports that no increase
would be demonstrated in blood levels of GTH in cases of Gushing's syndrome
associated with adrenal hyperplasia# These workers then administered ACTH
to normal subjects in amounts too small to lead to detectable concentrations
of blood ACTH, (viz, 1,5 - 5.0 I,U, AGTH intravenously per day for
4 days). They proved that, under such circumstances, constant elevation of
plasma 17-hydroxycorticosteroids, with loss of diurnal variation and increased
responsiveness to maximum stimulation by AGTH, occurred in these normal
subjects. These workers, therefore, concluded that, (l) the possibility
that Gushing's syndrome associated with adrenal hyperplasia might result
from increased secretion of ACTH could not be excluded on the grounds that
increased blood levels of ACTH were not demonstrable, (2) patients with
Gushing's syndrome and adrenal hyperplasia might secrete ACTH at an abnormally
high rate during at least part of the day, (3) the site of this pituitary
"dribbling" of ACTH is not known; it may be in the hypothalamus, the pituitary,
in the interconnecting pathways or in some other controlling mechanisms.
The hypothesis that sudden increases of adrenal activity occur in the
form of "bouts", whether due to adrenal or pituitary cause, rather than the
hypothesis of "dribbling" of the pituitary is supported by other workers.
Thus Prunty (1961) showed that, in Cushing's syndrome due to hyperplasia, in
addition to changing levels of 17-KGS, spontaneous fluctuations of plasma
Cortisol and CPR, gross discrepancies occurred between the plasma Cortisol
level/
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level and the response to ACTHj for instance, a low value for the plasma
Cortisol level was associated with a very high response to ACTH stimulation,
Rrunty stated that such lability prompted the question whether some patients
developed their symptoms as a result of sudden increases of adrenal secretion
during their daily lives, whilst measurements made under basal conditions
in hospital gave a falsely low idea of their adrenal activity.
The mechanism by which glycosuria occurs in the presence of excess ACTH
is not known. It might be due to a direct effect on the p-cells of the
islets of Langerhans of the pancreas,
(c) stosaifaaggBa adalB&airafelsa
Maximum suppression occurred in the group of Gushing*s syndrome on
the third day, in the 'Gushingoid * group on the second and third days and
in the obese group mostly on the third day but sometimes on the second day,
f-fetrked suppression on the third day was observed in all cases except patient
J,A, in the group with Cushing*s syndrome. This, together with the fact that
suppression on the second day was almost equally marked in many cases and that
plasma Cortisol level was too low to be estimated on the third day, justified
carrying out all the tests on the second day of dexamethasone administration
instead of the third day, Excretion of 5.0 mg,/24. hrs,, or less of total
17-KGS, was again noticed on the second day in some cases of the 'Cushingoid*
and obese groups. More estimations in these two groups and in the normal
subjects and patients with Cushing*s syndrome await further work, to see if
there will be any significant separation of the levels reached in the four
groups.
- 241 -
B* ggti-iatiofi of cortip^ 1*9^140^ fate, plasma 9cyUg0.il
ar4 P^gn^-protelr^ blading of cort^
l. figntroi gstfcwUppg
Table 19* provide the results obtained by the in vitro method (see
also figure 24 - 26, table 28 and 29)♦ The In vivo method was also carried
out in one normal and two 'Cushingoid1 subjects.
(a) Tptal PlflPTO coptl^
The highest level was recorded by a patient in the 'Cushingoid' group.
The level attained by the patient with Cushing's syndrome came next and was
higher than any of those in either the normal or obese groups. The lowest
mean was that of the obese group and the lowest single level was also
recorded by a patient of the obese group. The level reached by the patient
with Cushing's syndrome is significantly higher than the mean of the normal
group. Because of the small number of cases studied in the group of
Cushing's syndrome and in the obese group, the difference between the level
of the patient of the former group and the means of the two patients of the
latter group is not significant. The level of total plasma Cortisol follows
more or less the Cortisol production rate but the relationship is not linear.
The normal range and mean reported in this study agrees very well with
those reported by other workers (see table 4)>although some authors presented
higher means or wider ranges. For instance, Peterson and Wyngaarden (1956) reported
a range of 4.0 - 24.0 jig./lOO ml., Waxman et al (1961) 2.1 - 22,6 ^g./lOO ml.,
Layne et al (1962) 13.7 ± 4.3 (S.E.) ng./lOO ml., Beck et al (1962) 3.0 - 28.0
{ig.AOO ml. and Nugent et al (1963 ) 8.0 - 29.0 pg,/l00 ml. Similarly, most
workers/
*Hangea and means of CFR estimations are not given. These are provided in table
9 for a larger number of subjects in each group.
Tablg(3,9)
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workers have observed normal or lowered means in obese subjects, which agree
with the findings of the present study. Thus Poisnick and MRaimondo (1956)
reported that plasma 17-hydroxycorticosteroids were within normal limits in a
4 ^ ba
group of obese women in spite|that excretion of 17-hydroxycorticosteroids was
increased in some of them, Szenas and Pattee (1959) observed lowered plasma
Cortisol levels in obese subjects (5»9 ± 0,58, S.D,, pg./lOO ml, against
12,14 - 0,6 pg./lOO ml, in normal subjects), and reported a more rapid
disappearance of Cortisol from blood than in normal subjects, from which they
suggested that the low plasma Cortisol levels in obesity might be due to either
(a) diminished CPR (b) greater dilution by increased volume of body fluids or
tissues (i.e. a larger volume of distribution), or (c) increased removal of
Cortisol (which could be a reflection of either increased metabolic conversion,
increased excretion or absorption by body depots).
Hoet et al (1962) reported a mean level of plasma Cortisol of 10,1 pg,/l00 ml.
in obese against 10,6 pg./lOO ml, in normal subjects. From calculations of
the volumes of distribution, they concluded that Cortisol has a volume of
distribution approaching the volume of tho extracellular space, and accordingly
that the apparent volume of distribution must be influenced by the same factors
as this space. Therefore, these workers suggested that, with an increased
volume of distribution, a steady CPR and a steady rate of turnover, plasma
Cortisol levels must be diminished. Mlynaryk et al (1962) similarly reported
decreased plasma levels of Cortisol in obese subjects. Gogate and Prunty (1963),
however, found a range of plasma Cortisol concentration of 5.2 - 22.3 pg./lOO ml.
in an obese group against 5.0 - 16.0 pg./lOO ml. in normals, but only in
2/
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2 cases was the upper limit of normal exceeded.
In Cushing's syndrome, Sweat (1955) reported plasma Cortisol levels up
to 135 pg.AOO ml. Doe et al (i960 b) found a mean of 32.7 pg.A00 ®1* in
4 cases due to bilateral hyperplasia (normal mean 17.2) and, in another
report, Doe et al (I960 a) reported a mean of 27.0 pg./lOO ®1. against a
normal range 4*° - 26.0 pg./10° ®1« (mean 13.6). These workers observed
a diurnal variation ir. the normal group, which was lost in the patients
with Cushing's syndrome. Dyrenfurth et al (I960) obtained a mean of 20,2
pg,/l0° ml, in Cushing's syndrome, against I4.3 pg,/l00 ml. and 13,8 p.g.A°0 ®1*
for normal males and females respectively. Gray et al (1962) obtained a
level of 55 |Ag./l00 ml, in a case of Cushing's syndrome and Doe et al ( 1963)#
using radioisotopic Cortisol to correct for losses during the experiment,
obtained a mean of 27.7 pg./lOO ml, in 4 cases of Cushing's syndrome against
18.1 jig.ADO ml, in normal subjects.
On the other hand Frunty (1961) doubted the value of this test in
diagnosing Cushing's syndrome. He obtained a range of plasma Cortisol of
3.0 - 56.O pg./lOO ml. in 12 cases of Cushing's syndrome, but in only 6 of
them was the upper limit of normal exceeded. He also reported fluctuations
of levels from time to time. Brooks et al (I963) supported this view,
as they obtained a range of 3,0 - 25.0 pg./l00 ml. in adrenal hyperplasia and
15.0 - 26.0 pg./l00 ml. in adrenal adenoma compared with 5.0 - 16.0
Hg.AOO ml, in normal subjects. Tait (I963) stated that for steroids with a
low clearance, such as Cortisol, it is to be expected that there will be
an appreciable lag in the response of the plasma concentration to variations
in secretion rate. This, together with the influence of variable volumes
of distribution and fluctuations of CHI, as reflected in plasma levels of
Cortisol/
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Cortisol, might explain some of the unsatisfactory results just mentioned.
The value of this test, however, seems to be considerable in the
differential diagnosis of Cushing's syndrome from obesity. Thus, Hoet
et al (1961) reported a range of 17.4 - 27.1 ng./lQO ml. Cushing's
syndrome due to adrenal hyperplasia as compared with a mean of 9.8 ± 3.4
(S,E,) jig./lGO ml. and 9.7 t 2.4 Hg./lOG ml, in obese and normal subjects
respectively. Similarly, Schteingart et al (I963) found a mean of
28.3 i 3*85 (S.i£.) jig./lOO ml, in Cushing's syndrome against 14.36 ±
3,12 pg./lOO ml, and 25.2 ± 2.46 ^g./lOC ml. in obese and normal groups
respectively. The mean in the obese group was significantly lower than
that of the normal group and actually 8 of the 14 patients gave values
below the lowest normal.
(b) Npg-pyototo-boui^ ?9rt4,?pl
i- Expressed as "percent of the total rilaama Cortisol". Although,
the level reached by the patient with Cushing's syndrome is higher than any
of the normal group, marked overlapping occurs among the group of Gushing's
syndrome, the 'Cushingoid' group and obese groups, and no significant difference
occurred between any two of these groups.
These figures are higher than those reported by Mills et al (1959), who
found 5$ unbound Cortisol at plasma concentrations of 10 p-g./lOO ml.,, 20%
at 40 p.g./l00 ml. and 28$ at 80 pg./lQO ml. Mills et al (I960) reported an
average of 10$ unbound Cortisol in normal subjects. Layne et al (I962),
however, reported a much lower degree of binding in normal subjects, namely
78$ ± 3*7 (S.E.). Gray et al (1962) comparing normal subjects and patients
with/
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with Cushing's syndrome reported a level of Jl% unbound Cortisol in a case
of Gushing's syndrome due to adrenal hyperplasia against a range of 4-.0 -
10.0% in normal subjects.
ii- '-*on-protein-bound Cortisol, expressed as its absolute va"1 us.
i.e. in pg,/l00 ml. The highest levels are reached by the patient with
Cushing's syndrome and by one of the patients in the ,Cushingoid, group,
and there is a wide separation between the level of the Cushing's patient
on one hand and all the subjects in either the normal or obese groups on
the other. There is a highly significant difference between the level in
the patient with Cushing's syndrome and the mean of the normal group. Again
because of the small number of cases in the group of Cushing's syndrome and
the obese group, the difference between the level of the patient of the
former group and the means of the two subjects of the latter group was not
significant.
Doe et al (I960 b) reported a mean of 16.6 pg. WEB/100 ml, plasma in
4- cases of Cushing's syndrome due to bilateral hyperplasia against 0,9
Hg./l00 11 normal subjects, and Gray et al (1962) reported a level of
20.0 pg./lOO ml, in one patient with Cushing's syndrome due to adrenal
hyperplasia against a normal range of 0.39 - 1,28 pg,/100 ml* (mean 0.67).
Recently, Doe et al (1963)* adding radioisotopic Cortisol to plasma and using
a dialysis technique at 37.5°C, obtained a mean of 6,0 p.g»/l00 ml, in 4,
cases of Cushing's syndrome against a range of 1,1 - 2.7 pg./lOO ml. (mean
1.8) in normal subjects. These results agree very well with those reported
in the present study. When NPB Cortisol was expressed as pg,/lOO ml., Doe
et al observed circadian rhythm in the normal group but not in patients with
Gushing's/
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Cushions syndrome; the mean percentage of NPB Cortisol remains constant
during the 24 hours. This again agrees with the findings in the present
study, and confirms the superiority of expressing results as pg. NPB Cortisol/
100 ml, instead of as a percentage of the total plasma Cortisol,
In the in vivo method lower values were observed than the in vitro












2. JWtftUong aft?r ACTI-| stimulation
Table 20* provides the results obtained by the in vitro method on
the morning of the third day of ACTH stimulation in subjects from the
normal, 'Cushingoid' and obese groups (see also figures 24 - 26). The
in vivo method was simultaneously carried out in three subjects of the
normal group and one patient of the 'Cushingoid* group.
(a) Tfotfll plagmq
The highest level was reached by a patient in the 'Cushingoid' group
and the ranges of the normal and obese groups were almost similar. There
is no significant difference between any two of these means. The
relationship between Cortisol production rate and total plasma Cortisol
by this method was less clear after ACTH. The difference between the
mean of total plasma Cortisol concentration of each group and its corresponding
control mean was, however, highly significant.
Expressing the results of total plasma Cortisol as "increase over
the control level" in pg., the highest level was observed in the 'Cushingoid'
patients, but an overlap occurred between the levels in the three groups and
there was no significant difference between the means. Similarly, when
results were expressed as "percent increase over the control level", there was marked
overlapping between the ranges found in the three groups and no significant
difference between them.
No detailed comparison could be made with figures of other workers, because
of the different dosage of ACTH used in this study. Most workers, however, obtained
significant/
* Hanges and means of CPR estimations are not given. These are provided in
table 11 for a larger number of subjects in each group.
^blefeO)






























































































































































































































































































































































significant separation of cases of Cushing's syndrome from either normal or
obese subjects by employing ACTH stimulation followed by total plasma Cortisol
estimations# Thus, Djrrenfurth et al (i960) obtained a mean of 62»1 pg. Cortisol/
100 ml. plasma in cases of Cushing's syndrome against 35,5 pg./lOO ml# and
37.8 pg./lOO ml. for normal males and females respectively# Hoet et al
(1961) obtained the following means on the first day of ACTH stimulation 4.2,2
± 2.0 (S.E.) pg./lOO ml., 44.8 ± 8.7 pg./lOO ml. and a range of 79.1 - 108.2
pg./lOO ml. for normal and obese subjects and cases of Gushing's syndrome
respectively and 53.7 ± 7.7 pg./lOO ml., 55.1 ± 18.0 pg./lOO ml. and a range of
69.9 - 107.0 pg./lOO ml, for the same groups on the second day of ACTH
stimulation. Beck et al (1962) obtained mean values of 35.5 pg./lOO ml,
37.8 ^g./lOO ml. and 62.1 pg./lOG ml. for normal males, normal females and
patients with Cut hing's syndrome respectively. Expressed increase of plasma
Cortisol over control levels, values were 21.2, 24.0 and 41,0 pg., but when
expressed as percent increase over control values the values were about 170,
135 and 200$ respectively j this supports the findings of the present study
which show the superiority of expressing results as their absolute value and
not as increased values over the control.
Grant (1963) believed that the ACTH test was the most important and
reliable test to differentiate normal and obese subjects on the one hand from
Gushing's syndrome on the other, employing plasma Cortisol estimations. He
reported levels of 30,0 - 55.0 pg. cortisol/100 ml. plasma in normal subjects
and found that obese subjects gave the same or slightly higher levels but
that the increase in them always parallelled that of the normal subjects,





NORMAL CUSHI NG'S CUSHINGOID OBESE
FIGURE 25 °/o PLASMA NON-PROTEIN-BOUND CORTISOL
CONTROL ESTIMATIONS AND ESTIMATIONS AFTER ACTH
- 252 -
an ACTH infusion lasting L, hours. Jailer (1962) reported that 4.5 of his
4.6 patients with Cushing's syndrome due to bilateral adrenal hyperplasia
showed hypersensitivity to ACTHj in one case there was a normal response
but this rose above normal after 3 days stimulation by ACTH.
(b) ';op-pyoteln-bounl cort^so^
i- noi^-ppotein-bounfl gortftgpjl- The highest level was reached
by a patient in the 'Cushingoid' group, but overlapping was again observed, and
there was no significant difference between the means of the three groups.
Comparing the means in each group to the corresponding control values revealed
a highly significant increase in the normal group and a significant increase
in the 'Cushingoid• group after ACTH stimulation but no significant difference
in the obese group.
Expressing the results of this parameter as "absolute increase above control
value" the highest value was observed in one of the 'Cushingoid' patients, but
the ranges overlapped in the three groups and there was no significant difference
between the means of any two of them. When results were expressed as "percent
increase above control value", there was even greater overlap, and no significant
difference between the means.
ii- Kon-protein-bound Cortisol expressed as Its absolute value/in |ig,/l00m1). The
highest level was reached by one of the 'Cushingoid' patients, but there was
no significant difference between the means of any two groups, although the increase
of the mean in the normal and in the obese groups over their corresponding
control values were highly significant, and for the 'Cushingoid' group the increase
was significant.
Expressing the results of this parameter as "increase over the control level"













NORMAL CUSHING'S CUSHINGOID OBESE
FIGURE 26: PLASMA NON - PROTE IN-BOUND CORTISOL
CONTROL ESTIMAT.ONS AND ESTIMATIONS AFTER ACTH
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Overlap occurred among the rest of the levels and there wag no significant
differences between the means in the three groups. Expressing results as
"percent increase over the control value" also showed marked overlapping of the
ranges with no significant differences between the means.
In a study of plasma Cortisol in 7 normal subjects before and after a
standard intravenous AGTH test, Doe et al (i960 b) reported that a rise
occurred only in the NPB fraction, the range of this rise being 20.0 - 36.0
pg. EPB cortisol/100 ml. plasma (mean 27). The same group of workers in
I963 reported a normal mean of I3.2 pg./lOO ml. in normal subjects, and a
level of 431.7 pg./lQO ml. in a patient suffering from Cushing's syndrome.
^Qft-ftrot^fi-bouitf cprtj.ppl ag egtir^t^d by tfa vj,vp pefogq
When MPB aortisol was expressed as its absolute value (^g./lOO ml.) or
as a percent of total plasma Cortisol, the difference between the level of the
,Cushingold, patient and the mean of the three normal subjects was not
significant. The levels here are lower than the corresponding in vitro
figures, the difference being sometimes quite marked, Provided both techniques
were performed under exactly the same conditions, and the amount of radioactive
Cortisol added to the plasma In the In vitro method was of the same order as
that present in the plasma In the in vivo method, the only explanation for the
discrepancy between these two techniques must be that more binding occurs
inside the human body than in the test tube.
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3. tfgtjflatfong ftftgr 4e^?.gth^^one spppyggg^pq
As stated previously, CPR after dexamethasone suppression could not
be estimated by the blood method, because of the extremely low plasma
levels. Similarly, the radioactivity of the ultrafiltrate gave figures
almost as low as the background. Accordingly, neither plasma Cortisol
ncr the BPB Cortisol level could be calculated. This applied to all cases
to whom dexamethasone was administered except J.A. (Case 10), a patient
with Cushlng's syndrome.
The test was applied to (l) case 10. (J.A,),one of the patients with
Oushing's syndrome, (2) patients 18, (A.D.), 20, (D.M.), and 23. (D.S.) of
the 'Cushingoid' group, and (3) patients 28. (T.A.) and 31. (A.I.-} of the
obese group. In patient J,A., suppression was not marked and a CHI of
33.6 rag./24 hrs., plasma Cortisol of 9.0 pg./lOO ml. and an NPB Cortisol
of 7.5$ (0.67 pg./lOO ml.) were observed. The experiment showed that, at
least in some obese and • Gushingoid' patients, marked suppression of adreno¬
cortical activity occurred after dexamethasone. More data are needed,
especially in Cushing's syndrome and in obese individuals to see if this test
is of value in differentiating these two conditions.
The dose of radioactive Cortisol (2 pc.) contains between 30 and 35 pg. of
Cortisol. When introduced into the body it increased the Cortisol level by
less than 0,3 pg./lOO ml. Introduction of a bigger dose to facilitate
counting the ultrafiltrate, i.e. obtaining readings well above the background,
could significantly raise the plasma level of Cortisol and possibly affect the
degree of binding, thus rendering interpretation of the results dubious.
Grant (1963), however, believed that variable results were obtained in the
dexamethasone test. He stated that normal (maximal) suppression of plasma
Cortisol/
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Cortisol usually occurred with the smaller dose (0,5 mg, 6 hourly for 2 days),
suppression of cases of adrenal hyperplasia occurred with the larger dose
(2 mg. 6 hourly for 2 days), and that no suppression occurred when either dose
was given to patients with autonomous tumours. He noticed, however, that
cases were sometimes encountered in whom a response occurred that was
intermediate between hyperplasia and autonomous tumours, and he suggested that
these cases could be due to nodular hyperplasia. He stated, however, that
response to dexamethasone did not always correlate with definite pathology of
the adrenal cortex.
Conclusion
The simultaneous estimation of OPR., plasma Cortisol and plasma NPB Cortisol
offers the following advantagesi-
1. Three of the most accurate tests for the assessment of adrenocortical
function are carried out simultaneously. The accuracy of these tests depends
ultimately on the accuracy of the fluorometer and/or the radioactive counting
machine. The accuracy (99% confidence limit) of the fluorometer was found to be
5,5% far samples containing 0.1 pg, Cortisol (= 10 pg./lQO ml. plasma) while that
of the counting machine ranged from less than 1% for highly active specimens to
10% for specimens of low activity.
2. The results can be obtained after three days' work.
3. The use of radioisotopic Cortisol to correct for losses during the
procedure makes the estimation of plasma Cortisol extremely accurate. The ranges




U* Because of the great sensitivity of counting equipment, a relatively
small amount of plasma is needed for estimation of NPB Cortisol by ultra¬
filtration, viz 5 ml| other methods, using chemical techniques for
estimation of Cortisol in the ultraftitrate, need at least 15 ml. of
plasma.
5. NPB Cortisol is estimated 'directly1. This is in contrast to all
other methods (except the ultrafiltration methods), which either estimate
the CBG (or transcortin), or its 'capacity' to combine with Cortisol. These
methods, besides being 'indirect' methods for the assessment of the NPB
Cortisol, are usually time-consuming since a few days are needed for the
equilibrium dialysis to be completed. These methods have, therefore, to be
o
carried out at abnormally low temperatures (usually A C), to prevent
bacterial growth, which could reduce the Cortisol in the plasma and accordingly
affect the accuracy of the results. In the present study, ultrafiltration
for 5 hours was enough to obtain an ultrafiltrate containing a measurable amount
of radioactivity, and ultrafiltration could be carried out at 37°C, The
present technique would appear, therefore, to be more accurate from the
physiological point of view, since it yields results which should correspond
very closely to the conditions inside the human body,
6. The main reason for using radio-isotopic techniques is to introduce into
the body an amount of Cortisol that is too little to cause a significant increase
in the plasma level of Cortisol or in its degree of binding by plasma proteins,
but which, at the same time, contains an amount of radioactivity easily
detectable in the final extracts by sensitive counting equipment. At first,
it/
- 257 -
it was not possible to produce Cortisol of a high specific activity. Thus
Peterson and Wyngaarden (1956), the originators of this method, used radioactive
Cortisol doses containing 200 - 500 p.g. Cortisol. When radioactive Cortisol
of higher specific activity became available, it was possible to introduce into
the body smaller amounts of Cortisol. Thus, Hoet el al (1961), for instance,
used doses of radioactive Cortisol containing between 60 and 80 ^g., and
Chen et al (1961) used radioactive Cortisol of S.A. 4..17 pc./mg. In the present
research, Cortisol of a very high S.A., vis 60 nc./mg,, was used, which meant
that the amount of Cortisol introduced into the body (about 30 pg.) was
much less likely to affect either the Cortisol level or degree of binding to
plasma proteins. Results obtained with the more highly radioactive Cortisol
should more closely represent the conditions inside the body.
7. Lastly, an in vivo modification for the estimation of NPB Cortisol has
been described. In this technique equilibration between radioactive and non¬
radioactive plasma Cortisol was allowed to take place under physiological
conditions, in the body itself. In the in vitro method, the temperature and
pH of the plasma during the experiment were adjusted to simulate conditions in
the human body, but, in spite of this, differences were noticed between the
results of the two methods. This showed that, even when temperature and pH were
adjusted, equilibration of radioactive Cortisol inside the human body was more
efficient than in the test tube, since the degree of binding was always more
in the in vivo method.
The factor, or factors,responsible for this difference in binding between the
two methods is not known. It may be that one of the tissues in the body is
necessary/
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necessary to enhance the union of Cortisol to its binding sites on CBG.
The results obtained by the in vivo technique should, therefore, be more
representative of the physico-chemical processes which occur inside the human
body, and should at present be regarded as having greater physiological
value.
The in vitro method gave a higher value for the patient with Cashing*s
syndrome than the upper limit of the range for the normal group. This
suggests that it could be an extremely important index for assessing
adrenocortical function, yet the ranges given could be the ranges of the
method rather than physiological ranges. The author, therefore, recommends
using the in vivo method, the results of which should represent both the
ranges for the method and the actual ranges, thus reproducing the conditions
inside the human body.
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C. Treatment of Gushing's syndrome by adrenalectomy
1. Unilateral adrenalectomy
Assessment of adrenocortical function in a patient with Gushing *s
syndrome (case 10,, J,A,) after unilateral adrenalectomy was performed by
repeating the tests of Cortisol production rate and urinary steroid
excretion after the operation. Table 22 provides the results of these
estimations, and allows comparison to be made between pre-operative and
post-operative values.



































c. 17-KS (mg./24 hrs.) 18.7 4.8
d. Total 17-KGS (rag./24 hrs.) 54.9 20.3
* Tests performed 3 weeks after the operation
The miscible pool and rate of turnover dropped to nearly half their
original value, and the production rate by the blood method dropped from
177.6/
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177.6 to 52.8 mg./24 hrs. The latter value was, however, still higher than
normal, and the size of the miscible pool was still above normal. Cortisol
production rate by the urine method showed a similar drop, but the new level
was still well above normal. On the other hand, 17-KS excretion fell from
a level just above the normal range to a below-normal level, and total
17-KGS, which were originally moderately elevated, fell to the upper level
of normal. This shows again the superiority and sensitivity of Cortisol
production rate tests over measures of steroid excretion, especially 17-KS
determinations, in detecting moderately elevated adrenocortical activity,
Hoet et al (1961) studied the CFR (blood method) in two patients
suffering from Cushing's syndrome after unilateral adrenalectomy. They
reported that the miscible pools were 0.65 and 3.0 mg., the rate of
turnover 0.59 and 0.£7 pool/hr. and CHI 0.38 and l.A mg./hr. Liddle (i960)
found that patients suffering from Cushing's syndrome due to adrenal
hyperplasia showed resistance to endogenous-ACTH suppression by dexaraethasone
post-operatively indistinguishable from that observed before operation.
This agrees with the findings of the present study (see table 14)#
Signs and symptoms of Cushing's syndrome In patient J,A. were still
present, after unilateral adrenalectomy, although considerably improved,
Liddle (I960) on the contrary, stated that unilateral adrenalectomy did not
result in a significant decrease in basal steroid excretion and failed to
produce any clinical improvement. The persistence of the clinical manifestations
of Gushing's syndrome in patient J.A., with high CFR and urinary steroid excretion




2, afoeftSgeqtQBff with adrenogoptigal ggto-tfangpIgnl^ioB
As stated in the introductory discussion of Cushing's syndrome
(Chapter III), the treatment of choice has been adrenalectomy (total,
subtotal or unilateral). Sametimes hypophysectomy or irradiation of the
pituitary gland may be employed, or, in desperate cases, adrenocortical
inhibitory therapy, although this is still in its experimental stage. It
was also mentioned then that any of these lines of treatment suffered
disadvantages such as recurrence of Cushing's syndrome or the administration
of maintenance therapy throughout life.
A new approach was the introduction of the auto-transplantation operations,
as a method of surgical treatment which did not suffer from the above
drawbacks. The principle of such operations is that bilateral adrenalectomy
is performed, part of one adrenal gland is divided into small pieces, and
these are transplanted, in small "heaps", into the rectus sheath of the
anterior abdominal wall. The two important advantages offered by this type
of operation are: (l) part of the adrenal tissue is left inside the body and
this can secrete the necessary amounts of corticosteroids, thus relieving
patients from the requirement of being maintained on steroid therapy throughout
the rest of their lives; (2) the transplanted adrenal fragments are located
in an easily accessible part of the patient's body, so that further removal of
adrenal tissue can be easily performed, even tinder local anaesthesia, if
















FIGURE 27: CORTISOL PRODUCTION RATE ( U R IN E MET HO D )
BEFORE AND AFTER BILATERAL ADRENALECTOMY
WITH ADRENOCORTICAL AU TO -T R A N S P LANT A T IO N
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Tftbl? (33)
Aftrenocorticq fup^j,oq a^er ^lateral
a^g autft-trqnsplantatioa
Case CPR 17-KS Total 17-KGS
Urine method
(mg./24hrs) (mg./24.hrs) (rag./24 hrs)
11. J.T, pre-operative 62.2 14.2 15.8
post-operative
(2 months) 8.3 1.6 3.0
(7& months) 4.2 1.6 3.7
12. M.C, pre-operative 24..6 10.2 21.8
post-operative
(2^ months) 0.44 2.6 2.4
14. C.F, pre-operative 23.0 32.7 45.4
post-operative
(1 year) 9.0 11.5 18.4
(gl.)*
♦glycosuria
Table 23 summarises the results of Cortisol production rate and steroid
excretion tests before and after such an operation in three patients with
Cushing's syndrome (see also figure 27). In the first case (11., J.T.) a
production rate of 8.3 mg./24 hrs. was detected two months after the operation,
associated with marked improvement of the clinical condition. Seven-and-a-half
months after operation, however, the patient started to show signs and symptoms
of hypoadrenocorticism; Cortisol production rate was estimated, found to be
4..2 mg./24 hrs., and steroid maintenance therapy had to be started. In the
second case, (12., M.C.), a post-operative Cortisol production rate of a negligible
value was detected two-and-a-half months after the operation, associated with
a clinical picture of hypoadrenocorticism; again, steroid maintenance therapy
had to be started. In the third case (14.» G.F.), one year after operation a
Cortisol/
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Cortisol production rate just below the lovfer Unit of normal vas detected,
associated with a marked clinical improvement of the patient's condition, and
it was not considered necessary to give any replacement therapy. Glycosuria,
however, persisted in this third patient after operation, which suggests that,
at least in some cases, glycosuria or even Cushing 's syndrome itself are
caused by pituitary or hypothalamic disorder rather than by an adrenal
disorder.
Only one sixth of the total adrenal tissue was transplanted in these
three cases. This should, theoretically, have given a lower than normal
secretion of Cortisol in all of them, and the ultimate failure of two out
of these three operations could therefore be due to the surgeon having
transplanted an amount of adrenal tissue that was insufficient to secrete the
normal requirements of steroids. This small amount of transplanted tissue,
perhaps after temporary hypertrophy, probably underwent exhaustion atrophy.
These suggested changes in the adrenocortical tissue were described a long
time ago by Selye (194-6), who defined three consecutive stages in the "stress
or adaptation syndrome", namely alarm, resistance and exhaustion, The second
of these phases has been associated with hypertrophy and hyper-reactivity of
the adrenal cortex, and the third phase only occurs if the degree or persistence
of stress exhausts the adrenal defence mechanism. Leaving too little adrenal
tissue inside the body to deal with the normal and stressful conditions of
every-day life could well be such a stress to this small transplanted portion
of adrenal tissue as to lead to the above mentioned changes.
Franksson et al (1956) were the first to suggest the auto-transplantation
technique,/
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technique. They later on (Franksson et al, 1959) described 5 females,
suffering from Gushing's syndrome, who had been treated by this method.
The post-operative period ranged between 3 months and 2 years. Symptoms
subsided in all cases and little or no exogenous steroids were required
post-operatively. The adrenal pathology in these 5 cases was diffuse
adrenal hyperplasia. These workers stated that it was very difficult to
gauge correctly how much adrenocortical tissue to transplant, mainly because
the cells of different adrenal glands seem to vary in steroid-producing
capacity* The site of transplantation in their cases was the sartorius
muscle. In the cases reported in the present study, the site chosen was
the rectus sheath of the anterior abdominal wall, probably because it is
a cleaner site than the thigh.
Conclupjcffl
Because one of the three operations studied in this thesis was
successful, the author believes that it is a potentially valuable method of
treatment, and he suggests that the Cortisol production rate estimation
should be taken as the basis for deciding how much adrenocortical tissue
to transplant. It Is too early to state whether some other factors,
related to the surgical technique itself, was responsible for the failure of
some of these operations.
3./
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3. ftrtfrolpflj-gaili e^mxna^pn of glyKjg remove^ t?y yfrgnalectosiy
Table 24 shows the results of pathological examination of adrenal glands
removed from seven patients suffering from Cushing's syndrome. In only one
case was the weight of the glands increased significantly above the normal
limits; in this patient, the histology was normal. In two cases, adenoma
was found (macroscopic or microadenomata), and signs of hyperplasia were
detected in the rest of the glands.
The finding of histologically "normal" adrenal glands or adrenal glands
of normal weight is not new. Sprague et al (1955) stated that 34- out of 88
individual adrenal glands removed from patients with Cushing's syndrome were
histologically normal, that 50% of these glands weighed less than 8 grams
and that 78% of them weighed less than 10 grams. Liddle (i960) reported
that, after operation, 7 of his 27 cases had histologically normal glands,
although diagnosed clinically and by 17-KG3 and 17-KS estimations before and
after dexamethasone as Cushing's syndrome with adrenal hyperplasia. Ekman et
al (1961), similarly, reported that two of their 22 patients with Cushing's
syndrome had normal glands. Symington and Jeffries (1962) also examined
individual adrenal glands removed from patients suffering from Cushing's
syndrome and found that 35% of them are histologically normal; 45% of them
weighed less than 8 gram and 81% were less than 10 gram.
Patient J.A. (case 10), who showed clinical and laboratory findings typical
of Gushing's syndrome, had histologically normal glands. This patient had a
basal CFR about 6 times the normal value, and his adrenals were increased in
weight to approximately twice the normal value. The aetiology of Cushing's
syndrome in this patient could not be due to an "increased adrenal functioning









































using radioactive Cortisol precursors, of the adrenal glands of this patient
revealed a hyperplastic pattern. It is possible that electron microscopy
could detect changes, in such glands, that could not be detected by the
ordinary histological techniques and this question remains to be answered.
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2- Mrttonehlp 9f a3r9ap<?grtj,gal fwri: ^ tp weight, freigfrt and
muse,nature
Table 25 represents the weight, height, surface area (calculated from
the weight and height), total body lean cell mass and total body fat (calculated
from the weight and total body water estimation), creatinine excretion (as a
measure of body musculature), and Cortisol production rate (blood method)
in all cases of the four groups studied.
With the data on weight, the difference between the mean of the normal
group and the three other groups is highly significant (see table 28). The
increase above the desired weight in the obese group ranges from 4.1 - 117,9%
(average 68.01).
In height, the difference between any two means is not significant.
In estimations of the surface area, the difference between the means of
the normal group and the group of Gushing's syndrome is significant, and
between the mean of the normal and obese group is highly significant.
With the total body lean cell mass, the mean of the normal group is
significantly lower than that of either patients with Gushing's syndrome or
patients in the 'Cushingoid' group. If the total body lean cell mass is
expfessed as "percent of the total body weight", the same result is obtained.
If total body fat is expressed in Kg,, the mean of the normal group is
significantly lower than the obese group, and the difference between the
normal group and both the group of Gushing's synoroae and the 'Cushingoid'
group is highly significant, Expressed as "percent of the total body weight",
the mean of the normal group is significantly lower than that of the group of
Cushing's syndrome and the 'Cushingoid' group but not of the obese group.
The difference between the mean of the four groups, as far as creatinine
excretion is concerned is not significant except between the normal and
«




amounts of creatinine than normal subjects. au-a^tmr.too
■jass- 4 .id not aiffor much among individuals-of the four groups studied.
in 1956, Gray et al, studying the effect of weight reduction in
obese subjects, suggested that in obese individuals with symptoms suggesting
Cushing's syndrome, the possible effect of food intake on increased steroid
excretion could be of diagnostic and therapeutic importance. Borth et al
(1957) found that the differences in steroid excretion values for men and
women was attributable entirely to the fact that, on the average, men
are taller and heavier than women. Tanner et al (1959), studying healthy
male medical students found a significant relationship between urinary 17-KGS
excretion and weight, height and surface area. Significant relationships
between weight and steroid excretion were also reported by Cohen (1958),
Szenas and Pattee (1959), Simkin (1961) and Green et al (1961). Similar
relations between weight and CPR were reported by Eckert et al (1961),
Karl and Raith (1961) and Mlynaryk et al (1962).
Significant relationships between the surface area and steroid excretion
(Poisnick and DiRaiinondo, 1956j Tanner et al, 1959), surface area and CPR
(-ctert et al, l9ol) and between the surface area and the logarithm of the
values for urinary excretion of major tetrahydro-a-ketolic metabolites of
Cortisol (Dohan et al, 1962) were reported.
iilynaryk et al (1962) found that, when GPR was expressed as a fmiction of
creatinine excretion, the original raised CPR in obese subjects persisted,
implying that muscle mass was not the factor involved in the higher OPR.
These workers noticed that CPR, expressed as a function of weight, was similar
W
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in normal and obese groups, implying that the increased CPE in obese subjects
was due to increased weight. These workers, therefore, concluded that the
rise in CFR correlated better with body weight than with surface area, ideal
body weight or estimated amount of fat. Similarly, DeMoor et al (I963)
stated that the significant difference in hormone excretion between normal
males and females disappeared when the data for hormone excretion were
recalculated per unit body weight, height or surface area.
Schteingart et al (1963), on the other hand, found no correlation
between either urinary 17-hydroxycorticosteroid excretion or CPR on the
one hand, and the absolute body weight or the degree of overweight on
the other. Similarly, in a group of normal and obese subjects, Gogate and
Prunty (1963) found that the coefficient of correlation of CFR with body weight
or surface area were not significant, viz 0.290 and 0.388 respectively.
As far as the relation between adrenocortical activity and body musculature
is concerned, Romanoff et al (1961) found that, when CPR was expressed in terms
of creatinine excretion, the difference between CFR of young and elderly
men disappeared, Klynaryk et al (1962), however, did not observe a
relationship between adrenocortical activity and body musculature.
In view of these contradictory results, it was felt worthwhile to reassess
the relationship between GPR and weight, height, surface area, lean cell mass,
body fat and musculature in the groups studied in this research.
Assuming that cases of Cushing's syndrome, and probably some of the
cases of the 'Cushlngoid' group, represent abnormal and varying adrenocortical
function, only the subjects of the normal and obese groups were used to
investigate these relationships (see table 26 and figures 28-34)* Fatients of
the Cushing's and 'Gushingoid' groups were, however, included in the diagrams






















FIGURE28RELATIONSHIPB TWEENCOR ISOLPRODUCTIRAAND TOTALB DYWEIGHT
CPR BLOODMETHO (mg./24hr)
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Relatiunship between Qi-R and weight, height, surface area," body-lean coll ma3s, body fat and body musculature.
Case Age Sex height Height Surface Total To tall body LGM Total body fat Creatinine OPR
area body exoretion (control:
O water blood method)
(yrs) (Kg ) (om) /v® ; (1) (Kg) (^t of total kg; (;% of total (g/24hr) (mg/24hr)
body weight) body weijit)
1. Normal group
1. B.A. 29 M 63.0 175.0 1.77 20.4
2. R.B. 65 M 63.4 177.8 1.79 31.1 43.32 68.33 20.08 31.67 30.0
3. W.J. 35 M 54.0 170.0 1.62 32.3 44.98 83.30 9.02 16.70 1.47 17.5
4. w.h. 55 M 83.4 171.4 1.96 39.7 55.29 66.30 28.11 33.70 51.2
5. m.l. 42 P 44.0 156.2 1.38 27.6 38.45 87.35 5.57 12.65 1.10 21.8
6. M.H. 35 P 52.0 165.1 1.56 26.3 36.63 70.45 15.37 29.55 0.97 28.8
7. M.R. 23 P 56.7 157.4 1.56 25.8 35.93 63.57 20.77 36.63 1.30 26.9
range 23-65 44.0-33.4 156.2-177.8 1.38-1.96 25.8-39.7 35.93-55.29 63.37-87.35 5.57-28.11 12.65-36.63 0.97-1.47 17.5-31.2
mean 40.6 59.5 167.6 1.66 42.43 73.18 16.49 2b. 82 1.21 25.2
S.d. 12.47 8.347 0.19 7.27 9.77 8.31 9.77 0.220 5.3
3.E. 4.713 3.155 0.072 2.970 3.990 3.393 3.990 0.110 2.00
2. Gushing1s group
a. Operated upon
40.96 46.0210. J. A. 55 M 89.0 157.4 1.90 34.5 48.04 53.98 177.6
11. J.T. 17 P 37.0 160.0 1.90 36.2 50.42 57.95 36.58 42.05 1.40 54.7
12. M.C. 36 P 108.0 166.3 2.14 40.1 55.85 51.71 52.15 48.29 1.46 37.9
b. Not operated upor i
17. C.m.. 18 F 83.3 38.6 53.76 64.54 29.54 35.46 34.1
range 17-55 83. >108.0 157.4-166.3 1.90-2.14 34.5-40.1 48.04-55.85 51.71-64.54 29.54-52.15 35.46-48.29 1.40-1.46 34.1-177.6
mean 31.5 91.8 161.2 1.98 52.0 57.04 39.81 42.96 1.43 76.1
s.d. 11.04 4.57 0.139 1.11 5.62 9.48 5.62 0.046 68.3
S.E. 5.520 2.639 0.080 0.556 2.8H 4.728 2.812 0.033 34.15
1 1
3. Cuahingoid group
18. A.D. 19 P 79.8 157.4 1.81 30.1 41.92 52.53 37.88 47.47 1.30 37.0
19. W.g. 27 M 133.6 180.3 2.49 58.7 81.76 61.2Q 51.84 38.80 1.86 23.0
20. D.M. 21 M 121.8 175.2 2.34 48.5 67.55 55.46 54.25 44.54 1.93 45.6
21. T.M 18 M 86.3 177.8 2.04 41.7 58.10 67.30 28.20 32.70 31.2
22. C.A. 26 P 61.1 154.9 1.60 8.6
23. d.S. 34 P 118.1 170. D 2.26 41.1 57.24 48.47 60.86 51.53 1.67 18.7
24. 14. K. 15 P 76.9 158.7 1.79 38.7 53.91 70.10 22.99 29.90 30.2
25. d.y. 32 F 75.7 148.5 1.70 34.2 47.63 62.92 28.07 37.08 1.45 26.4
range 15-34 61.1-133.6 148.5-180.3 1.60-2.49 30.1-58.7 a. 92-81.76 48.47-70.10 22.99-60.86 29.90-51.53 1.30-1.93 8.6—45.6
mean 24.0 94.2 165.4 2.00 58.30 59.71 40.58 40.29 1.64 27.6
S.d. 26.43 11.92 0.33 12.94 7.896 15.03 7.90 0.27 11.28
S.E. 9.345 4.179 0.115 4.899 2.984 5.680 2.985 0.119 3.98
4. Obese group
26. A.M. 34 M 152.7 *111.3 179.0 2.62 60.1 83.71 54.82 68.99 45.18 2.21 18.0
27. R.iu 12 M 67.4 * 25.7 149.8 1.63 38.3 53.34 79.14 14.06 20.86 0.98 25.9
28. T.A. 17 M 143.6 ♦117.9 170.0 2.46 1.56 22.1
29. C.S. 14 F 96.3 • 63.1 I63.8 2.02 32.2 44.85 46.57 51.45 53.43 1.58 28.8
30. H.L. 31 P 58.2 * 4.1 160.0 1.60 32.4 45.12 77.53 13.08 22.47 1.50 18.7
31. A.I. 24 P 97.0 ♦ 73.5 160.0 1.99 36.7 52.36 53.98 44.64 46.02 1.84 21.4
| 32. C.R. 20 P 95.9 * 87.6 151.1 1.90 34.2 47.63 49.67 48.27 50.33 1.10 13.2
33. M.s. 14 P 92.9 ♦ 60.9 162.5 1.97 36.0 50.17 54.00 42.73 46.00 1.52 30.5
range 12-34 58.2-152.7 149.8-179.9 1.60-2.62 32.2-60.1 44.85-83.71 46.57-79.14 13.08-68.99 20.86-53.43 0.98-2.21 13.2-30.5
mean 20.8 100.5 162.0 2.02 53.88 59.39 40.46 40.61 1.54 22.3
S.D. 32.90 9.50 0.36 13.56 13.27 20.34 13.27 0.39 5.8
S.E.
uk TVl AM A p i — « . MM — — MM _ —
11.632 3.359 0.127 5.125 5.015 8.295 5.015 0.137 2.06
These figures represent percent increase above ideal weight in the obese group. The range is 4.1-117.9# and the mean is 68 01%
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(26?
Coefficient of correlation between GPE and weight, height, surface area, creatinine




1, CPR: blood method
(mg./2A hrs.)
height (Kg.) - 0.189
2* » n ft Height (cm.) + 0.134
3. M « ti Surface area (m^) - 0.119
A. »» f? ft Creatinine excretion (g./24hrs) - 0,2(77
5. n n ti Total body lean cell mass (Kg.) - 0.255
6. « n ft Total body lean cell mass
(% of total body weight) - 0.065
7. n rt it Total body fat (Kg.) - 0.U5
8. ti tf tl Total body fat (up to 30 Kg.) + 0.791
9. t» It it Total body fat
{% of total body weight) + 0.065
10. n H ft Total body fat
(% of total body weight;
up to 35^)
+ 0.823
A wide scatter and a poor correlation exists between Cortisol production
rate and weight. The scatter is, however, less pronounced in the normal
group alone. Similarly, scatter and poor correlation exists when Cortisol
production rate is plotted against either the height, surface area, total
body lean cell mass (expressed in Kg. or as a percent of the total body weight),
total body fat (expressed in Kg. or as percent of total body weight) or
creatinine/
- 272
creatinine excretion. Again the scatter among the normal group alone is
less pronounced, when the surface area or the total body fat are examined,
but an interesting observation was the finding of a nearly linear relationship
between Cortisol production rate and total body fat, if only the subjects
of the normal and obese groups whose body fat was 30 Kg. or less were included
(see figure 32)j the coefficient of correlation for this group was + 0.791*
and the straight line in figure 32 corresponds to the regression equation:
Cortisol production rate = 0.576 x (total body fat) + 16.022
(blood method, mg,/24hrs) in Kg.
Similarly, a nearly linear relationship exists between Cortisol production
rate and the total body fat if the latter is expressed as percent of the total
body weight, if only subjects in the normal and obese groups whose body fat
is 35% or less of the total body weight are Included. The coefficient of
correlation in this case is + 0.823, and the straight line in figure 33
corresponds to the regression equation:
Cortisol production rate = 0.577 x (total body fat) + 11.076
(blood method, mg./24hrs) as % of total
body weight
The conclusions to be dr: wn from this study are? (l) that poor correlation
exists between the adrenocortical function and body weight, height, surface area,
lean cell mass or body musculature (i.e. creatinine excretion); and (2) that
there is a correlation between the adrenocortical function and total body
fat, if the latter is only up to 30 Kg. or 35% of the total body weight*
This, could mean that fat constitutes a mechanical stress to which the
adrenals/
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adrenals respond by increase of Cortisol production. The greater the total
body fat, the more Cortisol is produced, up to a limit, beyond which the
adrenals fail to cope with this extra mechanical stress. Szenas and Pattee
(1959) stated that a subject is considered overweight when there is 30%
or more increase in actual body weight, in relation to ideal weight.
According to the findings of the present research, obesity as a clinical
entity could be defined as "the clinical condition in which the total body
fat is 30 Kg. or more" or "the clinical condition in which the total body
fat is 35% of the total body weight or more".
Part 17
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A. Comparjgon of the method? of agggggment of adrenocortical funytfroq
In t^lg gtufo
Taking the group of patients with Gushing's syndrome and the group of
normal subjects as the two "reference groups", the most sensitive test
of detecting normal or increased adrenocortical activity under basal conditions
was estimation of Cortisol production rate. Results obtained with the blood
method were found to be better than those obtained in the urine method in
achieving a separation of these two groups.
The possible reasons for the occasional marked difference between the
results of the blood method and urine method include the presence of a
circadian rhythm of adrenocortical activity, incomplete collection of urine
samples, and the differences in calculation of results between single and
double compartment models. Under carefully controlled conditions, urine
collection should be complete, and it has been shown that the differences
between single and double compartment models play only a minor role at
basal conditions. It would seem, therefore, that the main cause of this
discrepancy must be the diurnal variation of adrenocortical activity, When
Peterson and Wyngaurden (1956), who first introduced the isotope method of
GPR estimations, repeated their determinations in the evening, they obtained
values which were approximately half of those which they obtained in the
morning for the same patients, and this finding has since been confirmed
by other workers (Hoet et al, 1961),
In the present thesis, CFR estimated by the urine method was higher
than in the blood method in 2 out of 4 cases of Gushing's syndrome (see
table 12 a), and this serves to confirm previous reports that the normal
diurnal rhythm is absent in patients suffering from this syndrome.
Comparing/
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Comparing Cortisol production rate on the one hand to steroid
excretion on the other have shown that the former is much more sensitive
in detecting abnormal adrenocortical function than the latterj this
applies particularly to urinary 17-K3 estimations. This is not unexpected
since it is well known that 17-KS and total 17-KGS methods can be affected
by the percentage of Cortisol recovered in urine as 17-K3 or total 17-KGS,
the presence or absence of renal insufficiency or, as recently suggested,
by the rate of secretion on the day before (lazarus, 1962). The last
mentioned factor will be important particularly in unsteady conditions of
adrenocortical function such as that seen in Gushing's syndrome.
Although estimations of total Cortisol level in plasma have provided
encouraging results in the present research, as to the diagnosis of normal
and hyperactive states of the adrenal cortex, much larger number of cases
of Cushing's syndrome need to be assessed by this method before finally
accepting this conclusion. The main drawbacks of this method for assessing
adrenocortical function should be taken into account, also. These arei
(1) total plasma level of Cortisol is a measure of the combined effects of
Cortisol production rate, rate of Cortisol disposal and the volume of
distributionj (2) plasma Cortisol level can be affected by temporary emotional
upset| and (3) only the non-protein-bound moiety is regarded nowadays by
most workers as the physiologically active component at the tissue or
cellular level.
The present findings agree with those reported by ftrunty (1961). He
studied cases of Cushing's syndrome due to adrenal hyperplasia by various
tests and reported that 17-KS exceeded the upper limit of normal in only
6 of 12 patients, 17-KGS raised in 2 of 6 patients, urinary excretion of
unme tabolised/
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unmetabollsed Cortisol raised in A out of 6 cases, and plasma Cortisol
levels raised in 2 of 3 cases, but that Cortisol production rate estimations
were raised in all the 6 patients studied by this method. He concluded
that determinations of CPR provided the best available diagnostic
criterion.
Recently, in a similar study, Brooks et al (I963) found that 17-KS
excretion was increased in only 9 out of 25 cases of Cushing's syndrome,
17-KGS excretion increased in 13 out of 25 cases, plasma Cortisol levels
increased in 9 out of 17 cases, urinary unraetabolised Cortisol excretion
increased in 17 of 21 cases but Cortisol secretion rate increased in all
cases studied by this method.
Estimation of plasma NPB Cortisol, in the present study, succeeded
in separating clearly a case of CushJLng's syndrome from normal and obese
subjects. The importance of this parameter as an extremely sensitive
index for the assessment of adrenocortical function has been recently
stressed by Doe et al (1963)* More cases of Gushing's syndrome, however,
are needed to decide whether or not the rise of NPB Cortisol is a
characteristic finding of all patients suffering from this clinical condition.
It has been shown that the discrepancy between CPR estimations on
the one hand, and urinary steroid excretion on the other, is even more
marked after ACTH, and that there are cases with very high CPR but only
moderately increased total 17-KG3 excretion. It has also been shown, from
studying steroid excretion patterns, that the number of doses of ACTH on
the third day of stimulation is not the responsible factor. Lazarus (1962)
suggested/
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suggested that, during ACTH stimulation, secretion of Cortisol on the day
before that of estimation of urinary steroids could influence the results
considerably. Very recently, James and Caie (19&4.) found that the
correlation between urinary total 17-KGS excretion (as determined by the
method of Few, 19&1) and secretion rate of Cortisol was acceptable in the
normal range, but became poor as the secretion rate increased above
35 mg./24 hrs. These workers proved that this discrepancy was not due to
increased faecal excretion of Cortisol and its metabolites or increased
conversion of Cortisol to 17-KS after ACTH stimulation. They also proved
that the accuracy of the determination of total 17-KGS was not less at
high excretion levels. They suggested, therefore, that it is likely that
6p-hydroxycortisol, 16-hydroxylated or other polar metabolites of Cortisol
may be formed, or their excreted amount increased, at high levels of Cortisol
secretion, and that probably they may not be extracted from the urine during
the assay procedure. These workers emphasised, therefore, the fact that
urinary steroid excretion within the normal range can not necessarily be taken
as evidence for the exclusion of adrenocortical hyperfunction.
In the present research, the best single test that provided the widest
separation between normal subjects and patients with Gushing's syndrome was
the CFR after ACTH stimulation. The blood method provided a much wider
separation than the urine method. The latter method, it was noticed, always
had values well below the former. As previously mentioned, the number of
doses of ACTH on the third day of stimulation can not be responsible for this
discrepancy, and the answer may lie in finding out whether or not estimations
by/
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by the blood method from a double compartment model will yield results
comparable to that of the urine method.
In the hands of other workers, the results of ACTH stimulation have
been very variable. In some occasions, hypersensitivity has been noticed
in Cushing's syndrome, and in other instances it has been absent. Many
factors are involved in the ACTH test which will decide whether the results
obtained will or will not be of any significance. Bayliss and Steinbeck
(1954-) pointed out the importance of the route of administration of ACTH,
and the timing of the plasma samples withdrawn in relation to the beginning
of ACTH administration. They noticed that intravenous infusion of 20 units
leads to an almost immediate rise of plasma Cortisol and a plateau which lasts
to the end of the infusion, i.e. for eight hours. The same amount of ACTH
given intramuscularly in the form of gel, in one dose, leads to a gradual
rise of plasma Cortisol and a peak after about 4, hours, whereas injection of
20 units of ACTH intramuscularIy> in saline, leads to a more rapid rise of
plasma Cortisol with a peak level after about 2 hours. These workers also
showed that repeated daily injections of ACTH gel led to progressive increase
in plasma Cortisol, with a maximum xevel reached on the third day. For fham
et al (1955) stressed the fact that the type of ACTH administered is very
importantj impure preparations were inactivated when given intramuscularly,
but this does not occur with newer preparations. The amount of ACTH injected
is also very important.
It has been shown in the present work that the type of test to be applied,
after ACTH stimulation, for the assessment of adrenocortical function is also




Beck et al (1962) stated that 20 I.U. given intramuscularly every 6
hours for 8 doses, i.e. a total of 160 I.U, over a period of two days, is
necessary to give maximal adrenocortical stimulation. These workers
summarised the factors which affect the results of the ACTH test, as followss-
1, The type of ACTH administered.
2* The amount of ACTH administered.
3. The route of administration of AGTH.
4. The duration of administration of ACTH,
5« The test for assessment of adrenocortical function applied after ACTH
stimulation.
6, Timing of the samples both as to time of day and their relation to the
beginning of ACTH administration.
They demonstrated the importance of these factors in the differentiation
of normal subjects from patients with Gushing's syndrome. Using the above
mentioned dose, Beck et al (1962) found that at the end of the 4.3 hour period
of the test, a significant difference existed between the means of these two
groups as shown by urinary 17-hydroxycorticosteroid estimations. Estimating
the plasma 17-hydroxycorticosteroid, the same result was obtained, namely that
patients with Gushing's syndrome gave significantly higher results than normals*
The means were 35.5 ± 7.7 pg./lOG ml., 37.8 1 12,3 pg./lOO ml. and 62,1 pg./lOO ml.
for normal males, normal females and patients with Cushing's syndrome
respectively. The increase above the control value was also significant, 21,2
fig., 24,.0 pg, and 41.0 pg, respectively. But when the values obtained four
hours after administration of the first injection of ACTH were considered, the
results were 38.5 ~ 2.5 pg./100 ml., 31.2 ± 5.2 pg./lOQ ml. and 4.O.3 ± 4.7
pg,/100 ml. respectively} the difference between these means was not significant.
Similarly,/
Similarly, Jailer (1962) noticed a hyper-response to AGTH at the
end of the first day of stimulation in 45 out of 46 of his patients with
Cushing's syndrome and hyperplasia. The one patient who showed normal
response demonstrated the characteristic hyper-response on the third day
of stimulation.
In the present research, a unique dose (60 I.U.) of a pure preparation
of ACTH gel was given intramuscularly every 12 hours for 3 days, i.e. a
total of 360 I.U. over 3 days. This dose is greater that that which has
been reported by others to give maximal adrenocortical stimulation. The
intramuscular route was chosen because it was the safest. This dose
produced maximal stimulation of the adrenal cortex as shown by study of the
steroid excretion patterns. Blood samples necessary for estimations of
CPR and plasma Cortisol levels were withdrawn on the morning of the third
day, and the urine samples collected on the third day served for estimation
of GPR by the wine method, and for steroid excretion estimations. By
using this dosage of ACTH, separation of normal subjects from Gushing's
syndrome was achieved with the CPR estimations (much wider in the blood method),
but urinary total 17-KGS and 17-K3 excretion were not of great help in this
respect.
Perhaps the various ways of administering ACTH have been responsible
for the contradictory results of this test reported by various workers. The
author, therefore, suggests the use of ACTH in the manner applied in the
present research, to achieve the best results as far as the diagnosis of cases
of Cushing's syndrome is concerned.
B./
B. :;v:ortance of grouping Ifte i,n the fl^renUqUo*) <?f oteflAty
Curing's syndroqg
The main purpose of the present research has been to achieve a laboratory
means of diagnosing Cushing's syndrome, and of separating patients suffering
from this condition from normal and obese subjects. This aim has been
achieved, first by the choice of sensitive tests of adrenocortical function,
but, perhaps of more importance, by classification of the subjects of this
study into four groups: (l) normal subjectsj (2) patients diagnosed
clinically, by laboratory tests, by examination of their adrenals removed
at operation and/or the favourable response after adrenalectomy as suffering
from Gushing's syndrome (these two groups represented the two "reference"
groups} the first represented normal adrenocortical activity and the second
represented hyperfunction of the adrenal cortex); (3) "Simple obese" subjects
were classified into a separate group, and (4.) all the cases which, besides
obesity, showed some of the clinical features of Cushing's syndrome were
classified into another group which was called 'Cushingoid1 group.
The existence of these 'Cushingoid' subjects was recognised many years
ago. Thus, Gray et al (1956) described certain "obese individuals with
symptoms suggesting Cushing's syndrome". Unfortunately, however, no attempt
has been made before to classify the subjects into these four groups. It
could well be, therefore, that many of the earlier estimations carried out
in "Gushing's syndrome" included obese subjects, which could explain the
occasional report of normal adrenocortical activity in Cushing's syndrome,
as measured even by sensitive tests such as GPR. It could also explain the
inclusion of patients with Cushing's syndrome among investigations of obese
subjects,/
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subjects, and hence also the frequent reporting of increased adrenocortical
activity in obese individuals. The following examples will help to
illustrate the importance of this classification if distinct separation of
Gushing's syndrome and obesity is aimed at.
Liddle (I960), after classifying his subjects into normal, Cushing's
syndrome due to hyperplasia and Gushing*s syndrome due to tumours, recognised
the presence of another two groups. In one of these two groups, (65 patients)
the patients had features "mimicking those of hypoadrenocorticism but with
normal basal steroid excretion levelsthese were not considered by Liddle
to have Cushing's syndrome because they responded markedly to dexamethasone.
In this group central obesity was present in 12, ecchymosis in 3, striae in
7, hypertension in 30, osteoporosis in 9* oedema in 10, emotional instability
in 24., oligomenorrhoea in 21, muscle vreakness in 6 and hirsutism in 44« The
other group included patients with equivocal evidence of Cushing's syndrome.
The clinical evidence alone was not strongly suggestive of the syndrome.
Control steroid excretions were above normal but this group was again excluded
because marked suppression by dexamethasone occurred. Again, in this group
of 14 patients, central obesity was present in 3> glucose tolerance impaired
in 4, hypertension in 5, osteoporosis in 1, striae in 3» emotional instability
in 3, oligomenorrhoea in 2, and hirsutism in 2. Liddle (I960), however,
noticed that steroid excretions later on fell to normal in 4 of these cases,
and that in none had there been any progression towards unequivocal Cushing's
syndrome.
Simkin and Arce (1962) reported their findings of increased 17-KGS
excretion in an "obese group", but stated that striae were present in all of
them/
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them, acne in 28$, seborrhoea in 21$, plethora in 21$, hirsutism in 34$#
oligomenorrhoea in 41%, trunk obesity with dreeal hump in 21$, systolic
hypertension in 31%# diastolic hypertension in 21% and hyperglycaemia in
12%.
Baird (1963)# similarly, reported increased urinary 17-KGS and 17-KS
excretion in an "obese group" of 20 females. Trunk obesity was present
in 4# hypertension in 10, impaired carbohydrate tolerance in.2, and
oligomenorrhoea or amenorrhoea in 5. Baird stated that Cushing's syndrome
was suspected in 11 of these 20 patients. 5 of these 11 obese subjects
who had also a clinical abnormality suggestive of an endocrine basis for
their obesity, had a raised corticosteroid output. In this group of 5
patients, including the patients with pink striae, the diagnosis of Gushing's
syndrome was "strongly doubted" but the results of steroid excretion were
nevertheless reported for all these patients, as one group.
Recently, Schteingart et al (1963)# comparing 32 "obese subjects" and
23 patients with Cushing's syndrome, reported significantly increased urinary
17-hydroxycorticosteroid excretion and significantly increased GPR in the
obese subjects as compared with normal individuals. These workers stated
that 3 of their patients, initially considered to have obesity without
Cushing's syndrome, later demonstrated deterioration of their clinical
condition and a diagnosis of Gushing's syndrome was eventually established in
all of these three.
These are a few of the many examples that could be cited from the
literature where no effort has been made to classify the subjects strictly
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FIGURE 35 : COMPARISON OF RESULTS IN THE FOUR GROUPS STUDIED
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By classifying the subjects of this study into four groups it was
possible to achieve the following results (see tables 27-30 and figure 35)t
1. Adrenocortical hyperactivity under basal conditions was proved in all
cases of Cushing's syndrome, especially so by the CPR estimations#
Adrenocortical hypersensitiveness to ACTH administration was similarly
proved. The response to dexamethasone was marked in all cases except one#
The cases of Cushing's syndrome studied in this research can be separated
into 2 groups.
The first group is represented by one patient (J.A., case 10)# In this
patient florid clinical manifestations of Cushing's syndrome, together with
a markedly increased basal activity of the adrenal cortex (as measured by CPR,
urinary steroid excretion, plasma Cortisol and plasma NPB Cortisol) were
noticed. After ACTH, although the level of his CPR was far above the normal
group, it represented only about two-fold increase from his control
estimations. Similarly, a slight response to dexamethasone suppression was
noticed. This patient represented the "classical" picture often described
in text books to illustrate the clinical condition and the state of the
adrenal cortex in cases of Cushing's syndrome.
The other group, comprising the rest of the patients with Cushing's
syndrome, had slightly or moderately increased basal adrenocortical activity,
but marked sensitivity to both ACTH stimulation and dexamethasone suppression.
Their levels of CER after ACTH stimulation were the highest observed and were
at least 10 times the control values, and the levels after dexamethasone
suppression were very low, being at most one tenth of the control values.
The results of the examination of the adrenal glands removed after
operation/
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operation and the response of the patients to surgery illustrates the fact
that the text-book examples of cases of Gushing1s syndrome are not as
frequent as they are thought to be.
In the group of patients with Gushing's syndrome as a whole, it was
possible, by studying the pattern of excretion of urinary steroids, to
demonstrate marked day-to-day fluctuation of adrenocortical activity in
comparison to normal subjects (see tables 17 and 18 and figures 22 and 23).
2. Cases of simple obesity showed CFR within the normal range in the
control estimations, but a lower-than-normal range was obtained after ACTH
stimulation. The response of obese subjects to ACTH stimulation, as
measured by urinary steroid excretion, was significantly less than in
normal individuals. The hyposensitivity of obese subjects to ACTH, in
contrast to the hypersensitivity of patients with Gushing's syndrome, adds
to the importance of the ACTH test in the differential diagnosis of these
two conditions.
The suggestion that adrenocortical function is not hyperactive in
obesity was recently supported by Gogate and rrunty (1963), who studied
obese patients by various tests of adrenocortical function (17-KS, 17-KGS,
unmetabolised Cortisol excretion, plasma Cortisol level, Cortisol secretion
rate, ACTH stimulation and dexamethasone suppression) and found that in no
subject were two indices of steroid metabolism simultaneously abnormal.
In contrast to cases of Cushing's syndrome, day-to-day fluctuations of
adrenocortical activity in the obese group were found to be slight, i.e.
much the same as in normal subjects (see tables 17 and 18 and figures 22 and 23).
3. In the 'Gushingoid' group, the results of these investigations allowed
separation/
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separation into three categories*
(a) This category is represented by patient A.D. (case 18), who
showed slightly Increased basal adrenocortical activity, as measured by
CFR, but marked response to ACTH stimulation, to well within the range for
Cushing's syndrome. Cb. repetition of these tests 5 months later, when the
clinical condition deteriorated (see table 16), the control estimations
did not change significantly but the hyper-response to ACTH was more marked.
Therefore, it was justifiable to re-classify this patient as having Cushing's
syndrome, and to deduce that the ACTH test was more sensitive in revealing
Cushing's syndrome than the clinical condition and that the CPR test by the
blood method is superior to any other test in achieving this result.
(b) The second category includes 5 patients (T.M., case 21 j C.A.,
case 22j D.S., case 23} M.K., case 2U and D.I., case 25). In these patients,
values for all tests applied comparable to normal values were obtained,
especially after ACTH stimulation. Accordingly, again, it was considered
justifiable to re-classify them into the simple obese group. These patients,
like the other obese individuals, were put on a reducing diet.
(c) The true 'Cushingoid' group, or group of patients in whom a
diagnosis of Cushing's syndrome or of simple obesity could not be made with any
certainty was, therefore, reduced to only two patients (W.C., case 19, and
D.M., case 20). These represent the third category of the "doubtful" cases.
In the former patient, normal control estimations were associated with a
hyper-response to ACTH by the CFR (blood method). The caloric intake of
this patient, however, was in the region of 12,000 calories per day. In the
latter patient moderately elevated control CPR was associated with a normal
response/
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response to ACTH, The values for his plasma Cortisol and NPB Cortisol,
under basal conditions, were elevated, but only the plasma Cortisol level
wxs increased above normal after ACTH stimulation.
Classifying subjects into these four groups, therefore, made it possible
to separate Cushing's syndrome from obese subjects, and to reduce the
number of the 'Cushingoid1 group from eight to two.
The interpretation of the findings in the two patients who remained in
the 'Cushingoid' group is a matter for speculation. Perhaps some obese but
otherwise normal individuals have abnormally high adrenocortical activity, and
perhaps others are undti responsive to stress and to 1CTH stimulation. On
the other hand, while the fully developed clinical appearance of simple
obesity and of Cushing's syndrome are well known, nothing is known of the
adrenal activity during the months or years leading up to the complete
syndrome, and it is possible that an increased adrenocortical basal activity,
or hypersensitive response to ACTH, is an early manifestation of Cushing's
syndrome. These two patients were put on a weight-reducing diet and it is
planned to repeat the tests, if considerable weight-reduction, or alternatively
more progress of the clinical conditions towards Cushing's syndrome occurred.
It is, therefore, anticipated that, in these two cases, typical findings of
one or the other clinical conditions may develop in due time.
As a result of this classification, therefore, it is concluded that precise
tests of adrenocortical function, such as CPU estimations especially after
ACTH, are quite reliable in the differential diagnosis of obesity and
Cushing's syndrome} normal results should exclude the latter and higher than
normal results in an obese subject should lead to suspicion of the presence
of Cushing's syndrome and warrant a careful follow-up for the development of
further/
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further clinical features of that syndrome.
As already mentioned, other workers have found the clinical features
alone very misleading, since many of the signs or symptoms are common to
obesity and Gushing*s syndrome. Similarly, in the present study, inspite
of the association of a greater number of signs and symptoms with Cushing's
syndrome than with obesity, no specific clinical manifestation was
consistently present in one particular group (see Appendix l). For example,
trunk obesity, although present in all 8 cases of Cushing's syndrome, was
encountered in U of the 8 obese subjects. Plethora was present in 3 patients
with Cushing's syndrome and 2 obese patients. Striae were found in all
cases with Cushing's syndrome (purple, pink or red in 6 and white or pale
in 2), but were also found in 6 of the obese group (purple, pink or red in
5 and white in l)» Oedema was present in a patient with Cushing's syndrome
and in an obese subject, hypertension in L, cases of Cushing's syndrome and
one obese patient, acne or skin infection in 3 patients with Cushing's syndrome
and one obese subject and osteoporosis in one patient with Cushing's syndrome
and one obese subject. Menstrual disturbances were reported by 1 of the
5 females with Cushing's syndrome (araenorrhoea and menorrhagia) and by
3 obese females (amenorrhoea and irregular periods). Psychological
disturbances were also met with in 4- cases of Cushing's syndrome (depression
and instability) and in an obese subject (depression and irritability).
Diabetes mellitus, however, was not discovered in any of the obese group and
was found in only one patient with Cushing's syndrome (elevated fasting blood
sugar, delayed glucose tolerance and glycosuria). Similarly, easy
bruisability/
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taruisability wag not found in any of the obese subjects but was found in
one case of Cushing's syndrome, and muscle weakness was observed in only
two other cases. Varying degrees of hirsutism were met with in U of the
5 females with Cushing's syndrome (in 3 of whom male pubic distribution of
hair was observed), and this was not seen in any of the obese subjects,
but hirsutism was observed in 3 of the 'Cushingoid' group who were subsequently
re-classified into the obese group (in one of them a male pubic distribution
of hair was observed).
The haematological findings and electrolyte levels in blood were within
normal limits in all the subjects studied.
Therefore, it can be concluded that the present findings support previous
reports on the unreliability of the clinical features and the non-steroid
laboratory investigations in the differential diagnosis of Cushing's syndrome
from obesity, and that precise tests of adrenocortical function are not only
reliable but also very essential for the pre-operatlve differentiation of
these two clinical conditions.
Table(27)'
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Table (28)
SfrftigtfrQfll, of the difference? between the meaqg ?£ tfre fogfa
among the four croups studied
Normal Normal Normal Gushing's Cushinc's Oushingoid
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Statistical analyses of the differences frg&gga the IflflBft of the vsr.lo.ns tests




















































































































































































Comparison of the results of the various teats in individual oases of the four groups studied
Case

















| CPR 17-KS Total
17-KES












— — + ± — — —
— — — ± — — — — — ± ± — — —
- ± + - — - — — ± + — — — I
- - ± + — - — — - ± — — —
- - — - - - — - - ± + - - -












b. Not operated upon
17. C.M.
+ + + + + + + ♦ + ± + + ± +
+ + + + + + + ± + + +




















+ + - + + - - + ± - -
- + - ± — + ± + + + + + + + - - —
- - + ± + - + ± - - +
+ + + + + ± + - - + ± + - - - -
- ± ± + [ - - ± ± ±
-
- + ±
- - + ± - - - - — — ± - - - 1 -
- + + ± - - - - - ± ± - - - i 1i
- - - ± - ± - - ± —
4. Obese group
2b. A.M. " I
- - ± I
27. R.A. _ ] - ± - - - ± - - ± -
28. T.A. - - ± ± - +
■
- ± ± - - - - ± -
29. G.S. — ± + ± - - ± - - -




- + + - - - - - - - - - ± ± -
I32. G.R. — - ± — — - ± ± -
a53« M. A. - 1 ± ± — - + - ± -
jaaaaaflBt-ilfflUaa-Jja--yie_noi'mal range, + represent figures in the Gushing'3 range, ± represent figures in overlapping ranges. After defamethasone suppression
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Suggestion? fqr future yopfc
The author suggests the following points to be investigated in future
work:
1. Investigations into the discrepancy between the blood and the urine
method of CHI after ACTH stimulation. This should comprise firstly,
estimations of the excretion of 6 £-hydroxycortisol and other polar steroids
and secondly, the volume of distribution and whether estimations of CPR
from a double compartment model, instead of from a single compartment model,
would explain this discrepancy.
2. Investigations into the value of estimations of unmetabolised Cortisol
excretion as a possible important means of diagnosing Cushing's syndrome,
3. Establishment of ranges for the in vivo method of simultaneous estimation
of CPR, plasma Cortisol and plasma-protein binding of Cortisol in a larger
number of subjects from the four groups (normal, Cushing's syndrome, 'Cushingoid'
and obese). The author recommends the routine determination of plasma
proteins in the sample used for estimation of NPB cortisolj allowance for
the volume of plasma proteins will, therefore, be made, and accordingly the
results of estimations of NFB Cortisol will be more accurate,
4. Investigation into the question of whether or not a circadian rhythm in
plasma Cortisol and the NPB fraction normally exists, and whether or not it
is always lost in cases of Cushing's syndrome. This may prove to be of
great help in the early diagnosis of Cushing's syndrome.
5. Estimation of CPR and steroid excretion after dexamethasone suppression
in a large number of normal subjects, and in cases of Cushing's syndrome, for
the/
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the assessment of the value of this test in diagnosis.
6. The electron microscopic study of each adrenal gland removed from
cases of Cushing 's syndrome, together with ordinary histological examination,
with the aim of detecting any abnormality that may not always be detected in
glands from patients with Cushing's syndrome by the latter methods.
7. Study of the effect of weight reduction on adrenocortical function in
obese subjects. Similarly, in cases of Cushing's syndrome, if the clinical
condition is not so rapidly progressive as to warrant an immediate surgical
interference, it would be worthwhile to determine the effect of weight reduction
over a few weeks or a few months (according to the progress of the condition)
on adrenocortical function, and to compare this with the response of obese




(see Appendix XI for abbreviations)
The following are the normal ranges for the methods used:-
serum or plasma
Sodium 135 - 150 m.eq/l.
Potassium 3*5-5*5 "
Bicarbonate 22,0 - 28.0 "
Blood urea 14.0 - 4-0.0 mg.A00 ®1.
Calcium 9.0-11.0 "
Phosphate 2.5 - A.O "
Fasting blood sugar 60 - 95 "
Bilirubin 0.1 - 0,8 "
Glutamic-pyruvic transaminase 5-35 units/ml.
Alkaline phosphatase 3-12 King-Armstrong unitsA00 ml.
Thymol Turbidity 1-5 units. "
Creatinine clearance 90 - 150 ml/min.
I fTfwp
Pag? B,A. Sex: M Age: 29 yrs.
Normal volunteer
Wti 63 Kg. Ht: 175 cm.
Case No.2 H.B. Sex: M Age: 65 yrs.
Diagnosis: Chronic bronchitis
Wti 63.A Kg. Ht: 177.8 cm. B.P. 135
90
Investigations:
Xray chest: mild congestion of lungs
Blood picture: Hb. 111*%, PCV 50%, MCHC 32%, WCC 6500, Diff. N 69%,
L 26%, M 2%, E 3%.
Electrolytes in blood: Na 136 meqA» K 4. meq/l, B.U, 27 mg.A00
GPT less than 20 units/ml, alk.Phos. 10 K-A unitsA°0 ml, T.T, 2 units.
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Case No.3 W.J. Sex: M Age: 35 yrs.
Diagnosis! Barbiturate overdose, acute renal failure, fully recovered.




X-ray chest: NAD X-ray skeleton: MAD
Blood picture: Hb. 98%, PCV UB%, MCHC 37%, platelets 350,000,
WCC 9000, Diff. N 83%, L 17'/.
Electrolytes in blood: Na 140 meq/l, K 4.3 meq/1, HCO^ 20.6 meq/l,
B.U. 39 mg./lOO ml.
Ga 10.4 mg./lOC ml, PO^ 4*9 mg./lOO ml.
Bilic 0,8 mg./lOO ml. GPT less than 20 units/ml.
Alk.Phos, 11 K-A units/100 ml, T.T. 1 unit.
Cr.cl. 142ml/min.
Urine examination: MAD
Case Mo.4 W.H. Sex: M Age: 55 yrs.
Diagnosis: ? Pericarditis ? myocardial infarction, completely recovered.
Wt: 83.4 Kg. Ht: 171.4 cm. B.P, llg
Investigations:
SCG: ? pericarditis ? myocardial Infarction.
X-ray chest: heart enlarged.
Blood picture: Hb. 101%, WCC 10800, Diff. N 80%, L 11%, M 9%.
Electrolytes in blood: Na 140 meq/l, K 5.0 meq/l, HGO^ 23 meq/l
Bill. 0.8 mg./lOO ml, GFI 26 units/ml. Alk.Phos. 9 K-A units/100 ml.
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Case No>5 M.L. Sex: F Age: 42 yrs.
Diagnosis: Functional polyuria and stress incontinence.
tfti 44 Kg. Ht: 156.2 cm. B.P. 120
80
Investigations:
Blood picture: Hb, 96%, FCV 12%, MCHC 3/,%, platelets 105,100,
WCC 6600, Diff. N 69%, L 27%, M 3%, 2 1%.
Electrolytes in blood: Na 139 meq/l, K 4..8 meq/l,
HCO^ 26.1 raeq/l, B.U, 27 mg./LOO ml.
Ca 10.0 mg,/l00 ml.
Alk.Phos. 4 K-A units/100 ml.
Urine examination: NAD
Cr.Cl. 157 ml/min.
Case No.6 M.H, Sex: F Age: 35 yrs.
Diagnosis: Dysuria
Wtt 52 Kg. Ht: 165.1 cm. B.P. JJJ2
80
Investigations:
X-ray chest: NAD X-ray skeleton: NAD
Blood picture: Hb. 81%, PCV 38%, MCHC 29%, tfCC 8700, Diff. N 75%,
L 19%, M 5%, E 1%.
Electrolytes in blood: Na 140 meq/l, K 4.6 meq/l, B.U. 26 mg./lOO ml.
Ca 10.6 mg./lOO ml, PO^ 3.1 mg./lOO ml.
Bili, 0.4 mg./LOO ral, GPT less than 20 units/ml, Alk.Phos. 7 K-A units/lOGml,
Cr.cl. 67 ral/min.
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Case No.7 M.K. Sex: F Age: 23 yrs.
Diagnosis: Acute renal failure, fully recovered.
tfti 56.7 Kg. Ht» 157.% cm.
Investigational
Blood picture i Hb. 68%, PGV 32%, MCHC 31%, WCC 9700, Diff. N 7%%,
L 20%, K U%9 E B
Electrolytes in bloodi Ha 1%1 meq/l, K %,0 meq/l,
HCO^ 21.0 meq/1, B.U, 20 mg./lOO ml,
Cr.cl. 150 ml/min.
Case Mo.8 T.T, Sex: M Agei 72 yrs.
Diagnosis; dermatitis herpitiformis -
Investigations:
B.P. 160 i-ray chest: NAD
100
Blood picture; Hb. 73%, PCV 37%, MCHG 29%, WCC 9000, Diff. N 75%,
L 22%, M 1%, E 2%.
Fasting blood sugar 82 mg./lOO ml.




(see also table 24 for results of examination of adrenal glands removed at
operation).
Case No. 10 J.A. Sex: M Age: 55 yrs.
a. Symptoms: increased girth of lower limbs and abdomen, swelling of ankles,
intermittent claudication and plethoric appearance. Duration 6 months,
b. Examination: 'aft: 89 Kg, Ht: 157.4 cm. B.P, 205
120
Skin: scaly and red. Boils: recurrently occurring.
Obesity: marked, mainly at lower abdominal girth.
Striae: numerous on lower abdomen. Purple. Oedema: at lower limbs.
Face: plethoric. Hiscle weakness: marked. Easy bruisability.
c. Investigations:
EGG: NAD.
X-ray chest: considerable cardiac enlargement.
X-ray skeleton: lumbar scoliosis with wedge deformity of L 1-4.
Blood picture: Hb. 952, PCV 43%, MCHC 32,5%, WCC 10200, Diff. N 75%,
L 152, M 5%.
Electrolytes in blood: Na 141 raeq/l, K 4,3 meq/l, HCO^ 25.8 meq/l,
B0 51 mg./lOO ml.
Ca 12.0 mg./lOO ml, P0^ 2.8 mg./lGO ml.
Bili. 0.5 mg./lOO ml. GFT less than 20 units/ml.
Alk.Phos. 5 K-A units/100 ml, T.T. 1 unit.
G.T.T. : F 73 rag./l00 ml, £hr 95 mg./lOO ml, 1 hr 133 mg./lOO ml,
1|- hrs, 85 mg./lOO ml, 2 hrs. 73 mg./lOO ml.
Gr.cl 92 ml/min,
d. Treatment and follow up: Bilateral adrenalectomy and replacement therapy.
Marked improvement of clinical picture after operation.
- 3%-
Case No. 11 J.T. Sex: F Age: 17 yrs.
a. Symptoms: increase in weight of 32 Kg., striae and Menorrhagia in the
past 6 months.
b. Examination: Wt: 87 Kg. Ht: 160 cm. B.P. 150
110
Skin: NAD. Acne: nil. Bruising: nil. Hirsutism: nil.
Obesity: marked, mainly trunk obesity,
<*.yi£&u.
Striae: marked. Cta assiUe, breasts, flanks and abdomen. Heddish.
Face: round and full. Oedema: nil. Genitals: normal.
c. Investigations:
EGG NAD
X-ray chest: NAD. X-ray skeleton: HAD,
Blood picture: Hb. 94%, PCV 43%, MCHC 30%, WCC 6700, Diff. N 80%,
L 15%, M 4%, L 1%, platelets 270,000.
Electrolytes in blood: Na 133 meq/l, K 4.5 meq/l, HGO^ 24 meq/l,
BU 10 mg./lOO ml.
Ca 9«4 mg./lOO ml, PO 3.0 mg./lOO ml.
4
Bili. 0.2 mg./lOO ml, GPT 21 units/ral. Alk.Phos. 5 K-A units/100 ml,
T.T, 2 units,
G.T.T.: F 72 mg./lGO ml, ighr 148 mg./lOO ml, 1 hr 1A4 mg./lOO ml,
li hrs 120 mg./lOOml, 2 hrs 118 mg./lOO ml, 2^ hrs 82 mg./lOO ml,
3 hrs 60 mg./lOO ml.
Cr.cl 162 ml/rain.
d» Treatment and follow up: Bilateral adrenalectomy and auto-transplantation.
Marked improvement of the clinical condition post-operatively.
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Case No,12 M.C. SexJ F Age: 36 yrs.
a. Symptoms* hirsutism, gain in weight of 30 Kg. Duration 10 years.
Amenorrhoea and depression for 6 months.
b, Examination: Wt: 108 Kg. Ht: 166,3 cm. B.P, 190
118
Skin: NAD. Acne: slight. Bruising: nil. Hirsutism: marked. On
cheeks, chin, chest with a pubic masculine distribution.
Obesity: marked. Mainly trunk obesity. Cervieo-dorsal hump.
Striae: present. White. On abdomen and thighs. Duration 10 years.
Face: Plethoric, moon face. No muscle weakness.
Genitals: normal. No oedema,
c• Investigations:
BOG: NAD
X-ray chest: NAD X-ray skeleton: NAD
Blood picture: Hb. 94%, PCV 39%, MCHC 35.5%, WCG 11000, Biff, N 63$,
L 35%, M 2%>, platelets 380,000.
Electrolytes in blood: Na 14-0 raeq/l, K 4.8 meq/l, HGO^ 18.8 meq/1
BU 10 mg./lOQ ml.
Ca 10.8 mg. /100 ml, PO^ 2.9 mg./lOO ml.
Bili. 0.7 mg./lOO ml. GPT 31 units/ml.
Alk.Fhos. 3 K-A units/100 ml, T.T, 3 units,
G.T.T.: F 72 mg./lOO ml, £ hr 90 mg./lGO ml, 1 hr 100 mg./lOO ml,
l£ hrs 68 mg./lOO ml, 2 hrs 48 mg./lOO ml, 2% hrs 60 mg.AOO ml,
3 hrs 60 mg./lOO ml.
Cr.cl 169 ml/min«
d. Treatment and follow up: Bilateral adrenalectomy and auto-transplantation,
iiarked improvement of clinical condition post-operatively.
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Case Ho. 13 J.M. Sexi M Aget 31 yrs.
a. Symptoms* progressive increase in weight since 5 years. Weakness and
Depression since 6 months.
b. Examination* Wt* 116.8 Kg. B.P. 130
90
Skin* NAD Acne* on chest and back. No bruising.
Thinning of the frontal scalp hair.
Obesity* marked. Mainly trunk. Supraclavicular pads of fat.
Striae* present on the abdomen. Purple.
Face* round and flushed.
No muscle weakness or oedema.
c. Investigations*
X-ray chest* NAD X-ray skeleton* NAD
Blood picture* Hb, 10$, PCV Uo%t MCHC 31.5#, WCC 880C.
Electrolytes in blood* Ma 154- meq/l# K 5.3 meq/l,
HCO 24.6 meq/l, BU 15 mg./lOO ml.
i 1
G.T.T. * F 80 mg./lOO ml, £ hr 136 mg./lOO ml, 1 hr 100 mg./lOO ml,
l£ hrs 68 mg./lOO ml, 2 hrs 72 mg./lOO ml, hrs 68 mg./lOO ml.
d. Treatment and follow up* bilateral adrenalectomy and replacement therapy.
Marked improvement of clinical condition post-operatively.
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Case No. 1A G.F, Sex: M Age: 27 yrs.
a. Symptoms: progressive increase in weight. Depression.
b. Examination: Wtt 78.8 Kg. Ht. 166.3 cm. B.P. UP
105
Skin: NAD No acne or bruising.
Obesity: marked. Mainly trunk obesity.
Striae: present on the abdomen. Purple.
Face: moon face. Plethoric.
No muscle weakness or oedema.
Psychological disturbances.
c. Investigations:
X-ray chest: NAD X-ray skeleton: NAD
Blood picture: Hb. 111%, PCV 51%, MCHC 32%, WCC 11200, Diff. N 68%,
L 28%, M 1%, B 1%, E 2%.
Electrolytes in blood: Na 14.1 meq/l, K 4.8 meq/1,
HGO- 23.3 meq/1, BU 12 rag./lOO ml.
j
GPT less than 20 units/ml.
Alk.Phos. 7 K-A units/100 ml, T.T. 1 unit,
G.T.T.: F I46 mg./lOO ml, hr 204 mg./lOO ml, 1 hr 264 mg./lOO ml,
l-£- hrs 246 mg./lOO ml, 2 hrs 200 mg./lOO ml, 2% hrs 182 rag./lOO ml,
3 hrs 160 mg./lOO ml.
Urine examination: glycosuria.
Cr.dl 115 ml/min.
d. Treatment and follow up: bilateral adrenalectomy and auto-transplantation.
Marked improvement of clinical condition post-operatively - glycosuria
persisted.
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Case No. 15 H.T, Sexi F Age: 21 yrs.
a. Symptoms : progressive increase in weight, hirsutism, amenorrhoea and
depression. Duration 18 months.
b. Examination: Wti 85.1 Kg. Htj 158.7 cm. B.P. 125
70
Skin: NAD Mo acne or bruising.
Hirsutism: marked. Abdominal musculine distribution.
Obesity: marked. Trunk obesity.
Striae: present on the abdomen. Purple.
Face: full. Normal genitalia.
Mo muscle weakness or oedema.
Psychological instability.
c. Investigations:
X-ray chest: MAD X-ray skeleton: HAD
Blood picture: Hb. 98%, PCV 45%, MCHC 32.5%, WOC 11900,
Diff. 53%, L 34%, M 5%, B 3%.
Electrolytes in blood: Ha 132 meq/l, K 4.1 meq/L,
HC03 24.6 meq/l, BU U mg./lOO ml.
Ca 9.9 mg./lOO ml, PC 4.6 mg./lOO ml.
4
d. Treatment and follow up: bilateral adrenalectomy. Marked improvement after
operation of her clinical condition.
- 309 -
Case No. 16 E.S. Sexs F Ages 22 yrs.
a. Symptoms8 increased body weight, growth of facial and abdominal hair;
duration 4 years. Amenorrhoea; duration 2 years.
b. Examinations Wts 54-.2 Kg. Hts 157.4 cm. B.P. 1Z.Q
90
Skint very fine. No acne or bruising.
Hirsutism! on chin, abdomen, arms, buttock and sacrum. Hale pubic
distribution of hair.
Obesity: moderate. Mainly trunk.
Striaes present on upper arms and abdomen. Pale.




Blood picture: Hb. <?(>%, PC? J,6%, MCHC 30%, WCC 8700,
Diff. N 61%, L 33%, M 6%.
Electrolytes in bloods Na 142 meq/1, K 3.8 meq/l,
HC03 27.7 meq/1, BU 10 mg.AOO ml.
G.T.T. t F 88 mg./lOO ml, hr 14-0 mg./lOO ml, 1 hr 94 mg.A00 ®1»
l£ hrs 80 mg./lOO ml, 2 hrs, 82 mg./lOO ml, 3 hrs 80 mg.A00 ol*
d. Treatment and follow upt bilateral adrenalectomy and replacement therapy.
Harked improvement after operation of the clinical condition.
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Case No. 17 C.M. Sex: F Age: 18 yrs.
a. Symptoms: progressive increase of weight since age of 8. Hirsutism
started with onset of menstruation.
b. Examination: Wt: 83.3 Kg# B.P. 1A0
90
Skin: NAD No acne or bruising.
Hirsutism: marked. Upper lip, chin, chest, back, arms and legs.
Cfcesity: moderate. Mainly trunk.
Striae: present on upper arms and flanks. Fink.
No muscle weakness or oedema. Normal genitalia.
c. Investigations:
ECG; NAD
X-ray chest: NAD X-ray skeleton: NAD
Blood picture: Hb. 90$, FCV 4.0%, platelets 320,000, WCC 5800.
Electrolytes in blood: Na 14& meq/l, K 4,1 meq/l,
HC0 23 meq/1, BU 16 mg./lOO ml.
5
G.T.T.: F 88 mg./lOO ml, hr. 114 mg./lOO ml, 1 hr 122 mg./lOQ ml*
1^ hrs 108 mg./lOO ml, 2 hrs 83 mg./lOO ml, 2£ hrs 92 mg./lOG ml,
3 hrs 92 mg./lOO ml, 3|- hrs 86 mg./lOO ml.
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III 'Cushingoid1 group
Gase No. 18 A.D. Sex: ? Age: 19 yrs.
a* Symptoms: increase in weight, tiredness, low back pain, striae on thighs.
Duration 6 months.
b. Examination: -ft: 79.8 Kg. Ht: 157.4. cm. B.P. 130
80
Skin: NAD No acne or bruising. No hirsutism.
Obesity: moderate. General but mainly trunk obesity.
Striae: present on thighs and abdomen. Purple.






X-ray chest: NAD X-ray skeleton: NAD
Blood picture: Hb. 93%, PCV a%, MCHC 33%, WCC 4200, Diff. N 65$,
L 3Q£, M 3%, S 2%, platelets 150,000.
Electrolytes in blood: Na 138 meq/l, K 3.7 meq/l,
H003 25.3 meq/l, BU 32 mg./lOO ml.
Ca 11.2 mg./lOO ml, PO. 4.7 rag./lOO ml,
4
Bill, 0.3 mg./lQO ml, GFT less than 20 units/ml.
Alk.Phos. 4 K-A units/100 ml, T.T, 1 unit
G.T.T.: F 92 mg./lOO ml, £ hr 118 mg./lOO ml, 1 hr 104 mg./lOO ml,
1|- hrs 106 mg./lOO ml, 2 hrs 82 mg./lOO ml.
Cr.cl, 123 ml/min.
Follow-up: patient was kept tinder observation. The clinical condition
deteriorated after 5 months and the patient became more psychologically
unbalanced.
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Case Hp. 19 W.C. Sex: M Age: 27
a. Symptoms: progressive increase in weight since 6 years# Dyspnoea.
Excessive sweating.
b. Examination: tfts 133.6 Kg. Ht: 1*0.3 cm. B.P. 180
118
Skins HAD Ho acno or bruising.
Obesity: marked. Mainly trunk.
Striae: present over axillae, chest, abdomen and thighs. Purple.
Duration 1 year.
Pace: moon face,plethoric. No muscle weakness or oedema.
c. Investigations:
ECG HAD
X-ray skeleton: Lumbar osteoporosis.
Blood picture: Hb. 80%, PC? 59%, MCHC 31%, WCC 11700, Diff. N 75%,
L 19%, M 6%, platelets 215,000.
Electrolytes in blood: Na 138 meq/l, K 3.8 meq/l,
HC03 30.0 raeq/l, BU 40 mg./lOC ml,
Ca 9.8 mg,/100 ml.
Bill, 0.5 mg./lOO ml, GPT less than 20 units/ml,
Alk.Fhos. 10 K-A units/100 ml. T.T. 2 units.
G.T.T.: F 62 mg./lOO ml, -|-hr 116 mg./lOO ml, 1 hr 112 mg./lOO ml,
1^- hr 66 rag./lOO ml, 2 hr 40 mg./lOO ml.
Cr.cl 138 ml/rain.
d. Follow-up: had it not been for the fact that the caloric intake was 12,000
calories/day, a diagnosis of Cushing's syndrome would have been justified.
The patient was given a dietary regimen to reduce his weight and was kept
under observation.
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Case No. 20 D.M. Sex* M Age* 21 yrs.
a. Symptoms: increase in weight. Dyspnoea, Oedema around the ankles.
Duration 6 years.
b# Examination* Wt* 121.8 Kg. Ht: 175.2 cm. B.P. 150
80
Skin* NAD No acne or bruising.
Obesity: marked. Mostly on face, neck, abdomen and buttocks.
Striae* Present on the abdomen, chest and buttocks. Pink.
Face: full. No muscle weakness.
Slight oedema of nkles.
c• Investigations *
EGG NAD
X-ray chest* NAD X-ray skeleton: narrowing of 1^-5 space
Blood picture* Hb. 100$, PCV 47$, MCHC 35%, ^CC 8600, Oiff. N
L 30$, M 11$, E 5$, platelets 250,000.
Electrolytes in blood* Na 143 meq/l, K 4.2 meq/l,
HC03 22.7 meq/l, BU 33 mg./lOO ml.
Ca 10 mg./lOO ml, PO. 3.5 mg./lOO ml.
4
Bili, 0.8 mg./lOO ml, GPT less than 20 units/ml.
Alk.Phos. 13 K-A units/100 ml, T.T, 2 units.
G.T.T.: F 92 mg.AOO ml, £ hr 133 mg./lOO ml, 1 hr 150 mg./lOO ml
l£ hrs 133 mg./lOQ ml, 2 hrs 92 mg./lOO ml.
Cr.cl 157 ml/rain.
d. Follow-up* patient was put on a reducing diet and kept under observation.
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Case No, 21 T.M. 3ext M Age I 18 yrs.
a. Symptomsi sudden increase in weight with development of striae on the
buttocks. Duration one month.
b. Examinationi Wti 86.3 Kg, Hti 177.8 cm, B.P. 160
90
Skini NAD No acne, bruising or oedema.
Obesity: moderate. Mainly on the buttocks.
Striae: present on the buttocks. Red,
Face: full. No muscle weakness.
c. Investigations:
ECG NAD
X-ray chest: NAD X-ray skeleton: NAD
Blood picture: Hb. 102$, FCV 47$, MCHC 32$, WCC 5850.
Electrolytes in blood: Na 137 meq/l, K 4.4 rneq/l,
HC0_ 25 aeq/1, BU 2.9 mg./lOO ml. Ga 9.8 mg./lOQnl. PO. 2.9 mg./lOQnl.
3 4
Bili# 0.6 mg./lOO ml, GET 3 units,
Alk.Phos. 1$. K-A units/100 ml, T.T. 2 units.
G.T.T.: F 103 mg./lOO ml, -fhr 136 mg./LOO ml, 1 hr 126 mg./100 ml,
1^- hrs 110 mg./lOO ml, 2 hrs 106 mg./lOO ml.
d. Follow-up: patient was put on a reducing diet. Reduction in weight and
improvement of the clinical condition occurred.
Ga-se No. 22 C.A. Sex: F Ages 26 yrs.
a. Symptoms: hirsutism, increase in weight and irregularity of periods.
Duration A years.
b. Examination: Wt: 61.1 Kg. Ht» 15A.9 cm. B.P. 135
75
Skin: NAD No bruising, oedema or acne.
Hirsutism: marked on face. Slightly on legs and abdomen.
Obesity: patient is plump rather than obese, especially at the abdomen.
Striae: present on the abdomen. White.
Face: full. No muscle weakness and normal genitalia.
c. Investigations:
X-ray chest: NAD X-ray skeleton: NAD
Blood picture: Hb. 88$, FCV A2$, MCHC 30.5$, WCC 10000,
Diff. N 5A$, L 39$, M U%, E 2%, B 1$.
Electrolytes in blood: Na 1X2 meq/l, K X.5 meq/1,
HC03 27.7 meq/l, BU 15 mg./lOO ml.
G.T.T.: F 78 mg./lOO ml, £ hr 90 mg./lOO ml, 1 hr 108 mg./lOO ml,
1^- hrs 112 mg./lOO ml, 2 hrs 78 mg./lOO ml, hrs 60 mg./lOO ml.
d. Follow-up: patient was put on a reducing diet and kept under observation.
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Case Mb. 23 D.3. Sex: F Age: 34 yrs.
a. Symptoms: obesity started 4 years ago, hirsutism started 8 years ago,
lethargy began 11 years ago and irregular menstruation with periods of
amenorrhoea started 16 years ago. There was a family history of obesity.
b. Examination: Wt: 118.1 Kg, Ht: 170 cm. B.P. LAO
90
Skin: NAD No acne, bruising or oedema.
Hirsutism: moderate.
Obesity: marked. General but mainly trunk obesity.
Striae: present on breasts and abdomen. Purple.
Face: full.
No muscle weakness and genitalia are normal.
c. Investigations:
SCO NAD
X-ray chest: NAD X-ray skeleton: NAD
Blood picture: Hb. 89$, FCV 46$, MCHC 29$, WCC 6600, Biff. N 78$,
L 20$, M 1$, E 1$. Platelets 250,000.
Electrolytes in blood: % 136 raeq/l, K $.8 raeq/l, HCO^ 24.3 meq/l,
BN 30 mg./lOO ml,
Ga 8,9 mg./LOO ml, PO 3.4 mg./lOO ml,
4
Bill, 0.4. mg./lOO ml, GFT Less than 20 units/ml.
Alk.Fhos. 7 K-A units/100 ml. T.T. 2 units.
G.T.T.i F 84 mg./lOO ml, £ hr 128 mg./lOO ml, 1 hr 150 mg./lOO ml,
l£ hrs 118 mg./lOO ml, 2 hrs 80 mg./lOO ml.
Cr.cl, 105 ml./min.
d« Follow-up: patient was put on a reducing diet and kept under observation.
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Case No. 2L M.K, Sex: F Age: 15 yrs.
a. Symptoms: 3udden increase in weight, started three years ago, with
pigmentation of areas of pressure (waist, brassier) and nipples.
b. Examination: /ft: 76,9 Kg. Ht: 158.7 cm. B.P. 115
70
Skin: NAD Slight acne on face.
No bruising, oedema or hirsutism.
Obesity: moderate. Mainly trunk and upper thighs.
Striae: present on breasts, abdomen and axillae. Pinkish white.
Face: round. No muscle weakness and genitalia are normal,
c. Investigations:
Blood picture: Hb. 96%, FCV 36%.
Blood electrolytes: Na 145 meq/l, K 4.,7 raeq/I,
f£03 23.5 meq/L, BU 30 mg./lOO ml.
d. Follow-up: patient was put on a reducing diet and kept under observation.
- 318 -
Case No. 25 D.Y. Sex* F Age* 32 yrs.
a. Symptoms* increase in weight, hirsutism of the face and oedema around the
ankle. Duration 13 years.
b. examination* \fbt 75.7 Kg. lit* 148.5 em, B.P, 120
70
Skin* HAD No bruising or oedema but acne are present on face.
Hirsutism* present on chin, side of face, around nipples, on legs and
arras. Pubic male distribution.
Obesity* moderate. Mainly trunk obesity.
Striae* present on abdomen, thighs and arms. Purple.
Face* round.




Blood picture* Hb. 77%, WCC 8500.
Electrolytes in blood* Na 131 meq/l, K A,6 meq/l,
HC0_ 21 meq/l, BU 34 ng./lOO ml,
3
Ca 11.2 mg./lOO ml, PO^ 3.7 mg./lOO ml.
Bill. 0.5 mg./lQO ml, OPT less than 20 units/ml.
Alk.Fhos. 7 K-A units/100 ml.
G.T.T.* F 75 rag./lOO ml, ^hr 158 mg./lOO ml, 1 hr 220 mg./lOO ml,
ljr hrs 175 mg./lOO ml, 2 hrs 116 mg./lQO ml, 2& hrs 90 mg./lOO ml,
d. Follow-up* patient was put on a reducing diet and kept under observation.
- 319 -
IV Cbe3Q firgup
Case No. 26 A.M. Sexs M Age: 3X yrs.
a. Symptoms: obesity, breathlessness on slight or moderate exertion. Duration
since childhood.
b. Examination: Wt: 152.7 Kg. Ht: 179 cm. B.P. 170
120
Skin: NAD No bruising, acne, oedema or muscle weakness.
Obesity: marked. General.




X-ray chest: RAD X-ray skeleton: NAD
Blood picture: Hb. 95%, KJV X7%, MCHC 31.5%, WCC 7X00, Diff, N 53%,
L 38%, M 9%, platelets 310,000.
Electrolytes in blood: Na H4. meq/l, K 3.7 meq/l,
IC03 27.6 meq/l, BU 8 mg./lOO ml.
Ca 11.6 mg./lQO ml, FO^ X mg./lOO ml. Bili. 0.3 mg./lOO ail.
Alk.Phos. 6 E-«A units/100 ml. T.T, 1 unit. GET less than 20 units/ml.
G.T.T.: F 82 mg./l00 ml, i hr 102 mg./lOO ml, 1 hr 120 mg./lOO ml,
l£ hrs 80 mg./lOO ml, 2 hrs 72 mg./lOO ml, 2 't'hrs 72 mg./lOO ml,
3 hrs 70 mg./lOO ml.
Cr.cl 61 ral./min.
d. Follow-up: patient was put on a reducing diet and kept under observation.
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Case No. 27 R,A, Sex? M Age 12 yrs.
a* Symptoms: breathlessness on slight or moderate exertion. Of 1-2 years
duration,
b, Examination: Wt: 67,4- Kg, Rt. 14.9,8 cm, B,P. 140
Skin: NAD No bruising, oedema or muscle weakness.
Slight acne on face.
Obesity: moderate. Mainly trunk.




X-ray chest: NAD X-ray skeleton: slight loss of bone density (except in
skull).
Blood picture: Hb. B8%, PCV 405S, MCHC 33%, WCC 3800,
Diff. N 32%, L 58%, M 10&, platelets 320,000.
Electrolytes in blood: Ma 138 raeq/l, K 4,5 meq/l,
ISO. 23.8 meq/l., BU 32 mg./lOO ml,
3
Ga 11.2 mg./lOO ml, FO^ 4,8 mg./lOO ml.
Bili, 0.2 mg./lOO ml, GPT less than 20 units/ml.
Alk.Fhos. 19 K-A units/100 ml, T,T. 1 unit.
G.T.T.: F 80 mg./lOO ml, £ hr 84 mg,/lG0 ml, 1 hr 92 mg./lOO ml,
l£ hrs 89 mg./lOO ml, 2 hrs 88 mg./lOO ml,
Or.cl 108 ml/rain,
d. Follow-up: patient was put on a reducing diet and kept tinder observation.
*
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Case rib. 28 T.A. Sex* M Age* 17 yrg.
a. Symptoms* obesity. Dyspnoea on moderate exertion. Duration 8 years.
b, Examination* Wt* 14.3.6 Kg. Ht. 170 cm. B.P. 14.0
80
Skint NAD No acne, bruising or oedema.
Obesity* marked. Chest, neck, abdomen and buttocks.
Striae* Present on thighs and abdomen. Ftirple.




Blood picture* Hb. 95%, FCV 4.3%, HCHC 32%, WCC 8300, Diff. N 51%,
L 32%, M 11$, E 6%, platelet 250,000.
Electrolytes in blood* Na 136 meq/l, K 3,9 meq/1,
HC03 20 meq/1, BD 31 mg./lOO ml.
Ca 9.6 mg./lOO ml, PO. 3*2 mg./lOO ml.
4
Bill. 0.8 mg./lOO ml, GPT less than 20 units/ml.
Alk.Phos. 13 KWl units/100 ml, T.T. 1 unit.
G.T.T.t F 78 mg./lOO ml, &r 116 mg./lOO ml, 1 !ir 98 mg./lOO ml,
1^ hrs 70 mg./lOO ml, 2 hrs 64- mg./lOO ml,
Cr.cl. 234. ml/min.
d. Follow-up* patient was put on a reducing diet and kept under observation.
SftM.ffoii SI C.S* 2«xi P Ages u yra.
a# Bynptcew* increase la weight. ihtraiien 3 years. Faulty history of obesity.
b. Examination! Wti 96*3 Kg* 3ts 163*6 est* B.P. 120
Skin* S4U Bo bruising, aeno or oede?ss
"k> hirsutlsa ©r auecls weakness.
Obesity* «rked* General,
trtae* tm m thighs and axillae. Red.




siood picture 1 Hb. 98%, PC? Ujt, mm %%, ycc 7700, Biff* f; to,
L 27*, K 8*, SS IS, platelets 250,000
..electrolytes in blood* % IX «e*|A» I 4.*3 aeqA*
ICC3 2&.S MqA* SB 27 ag.AOO al*
Ca 10.4 ag./XOO ad, FO^ 3.3 «K»/1C0 UU
Bill. 0,6 iag,/XGG si* OFT lees than 20 unite/isl.
ivlk* Phos. 9 &4> uait/LOO al, T.T. 1 unit.
G.T.T.t P 70 sif»/100 «1, hr 76 »g*A00 «l, 1 hr. 76 ug«A®0 sal,
l£ hr 76 ag.AOC »1, 2 hr 78 eg.AOO el, 2* hr 53 eg.ACO el,
3 hr 53 eg,A00 el.
Cr.ci 123 mi/-sis,
d. Pollcw-upi patient use put on a reducing diet cad kept under observation.
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Case Mo. 30 H.L. 3ex« F Age I 31 yrs.
a. Symptomsi gradual increase in weight. /ague sensations of aches and
dizziness. Thirst, polyuria and depression. Duration 1 year.
b, examination» *ift» 58,2 Kg, Ht: 160 cm. B.F. 160
94
Skint rather dry. No acne, bruising or oedema. No hirsutism.
Obesity t slight. General,
Striae: nil.
Face: normal.
Mo muscle weakness. Normal genitalia,
c• Investigations:
EGG ?RBBB (Right bundle branch block)
X-ray chest: NAD X-ray skeletont NAD
Elood picture: Hb. 89%, PCV 42%, MGHG 31.5%, WCC 7000, Diff. N
L 30%, K 3%, 2 2%, platelets 150,000.
Electrolytes in blood: Ma 13S meq/1, K 4.3 meq/l,
HCO^ 23 meq/l, BD 32 rag./lOC ml.
Ca 10.4 mg./lOO ml, FO. 3.1 mg./100 ml.4
Bill, 0.3 mg./lOO ml. GFT less than 20 units/ml.
Alk.Phos. 5 K-A units/100 ml. T.T. 6 units.
G.T.T.: F 82 mg./lOO ml, i hr 114 ng./lDO al, 1 hr 100 mg./lOO ml,
l£ hr. 92 mg./lOG ml, 2 hr 84 mg./iOQ ml.
Gr.cl 109 ml./min
d. Follow-up: patient was put on a reducing diet and kept under observation.
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Case Wo. 31 A.I, Sex! F Agei 24 yrs.
a, Symptomst increase in weight of 3 years duration. Lethargy, bouts of
depression and irritability and irregularities of menstruation of 7 months
duration. There was a family history of obesity.
b, Examination! Wti 97 Kg. Hti 160 cm. B.P. 110
80
Skini soft No acne, bruising or oedema.
No hirsutism or muscle weakness. Normal genitalia.
Obesity: marked. Mainly on chest and abdomen.




X-ray chests NAD X-ray skeletons NAD
Blood picture! Hb. 92%, PCV 43%, MCHC 31.5%, WCC 7400, Diff. N 41%,
L 53%, M 3%, E 3%, platelets 270,000.
Electrolytes in bloodi Na 136 raeq/l, K 4*5 meq/l,
IKO 24»9 meq/l, BU 29 mg./lOO ml.
3
Ca 9.5 mg.A00 ®1, PO^ 4»0 mg.A^O
Bili, 0.5 mg./lOO ml, GPT less than 20 units/ml.
Alk.Phos. 5 K—A units/100 ml, T.T. 2 units.
G.T.T, i F 92 mg./lOO ml, £ hr 140 mg./lOO ml, 1 hr 140 mg./lOO ml,
1-J- hrs 120 rag./lOO ml, 2 hrs 124 mg.A00
Cr.cl, 142 ml/min.
d. Follow-up! patient was put on a reducing diet and was kept under
observation.
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Case No. 32 C.R. Sex: F Age: 20 yrs.
a. Symptoms: increase of weight (38 Kg.) and amenorrhoea of 14 months duration.
Low back pain and blackouts of 6 months duration. Irregularity of
menstruation since menarche.
b. Examination: Wti 95.9 Kg. Ht: 151.1 era. B.P. 160
98
Skin: NAD No acne, bruising or oedema.
No hirsutism.
Obesity: marked. General but mainly on trunk.
Striae: present on axillae, thighs and abdomen. Reddish.




X-ray chest: NAD X-ray skeleton: NAD
Blood picture: Hb. 91$, PCV 42$, MCHC 32%, WCC 6800, Diff, N 64$,
L 34$» M 3%, platelets 350,000.
Electrolytes in blood: Na 142 meq/L, K 3.9 meq/1,
HCO. 27.3 meq/1, BU 20 mg./lOO ml.
J
Ca 11.5 mg./lOO ml, PO. 3.6 mg./lOO ml.
4
Bill, 0.2 mg./lOO ml. GPT less than 20 units/ml.
Alk.Phos. 80 K-A units/100 ml, T.T, 1 unit.
G.I.T.: F 74 mg./lOO ml, hr 152 mg./lOO ml, 1 hr 150 mg./lOO ml,
hrs 98 mg./lOO ml, 2 hrs 68 mg./lOO ml, 2& hrs 76 rag./lQO ml.
Cr.cl. 109 ml/rain.
d. Follow-up: Patient was put on a reducing diet and kept under observation.
Case No. 33 M.S. Sex: F Age: H
a. Symptoms: obesity since she was infant. Recent increase in obesity and
irregular menstruation. There was a family history of obesity.
b. Examination: Vft: 92.9 Kg. Ht: 162.5 cm. B.P. ISO
90
Skin: NAD No bruising, oedema or acne.
No hirsutism or muscle weakness.
Obesity: marked. General.
Striae: present on abdomen and axillae. Pink,
Face: round and slightly plethoric.
Normal genitalia,
c• Investigations:
X-ray chest* NAD X-ray skeleton: NAD
Blood picture: Hb. 85$, PCV 39%, MCHC 32.5%, WCC 4200,
Diff. N 54%, L 32%, M 11%, E 2%, B 1%, platelets 185,000.
Electrolytes in blood* Na 136 meq/l, K 3.9 meq/l,
HDO^ 26 meq/L, BU 29 mg,/l00 ml.
Ca 10.6 mg./lOO ml, FO. 4*0 mg./lOO ml.4
Bili. 0.2 mg./lOO ml, GPT less than 20 units/ml.
Alk.Phos. 13 K-A units/100 ml. T.T. 1 unit,
G.T.T.: F 112 mg./lOO ml, £ hr 160 mg./lOO ml, 1 hr 124 mg,/100 ml,
li|- hrs 132 mg./lOO ml, 2 hrs 102 mg./lOO ml, 2% hrs 102 mg./lOO ml,
3 hrs 100 mg./lOO ml.
Cr.cl 170 ml/mln.

















































Corticosterone, Reichstein's compound H (see below)
Cortisone, Reichstein's Compound Fa (see below)





















































C-19 adrenocortical steroids with a ketone group
at C-17
17-ketogenic steroids (17-oxogenic steroids, 17-OGS)
C-21 adrenocortical steroids with a 17a-hydroxyl
group so that the C-17 side-chain may be






















ACTH Adrenocorticotrophic hormone, corticotrophin
Alk.Phoe. Alkaline phosphatase
Bili. Bilirubin







cpm counts per minute
CRF Corticotrophin-releasing factor (s)
ODD l,l,-dichloro-2,2,bis (p-chlorophenyl)-ethane
Qiff. Differential white cell count




Glucuronic acid Glucosiduronic acid
























































3- (chloro-3-methy1-2-lndeny1 )-pyr idine
3- (1»2,3,4-—te tx"aiiydro-l-oxo-2-naphthyl)-pyr idino








(according to height and frame)*
Height Weight in pounds (in indoor clothing)
(in shoes)
1 inch heel for men
2 inch heel for women Small frame Medium frame Large frame
MSN
5' 2" 112-120 118-129 126-141
r 115-123 121-133 I29-I44
A" 118-126 124-136 132-148
5" 121-129 127-139 135-156
6" 124-133 130-143 138-156
y» 128-137 134-147 142-161
8M 132-141 138-152 147-166
9" 136-145 142-156 151-170
10" 140-150 146-160 155-174
11" 144-154 150-165 159-179
6' 0" 148-156 154-170 164-184
1" 152-162 158-175 168-189
2" 156-167 162-180 173-194
3« 160-171 167-185 178-199
An 164-175 172-190 182-204
WOMEN
4' 10" 92-98 96-107 104-119
11" 94-101 98-110 106-122
5' 0" 96-104 101-113 109-125
1" 99-107 104-116 112-128
2" 102-110 107-119 115-131
3" 105-113 110-122 118-134
A" 108-116 113-126 121-138
5" 111-119 116-130 125-142
6" 114-123 120-135 129-146
7" 118-127 124-139 133-150
8" 122-131 128-143 137-154
9" 126-135 132-147 141-158
10" 130-140 136-151 145-163
11" 134-144 I4O-I55 149-168
6' 0" 138-148 144-159 153-173
♦firepared by the Metropolitan Life Insurance Company. Derived primarily from





1. A choice of one of the following items*
(a) Che egg
(b) Che rasher bacon grilled crisp and drained of fat
(c) 3 oz. white fish
(d) 3 oz, finnan haddock with a little milk (no added fat)
2. A choice of
(a) 1^- oz. bread (may be toasted)
(b) 3 squares of ryvita
3. Tea or coffee without sugar
U, Milk and butter from daily allowances (see below)
A choice of one of the following items*
(a) Cup of tea with milk (from daily allowance)
(b) Cup of bovrll
(c) Cup of marmite
Lunch
1» Clear soup
2. A choice of one of the following items (no added fat in cooking)
(a) 1^- oz. lean red meat
(b) " " chicken
(c) " " cold tongue
(d) n " lean ham
(e) 2 oz# fish
(f) " " tripe
(g) " " liver
3. large helping of tomato, salad or any vegatable (except peas, beans
and potatoes)
U, A piece of fresh fruit (may be stewed in water without sugar)
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Tea
X, A choice of one of the following:
(a) l£ oz. bread
(b) 3 squares ryvita
(c) 3 rich tea biscuits
2, Tea with milk (from daily allowance) no added sugar
3. Butter from daily allowance
Supper
1* A choice of either
(a) l£ oz. meat (as at lunch, item 2)
(b) One egg and •§■ oz. cheese
2. Tomato, salad or any vegetables (as at lunch, item 3)
3. A choice of one of the following:
(a) l£ oz. bread
(b) 3 water biscuits
(c) 2^ oz, plain boiled potatoes
4. Helping of fruit (as at lunch)
5. Tea or coffee (milk and butter from allowance)
Daily allowance of milk : 1/4 pt.
Daily allowance of butter: 3/4 oz.
N.B. 1, No fat to be used in cooking (unless from daily allowance)*
2. dweeta, chocolate or sugar are not allowed,
3. The use of salad dressing, or oil in salad, is not allowed.
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Summary
1. The literature concerning human adrenal cortex and its hormones and the
methods of assessing adrenocortical function has been reviewed, and an account
is given of the clinical conditions, Gushing's syndrome and obesity.
2. Classification of subjects, when attempting to differentiate obesity from
Gushing's syndrome, has been performed for the first time as part of this
study. The subjects were classified into normal, Gushing's,obese and
•Gushingoid' groups.
3. The methods used in this research includedt (a) estimations of Cortisol
production rate, by the blood and urine techniques, using isotopically labelled
Cortisol, (b) estimations of urinary 17-ketosteroid excretion, (c) estimations
of urinary total 17-ketogenic steroid excretion, (d; adrenocortical stimulation
tests using A.CTH and (e) pituitary—adrenocortical suppression test using
dexamethasone.
A new technique for the simultaneous estimation of Cortisol production
rate, plasma Cortisol and plasma-protein binding of Cortisol has been
developed and an in vivo modification of this technique has been devised and
described.
A. Cortisol production rate estimations by the blood method provided the
best sensitive test for assessing adrenocortical function. Ranges for the
normal group under control conditions and after AGTH stimulation have been
established (17.5 - 31.2 mg./2A hrs. and 216 - 268 mg./2A hrs. respectively).
The dosage of ACTH used in this research (60 I.U. intramuscularly every
12 hrs. for 3 days) was higher than any dosage previously reported. Study of
the steroid excretion pattern proved that this dosage successfully established
maximum stimulation of the adrenal cortex.
All/
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All cases of Cushing's syndrome had higher-than-normal control levels
of Cortisol production rate and were hyper-responsive to ACTH stimulation.
All obese subjects, on the other hand, had normal control levels and
normal or lower-than-normal response to ACTH stimulation,
5, Cortisol production rates by the urine method were the next most
sensitive test for the assessment of adrenocortical function, but estimations
of urinary steroid excretion, especially 17-ketosteroids, were less sensitive,
and this was particularly noticeable after ACTH stimulation.
Discrepancies between the results of the various tests was noticed. It
was concluded that the discrepancies between the blood and urine methods of
Cortisol production rate were due to the diurnal variation of adrenocortical
activity in the control estimations, and to the possible role of a second
compartment after ACTH stimulation. The discrepancies between the Cortisol
production rate tests on the one hand and the urinary steroid excretion on the
other, especially after ACTH stimulation, were thought to be due to the small
percentage of Cortisol metabolised as steroids extraitable by the latter
methods.
6, Dexamethasone suppression was marked in obese and 'Cuahingoid' subjects
and in two patients with Cushing's syndrome but was less marked in one case
of Cushing's syndrome.
7, Taking the normal individuals and the patients with Cushing's syndrome
as the two "reference groups'*, it was possible to re-classify the patients of
the •Cushingoid' group according to the results of the various tests performed.
One patient was re-classified as having Cushing's syndrome, five patients were
re-classified into the obese group and two remained in the 'Cushingoid' group,
Therefore/
Therefore this group was reduced from eight to two patients. The
significance of this latter group is discussed.
8. Ranges for the plasma Cortisol and plasma non-protein-bound Cortisol were
established in the normal group (9.7 - 15*9 pg./lOO ml. and 1,0 - 2.59 pg.AOO ml*
respectively). A case of Cushing's syndrome gave higher values, but the
obese subjects gave values comparable to the normal subjects.
9. Cortisol production rate tests were applied to assess the success of the
operation of bilateral adrenalectomy with auto-transplantation of a part of
one adrenal into the rectus sheath of the anterior abdominal wall as a means
of treatment of Gushing's syndrome without post-operative substitution therapy,
encouraging results were obtained in one of three cases. The significance of
these results are discussed.
10. No correlation was found between adrenocortical function on the one hand
and total body weight, height, surface area, total body lean cell mass, total
body fat or body musculature on the other. When, however, the subjects who
had 30 Kg. of fat or less, or whose fat was 35% of the total body weight or
less, were considered separately, a correlation was found to exist between
adrenocortical function and total body fat. This suggests that obesity constitutes
a mechanic 1 stress to which the adrenal cortex reacts by increasing its
secretion of Cortisol up to a limit; beyond this limit the adrenal cortex can
no xonger cope with the extra stress provided by the increased amount of fat.
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